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THE EFFECTS OF GUIDED WRITTEN DISCLOSURE ON DISTRESS AND 
QUALITY OF LIFE IN WOMEN WITH OVARIAN CANCER AND THEIR 
PARTNERS 
 
By Emily J. Arden Close 
 
High levels of distress are often reported among women with ovarian cancer, 
and among spouses of cancer patients.  However, very few interventions have been 
tested on women with ovarian cancer, and those that are available rarely involve 
partners.  Recent evidence suggests that writing for 15 minutes a day over three days is 
effective in improving physical and psychological health across a variety of illnesses, 
and may benefit cancer patients.  However, very few studies have tested the 
effectiveness of guided writing. The aim of this thesis was to test the effectiveness of 
writing about the patient’s diagnosis and treatment of ovarian cancer according to a 
structured protocol (the GDP) on reducing distress and improving quality of life in 
women with ovarian cancer and their partners.  A second aim was to test two theories 
that may account for the beneficial effects of written disclosure, the cognitive 
processing hypothesis and the social interaction hypothesis.   
Two studies and a systematic review were completed.  A pilot study used an 
AAB design to test the efficacy of the GDP plus stress management in 27 women with 
ovarian cancer.  The intervention led to reductions in perceived stress and intrusive 
thoughts at one month follow up, which were related to word usage.  A randomized 
controlled trial comparing the GDP to control writing (about what the patient did the 
previous day), demonstrated no main effects on any of the outcomes, except an increase 
in intrusive thoughts for partners.  However, certain moderators and moderated 
mediators of the intervention were identified.  Patients in the GDP group had improved 
quality of life if they improved in illness related couple communication, and if their 
partners had higher levels of intrusive thoughts at baseline.  Within the GDP group, use 
of positive emotion words was related to improvements in illness related couple 
communication for patients and partners.   
Overall, these findings suggest that the GDP was not effective at improving 
quality of life or reducing perceived stress in partners of ovarian cancer patients, nor for 
the majority of patients.  However, there was tentative evidence that it may benefit 
patients in certain circumstances.  Possible mechanisms of improvement include 
changes in communication (in line with the social interaction hypothesis), and increased 
benefit finding   Further research is needed to determine whether writing about positive 
events is associated with improvements in health, whether patients benefit from 
interventions to improve illness related couple communication, and for whom the GDP 
may be effective. 
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Chapter 1: Introduction to the thesis 
1.1 Thesis Outline 
 
The current research was designed to test the efficacy of guided written 
emotional disclosure in reducing perceived stress and improving quality of life in 
women with ovarian cancer and their partners.  It starts by describing biological, 
epidemiological, diagnostic, treatment and prognostic factors in ovarian cancer.  From 
this it can been seen that ovarian cancer is often diagnosed at an advanced stage, which 
means that treatment is aggressive, the prognosis is poor, and risk of recurrence is high.  
In addition, there is preliminary evidence that psychiatric morbidity is associated with 
worse survival.  Not surprisingly, research has shown that ovarian cancer patients often 
experience significant levels of distress.  However, since this is not uniform, it is 
important to identify demographic, illness related and psychological correlates of 
psychosocial adjustment.  Identification of demographic and illness related correlates of 
distress enhances the accuracy of judgements about whom to target when designing 
psychological interventions.  Identification of psychological factors enables the design 
of hypothesis based interventions to target those factors.  The following chapter is a 
systematic review on correlates of psychological distress and quality of life in ovarian 
cancer, in which study quality is assessed, in order to draw more definite conclusions 
about the evidence available.  In addition, several studies that did not meet the strict 
inclusion criteria for the systematic review but were considered highly relevant to the 
thesis are discussed, in order to assess the influence of coping strategies on adjustment, 
and the psychological interventions for patients with gynaecological cancer that have 
been carried out to date. 
Evidence also suggests that not only are individual differences important when 
understanding cancer related distress, but that partner and couple related factors are also 
important influences on adjustment to a cancer diagnosis.  Chapter 3 is a literature 
review on cancer in the context of marriage.  It addresses the prevalence of 
psychological distress and correlates of psychological adjustment in partners of cancer 
patients, the influence of partners’ distress on patients’ adjustment to cancer, and the 
relation between couple communication and adjustment in both members of the couple.  
Psychological interventions for couples in which the woman has cancer are discussed 
and evaluated, in order to assess the strengths and limitations of interventions that have  
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been carried out to date.  Finally, methodological factors to be taken into account when 
conducting research on couples in which one partner has cancer are examined in detail.   
Couples in which one partner has cancer experience significant demands on their 
time and ovarian cancer patients are often too ill to travel to participate in interventions.  
Thus, brief interventions involving little contact with the health services may be 
appropriate for them.  One such intervention that has been shown to be effective in 
improving physical and psychological health in a number of populations is written 
emotional disclosure of traumatic events for 15 minutes a day over three days.  
However, many such interventions have been unstructured, whereas evidence from 
theory regarding cognitive processing of trauma suggests that guided writing 
interventions may be more effective.  In addition, the effectiveness of guided writing 
has been tested in very few studies.  Chapter 4 reviews the literature on written 
disclosure studies.  The basic paradigm and the rationale behind the written disclosure 
intervention are explained and evidence for its effectiveness is presented.  The Guided 
Disclosure Protocol (GDP), which will be used in this thesis, is described, with an 
explanation of its rationale, and evidence for its effectiveness.  Written disclosure 
studies on populations with chronic illness, with a focus on studies involving cancer 
patients, and studies using written disclosure in the context of relationships are 
discussed, in order to provide a reasoned argument for why written disclosure would be 
effective for couples where one partner has ovarian cancer.   
Theoretically, it is important to understand why written disclosure may be 
beneficial for health.  Therefore, in Chapter 4, several theories developed to explain this 
are discussed, including the emotional inhibition hypothesis, exposure/emotional 
processing theory, the cognitive processing hypothesis and the social interaction 
hypothesis.  Previous studies have assessed single theories in isolation, although recent 
research recommends that multiple models are assessed simultaneously.  Since the GDP 
was developed based on research regarding cognitive processing of trauma, it was 
deemed appropriate to test the cognitive processing hypothesis, by assessing intrusive 
thoughts and use of insight, causality and emotion words when writing.  Also, since the 
intervention involved patients and their partners, it was decided to test the social 
interaction hypothesis, which holds that writing about a traumatic event changes the 
way in which people interact with others, by assessing marital communication. Finally, 
methodological issues are discussed, to provide justification for the specific 
methodology regarding the intervention used in this thesis.   
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The feasibility and effectiveness of the GDP in conjunction with 30 minutes of 
stress management over the telephone in reducing distress and improving quality of life 
in women with ovarian cancer is tested in a pilot study which utilizes an AAB design.  
The main study, a randomized controlled trial, assesses the efficacy of the GDP 
compared to control writing on reducing perceived stress and improving quality of life 
in women with ovarian cancer and their partners, at three and six month follow ups, and 
identifies predictors, mediators and moderators of improvement.  Involving partners 
serves two purposes: first, it enables a test of whether involving partners in a writing 
intervention is beneficial for both the patients and their partners, and second, it provides 
an opportunity to test the social interaction hypothesis.  The hypotheses are discussed in 
more detail in Chapter 6. 
In  the  final  chapter,  the  results  of  the  pilot  study  and  the  main  study  are 
discussed and compared with regards to their strengths and limitations.  Theoretical and 
clinical  implications  of  the  research  are  also  discussed,  to  describe  the  unique 
contribution it has made to the fields of health psychology and psycho oncology. 
 
1.2 Medical aspects of ovarian cancer 
 
Cancer can be defined as any malignant growth or tumour caused by 
uncontrolled cell division.  Ovarian cancer can be defined as cancer of the ovary.  This 
section provides background medical information about ovarian cancer.  The biology, 
epidemiology, risk factors, diagnosis, treatment and prognostic factors are discussed. 
Ovarian cancer is the most common gynaecological cancer in UK women.  
There are over 6600 new cases per year (Office for National Statistics, 2007), and over 
4400 deaths (Office for National Statistics, 2006).  The five year survival rate in the UK 
was 29% for women diagnosed with ovarian cancer between 1991 and 1993 (Office for 
National Statistics, 2008).  Although survival is over 70% if patients are diagnosed with 
early stage disease, only 20% of patients are diagnosed at early stages.  The rate of 
survival for metastatic disease is 15%, and one third of patients are diagnosed with 
distant metastases (Engel et al., 2002) since most patients are asymptomatic until the 
disease has metastasized (Pan, Ugnat, Mao, Wen, & Johnson, 2004).  Even when 
symptoms are present, they are generally non specific, including abdominal bloating, 
increased urinary frequency, and diarrhoea. Hence, they may be misdiagnosed as other 
conditions.  Ovarian cancer is the leading cause of death from gynaecologic 
malignancies.  During the last 20 years, survival time has been prolonged, mainly for  
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patients diagnosed with early stage disease, but there has been no improvement in the 
cure rate (Engel et al., 2002).  However, the rate of survival is higher in younger 
women, reflecting the fact that they are more likely to be diagnosed with early stage 
disease (Engel et al., 2002). 
1.3 Epidemiology 
 
Ovarian cancer is predominantly a disease of perimenopausal and 
postmenopausal women   85% of cases are diagnosed in women over 50 (Office for 
National Statistics, 2007).  Onset is very low in the under 40s, and rises through the fifth 
decade.  However, the rate of increase slows down after 50 years.  Incidence is most 
common in the 55 to 59 age group, with the median age at diagnosis being 61 years 
(Barber, 1993). Incidence is highest in western industrialized countries and lowest in 
Japan and developing countries (Coleman, Esteve, Damiecki, Arslan, & Renard, 1993).  
The majority of ovarian cancers are sporadic – only about 5 10% are familial. 
Epithelial ovarian tumours, which account for 90 95% of ovarian tumours, arise 
from the germinal epithelium on the surface of the ovary.  This forms invaginations into 
the ovarian stroma during adulthood, which are the earliest developmental stage of 
serous tumours.  Epithelial tumours generally arise where the surface epithelium has 
penetrated into underlying stroma, forming cysts.   
Several theories have been developed regarding the aetiology of ovarian cancer.  
Fathalla (1971) hypothesised that incessant ovulation, which involves repetitive 
disruption and repair of the ovarian surface epithelium, may lead to increased likelihood 
of spontaneous mutations and thereby increase the risk of ovarian cancer. According to 
this theory, risk decreases with increasing number of births because pregnancy 
interrupts the tearing of ovarian cancer surface epithelium (OSE) with each ovulation.  
However, this model does not explain why infertility is associated with increased 
ovarian cancer risk. More recently, studies of ovaries removed prophylactically from 
high risk patients have shown a wide variety of histologic changes, leading to the 
speculation that these changes are characteristic of a premalignant phenotype (Salazar et 
al., 1996).  In an attempt to suggest why the rate of increase in the incidence of ovarian 
cancer slows down after menopause, Pike, Pearce, & Wu (2004) hypothesised that (sex) 
hormones affect cancer incidence through their effect on mitotic rates in the stem cell 
compartment, partly by increasing the probability of a DNA damaging event being 
fixed as a mutation, partly by promoting such an effect.  Since the menopause reduces  
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mitosis (and sex hormones), it slows down the rates of spontaneous and 
environmentally induced mutations in the relevant stem cells.   
 
1.4 Risk Factors 
 
The most significant risk factor for ovarian cancer is a family history of the 
disease.  It is estimated that 5–10% of epithelial ovarian cancers are hereditary or 
familial.  The risk of ovarian cancer depends on the number of affected first  and 
second degree relatives, and their age at diagnosis with ovarian or breast cancer 
(Holschneider & Berek, 2000).  A mutation in the genes BRCA 1 and 2 is responsible 
for approximately 90% of familial ovarian cancers.   
Nulliparity has been consistently reported as a risk factor for ovarian cancer.  
However, after controlling for voluntary nulliparity, many studies suggest that infertility 
is a significant risk factor in ovarian cancer (Bristow & Karlan, 1996).  It has been 
suggested that the use of fertility drugs is a risk factor for ovarian cancer.  However, 
across a wide variety of studies, women who used fertility drugs and then became 
pregnant did not have an increased risk of ovarian cancer, whereas an increased risk has 
been reported in infertile women who received prolonged treatments with fertility drugs 
(Harris, Whittemore, & Itnyre, 1992; Rossing, Daling, Weiss, Moore, & Self, 1994).  
Based on these observations, it is plausible that, rather than fertility drugs being a cause 
of ovarian cancer, futile use of fertility drugs may be a marker of an underlying 
pathology leading to both ovarian cancer and refractory infertility.  
There are several important protective factors against ovarian cancer.  These 
include parity, with each delivery conferring a 16 22% risk reduction, independent of 
the age of first pregnancy (Adami et al., 1994), lactation (Hankinson et al., 1995), and  
oral contraceptive use   the risk of ovarian cancer declines with increased usage and the 
protective effect appears to persist after discontinued use (Schlesselman, 1995). In 
contrast, large scale epidemiologic studies have demonstrated that hormone 
replacement therapy (HRT) is a risk factor for ovarian cancer (Salehi, Dunfield, 
Phillips, Krewski, & Vanderhyden, 2008).  
A variety of environmental factors have been investigated as risk factors for 
ovarian cancer, since the highest incidence occurs in industrialized countries.  The 
evidence is based on case control studies.  However, only limited conclusions can be 
drawn from these studies, since they are usually retrospective.  Where possible, the 
evidence given here is based on systematic reviews, to control for this.  Still, there are a  
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number of contradictory findings, which may be partly due to confounding factors.  
Factors associated with increased risk of ovarian cancer include cigarette smoking, with 
a particularly strong relationship for mucinous tumours (Pan et al., 2004), and high 
intake of animal fat (Zhang, Yang, Binns, & Lee, 2002).  Protective factors include 
increased physical activity (Zhang, Lee, & Binns, 2003), and increased consumption of 
fruits and vegetables (Zhang et al., 2002).  The evidence regarding the relation between 
body weight and ovarian cancer risk is inconclusive, with one review concluding that 
there is a direct, but weak association between increased BMI and ovarian cancer risk 
(Purdie et al., 2001), but another study demonstrating an inverse relationship between 
body mass index and ovarian cancer, such that increasing body weight may offer 
protection (Lukanova et al., 2002).  Research has suggested that talcum powder may 
increase the risk of ovarian cancer if it ascends the genital tract.  However, further 
studies are required to explore this relation (Muscat & Huncharek, 2008).  Tavani et al. 
(2004) found that a family history of ovarian cancer leads to moderate increase in risk 
when hormonal and lifestyle risk factors are low, but excess risk when they are high, 
pointing at synergism between risk factors.   
Finally, it is important to examine risk factors that are directly related to 
psychiatric morbidity.  An association has been demonstrated between self reported use 
of psychotropic medication for six months or longer and increased risk of ovarian 
cancer, primarily for medications that operate through dopaminergic systems (Harlow, 
Cramer, Baron, Titus Ernstoff, & Greenberg, 1998).  This evidence supported the 
hypothesis that psychotropic medications increase gonadotropin secretion.  However, no 
association was found in two more recent studies, one based on medical records 
(Dublin, Rossing, Heckbert, Goff, & Weiss, 2002) and one based on self reports 
(Moorman, Berchuck, Calingaert, Halabi, & Schildkraut, 2005).  Importantly, none of 
the studies found increased risk of ovarian cancer from selective serotonin reuptake 
inhibitors, which are currently the most commonly used class of antidepressants.  
Medicines that operate through dopaminergic mechanisms are not widely used 
nowadays. 
1.5 Diagnosis 
 
Ovarian cancer is usually diagnosed at an advanced stage (Stage III is most 
common) due to non specific symptoms or lack of symptoms.  Although ovarian cancer 
is often described as ‘the silent killer,’ previous studies have shown that 79 84% of 
women had symptoms prior to diagnosis (Chan, Ng, Lee, Ngan, & Wong, 2003).  These  
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symptoms included abdominal/pelvic pain, increased abdominal girth, change in bowel 
habits, urinary frequency/dysuria, a sense of abdominal pressure and decreased appetite.  
In Chan et al.’s study, only 10% of patients were asymptomatic prior to diagnosis, and 
the participants generally sought medical advice within 2 weeks of the onset of 
symptoms.  However, it can take up to a year after receiving medical advice for patients 
to receive a diagnosis.  Reasons for treatment delays attributable at least in part to the 
doctor include non investigation of symptoms, treatment for non cancer causes and lack 
of follow up (Evans, Ziebland, & McPherson, 2007).  Koldjeski, Kirkpatrick, Swanson, 
Everett, and Brown (2005), found that primary care was characterized by misdiagnosis 
and ineffective management, whereas specialist care was characterized by specialized 
examinations, tests and definitive diagnoses.  Based on communication with ovarian 
cancer patients, it is likely that these factors significantly impair the patient’s 
relationship with their GP, although this has not been researched scientifically.  This is 
particularly important with regard to patients in the UK, since under the National Health 
Service the GP is always the first point of contact. 
Routine pelvic examination can detect asymptomatic ovarian cancer.  However, 
this is rare – examination of only one in 10,000 women will reveal an ovarian cancer, 
because the majority of palpable adnexal masses in premenopausal women are not 
malignant (Whittemore et al., 1989).    
Radiologic imaging can be very useful if the patient has an adnexal mass or 
symptoms of ovarian cancer.  Abdominal ultrasound can provide information on 
characteristics of a mass which are suggestive of a malignancy, such as bilateral ovarian 
involvement, irregular borders, presence of solid components with papillary projections, 
multiple dense irregular septae, and the presence of ascites and involvement of other 
organs (Dershaw & Panicek, 1993).  Transvaginal sonography is commonly used both 
in screening and to evaluate adnexal masses (van Nagell, DePriest, Gallion, & Pavlik, 
1993).  Computed tomography (CT) scans are frequently used in the diagnosis or 
preoperative evaluation of ovarian cancer.  They can be useful in identifying liver or 
lung nodules, and are used in routine follow up appointments to monitor pelvic and 
abdominal masses for response to therapy (Bragg & Hricak, 1993).   
Tumour markers have been investigated in the detection and treatment of a 
variety of cancers, as they have the potential to contribute to screening, diagnosis and 
progress, and provide a means of monitoring response to treatment and indicating 
relapse during follow up (Meyer & Rustin, 2000) with relatively simple and 
inexpensive tests. With regard to the diagnosis and treatment of epithelial ovarian  
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cancer, evidence has shown CA 125 to be the most useful marker currently available.  
Bast et al. (1983) developed an assay to detect serum levels of CA 125.  The initial 
results of this assay found that only 1% of 888 healthy individuals and 6% of 143 
individuals with benign diseases had levels of CA 125 above 35U/ml, compared to 82% 
of 101 ovarian cancer patients.  Further, among 38 individuals with ovarian cancer 
monitored on 2 18 occasions over a period of 2 60 months, rising or falling levels of 
CA 125 correlated with progression or regression of disease in 93% of instances.  
However, when there is only minimal disease present, serum antigen levels are 
frequently undetectable.   
 
1.6 Treatment 
 
There are a wide variety of factors involved in considering the approach taken in 
treatment of ovarian cancer, and it is important to involve the patient in the decision 
making process (Stewart et al., 2000).  The majority of ovarian cancer patients are aged 
between 40 and 60, and require aggressive treatment, which usually consists of 
cytoreductive surgery, followed by combination chemotherapy.  Originally, a staging 
laparotomy is performed to diagnose the malignancy and determine the extent of 
disease.  To determine the volume and distribution of disease, the peritoneal surfaces of 
the abdominal cavity are explored systematically.  Cytoreductive surgery then aims to 
remove as much of the tumour as possible without undue surgical morbidity, and is 
important because, firstly, it can result in mechanical and metabolic improvements in 
the patient, and secondly, it can convert a patient from a poor prognostic group to a 
more favourable one.   
With regard to chemotherapy, the NICE guidelines (National Institue of Clinical 
Excellence, 2003) recommend a choice of either paclitaxel in combination with a 
platinum therapy (cisplatin or carboplatin), or platinum drugs alone as standard initial 
therapy.  The standard treatment in the UK is 6 cycles of therapy – more than that is 
associated with an increase in toxicity experienced, and does not significantly improve 
median survival (Hakes et al., 1992).  However, if the patient is older and has medical 
problems, or if cytoreductive surgery is not possible, then treatment may be aimed at 
palliation of symptoms.  Evidence suggests that adding paclitaxel to standard platinum 
based chemotherapy prolongs life by a median time of 10 11.5 months.  Addition of 
paclitaxel is associated with a greater occurrence of side effects, but research has 
documented quality of life to be comparable to that associated with use of platinum  
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based chemotherapy alone.  For a recurrence of ovarian cancer the NICE guidelines 
(National Institue of Clinical Excellence, 2005) recommend drug treatment with a 
combination of paclitaxel (Taxol) and a platinum drug if the cancer comes back more 
than a year after treatment, a choice of either Taxol and a platinum drug or Liposomal 
doxorubicin (Caelyx or Doxil) if the cancer comes back within 6 12 months, or a choice 
of Taxol, Liposomal doxorubicin or Topotecan (Hycamtin) for platinum refractory (the 
cancer coming back within 6 months) or platinum resistant cancer.    
    
1.7 Prognostic Factors 
 
One of the most important prognostic factors in ovarian cancer is disease stage 
at diagnosis – a large scale US study based on the National Cancer Institute’s 
Surveillance, Epidemiology and End Results reported the following five year survival 
rates: Stage I (93%), Stage II (70%), Stage III (37%) and Stage IV (25%) (American 
Joint Committee on Cancer, 1997).  Staging is based on surgical pathological findings, 
following exploratory laparotomy, peritoneal washings, total abdominal hysterectomy, 
bilateral salpingo oophorectomy, omentectomy, multiple peritoneal biopsies, and pelvic 
and para aortic lymph node staging.  In 1971, the International Federation of 
Gynecology and Obstetrics developed the first classification system for staging ovarian 
cancer.  This is commonly used by gynaecologic oncologists worldwide and regularly 
updated in the light of new information.  According to this system, Stage I disease is 
defined as the tumour being limited to the ovaries, Stage II is defined as the tumour 
involving one or both ovaries with pelvic extension, Stage III is defined as the tumour 
involving one or both ovaries with microscopically confirmed peritoneal metastasis 
outside the pelvis and/ or regional lymph node metastases, and Stage IV is defined as 
there being distant metastasis. 
In advanced ovarian cancer, the size of the remaining tumour at the end of the 
operation is the most important prognostic indicator   remaining tumours ≤ 1cm have 
been associated with a better prognosis (Hoskins, 1993).  Eisenkop, Friedman, and 
Wang (1998) in a study of women with Stage IIIc and Stage IV ovarian cancer reported 
a significant effect of completeness of the cytoreductive operation on the probability of 
five year survival. 
Following initial treatment, CA 125 has been found to correlate with disease 
stage and amount of residual disease.  In 93% of the patients originally studied, CA 125 
correlated well with disease progression or recurrence.  Sensitivity for detecting non  
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mucinous ovarian cancers after treatment was found to be 88% (Meyer & Rustin, 2000).  
If CA 125 has fallen to normal within three months of chemotherapy, second look 
surgery is likely to be negative, whereas if it takes longer than three months to fall to 
normal range, residual disease is generally found at second look laparotomy.  To 
illustrate this, Fayers et al. (1993), who used values of CA 125 before the third course of 
treatment, with a cut off of 70 U/ml, found that 57% of participants in their study with 
levels above this were correctly predicted to show cancer progression or die within 12 
months, whereas 80% with a level below this were alive and progression free.  More 
recently, Markman, Federico, Liu, Hannigan, & Alberts (2006) found that 
concentrations of CA 125 eight weeks after initiation of chemotherapy was an 
independent prognostic factor in patients with suboptimal residual Stage III and Stage 
IV ovarian cancer, with median survival being 26 months for those with a CA 125 < 35 
U/ml but 15 months for those with CA 125 > 35 U/ml. 
CA 125 is one of the only serological markers with such strong prognostic 
importance.  Certainly, many ovarian cancer patients take it very seriously   Parker et al. 
(2006) found that in patients with lower levels of knowledge about ovarian cancer, 
greater preoccupation about CA 125 levels was associated with increased levels of 
depression; and that increased anxiety was associated with lower levels of knowledge 
about ovarian cancer, and higher levels of preoccupation with CA 125.  Recent research 
has shown significant relations between CA 125 levels and psychological factors.  de 
Moor et. al (2006) in a longitudinal study of women with ovarian cancer undergoing 
chemotherapy, found that optimism was negatively associated with CA 125 at follow 
up, and that dispositional optimism at baseline predicted CA 125 level at follow up, 
after controlling for baseline CA 125.  Based on this evidence, it was decided to assess 
CA 125 levels in the current research, to explore the impact of the intervention on a 
biological factor. 
Very few studies have assessed the prognostic importance of socio medical risk 
factors after diagnosis.  One study of 704 patients with ovarian cancer followed up for a 
mean of 6.2 years post chemotherapy found that psychic disorders were associated with 
a worse prognosis, as was higher parity (von Georgi, Schubert, Franke, & Munstedt, 
2002). This evidence suggests that it is important to develop psychological interventions 
for ovarian cancer patients, as they may improve survival.  However, psychological 
problems were assessed by GPs using a yes/no question, which means that the measure 
may have been influenced by GP characteristics.  Further research is required to explore 
this issue.  
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1.8 Summary  
 
The current section has addressed biological, epidemiological, diagnostic, 
treatment and prognostic factors in ovarian cancer, in order to provide a background and 
explain why ovarian cancer patients might experience high levels of distress.  Chapter 2 
is a systematic review that expands this information by identifying correlates of 
psychosocial adjustment in ovarian cancer.   
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Chapter Two: Correlates of psychological adjustment in ovarian Cancer: A systematic 
review 
 
In order to understand factors affecting psychological adjustment (defined as 
anxiety, depressive symptoms and quality of life) in ovarian cancer, a systematic review 
of the literature was carried out.  The rationale behind the review is explained, 
methodology is reported, quality assessment criteria are set out, and the results are 
reported.  Findings, limitations and implications for future research are discussed.  In 
addition, several relevant studies that did not meet the inclusion criteria for the 
systematic review are discussed and evaluated. 
 
2.1 Introduction 
 
A number of studies have found elevated levels of anxiety and depression in 
patients with ovarian cancer (Miller, Pittman, Case, & McQuellon, 2002; Norton et al., 
2004; Norton et al., 2005).  However, one longitudinal study found that 23% of patients 
experienced little or no distress (Kornblith et al., 1995).  Thus, the psychological 
sequelae of ovarian cancer are quite heterogeneous.  Identifying systematic and reliable 
research based risk factors of psychological distress and reduced quality of life could 
help to guide psychological support and/ or interventions to those who require them the 
most.   
This is a significant issue.  A study of 143 women diagnosed with ovarian 
cancer found that although 55% of participants had experienced some depressive 
symptoms, very few had been offered counselling (Norton et al., 2004).  Failure to 
participate in mental health services may be due to lack of availability and awareness 
rather than choice.  Gynaecological cancer survivors report positive attitudes to 
psychological services such as individual counselling, support groups and couple 
counselling, with over half saying that they would have used psychological services 
when they were diagnosed if such services had been available (Pistrang and Winchurst, 
1997; Wenzel et al., 2002).  Desire for such services is likely to be greater in patients 
experiencing increased levels of distress, as they desire more information about the 
psychological aspects of cancer and coping strategies (Stewart et al., 2000). Given this 
evidence, it is plausible to assume that psychological interventions may be well received 
by ovarian cancer patients, particularly those experiencing high levels of distress.    
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However, despite the increased prevalence of distress in ovarian cancer, very 
few psychological interventions have been developed for patients.  A search of the 
literature from 1980 – 2007 revealed only seven psychological intervention studies for 
patients with gynaecologic cancers (Cain, Kohorn, Quinlan, Latimer, & Schwartz, 1986; 
Capone, Westie, & Good, 1980; Chan et al., 2005; Manne et al., 2007b; Petersen & 
Quinlivan, 2002; Wenzel, Robinson, & Blake, 1995; Worden & Weisman, 1984).  
Furthermore, these studies found mixed results, possibly because they did not screen for 
levels of psychological distress.  To further this research, it is necessary to identify 
correlates of psychological distress and quality of life.  This will allow us to improve 
the screening for these interventions, guide their therapeutic contents and improve their 
efficacy, which has not been done until recently – a search of four major scientific 
databases revealed no studies assessing levels of psychological distress in ovarian 
cancer (and very few on other gynaecologic cancers) before 1995. 
  Research suggests that five main factors are associated with anxiety and 
depression following a diagnosis of cancer: demographics, degree of disease severity, 
optimism/ pessimism, stress response symptoms of avoidance and intrusive thoughts, 
and use of engagement and disengagement coping strategies (patient responses to the 
stress of their cancer diagnosis) (Epping Jordan et al., 1999).  The results and discussion 
will therefore be structured according to these five factors. 
   When assessing the literature, it is important to consider study quality, as this 
can vary widely.   Montazeri, Ewen, and McGillis (1996) in a review on quality of life 
in ovarian cancer based on 20 studies published between 1976 and 1994, noted several 
important issues related to study design.  First, the absence of a clear cut definition of 
quality of life led to uncertainties in theoretical and operational concepts.  Second, very 
few studies controlled for disease stage and other prognostic factors.  Third, many 
studies modified valid versions of psychometric instruments.  Fourth, many studies used 
small samples, with possible insufficient statistical power.  Fifth, some studies included 
patients with a variety of cancers, without presenting ovarian cancer results separately, 
meaning that inferences about ovarian cancer could not be made. Since many different 
measures were used, it was not possible to do a meta analysis. Overall, only limited 
conclusions could be drawn.   
However, study quality has been improving since the previous review.  For 
example, as quality of life is now routinely assessed in drug trials, there are a number of 
reliable and valid measures available.  Quality of life is now more routinely assessed 
using standardized measures, which break it down into physical, social, emotional and  
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functional well being.  Cella (1995) has defined health related quality of life as the 
extent to which one’s usual physical, emotional and social well being is affected by a 
medical condition and its treatment.  In addition, during the past decade, there has been 
a substantial increase in research assessing levels of psychological distress and factors 
affecting psychological adjustment in ovarian cancer.  Although Pearman (2003) carried 
out a review on quality of life and psychosocial adjustment in gynaecologic cancer 
survivors, several issues limit the conclusions that can be drawn from this review.  First, 
no specific period for the literature search was provided.  Second, the only database 
searched was Medline.  Third, gynaecologic cancer patients were not differentiated, 
although factors that may play a role in psychological adjustment can differ 
considerably, depending on diagnosis. For example, ovarian cancer generally has a 
worse prognosis than cervical and endometrial cancers, since it is more likely to be 
diagnosed at a later stage.  Fourth, studies were not quality assessed, and therefore the 
strength of evidence could not be assessed.  Furthermore, in recent years new articles on 
psychological distress and quality of life in ovarian cancer have been published. 
The purpose of this review was to assess correlates of psychological adjustment, 
conceptualized as levels of distress (anxiety and depression) and quality of life in 
ovarian cancer.  This review covered the period from January 1994 (to include any 
articles missed by Montazeri et al.’s review) to December 2007 (when the systematic 
review was conducted).  The studies were quality assessed, and divided into good, 
average and poor quality, in order to assess the strength of evidence. 
 
2.2 Method 
2.2.1 Search strategy 
I used four methods to locate relevant studies: a keyword search, a backward 
search, a manual search of relevant journals, and a manual conference program search.  
Using the keyword search method, I conducted a search of the databases Medline, 
PsycInfo and Embase for articles covering the period from January 1994 (to ensure I 
included any articles missed by the previous review, which had searched only Medline) 
to December 2007 (when the search was carried out) with the provision that any articles 
published in 1994 and included in the previous review were not included.  The search 
included the following terms: ovarian cancer, ovarian carcinoma, gynaecologic cancer, 
gynecologic cancer, psych$, depression, major depression, anxiety, anxiety disorders, 
quality of life, distress, coping, coping behaviour and stress.  After each term had been  
 
15 
entered into the keyword function, the cancer related terms were combined using the 
OR function, and so were the psychological terms.  A further search was then 
conducted, whereby the results of the previous searches were combined using the AND 
function.  This generated 1887 hits.  Since a search through the titles revealed that a 
number of the articles dealt with drug trials or genetic testing (not relevant to my 
research question), the cancer related terms were narrowed down using the NOT 
function.  Using the words NOT genetic NOT drug trial reduced the number of hits to 
1572.  Genetic testing was not of relevance, since this review aimed to identify 
corrrelates of psychosocial adjustment in women who had been diagnosed with ovarian 
cancer, not women who were at risk of developing the disease.  Drug trials were not of 
relevance, since I aimed to identify non chemotherapeutic correlates of psychosocial 
adjustment.  This search obtained 96 articles. 
     Following the keyword search, I carried out a backward search, in which I located 
papers by examining the reference lists of all papers obtained from the first step (as well 
as a recent non systematic literature review; Pearman, 2003).  This identified three 
further articles.  I then carried out a search of the journals Gynecologic Oncology (from 
which I had identified a number of articles) and Psycho-Oncology for the period 
January 1994 – November 2006.  This identified one further article.  Following this, I 
contacted the authors of unpublished dissertations, to enquire whether they had written 
any relevant articles based on their dissertation.  This method identified two 
unpublished manuscripts.  Overall, 100 published studies and two unpublished studies 
were identified and obtained. 
2.2.2 Inclusion and exclusion criteria 
Once the studies had all been identified and obtained, I examined the papers to 
determine eligibility for inclusion in the systematic review. To be included, studies had 
to meet the following criteria: 
1)  Either include ovarian cancer patients only, or present the results for ovarian 
cancer patients separately.  Thirty seven studies were excluded according to this 
criterion, either because they were concerned only with patients with cervical 
and endometrial cancer (five studies), or because ovarian cancer results were not 
presented separately (32 studies).   
2)  Be a quantitative study with standardized or validated measures of psychological 
distress and/ or quality of life.  Eleven studies with qualitative methods and one 
case study were excluded.  
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3)  Present new data not already reported in an earlier source.   Sixteen review 
articles were excluded according to this criterion. 
2.2.3 Coding procedure 
     The following information was extracted from each study: report information 
(authors, year of study, source of study), ovarian cancer sample size, age of participants, 
disease stage at diagnosis, time since diagnosis, measures used (including whether they 
were standardized), design and major findings.  
2.2.4 Ratings of study quality 
     A methodological quality assessment list was used to assess the studies.  This was 
devised based on reviewing existing quality assessment lists (Ariens, van Mechelen, 
Bongers, Bouter, & van der Waal, 2001; Gardner, 2003) extracting those criteria that 
were considered relevant, and devising further criteria based on consultation, to cover 
all stages of the article.  Since quality assessment was generic, the criteria could be 
applied to a variety of different types of study design.  These criteria are summarized in 
Table 1.  To reduce subjectivity in ratings, most criteria (10/12) could be assessed 
objectively with little interpretation. Each criterion was assessed out of 3 points. 
Assessment is elaborated on below. 
 
Table 1. Criteria for quality assessment  
  Item definition 
Rationale  Was there sufficient theoretical background to justify the study aims? 
Disease 
variables 
Was time since diagnosis reported? 
  Was disease stage reported? 
  Were background biomedical and demographic variables reported? 
Study design  Was the study cross sectional/ case control, prospective or a RCT? 
  Was the choice of design adequate for the research question 
Analysis and 
data 
presentation 
Were adequate statistical tests carried out (of sufficient complexity)? 
  Were the descriptive and inferential statistics presented adequately? 
  Was the sample size sufficient in relation to the number of independent 
variables (at least 10 times the number of IVs in the analysis)? 
Measures 
used 
Were reliable and valid measures used to assess quality of life and 
psychological distress? 
Discussion  Were the conclusions justified based on the design and research findings? 
  Were the limitations reported? 
 
2.2.4.1 Overall assessment 
The studies were assessed out of 36 points (3 given to each criterion).  Studies that 
scored 30 points or more were classified as good, those that scored 26 29 points were  
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classified as average, and those that scored 25 points or fewer were classified as poor.  
According to these criteria, 19 studies were classified as good, 15 studies were 
classified as average, and 5 studies (mainly published prior to 2000) were classified as 
poor. 
   When collating the findings, the strength of evidence for a relationship between 
demographic and other factors and psychological adjustment was assessed by defining 
four levels of evidence.  Levels of evidence were based on those set out by Ariens et al. 
(2001), and related to both quantity and quality, and are as follows.   
1. Strong evidence: Consistent findings across two or more good studies; 
2. Some evidence: Consistent findings across two or more studies, provided one is 
average; 
3. Inconclusive evidence: Consistent findings in multiple poor studies, inconsistent 
findings, or only one study is available, irrespective of quality. 
 
2.3 Results 
 
Overall, 38 studies carried out by 27 research groups were included in this 
systematic review.  The majority of the studies were carried out in the USA (18 studies) 
or Canada (5 studies).  Other studies were carried out in Australia (3 studies), Austria (2 
studies), Hong Kong (3 studies), China (2 studies), Germany (1 study), Italy (1 study), 
Norway (1 study), the Sudan (1 study) and the UK (1 study).  Twenty seven of the 
studies dealt with ovarian cancer patients only (4 of those studies focused on survivors), 
and 12 dealt with women with a variety of gynaecological cancers including ovarian 
cancer, for which the pertinent results could be interpreted. 
The quality assessment brought up a number of limitations with the studies.  
First, some medical studies failed to report disease stage at diagnosis.  Second, 
psychological studies were less likely to report biomedical variables, such as type of 
treatment, and medical studies were less likely to report other demographic variables, 
such as socioeconomic status (SES), and marital status.  Third, some studies that 
compared the prevalence of anxiety and depression in ovarian cancer patients to that of 
the general population did not have a control group. Related to this, some studies did 
not use appropriate control groups.   
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Table 2. Data extraction and quality assessment  
Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to 
assess QoL/ 
distress 
Findings  Quality 
Assessment score  
1  (Awadalla et 
al., 2007) 
CR  18/181  Not 
reported 
3.6 years 
 (SD=5.2) 
WHO QoL 
scale 
1)Higher QoL than general population, psychiatric and diabetic 
patients 
2) Higher QoL a/w being married, medium/ high skill occupation, 
at least high school education, duration of illness, feeling well, 
having radiotherapy 
3)No differences between cancers 
4) Being cared for by spouse a/w higher social QoL 
30 
disease stage; 
sample size 
2  (Bodurka 
Bevers et al., 
2000)  
 
CR  246  181: III/ 
IV  
65: I/II 
0.3 364 
(median 28.5) 
FACT O; 
CES D; 
STAI – state 
anxiety  
1) 21% depression scores > 16 – indicates clinical diagnosis 
2) Poor performance status a/w high depression, anxiety, low QoL 
3) Younger age a/w greater likelihood of depression, poorer 
physical, ovarian specific and overall QoL 
4) Active treatment a/w poorer emotional and functional wellbeing 
5) 30 months or more since diagnosis and evidence of disease a/w 
more ovarian cancer specific concerns 
6) Being divorced/ separated a/w better SWB 
30  
disease stage/ time 
since diagnosis, 
study design, 
limitations 
3  (Boscaglia, 
Clarke, 
Jobling, & 
Quinn, 2005) 
 
CR  100  60: I;  
11: II;  
28: III; 
1: IV 
Less than 1 
year (Mean 
22.21 weeks, 
SD=14.58) 
BDI for 
Primary 
Care; STAI 
– state 
anxiety 
1) 24% symptoms of depression, mean anxiety higher than general 
population 
2) Younger age, later stage of disease, more negative religious 
coping: a/w higher level of depression 
3) More negative spiritual coping a/w higher levels of anxiety 
30  
sample size, data, 
demographics 
 
4  (Canada et al., 
2006) 
 
CR   125  110: III/ 
IV 
Not reported  FACT O;   1) Age positively correlated with QoL 
2) Greater level of religion/ spirituality a/w greater use of active 
coping, better QoL 
3) Greater use of active coping a/w better overall QoL, social and 
functional well being 
4) Association between religion/ spirituality and functional well 
being, overall QoL mediated by active coping 
30 
intro, time since 
diagnosis, 
demographics, 
limitations  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to 
assess QoL/ 
distress 
Findings  Quality 
Assessment score  
5  (Capelli et al., 
2002)  
 
CR  48/ 115  Ovarian: 
38: III/IV, 
Overall: 
56 III/IV 
Not reported  SF 36 (QoL)  1) HRQoL scores lower for progressive/ recurrent disease than 
primary disease  
2) Ovarian cancer better QoL scores than cervical carcinoma 
3) Lower scores a/w older age 
4) Ovarian cancer:  lower physical functioning, physical role and 
emotional role 
26  
time since 
diagnosis, 
demographics, 
design, data, 
sample size, 
limitations 
6  (Chan, Ng, 
Ngan, & 
Wong, 2003)  
LN  17  All IIIc/ 
IV 
Newly 
diagnosed  
EORTC 
QLQ C30 
1) Overall QoL improved after chemotherapy and continued to 
improve until 6 months (but role and cognitive functioning 
declined at 3 months after chemotherapy) 
 
26  
intro, 
demographics, 
design, stats, data, 
sample size, 
conclusions 
7  (Chan et al., 
2005)  
RCT  39 
intervention 
(T), 
36 control 
(C) 
88: I  
18: II;  
40: III;  
9:  IV 
 
Newly 
diagnosed 
BDI; Beck 
Anxiety 
Inventory;  
1) No effect of the intervention  
2) Lower educational level a/w less anxiety 
3) No significant differences between ovarian cancer and other 
gynaecologic cancers in levels of anxiety / depression 
 
31  
intro, data, sample 
size, limitations 
 
8  (Costanzo et 
al., 2005)  
 
CR  61  45: III,  
16: IV 
Newly 
diagnosed  
FACT G; 
POMS SF; 
CES D;  
1) Elevated levels of distress 
2) History of depression a/w higher levels of IL 6 in ascitic fluid 
3) Poorer physical and functional well being and greater fatigue 
a/w higher levels of IL 6 in peripheral blood  
33 
demographics  
9  (de Moor et 
al., 2006)  
LN  90 
(completed 
follow up) 
8%:  I 
7%: II 
66%:  III, 
17%: IV 
Mean 2.60 
years 
(SD=3.11) 
PSS; STAI; 
CES D; 
FACT O; 
1) Optimism negatively a/w anxiety, stress and depression at 
baseline and follow up 
2) Optimism positively a/w QoL at baseline, dispositional 
optimism a/w social and functional well being at follow up 
3) CA 125 a/w anxiety at baseline but not follow up 
35  
10  (Ding, Zhu, & 
Zhang, 2007) 
LN  75 (61 at 
follow up) 
19%   I 
20%   II 
47%   III 
14%   IV 
Newly 
diagnosed 
FACT O 
 
1)All reported good QoL by T3 
2)Overall, physical, additional concerns – went up over time 
3) Predictors of QoL at T1 – economic status, extra family support 
4) Predictor at T2, T3 – intra family support 
33 
demographics, 
stats, sample size  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to 
assess QoL/ 
distress 
Findings  Quality 
Assessment score  
11  (Donovan, 
Greene, 
Shuster, 
Partridge, & 
Tucker, 2002)  
CR  151  
(81 initial 
cancer,  
70 recurrent) 
77%:  III/ 
IV 
Recently 
diagnosed, 
(being 
treated)/  being 
treated for 
recurrent 
ovarian cancer 
FACT O; 
POMS SF;  
 1) No differences in QoL, POMS or spirituality/ religion 
 2) Meaning and peace a/w QoL 
 3) Faith a/w QoL  in recurrent cancer 
 4) Those in highest quartile on FACIT Sp and SBI 15R had better 
QoL (no group differences) 
 5) Religious beliefs a/w QoL in recurrent cancer, support a/w 
quality of life in both groups 
28  
intro, time since 
diagnosis, 
demographics, 
stats, sample size, 
limitations 
12  (Ersek, 
Ferrell, 
Hassey Dow, 
& Melancon, 
1997)  
CR  152  Not 
reported 
Mean 59.8 
months 
(SD=69.9) 
QoL CS  1) Active disease a/w worse physical, psychological and social 
well being, and total quality of life 
2) Quality of life was moderately high 
22  
intro, disease stage, 
demographics, 
design, stats, data, 
questionnaire, 
conclusions, 
limitations 
13  (Ferrell et al., 
2005) 
CR  1347  12%:  I, 
10%: II 
64%: III 
11%: IV 
Mean 4.1 
years  
Range 0 22 
years 
QoL CS  1)87% had symptoms pre diagnosis 
2)Higher QoL if Stage II, married, employed, higher annual 
income, older, lower if active treatment 
4)Social QoL higher if higher annual income, employed 
29 
intro, 
questionnaire, 
conclusions, 
limitations 
14  (Gil, Gibbons, 
Jenison, 
Hopkins, & 
von 
Gruenigen, 
2007) 
CR  33/157  36%: I/II 
64%: 
III/IV 
 
Newly 
diagnosed 
SF 36; 
FACT G 
1)Physical and mental health , older age, educational  level – 
lower BMI a/w physical QoL 
2) Physical and mental health , lower BMI a/w functional QoL,  
3) Mental health, lower BMI, lower educational level a/w social 
QoL 
4) Physical and mental health, older age a/w emotional QoL 
27 
intro, disease 
stage,design, 
means & SDs, 
sample size, 
conclusions  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures used 
to assess QoL/ 
distress 
Findings  Quality 
Assessment score  
15  (Gioiella, 
Berkman, & 
Robinson, 
1998)  
CR  11/18  Not 
reported 
Not reported  FLIC   1) Older patients   higher spiritual well being, better QoL 
2) Married patients    higher level of spiritual well being, but 
lower QoL 
3) Catholic patients   higher levels of spiritual well being, QoL 
4) Ovarian cancer patients: lower QoL and spiritual well being 
22  
time since 
diagnosis, disease 
stage, 
demographics, 
stats, data, sample, 
conclusions, 
limitations 
16  (Greimel & 
Freidl, 2000) 
 
LN  33/98  79%: 
III/IV 
Newly 
diagnosed 
Psychological 
well being 
index 
(standardized);  
 1) Ovarian cancer had lowest psychological well being before 
surgery, but increased by 3 months 
2) Psychological well being improved significantly from T1 to 
T3 
3) Age had no influence on functioning or well being 
4) No differences between early and advanced stage cancer 
29 
intro, 
demographics, 
stats, data, 
conclusions, 
limitations 
17  (Greimel, 
Thiel, 
Peintinger, 
Cegnar, & 
Pongratz, 
2002)  
LN  64/ 248 
(25.8%)  
Ovarian 
76.6% III/ 
IV 
Newly 
diagnosed  
EORTC QLQ 
C30; Quality 
of Life Index 
1) Global QoL, emotional and role functioning more affected 
than physical, social and cognitive functioning 
2) Physical, social and role functioning decreased after initial 
treatment 
3) Emotional and global QoL improved pre post treatment 
4) During chemo ovarian cancer patients had higher levels of 
emotional functioning than breast cancer patients 
5) At 6 8 weeks ovarian better role functioning than cervical  
6) Before treatment higher physical and role functioning and 
global QoL if early stage disease; during chemo emotional 
functioning higher if advanced disease 
7) Severity of surgery and Karnofsky performance status 
accounted for most variance in QoL 
31  
intro, limitations  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to 
assess QoL/ 
distress 
Findings  Quality 
Assessment score  
18  (Guo, Sheng, 
Liu, & Hua, 
2004)  
LN  65/146 
(44.5%) 
Ovarian 
70.7% III/ 
IV 
Newly 
diagnosed 
FACT O  1) Physical QoL lower if ovarian cancer, lower education, better 
if surgery only 
2) Advanced stage cancer a/w poor physical, emotional and 
functional well being 
3) Social well being was lower if age over 70, no help at home. 
4) Emotional well being was higher if over 70, and lower if less 
education and no help at home, ovarian cancer 
5) Functional well being was higher if college education, no 
radiation therapy, and home help. 
5) Overall QoL lowest in ovarian cancer patients, those with 
less education, and without help at home, better in older people 
28  
intro, 
demographics, 
questionnaire, 
conclusions, 
limitations 
19  (Hipkins, 
Whitworth, 
Tarrier, & 
Jayson, 2004)  
 
LN  57  65%:  III/ 
IV 
Mean 6.1 
months 
HADS; IES  1) Anxiety at T1, perceived emotional support and younger age 
a/w anxiety at T2 
2) IES intrusions at T1, perceived emotional support and 
younger age a/w anxiety at T2 
3) Depression at T1, perceived emotional support associated 
with depression at T2 
4) Increase in anxiety, decrease in depression over 3 months 
28 
demographics, 
data,  
questionnaire, 
limitations 
   
20  (Hodgkinson 
et al., 2007) 
 
CR  54 (27%)  59%:  I, 
17%:  II, 
22.6%: III 
1.5%: IV 
Mean 3.7 
years  
SD=2.3 
SF 12; 
HADS  
1) 5.5% cases of depression, 14% anxiety  
2)Correlates of distress: poorer physical and mental QoL, 
PTSD, higher total needs 
3) Extended survival a/w lower anxiety 
31  
intro, time since 
diagnosis, 
limitations 
21  (Kornblith et 
al., 1995)  
LN  151 at 
start 
86%: III/ IV  Not reported  FLIC;  
MHI;  
1) In 1/3 of patients, symptoms of anxiety and depression 
occurred at levels of moderate to very severe intensity 
2) High distress a/w more physical symptoms, worse physical 
functioning, worse current well being, advanced disease, being 
inpatient on study entry 
3) Physical symptoms, physical functioning, Karnofsky 
performance status predictors of psychological distress 
4) 23%   little or no distress 
25  
intro, time since 
diagnosis, disease 
stage, 
demographics, 
stats, data, sample, 
questionnaires, 
limitations  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to 
assess QoL/ 
distress 
Findings  Quality 
Assessment score  
22  (Lakusta et al., 
2001)  
 
CR/LN  60 (38 
cross 
sectional, 
26 
longitudin
al 
81% III/ IV  Not reported  EORTC 
QLQ 30 
1) As age increases, fatigue decreases 
2) Advanced stage associated with more sleep disturbance 
3) Recurrent disease associated with slightly lower levels of 
fuctioning  
4) If  newly diagnosed, QoL declined over treatment, but if 
recurrent disease, QoL improved over the course of treatment 
29  
intro, time since 
diagnosis, 
demographics, 
design, stats, 
sample 
23  (Le, Hopkins, 
& Fung Kee 
Fung, 2005)  
LN  253 (94 
chemo, 
159 
follow up 
Chemo: 
82% III/IV, 
Follow up: 
54% III/IV 
Not reported  FACT O  1)Salvage chemo a/w worse overall and emotional QoL, more 
ovarian cancer specific concerns, than first line adjuvant chemo 
2) Follow up: better than chemo in the physical, functional and 
ovarian cancer domains, and overall QoL 
27 
time since 
diagnosis, disease 
stage, 
demographics, 
design, data, 
conclusions, 
limitations 
 
24  (Le et al., 
2004)  
LN  72  60.2%: III 
16.3%:  IV 
Not reported  FACT O  1)  Exposure to 1 or fewer chemotherapy regimen a/w better QoL 
2) Older age a/w better physical and emotional QoL. 
3) Stage II disease a/w fewer ovarian cancer specific concerns 
than Stage IV, Stage 1 a/w better emotional QoL than Stage IV. 
4) Better performance status a/w better functional, physical QoL  
 
28  
intro, time since 
diagnosis, disease 
stage, 
demographics, 
data, sample, 
limitations 
25  (Liavaag, 
Dorum, Fossa, 
Trope, & Dahl, 
2007) 
 
CR  189  43%: I 
17%: II 
40%: III 
6.3 years (sd 
6.0) 
HADS; 
EORTC 
QLQ C30;  
1)QoL, anxiety a/w chronic fatigue 
2)Being on treatment a/w lower QoL 
3)Higher anxiety but lower depression than controls 
4)Worse QoL, physical and mental health, more fatigue than 
norms 
32 
intro, sample size 
26  (Lutgendorf et 
al., 2002b)  
 
CR  24  19: III/IV  New diagnosis 
(2 14 days 
before surgery) 
FACT G; 
POMS;  
1) Greater social well being a/w lower levels of VEGF 
2) VEGF > 380 pg/ ml (associated with poorer survival) – a/w 
lower levels of social well being 
3) Higher levels of helplessness a/w higher VEGF 
31  
sample size, data  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to assess 
QoL/ distress 
Findings  Quality 
Assessment score  
27  (Lutgendorf et 
al., 2005)  
 
CR  42  83% III/ IV  Newly 
diagnosed 
(following 
surgery) 
POMS (SF)  1) No significant differences in distress, depressed mood or 
social support between groups 
2) Higher levels of social support a/w higher NKCC in PBMC 
and TIL, whereas greater distress a/w poorer NKCC in TIL 
3) Greater social support a/w greater NKCC, greater distress a/w 
more impaired NKCC 
33  
sample size 
28  (Meden, Metz, 
& Monkeberg 
Tun, 1994)  
CR  85  5  I 
15 –II 
51 –III 
14 –IV 
28 months 
(range 3 116) –
tested after 
surgery and at 
least 3 cycles of 
chemo 
Heidelberg 
‘Sense of 
well being’ 
questionnaire 
1) Middle aged patients best QoL, then oldest, then youngest 
2) Patients with an illness lasting 2 3 years had the highest 
somatic QoL, those diagnosed less than 1 year had the lowest 
3) Those with an illness lasting 1 2 years had the highest 
psychological QoL, illness lasting more than 5 years    lowest  
4) Those with a secondary carcinoma had lower QoL 
5) 2 operations    highest QoL, 1 operation    lowest 
6) Lower somatic QoL after a partial resection of the intestine or  
colostomy, higher if less than 6 cycles of chemotherapy 
7) Somatically, QoL deteriorated in proportion to size of tumour 
residue after surgical treatment 
8) Oral chemo  a/w higher psychosocial QoL than intravenous  
20  
intro, 
demographics, 
data, design, stats, 
questionnaires, 
conclusions, 
limitations 
29  (Miller et al., 
2002)  
 
CR  10 (12%)  Not reported  39 months (6 
145) 
FACT G  1) Lower levels of physical well being a/w  lower level of 
education, longer time of treatment, 
2) Lower social well being a/w no help at home, age over 71 
3) Emotional well being higher if older, lowest in ovarian cancer 
4) Functional well being lowest in ovarian cancer, a/w lower 
levels of education, no home help, higher if no radiation therapy 
5) Overall QoL lowest if no help at home, less than high school 
education, only surgery, higher in older patients 
29 
disease stage, 
demographics, 
sample  
30  (Molassiotis, 
Chan, Yam, & 
Chan, 2000)  
 
CR  35 
(56.5%) 
3  borderline 
21 –I,  
19 –II,  
3 –III,  
1 –IV 
52.3 months 
(SD 45.1, range 
6 months – 13 
years) 
WHO QoL 
scale; POMS;  
1) Lower levels of mood disturbance, depression in ovarian than 
cervical cancer 
2) Younger age a/w better social relationships, psychological 
health 
3) Early stage disease a/w better psychological health 
4) Depression accounted for 45% of the variance in QoL 
30  
intro, study design, 
sample size, 
questionnaire  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used to 
assess QoL/ 
distress 
Findings  Quality 
Assessment score  
31  (Norton et al., 
2004)  
 
CR  143  39%   III  Mean 22 mths 
(49% under 6 
mths) 
BDI 
(somatic 
items 
excluded); 
MHI; IES;  
1) Higher levels of depression than community samples 
2) Higher levels of anxiety than depressive symptoms 
3) Younger age, less time since diagnosis and more advanced 
disease stage a/w greater levels of psychological distress 
31  
design, 
questionnaire, 
limitations 
32  (Norton et al., 
2005) 
 
CR  143  46%: III  18 months (SD 
= 2.3 years) 
MHI  1) Older age a/w less anxiety and depression, greater behavioural 
and emotional control, greater self esteem 
2) Higher levels of physical impairment a/w lower perceived 
control over the illness and in turn with greater psychological 
distress 
3) Higher levels of unsupportive behaviours from family and 
friends a/w lower self esteem, and in turn with greater 
psychological distress 
33  
questionnaire 
33  (Parker et al., 
2006)  
 
CR  126  85%: III/ IV  Mean 2.7 years 
(sd = 3.4) 
CES D; 
STAI;  
1) 25% scored above clinical cut off for depressive symptoms 
2) Age significantly a/w depressive symptoms and anxiety 
3) CA125 preoccupation significantly a/w anxiety; lower 
knowledge scores and higher CA125 scores a/w more depressive 
symptoms 
4) Knowledge moderated relationship between CA125 
preoccupation and depressive symptoms  
5) Current anxiety negatively a/w knowledge, but positively a/w  
CA125 preoccupation 
31  
demographics, 
questionnaires, 
conclusions 
34  (Petersen, 
Graham, & 
Quinlivan, 
2005)  
 
LN  9 (35%)  61%: I 
12%: II, 
27%:  III  
Newly 
diagnosed 
SCL 90; 
Perceived 
Social 
Support  
1) Levels of symptoms did not differ across first 6 weeks 
2) No significant differences in levels of symptoms between 
ovarian cancer and other sites 
3) More symptoms a/w poor perceived social support 
26  
intro, disease stage, 
demographics, 
design, stats, data, 
sample, limitations 
35  (Stevinson et 
al., 2007) 
CR  359  108 I, 55 II 
112 III 
26 IV 
Not reported 
(only more/ less 
than 60 mths) 
FACT O  1)If met guidelines for physical exercise, higher QoL than if 
insufficiently active/ sedentary (not dose response relation) 
2)Advantage greater for women with current disease 
31 
intro, time since 
diagnosis, stats  
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Ref 
no. 
Article 
reference 
Design  Ovarian 
cancer  
(N) 
Disease 
stage 
Time since 
diagnosis 
(months) 
Measures 
used 
Findings  Quality 
Assessment score  
36  (Stewart, 
Wong, Duff, 
Melancon, & 
Cheung, 
2001)  
CR  200  Not 
reported 
7.2 years 
(SD= 4.9) 
 MHI ; 
QoL CS 
1) Mental health not a/w  age, education, time since diagnosis 
 
26 
 intro, disease 
stage, stats, data, 
questionnaires, 
limitations 
 
37  (von 
Gruenigen, 
Frasure, 
Jenison, 
Hopkins, & 
Gil, 2006)  
LN  42  13: I/II 
29: III/ IV 
Newly 
diagnosed (1/2 
recruited pre 
operatively, ½ 
post 
operatively 
FACT G; 
SF 36,  
1) Questionnaires post op: lower physical QoL and fatigue 
scores, and lower SF 36 physical summary, but all improved 
over 6 mths  
2)  Questionnaires pre op: physical QoL and fatigue scores 
lower at 3 months, returned to baseline at 6 months; functional 
scores no change baseline 3 mths, but higher at 6 mths 
 
32  
intro, data, sample 
38  (Wenzel et al., 
2002)  
 
CR  49  38: I;  
11: II 
5 10 years  QoL CS; 
SF 36; 
IES R; 
CES D;  
1) Abdominal symptoms, gynaecologic symptoms, 
neurotoxicity and co morbid illness a/w physical well being 
2) Neurotoxicity a/w physical and psychological well being, 
depression 
3) Illness intrusiveness a/w overall QoL, survivor specific 
distress, 4) Emotional well being a/w confidence managing 
illness, depression 
5) As physical and social well being declined, increase in sexual 
discomfort 
6) Spiritual well being a/w personal growth, capacity to 
integrate cancer experience 
26  
demographics, 
stats, data, sample, 
questionnaires, 
conclusions, 
limitations  
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Third, there were a few issues with the statistical tests   dividing data into quartiles to 
address the issue of skew, rather than transforming variables (1 study), not using 
inferential statistics (1 study), doing Pearson correlations only, rather than regression (2 
studies), and not explaining the statistical tests used (1 study).  Fourth, means and 
standard deviations were not always reported.  Fifth, a number of studies had rather 
small samples, and very few met the criterion of 10 participants per independent 
variable required for three points.  Finally, some of the studies used non standardized 
assessment tools (that had not been validated and published) to assess secondary 
outcomes.    
2.3.1 Psychological distress 
Anxiety and depression were assessed in 20 studies.  Thirteen of these were 
good, six were average, and one was poor.  Levels of depression in ovarian cancer 
groups tended to be higher than in community samples, with percentages of those 
scoring above the clinical cut off ranging from 21 25% in the good studies, to 33% in 
the poor study (Kornblith et al., 1995) (though, interestingly, this study found that 23% 
of individuals experienced little or no distress).  Notably, the prevalence of depression 
decreased after the three month period following completion of treatment (Hipkins et 
al., 2004), although it does not appear to differ across the first 6 weeks post diagnosis 
(Petersen et al., 2005). However, in studies involving patients who were at varying 
stages of their cancer journey approximately 25% of participants scored above the 
clinical cut off, suggesting that depression may remain a significant problem for some 
patients.  Studies that looked at ovarian cancer survivors, defined as those who had been 
2 years or more without evidence of active disease, found that 6% scored above the 
clinical cut off for depression (Wenzel et al., 2002), which is comparable to the general 
population and that they scored higher on the Mental Health Inventory than population 
norms, indicating better mental health than the general population (Stewart et al., 2001).  
Overall, levels of anxiety tended to be higher than levels of depressive symptoms 
(Norton et al., 2004).  For example, Liavaag et al. (2007) reported that ovarian cancer 
survivors experienced higher levels of anxiety than the general population.  Hipkins et 
al. (2004) reported that the prevalence of clinical levels of anxiety was 47% three 
months after finishing treatment, and that anxiety increased from completion of 
treatment to three month follow up, in contrast with a decrease in levels of depression in 
the same period. They suggest that following completion of treatment, women are more 
likely to attend to physical symptoms and internal states, in an attempt to understand  
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whether they are remaining well.  This is likely to accentuate somatic symptoms, and 
thereby lead to increased anxiety.  Correlates of levels of anxiety and depression are 
reported in Table 3.      
 
Table 3. Correlates of levels of anxiety and depression in ovarian cancer  
Factor   Most frequently 
observed 
association  
Congruent 
with 
observations 
No relation  Incongruent 
with 
observations 
Level of 
evidence 
Age  Younger – more 
distress 
 
Good: 5 
Average: 1 
Average: 1 
(survivors) 
Good: 1  Strong 
Disease stage  More advanced 
– more distress 
Good: 3  
Poor: 1  
Average: 2 
(1 on 
survivors) 
 
  Strong 
Time since 
diagnosis 
Shorter – more 
distress 
Good: 3  Good: 1 
Average: 1 
(survivors) 
 
  Strong 
Disability status  Worse – more 
distress 
Good: 1  
Poor: 1 
 
Average: 1     Some 
Physical 
symptoms 
More symptoms 
– more distress 
Good:2 
Poor: 1 
 
    Strong 
Active 
chemotherapy/ 
follow up 
 
Chemotherapy – 
more distress 
  Good:1    Inconclusive 
Phase of 
treatment: initial/ 
recurrent 
 
Recurrent – 
more distress 
  Average: 1    Inconclusive 
Site of cancer 
 
 
Ovarian – more 
distress 
  Good:1 
Average: 1 
Good: 1  Inconclusive 
Perceived social 
support 
More social 
support – less 
distress 
 
Good:1 
Average: 2 
    Some 
Previous levels of 
depression 
More – more 
distress 
 
Average: 1      Inconclusive 
Previous levels of 
anxiety 
More – more 
distress 
 
Average: 1      Inconclusive 
Previous levels of 
intrusive 
thoughts 
More  – more 
distress 
 
Average: 1      Inconclusive 
Quality of Life  Poorer quality of 
life – more 
distress 
Good: 2  Average:1    Strong  
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2.3.1.1 Demographics 
One factor constantly associated with increased levels of depression in ovarian 
cancer patients included younger age, where evidence was found in five good studies 
(Bodurka Bevers et al., 2000; Boscaglia et al., 2005; Norton et al., 2004; Norton et al., 
2005; Parker et al., 2006) and one average study (Hipkins et al., 2004).   
In contrast, one average study (Stewart et al., 2001) found no relationship 
between age and depression in ovarian cancer survivors, and one good study 
(Molassiotis et al., 2000) found lower levels of distress in women under 45 years old 
(who were diagnosed with early stage disease).  The weight of the evidence therefore 
strongly suggests that younger patients experience more anxiety/ depression.  Chan et 
al. (2005), in a good study, found that a lower educational level was associated with less 
anxiety.      
2.3.1.2 Degree of disease severity and treatment 
Being diagnosed with advanced stage disease was associated with increased 
levels of psychological distress in three good studies (Boscaglia et al., 2005; Molassiotis 
et al., 2000; Norton et al., 2004) and one poor study (Kornblith et al., 1995), although 
two average studies found no relationship between disease stage and levels of distress 
(Hipkins et al., 2004; Stewart et. al, 2001 – ovarian cancer survivors).  Based on these 
results, there is strong evidence that having advanced stage disease at diagnosis is 
associated with higher levels of psychological distress.  Shorter time since diagnosis 
was associated with increased levels of distress in three good studies (Chan et al., 2005; 
Hodgkinson et al., 2007; Norton et al., 2004), although, importantly, this could not be 
assessed in a large number of studies where participants were recruited at diagnosis. 
Thus, there is strong evidence that longer time since diagnosis is associated with lower 
levels of distress. 
     Worse disability status was associated with increased levels of psychological distress 
in one good study (Bodurka Bevers et al., 2000) and one poor study (Kornblith et al., 
1995), although one average study (Hipkins et al., 2004), found no relationship between 
disability status and levels of depression/ anxiety.  Thus, there is inconclusive evidence 
for a relationship between disability status and levels of psychological distress.   
          Increased levels of physical impairment were related to increased levels of 
psychological distress in two good studies (Hodgkinson et al., 2007; Norton et al., 2005) 
and one poor study (Kornblith et al., 1995). Related to this, 1 average study on ovarian  
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cancer survivors (Wenzel et al., 2002) found that increased levels of self reported 
neurotoxicity was associated with increased levels of depression. From these findings, it 
was concluded that there is some evidence for a relationship between increased levels of 
physical symptoms and increased levels of psychological distress  Phase of treatment 
(active/ follow up) was not associated with levels of depression/anxiety, in the one good 
study that addressed this issue (Boscaglia et al., 2005).  Also no differences in 
psychological distress were found between those with newly diagnosed and recurrent 
cancer in one average study (Donovan et al., 2002), suggesting that both cancer phases 
are psychologically equally difficult.  
2.3.1.3 Type of cancer 
Three studies assessed several different types of gynaecologic cancers.  Two 
good studies (Boscaglia et al., 2005; Chan et al., 2005) and one average study (Petersen 
et al., 2005) found no differences between patients with ovarian cancer and those with 
other types of gynaecologic cancers.  However, one good study (Molassiotis et al., 
2000) found that women with ovarian cancer experienced lower levels of depression 
than those with cervical and endometrial cancer.  The majority of the ovarian cancer 
patients in this study had early stage disease, which may account for this difference.  
These results do not suggest any clear relation between cancer site and levels of 
psychological distress. 
2.3.1.4 Social support 
Poor perceived social support was associated with increased levels of anxiety 
and depression in one good study (Norton et al., 2005) and two average studies (Hipkins 
et al., 2004; Petersen et al., 2005).   This was assessed in different ways across the 
studies i.e. perceived social support (Petersen et al., 2005), perceived emotional support 
(Hipkins et al., 2004), and perceived unsupportive family/friend behaviours (Norton et 
al., 2005), which adds to the robustness of the evidence.  These findings suggest 
moderate evidence for a relationship between perceived social support and levels of 
psychological distress.   
2.3.1.5 Immune factors 
Finally, some interesting issues were assessed in single studies.  The relationship 
between levels of distress and immune factors was assessed in three good studies 
(Costanzo et al., 2005; Lutgendorf et al., 2002b; Lutgendorf et al., 2005).  Costanzo et 
al., (2005) found that a history of depression and increased depressed mood were  
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associated with higher levels of interleukin 6 in ascitic fluid.  Lutgendorf et al. (2002b), 
found that higher levels of helplessness were associated with higher levels of vascular 
endothelial growth factor, a pro angiogenic factor which is associated with poorer 
survival.  Lutgendorf et al. (2005), found increased levels of distress were associated 
with lower levels of natural killer cells in tumour infiltrating lymphocytes. Thus, 
various indices of distress are correlated with biomarkers of important prognostic 
factors in ovarian cancer.   
2.3.1.6 Coping strategies 
Parker et al. (2006), in a good study, found that lower levels of knowledge about 
ovarian cancer and higher CA 125 levels were associated with increased levels of 
depression. Furthermore, the latter association was moderated by knowledge levels, 
such that it did not occur if knowledge about ovarian cancer was low, suggesting that 
depth of understanding of the illness moderates the link between CA125 and depression.  
Increased anxiety was associated with lower levels of knowledge about ovarian cancer, 
and with higher levels of preoccupation with CA 125.  Boscaglia et al. (2005), in a good 
study, found that increased levels of negative religious coping (i.e., confusion and 
dissatisfaction with God, redefining the illness as a punishment) were associated with 
higher levels of anxiety and depression.  Wenzel et al. (2002), in an average study, 
found that survivor specific distress was significantly correlated with levels of 
depression in ovarian cancer survivors.  The results from these studies point at possible 
complex relations between information seeking, coping and distress in ovarian cancer.   
2.3.1.7 Miscellaneous factors 
de Moor et al. (2006), in a good longitudinal study, found that CA 125 level (a 
tumour marker with high prognostic value in ovarian cancer) positively correlated with 
anxiety and depression at baseline, but no prospective relations were found and that 
levels of optimism were negatively associated with levels of anxiety and depression at 
both baseline and follow up.  Depression at time of diagnosis was a significant predictor 
of depression 3 months later, and levels of anxiety and intrusive thoughts at time of 
diagnosis were significant predictors of levels of anxiety 3 months later in one average 
study (Hipkins et al., 2004).  Similarly, Hodgkinson et al. (2007), in a good study, found 
that post traumatic stress disorder was associated with more distress.  Increased levels 
of distress were associated with worse quality of life in two good studies (Hodgkinson 
et al., 2007; Molassiotis et al., 2000) and one average study (Gil et al., 2007), 
suggesting strong evidence for this relation.  Finally, Liavaag et al. (2007), in a good  
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study, found that anxiety was associated with increased likelihood of being diagnosed 
with chronic fatigue syndrome in ovarian cancer survivors. 
2.3.2 Quality of life 
     Quality of life was assessed in 29 studies.  Thirteen of these were good, 13 were 
average and three were poor.  Correlates of quality of life are reported in Table 4. 
Table 4. Correlates of quality of life in ovarian cancer  
Factor  Direction of 
Association 
Positive 
Correlation 
No relation  Inverse 
Correlation 
Strength of 
evidence 
Age   Older better 
QoL 
Good:2 
Average: 6 
Poor: 1  
Average: 1 
Poor: 1 
(unclear) 
Average: 1  Strong 
(subscales 
other than 
social) 
Educational 
level 
More 
education: 
better QoL 
Average: 2 
Average: 1 
(physical) 
  Average: 1 
(social) 
Some 
Disease stage    Good: 1 (at 
diagnosis) 
Average: 3 
Poor: 1 
Average: 1   Good: 1 (during 
chemotherapy) 
Some 
Disability status    Good: 2 
Average: 1 
Poor: 1 
    Strong 
Active 
treatment 
  Good: 2 
Average: 2 
    Strong 
Phase of 
treatment – 
intial/ recurrent 
  Average: 4 
Poor: 1 
Average: 1    Some 
Active disease 
(longer term 
survivors) 
  Good: 1 
Poor: 2 
    Some 
Surgery only  Surgery only – 
better QoL 
Average: 1  Poor: 1  Average: 1  Inconclusive 
Radiotherapy  Radiotherapy: 
worse QoL 
Average: 2    Good: 1 
(developing 
country) 
Some 
Site of disease  Ovarian cancer: 
worse QoL 
Average: 3 (1 
prior to 
treatment) 
Poor:1 
Good: 3   Average: 1  Inconclusive 
 
Being married   Married – 
better QoL 
Good: 1 
Average: 1 
Poor: 1 
  Good: 1  Some 
Having home 
help 
Home help – 
better QoL 
Average: 2      Some 
Spirituality  Greater levels 
of spirituality: 
better QoL 
Average: 2 
Poor: 1 
    Some 
 
2.3.2.1 Demographics 
Older age was associated with better quality of life in two good studies (Bodurka 
Bevers et al., 2000; Canada et al., 2006) five average studies (Ferrell et al., 2005; Gil et 
al., 2007; Guo et al., 2004; Le et al., 2004; Miller et al., 2002) and one poor study  
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(Gioiella et al., 1998), although one average study (Capelli et al., 2002), found that 
younger age was associated with better quality of life, one poor study (Meden et al., 
1994), found that middle aged people had the best quality of life, then oldest, then 
youngest, and one average study (Greimel & Freidl, 2000), found that age had no 
influence on functioning or well being.  Based on these findings, it was concluded that 
there is strong evidence for a relationship between older age and better quality of life.  
Regarding individual dimensions, older age was associated with better physical quality 
of life in one good study (Bodurka Bevers et al., 2000) and two average studies (Gil et 
al., 2007; Le et al., 2004), four average studies found that older age was associated with 
better emotional quality of life (Gil et al., 2007; Guo et al., 2004; Le et al., 2004; Miller 
et al., 2002) one good study found that older age was associated with fewer ovarian 
cancer specific concerns (Bodurka Bevers et al., 2000); and two average studies found 
that older age was associated with worse social quality of life (Guo et al., 2004; Miller 
et al., 2002).   One average study (Lakusta et al., 2001) found that older age was 
associated with less fatigue, and one average study of ovarian cancer survivors (Stewart 
et al., 2001), found that older age was associated with more positive perceptions of body 
image.    Taken as a whole, these findings suggest there is moderate evidence that older 
age is associated with better quality of life with regard to every dimension except social.  
Educational level was not assessed in many studies.  However, three average 
studies found that a low educational level was associated with lower physical quality of 
life (Gil et al., 2007; Guo et al., 2004; Miller et al., 2002), two found evidence that a 
lower educational level was associated with lower functional and overall quality of life 
(Guo et al., 2004; Miller et al., 2002), and Guo et al. (2004) found that low educational 
level was also associated with worse emotional well being.  Based on these studies, it 
was concluded that there is some evidence for a relation between lower educational 
level and worse quality of life.  However, Gil et al. (2007) found evidence that a lower 
educational level was associated with better social quality of life.  With regard to 
economic status, Ferrell et al. (2005), in an average study, reported that a higher annual 
income and being employed were associated with better social and overall quality of 
life, Ding et al. (2007) in a good study, found that higher self reported economic status 
was associated with better quality of life, and Awadalla et al. (2007) in a good study, 
reported that having a medium or high skill occupation was associated with better 
quality of life.  
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2.3.2.2 Degree of disease severity and treatment 
With regard to disease stage, the evidence is varied.  Le et al. (2004), found that 
those with Stage II disease had fewer ovarian cancer specific concerns than those with 
Stage IV disease, and those with Stage I disease had better emotional quality of life than 
those with Stage IV disease.  Lakusta et al. (2001), found that advanced stage disease 
was associated with more sleep disturbance.  Guo et al. (2004), found that advanced 
stage disease was associated with poor physical, emotional and functional quality of 
life.  Greimel et al. (2002) found that patients with early stage disease had higher 
physical and role functioning at diagnosis, but during chemotherapy those with 
advanced stage disease had better emotional quality of life.  Finally, Greimel & Friedl 
(2000), found no differences in quality of life between those with early and advanced 
stage disease.  From these findings, it was concluded that there is some evidence for a 
relationship between more advanced stage disease and worse quality of life. 
Worse disability status was associated with worse quality of life in two good 
studies (Bodurka Bevers et al., 2000; Greimel et al., 2002) one average study (Le et al., 
2004) and one poor study (Kornblith et al., 1995).  When this was broken down by 
subscale, Le et al. (2004) found that worse disability status was associated with worse 
functional and physical quality of life.  Based on these findings, it was concluded that 
there is strong evidence that worse disability status is associated with worse quality of 
life.  However, such relations may be spurious due to item overlap – measures of 
physical and functional quality of life often include items related to disability. 
One good study (Bodurka Bevers et al., 2000) and one average study (Le et al., 
2005) found that being on active treatment was associated with worse functional quality 
of life.  Further, one good study (Liavaag et al., 2007) and two average studies (Ferrell 
et al., 2005; Le et al., 2005b) found evidence for a relation between being on active 
treatment and worse overall quality of life.  Being on active treatment has also been 
associated with worse emotional quality of life (Bodurka Bevers et al., 2000) and worse 
physical well being and more ovarian cancer specific concerns than being on follow up 
(Le et al., 2005).  These findings suggest strong evidence for a relation between being 
on active treatment and worse quality of life.  
Several studies examined whether there was a difference in quality of life 
between those with primary and recurrent disease.  However, this could not be assessed 
in studies where all the participants were newly diagnosed.  Recurrent disease was 
associated with worse quality of life in four average studies, (Capelli et al., 2002; 
Lakusta et al., 2001; Le et al., 2004; Le et al., 2005) and one poor study (Meden et al.,  
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1994).  One average study (Donovan et al., 2002) found no differences in quality of life 
between those with newly diagnosed and recurrent cancer.  Specifically, being on 
salvage chemotherapy was associated with worse overall and emotional well being and 
ovarian cancer specific concerns (Le et al., 2005); recurrent cancer was associated with 
lower levels of functioning (Lakusta et al., 2001); and having had more than 6 cycles of 
chemotherapy was associated with worse somatic quality of life (Meden et al., 1994).  
Thus, these findings suggest some evidence for a relationship between being on 
chemotherapy and worse quality of life.  However, it is important to note that 
recurrence/ disease stage is often confounded with treatment – individuals who 
experience a recurrence will have more treatment – and therefore it is difficult to be sure 
whether it is the recurrence or the extra chemotherapy treatment that is associated with 
worse quality of life. However, Awadalla et al. (2007) found that longer time since 
diagnosis was associated with better quality of life, suggesting that the time of diagnosis 
is the point at which quality of life is most impaired. 
The relation between active disease and quality of life in longer term survivors 
was assessed in several studies.  One good study (Bodurka Bevers et al., 2000) and two 
poor studies (Ersek et al., 1997; Meden et al., 1994), found that active disease was 
associated with worse quality of life.  Specifically, Bodurka Bevers et al. (2000) found 
that more than 30 months since diagnosis and evidence of active disease was associated 
with more ovarian cancer specific concerns; Ersek et al. (1997), found that active 
disease was associated with worse physical, psychological and social well being and 
total quality of life, compared to no evidence of active disease; and Meden et al. (1994), 
found that psychological quality of life was worst in individuals with an illness lasting 
more than five years.  Thus, there is some evidence that active disease in long term 
survivors is associated with worse quality of life.  
With regard to other types of treatment, two average studies found that 
functional quality of life was better in individuals who had not experienced radiation 
therapy (Guo et al., 2004; Miller et al., 2002), but one good study found that having 
radiotherapy was associated with better quality of life (Awadalla et al., 2007).  The 
authors suggest this unusual finding is due to the patients’ appreciation of being able to 
receive radiotherapy in a country with limited economic resources.  With regard to 
surgery, the evidence is unclear.  Guo et al. (2004), found that physical quality of life 
was better in patients who had surgery only, but Miller et al. (2002), found that quality 
of life was worse overall in patients who had surgery only, and Meden et al. (1994),  
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found that quality of life was best in individuals who had had two operations, but lowest 
in individuals who had had one operation.  Interestingly, Meden et al. (1994), also 
found that somatic quality of life was lower in individuals who had had a colostomy or 
a partial resection of the intestine; those who had oral chemotherapy had higher 
psychosocial quality of life than those who had intravenous chemotherapy; and that 
somatic quality of life deteriorated in proportion to size of tumour residue after 
chemotherapy treatment.  Overall, the only conclusion that can be drawn from these 
findings is that there is some evidence that having radiation therapy is associated with 
worse quality of life in industrialized western nations.  
2.3.2.3 Immune factors 
Costanzo et al. (2005), found that higher levels of IL 6 in peripheral blood were 
associated with poorer physical and functional well being, and greater fatigue.  
Lutgendorf et al. (2002b) found that lower levels of vascular endothelial growth factor 
(VEGF) were related to better social well being, and that VEGF > 380 pg/ ml 
(associated with poorer survival) was associated with lower levels of social well being.  
This evidence suggests that the relation between immune factors and quality of life 
should be explored further. 
2.3.2.4 Type of cancer 
Among the studies on patients with gynaecologic cancer, having ovarian cancer 
tended to be associated with worse overall quality of life than having other types of 
gynaecologic cancers. This finding was reported in one poor study (Gioiella et al., 
1998) and three average studies (Greimel & Freidl, 2000; Guo et al., 2004; Miller et al., 
2002), although Capelli et al. (2002) found that those with cervical cancer had worse 
quality of life than those with ovarian cancer.  Three good studies found no difference 
in quality of life as a function of diagnosis (Awadalla et al., 2007; Hodgkinson et al., 
2007; Molassiotis et al., 2000).  When these results were broken down by subscales, 
Greimel and Friedl (2000) found that patients with ovarian cancer had the lowest quality 
of life prior to surgery.  Three studies found that those with ovarian cancer had lower 
emotional and physical quality of life (Capelli et al., 2002; Guo et al., 2004; Miller et 
al., 2002) and one found evidence for lower functional quality of life also (Miller et al., 
2002).  Finally, Greimel et al. (2002), found that patients with ovarian cancer had better 
emotional quality of life during chemotherapy compared to those with breast cancer, 
and those with ovarian cancer had better role functioning than those with cervical 
cancer at 2 months follow up.  However, these findings may reflect the willingness of  
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patients with advanced stage ovarian cancer to endure higher levels of toxicity in the 
hope of enhancing survival, due to its worse prognosis.  Although at face value these 
findings suggest having ovarian cancer is not necessarily associated with worse quality 
of life, when examined more carefully there is evidence that ovarian cancer may be 
related to worse emotional and physical quality of life relative to other gynaecologic 
cancers, possibly due to more aggressive treatment and fears of recurrence because it is 
often diagnosed at an advanced stage.   
2.3.2.5 Social support 
Several studies found that social factors were related to quality of life.  One 
good study (Awadalla et al., 2007), one average study (Ferrell et al., 2005) and one poor 
study (Gioiella et al., 1998) found that being married was associated with better quality 
of life.  In contrast, one good study (Bodurka Bevers et al., 2000) found that being 
divorced/ separated was related to better social/ family well being.  Two average studies 
found that having home help was related to better social, functional and overall quality 
of life (Guo et al., 2004; Miller et al., 2002), and Miller et al. (2002), also found that 
having home help was related to better emotional well being.  From these studies, it was 
concluded that there is some evidence being married is associated with better quality of 
life, and some evidence that having home help is associated with better quality of life.  
With regard to levels of social support, Awadalla et al. (2007) found that being cared for 
by a spouse was associated with better social quality of life, and Ding et al. (2007) 
found that extra family support was associated with better quality of life at the start of a 
course of chemotherapy, but intra family support was associated with better quality of 
life as the course progressed. 
2.3.2.6 Coping strategies/ optimism 
There has been very little research on coping strategies and personality factors in 
ovarian cancer.  de Moor et al. (2006), in a good study, found that optimism was 
positively associated with quality of life at baseline, and dispositional optimism was 
positively associated with social and functional well being at follow up.  Canada et al. 
(2006), in an average study, found that more active coping was associated with better 
overall, social and functional quality of life.  Spirituality (which can be viewed as a 
coping strategy) and quality of life was assessed in three studies.  One poor study found 
that being Catholic was associated with better quality of life (Gioiella et al., 1998).  
More broadly, one average study (Canada et al., 2006), found that a greater level of 
religion/ spirituality was associated with better quality of life, and in the case of  
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functional and overall quality of life this effect was mediated by active coping.  One 
average study (Donovan et al., 2002), found that a higher level of spirituality was 
associated with better quality of life.  Meaning and peace were associated with better 
quality of life in all their participants, and faith was associated with quality of life in 
recurrent cancer.  Stronger beliefs were associated with better quality of life in recurrent 
cancer, and support was associated with quality of life in both groups.  Importantly, 
there were no differences between those with newly diagnosed and recurrent cancer 
with regard to levels of spirituality.  Overall, these studies provide some evidence for a 
relation between a greater level of religion/ spirituality and better quality of life.  
2.3.2.7 Miscellaneous Factors 
Some interesting issues have been assessed only in single studies.  Stevinson et 
al. (2007), in a good study, found that meeting guidelines for physical exercise (150 
minutes of moderate intensity activity per week) was associated with better quality of 
life than being insufficiently active or being sedentary, and that the advantage was 
greatest for women on active treatment.  Gil et al. (2007), in an average study, found 
that a higher body mass index (BMI) was associated with lower physical, functional and 
social quality of life.  Liavaag et al. (2007) found that worse quality of life was 
associated with increased likelihood of caseness of chronic fatigue. 
 
2.4 Discussion 
 
To identify correlates of psychological distress and quality of life in ovarian 
cancer, a systematic review of the literature was carried out.  The results showed strong 
evidence for a relationship between younger age, being diagnosed with more advanced 
disease, more physical symptoms and shorter time since diagnosis with increased levels 
of anxiety and depression; some evidence for a relationship between low perceived 
social support and worse disability status and increased levels of anxiety/depression was 
also found. There was inconclusive evidence for a relationship between being on active 
chemotherapy, having a recurrence and having ovarian cancer (compared to other 
gynaecologic cancers) and levels of anxiety/depression. While the evidence for a 
relationship between quality of life and distress could be viewed as strong based on our 
criteria, the issue of item overlap (quality of life instruments often include measures of 
mood) spuriously inflated this relationship.    
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With regard to quality of life, there was strong evidence for a relationship 
between worse disability status , being on active treatment, and younger age (regarding 
subscales other than social) and worse quality of life.  There was some evidence for a 
relationship between lower educational level, being diagnosed with more advanced 
stage disease, having recurrent disease, having active disease (in longer term survivors), 
and having radiotherapy and worse quality of life. There was some evidence that being 
married, increased levels of religion/ spirituality and having home help were associated 
with better quality of life.  There was inconclusive evidence for a relationship between 
having surgery only with quality of life, and inconclusive evidence that having ovarian 
cancer was associated with worse quality of life.  With regard to both psychological 
distress and quality of life, these results are discussed in relation to the factors 
considered to be associated with psychological adjustment in ovarian cancer: 
demographics, degree of disease severity and treatment related factors, social support, 
optimism/ pessimism, avoidance/ intrusive thoughts and use of coping strategies. 
2.4.1 Demographics 
Overall, a constant relationship was found between younger age and increased 
levels of anxiety/ depression, in line with previous literature.  Individuals diagnosed 
when they are younger have a number of issues to contend with, including the impact of 
their diagnosis on those around them, issues about childbearing, and the possibility of 
an early death.  This finding was repeated for quality of life, with regard to all subscales 
except social well being.  In general, elderly people, whether they have cancer or not, 
may be lonelier than younger people.  Although younger women are more likely to be 
married (as opposed to widowed), and possibly have a wider social network, the disease 
is more likely to impact on their everyday lives.  This evidence suggests that younger 
women should be carefully assessed for symptoms of anxiety and depression.  
However, older people may also benefit from access to interventions, as a way to 
increase their social network.  
       A low educational level was associated with worse quality of life, possibly 
because less education may hinder patients in attempts to make sense of their disease 
and treatment, or to seek medical information in order to reduce uncertainty.  To reduce 
this problem, it is important that doctors assess the educational level of their patients, 
and in general, explain disease information in simple language, with the use of visual 
aids where necessary.  In contrast with this idea, Chan et al. (2005) found that a low 
educational level was associated with less anxiety.  Individuals with less education may  
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have limited awareness about the seriousness of their condition.  Alternatively, low 
educational level is often taken as a proxy for low socioeconomic status, and this relates 
to the finding that unemployed individuals and those with a lower income reported 
worse quality of life.  Individuals on a lower income are less likely to have access to 
private healthcare, meaning that they have to wait longer for treatment, and do not 
necessarily have access to the best treatments.  Overall, demographic factors appear to 
have a significant impact on quality of life.  Although most are not modifiable, the way 
in which they are appraised can be altered, and appraisal should therefore be tested in 
future studies. 
2.4.2 Disease severity and treatment-related factors 
More advanced disease was associated with increased levels of psychological 
distress and worse quality of life in newly diagnosed patients.  Advanced stage disease 
is associated with poorer survival and more symptoms, and patients are obviously aware 
of these threats    fear of recurrence is one of the major issues affecting ovarian cancer 
patients (Ferrell, Smith, Cullinane, and Melancon (2003)).  This evidence suggests that 
individuals diagnosed with advanced disease should be carefully assessed for anxiety 
and depression.  Similar findings were reported for quality of life.  However, 
interestingly, Greimel et al. (2002) found that patients with advanced stage disease 
experienced better emotional quality of life during chemotherapy than those with early 
stage disease.  In these patients chemotherapy may eliminate symptoms, whereas some 
patients with early stage disease are asymptomatic at diagnosis.  Alternatively, they may 
be willing to tolerate a higher level of toxicity in expectation of treatment benefits 
(Balmer, Thomas, & Osborne, 2001) or it may provide patients with advanced stage 
disease with more hope than those with early stage disease. However, these results were 
based on questionnaires that are not disease specific, so may not have addressed 
specific experiences related to living with gynaecologic cancer.     Alternatively, it is 
possible that patients with some early stage cancers receive more aggressive treatments 
than those with advanced disease, impairing the quality of life of the former more than 
the latter.   
As in other cancers (Helgeson, Snyder, & Seltman, 2004), levels of anxiety/ 
depression tended to decrease as time since diagnosis increased.  A cancer diagnosis is a 
traumatic event, and coming to terms with it requires a significant shift in perspective, 
which could explain these findings. This may reflect an adaptation process.  However, 
there was some evidence that active disease was associated with worse quality of life in  
 
41 
longer term survivors. Such individuals generally undergo several regimens of 
chemotherapy.  However, quality of life may improve over the course of treatment 
(Lakusta et al., 2001), as patients become accustomed to the side effects of the 
treatment, and chemotherapy reduces disease symptoms.  The impact of time since 
diagnosis on quality of life is difficult to assess, since it is often confounded with receipt 
of treatment.  Ideally, separate analyses should be performed on disease free individuals 
and those who have experienced a recurrence, but if this is not possible, recurrence 
status should be controlled for in all analyses. 
Physical symptoms/ impairment were also associated with increased levels of 
anxiety and depression, possibly because they are viewed as indicators of disease 
progression.  In addition, some treatment induced physical symptoms (e.g., nausea) may 
either induce or be associated with altered mood state as part of the “sickness response” 
(Reichenberg et al., 2001).  Similarly, worse disability status was associated with 
increased levels of anxiety/ depression, and worse quality of life – reduced ability to 
perform daily activities may reduce enjoyment of life.  This evidence suggests that 
individuals with limited ability to perform daily activities may benefit from 
psychological interventions.  Since this is a common problem, it is important to ensure 
psychological interventions are easily accessible to a wide variety of patients, and that 
these interventions are tailored to accommodate patient limitations (i.e., over the phone 
for people who are unable to travel).  Alternatively, depression or anxiety may lead to 
poorer performance status because depressed patients have reduced motivation (Beck, 
1967) leading to reductions in energy expenditure required for daily activities. It is also 
plausible that relations between self reported physical symptoms and distress may 
reflect the underlying personality trait of neuroticism (Watson & Pennebaker, 1989), 
manifested by corresponding scores on both outcomes.  Objective assessment of 
physical symptoms would enable a test of the true relation between impairment and 
distress. 
There was some evidence that being on active chemotherapy treatment was 
associated with worse quality of life, but not increased risk of anxiety and depression.  
This was surprising since chemotherapy can cause a number of unpleasant side effects, 
often greatly reducing life satisfaction and inducing the sickness response. Patients on 
active chemotherapy are recommended to restrict their activity, since the immune 
system is weakened, explaining in part the impaired functioning.  However, a number of 
the studies that assessed anxiety and depression included only newly diagnosed  
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individuals.  Patients undergoing chemotherapy are aware that their condition is being 
treated, which may reflect an important source of medical support. Upon completion of 
treatment, some patients experience anxiety that their progress is not being monitored, 
and that they will be unaware of a recurrence (particularly since ovarian cancer can be 
asymptomatic). Similar “separation anxiety” is found in patients leaving the intensive 
coronary care unit for less intensive monitoring and care in other parts of hospitals 
(Sarantidis et al., 1997). Also surprisingly, having a recurrence was not associated with 
increased levels of anxiety and depression, and although the majority of the evidence 
suggested that having a recurrence was associated with worse quality of life, this was 
not always the case.  In this context, it is important to note that quality of life scales tend 
to assess levels of physical symptoms, rather than the impact of such symptoms on 
everyday life.  To illustrate the difference, in a qualitative study of women receiving 
palliative chemotherapy, many participants reported that the impact of nausea and 
vomiting on their quality of life had significantly diminished relative to their initial 
chemotherapy (Houck, Avis, Gallant, Fuller, & Goodman, 1999).  This research tends 
to suggest limitations of quality of life scales with regard to addressing the impact of 
illness on each individual.   
With regard to the findings on anxiety and depression, individuals who had a 
recurrence were compared with newly diagnosed patients.  Comparing patients who had 
a recurrence with disease free individuals at a similar time since diagnosis may yield 
different results.  Alternatively, this result could be explained in the following way: by 
the time of recurrence, some individuals have been living with their illness for several 
years, and may have come to terms with their diagnosis and treatment – news of a 
recurrence may be less surprising than the initial diagnosis.  This issue requires further 
research. Alternatively, experiencing recurrences may lead to modifications in the idea 
of what is necessary for good quality of life (Lutgendorf et al., 2002a). On the other 
hand, recurrence could be worse than an initial diagnosis since it generally means that 
the disease is not curable, and therefore may induce greater responses of hopelessness.    
Having radiotherapy was associated with worse quality of life.  Radiotherapy is 
not a common method of treatment in ovarian cancer, and tends to be given only when 
individuals refuse chemotherapy.  Therefore, this finding may reflect the prognosis of 
the individuals given radiotherapy, rather than effects of the treatment.  The study 
finding a relation between having radiotherapy and better quality of life was carried out 
in the Sudan, a developing country, and the authors suggested that the patients were  
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grateful for the opportunity to receive treatment that was not widely available.  
However, radiotherapy can impair sexual functioning (Andersen, Woods, & Copeland, 
1997), and individuals treated in this way should be given advice on coping with these 
issues.  
   Although it was expected that having surgery only would be associated with 
better quality of life, the evidence was inconclusive.  Individuals who have surgery only 
may worry more about recurrence, which impacts on other aspects of their quality of 
life.  However, the impact of treatment on quality of life is likely to be influenced by the 
response of the individual to the treatment they receive.    Overall, disease and treatment 
related factors significantly impact on quality of life and distress, although treatment 
related concerns are likely to diminish as the disease free interval increases.  More 
longitudinal studies are needed across the course of treatment, in order to examine 
correlates of psychosocial adjustment following multiple recurrences. 
2.4.3 Immune factors 
A few well designed studies found that various indices of distress and quality of 
life were correlated with biomarkers of prognostic factors in ovarian cancer (e.g., 
VEGF, IL 6).  Since distress may lead to altered immune function, interventions to 
reduce distress need to be made a priority. These studies are important, since they point 
to potential mediators linking psychological factors with prognosis in ovarian cancer 
(von Georgi et al., 2002). However, this needs to be tested in longitudinal studies and 
randomized controlled trials, which would provide a better understanding of the 
direction of the relation between immune factors and psychological distress.  It is 
important to test this relation, since future studies may examine whether blocking 
biomarkers improves prognosis in distressed patients. 
2.4.4 Type of cancer 
The evidence assessed here suggests no differences in levels of anxiety and 
depression between patients with ovarian cancer and those with other gynaecologic 
cancers.  Similar findings were observed in two excluded studies (Chan et al., 2001; 
Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001).  Ovarian cancer has a 
worse prognosis as it is more likely to be diagnosed at an advanced stage, and 
consequently requires more aggressive treatment, both of which are distressing.  
However, provided disease stage was controlled for in these studies, this lack of 
difference is expected since cancer can be life threatening and all gynaecologic cancers 
may affect sexual relations and intimacy.  Thus, other factors related to the disease  
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mentioned above, rather than the mere diagnosis of ovarian cancer, should be 
considered when assessing anxiety and depression (Kornblith et al., 1995).  However, 
the evidence suggests that having ovarian cancer may be related to worse emotional and 
physical quality of life relative to other gynaecologic cancers, possibly due to more 
aggressive treatment and fears of recurrence because it is often diagnosed at an 
advanced stage. 
2.4.5 Social support 
   As expected, given previous studies on other types of cancer, i.e., Helgeson & 
Cohen, (1996) poor perceived social support was associated with increased levels of 
anxiety and depression.  This may result from patients not receiving sufficient 
emotional or instrumental support from close friends/ relatives. Alternatively, high 
patient distress may lead to reduced social support due to significant others not having 
the skills to manage such distress.  Similarly, being married (which is often viewed as 
proxy for social support) was associated with better quality of life.  Also, with regard to 
instrumental support, not having home help was associated with worse quality of life.  
Women generally play a considerable part in the running of their household, which is 
likely to be greatly impaired while they are receiving treatment.   
2.4.6 Quality of life and depression 
As expected, poorer quality of life was significantly associated with increased 
levels of anxiety/ depression.  Experiencing more physical symptoms and reduced 
ability to engage in leisure activities/ work is likely to decrease self esteem, possibly 
leading to greater distress. Future studies need to test whether self esteem mediates such 
a relation. This evidence suggests that interventions targeting quality of life are a high 
priority area for future research, and should be made widely available, particularly 
given the relations between quality of life and distress/ survival (Hoodin & Weber, 
2003; Mainio et al., 2006). However, as mentioned above, these relations may partly 
stem also from item overlap and need to be tested by removing questions assessing 
distress from quality of life instruments.  
2.4.7 Religion/ spirituality 
     The evidence assessed suggests that a greater level of religion/ spirituality 
was associated with better quality of life.  Religion and spirituality may give individuals 
a purpose in life, and some framework for making sense of their illness, thereby 
enabling them to confront the illness. Supporting this rationale, Canada et al. (2006),  
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found that the relation between spirituality and functional and overall quality of life was 
mediated by active coping.  This finding echoes that of Holland et al. (1999), that 
reliance on spiritual and religious beliefs was related to active coping in patients with 
malignant melanoma.  However, it is important to understand how the patient 
conceptualizes spirituality/ religion or what it does with its contents: Boscaglia et al. 
(2005) found that increased levels of negative religious coping (i.e., redefining the 
stressor as a punishment from God) were associated with higher levels of anxiety and 
depression.   
2.4.8 Optimism/ pessimism 
There have been very few studies on levels of optimism in gynaecologic cancer 
patients.  One good study (de Moor et al., 2006) found that optimism was negatively 
associated with anxiety, stress and depression at baseline and follow up; and positively 
associated with quality of life at baseline.  Further, dispositional optimism was 
associated with social and functional well being at follow up.  This may be related to 
coping strategies.  High levels of optimism at the time of diagnosis have predicted less 
psychological distress up to 12 months later in women with early stage breast cancer, an 
effect that was mediated by acceptance, denial and behavioural disengagement (Carver 
et al., 1993).  The relation between optimism and subjective distress may also be 
partially mediated by negative affectivity (Watson & Pennebaker, 1989).  
2.4.9 Avoidance/ intrusive thoughts 
Avoidance and intrusive thoughts have been assessed in very few studies on 
patients with ovarian cancer.  In ovarian cancer patients who have completed 
chemotherapy, levels of intrusive thoughts at baseline have been associated with 
symptoms of anxiety at three month follow up (Hipkins et al., 2004).  Related to this, 
Hodgkinson et al. (2007) found that PTSD symptoms were associated with increased 
levels of distress.  It is likely that the combination of lack of knowledge and being 
diagnosed with advanced stage disease causes increased levels of distress in ovarian 
cancer patients.  A longitudinal study of 80 women newly diagnosed with breast cancer 
found that younger age was associated with levels of anxiety/ depression at baseline, 
and this relation was mediated by magnitude of intrusive thoughts.  At three months 
post diagnosis, intrusive thoughts was the only predictor of changes in symptoms of 
anxiety/ depression (Epping Jordan et al., 1999). This is important because intrusive 
thoughts are typically reported at high levels at time of diagnosis, and may persist for 
years following the initial diagnosis and treatment.  Therefore, interventions need to be  
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developed to reduce intrusive thoughts. 
2.4.10 Health-related factors 
A few interesting issues have been assessed in single studies.  Stevinson et al. 
(2007) found that being insufficiently active or sedentary was related to worse quality of 
life, and that this relation was particularly strong for individuals on treatment.  As over 
70% of their participants were not sufficiently active, this evidence is cause for concern.  
Gil et al. (2007) found that a higher body mass index (BMI) was associated with worse 
quality of life, possibly because it puts the individual at increased risk of co morbidity 
and is associated with increased fatigue following exercise.  Related to this, Liavaag et 
al. (2007) found that increased levels of anxiety and worse quality of life were 
associated with caseness of chronic fatigue syndrome in ovarian cancer survivors.  
Anxious individuals may be particularly in need of graded exercise interventions, as 
their anxiety may have been related to reduced levels of activity.  Overall, the evidence 
from these preliminary studies suggests that the relation between exercise and quality of 
life should be tested longitudinally in order to gain increased awareness about the 
direction of causality, and assessed in randomized trials. 
2.4.11 Limitations and directions for further research 
Regarding methodology/ reporting, several issues need to be addressed in future 
studies.  First, information should be collected on whether the individual is living alone 
or with a partner, socioeconomic status, type of treatment received and whether the 
patient has had a recurrence.  Second, more prospective studies and randomized 
controlled trials are needed, the latter enabling causal inferences and having potential 
clinical value.  In addition, longitudinal studies should test trajectories of change in 
distress following diagnosis and treatment.  Third, more attention should be given to 
sample size. Fourth, questionnaires should be validated prior to usage if possible.  Fifth, 
importantly, studies should use models to structure their research questions – most 
studies have not been based on theory regarding adjustment to illness.  Finally, 
limitations and possible future directions for research should be provided.  Although the 
majority of these conclusions echo those of Montazeri et al. (1996), which would 
suggest lack of progress in recent years, the studies published in the current decade were 
rated  ‘average’ or better, in contrast with the studies published in the 1990s.  It is also 
encouraging to see that the volume of published research on ovarian cancer has been 
increasing in recent years – over half the studies included in this review were published 
after 2003.  In addition, the studies revealing relationships between distress and disease  
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biomarkers indicate promising avenues and call for testing whether treating distress 
could alter such biomarkers and improve prognosis in ovarian cancer.  Also, some 
studies point to a number of modifiable factors affecting levels of distress and quality of 
life, such as levels of knowledge and coping strategies, which were not assessed in the 
ovarian cancer literature before the late 1990s. Given recent reviews on psychological 
interventions and prognosis in cancer (Coyne, Stefanek, & Palmer, 2007), future studies 
need to design alternative interventions for modifying psychosocial factors. 
This systematic review had a few limitations.  The studies were quality assessed 
by only one author, so inter rater reliability could not be assessed.  However, since nine 
out of the 12 criteria could be assessed objectively with little interpretation, this is 
unlikely to seriously impact on the results.  Some correlates of distress (e.g., immune 
factors, coping) were tested in too few studies to enable firm conclusions to be drawn.   
Overall, this review has provided a first step towards identifying factors that 
may impact on psychological distress and quality of life in ovarian cancer, a disease that 
has often been neglected in psycho oncology research until recently. This is also the 
first review to quality assess studies, and therefore provides a more stringent test of the 
evidence than previous reviews on ovarian cancer.  The evidence here can be used as a 
preliminary guide when deciding which patients to assess for anxiety and depression 
and whom to target when designing psychological interventions.   
 
2.5 Evidence excluded from the systematic review 
 
The following section discusses studies that failed to meet the strict inclusion 
criteria for the systematic review, mainly because ovarian cancer results were not 
presented separately.  This research helps to clarify the relation between coping 
strategies and quality of life in cancer with regard to similar populations, and examine 
the effectiveness of psychological interventions for gynaecological cancer patients. 
2.5.1 Coping strategies 
Greater use of active coping has been related to better social well being and less 
overall distress cross sectionally (Lutgendorf et al., 2000) and greater use of positive 
reframing and acceptance has been associated with better functional well being in 
gynaecological cancer patients (Costanzo, Lutgendorf, Rothrock, & Anderson, 2006) 
and greater functional, emotional and physical well being in newly diagnosed 
gynaecological cancer patients one year later (Lutgendorf et al., 2002a).  
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On the other hand, avoidant coping has been associated with poorer emotional 
and physical well being, and greater anxiety, depression, fatigue and total mood 
disturbance, in women extensively treated for gynaecologic cancer (Lutgendorf et al., 
2000).  Use of behavioural disengagement in patients newly diagnosed with 
gynaecological cancer has been associated with poorer functional and emotional well 
being and overall quality of life, greater distress and total mood disturbance, and less 
vigour one year later (Lutgendorf et al., 2002a).  More specifically, greater use of 
mental disengagement has been related to poorer emotional well being, greater anxiety 
and greater depressed mood; use of behavioural disengagement has been related to 
poorer functional well being, and denial has been associated with greater anxiety 
(Costanzo et al., 2006).  Overall, the evidence suggests that active coping is associated 
with better quality of life, whereas denial, avoidance and behavioural disengagement are 
associated with worse quality of life and increased levels of distress.  Thus, 
interventions designed to increase levels of active coping may be beneficial. 
2.5.2 Psychological interventions 
 The few intervention studies involving gynaecologic cancer patients are 
reviewed here.  Cain, Kohorn, Quinlan, Latimer, and Schwartz (1986), found that 
participation in group or individual thematic counselling led to lower levels of 
depression and anxiety at post test and follow up in gynaecologic cancer patients than 
standard personal counselling.  Among early stage gynaecologic cancer patients, 
Wenzel, Robinson, and Blake (1995) found that five weekly group counselling sessions 
did not lead to greater improvement relative to a control condition regarding adjustment 
to the illness at five week follow up.  However, participants reported low levels of 
distress prior to participation.  Petersen and Quinlivan (2002) found that a one hour 
relaxation and counselling interview performed by a medical practitioner involved in 
the patient’s care led to significant reductions in levels of anxiety and depression 
relative to usual care.  However, these studies used small samples, the interventions 
were un standardized, medical and demographic factors were not taken into account, 
intention to treat analyses were not carried out, and there was no comparison of 
treatment approaches.  Therefore, only limited conclusions can be drawn. 
Manne et al. (2007b), in a manualized RCT that controlled for medical and 
demographic factors, found that coping and communication skills led to significant 
reductions in levels of depression at six and nine months relative to usual care in 239 
patients with gynaecologic cancer (over 80% had ovarian cancer).  Such evidence  
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provides support for the use of psychological interventions in gynaecologic cancer 
patients.  However, given that mutual partner support may be critical in adjustment to 
cancer, it should be noted that the interventions addressed here did not involve spouses.  
Couple related interventions will be discussed in Chapter 3. 
 
2.6 Review of the chapter 
 
This chapter has drawn together the main findings from the literature to identify 
demographic, illness related and psychological correlates of psychosocial adjustment 
(quality of life, anxiety and depression) in ovarian cancer.  Chapter 3 discusses cancer 
in the context of marriage, in order to identify couple related correlates of psychosocial 
adjustment in the patient and correlates of psychosocial adjustment in the spouse.  This 
evidence is required in order to determine what type of intervention may be effective for 
couples where one partner has cancer.  
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Chapter 3: Cancer in the context of marriage 
3.1 Outline of chapter 
 
When looking at adjustment to cancer, it is helpful to consider the patient's 
relationship with their spouse/ partner as this can be a very important determinant of the 
patient's psychological adjustment.  This chapter therefore addresses the impact of 
cancer on couples.  Studies assessing levels of patient and spouse distress are reviewed, 
with the aim of estimating the extent of disruption the cancer causes to the couple. 
Predictors of patient and spouse distress are then discussed, in order to determine ways 
in which distress might be modified.  Next, observational studies of couple 
communication are examined in detail, so that the impact of perceived negative spouse 
behaviours on patient adjustment can be examined in more depth.  The few 
interventions that have been carried out on couples experiencing a diagnosis of cancer 
are discussed and assessed, to provide a clear picture of what has been done previously.  
Finally, methodological issues to be taken into consideration when conducting studies 
with couples are addressed, and the way in which these issues will be dealt with in the 
main study is explained. 
 
3.2 Introduction 
 
Marriage can be distinguished from other relationships by its intensity, duration 
and interdependence (Coyne & Fiske, 1992).  Individuals are likely to depend most on 
their spouses for assistance in times of crisis.  There is a general assumption that 
spousal support for seriously ill individuals increases to meet their partners’ needs.  
However, serious illness can produce marked stress for the spouse, and makes some 
marriages vulnerable to deterioration.  Chronic illness involves the disruption of 
‘normal’ life experience.  Patients and their families are plunged into an unknown 
environment, with limited opportunity or control to remove or act on the stress target.  It 
is an experience with no predictable end, and inability to justify or explain the pain and 
suffering is often associated with experience of stress.  This chapter starts by describing 
levels of distress and adjustment in couples experiencing cancer.  
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3.3 Levels of distress and adjustment in the healthy spouse and patient 
 
A number of studies have attempted to quantify differences in psychological 
distress between patients and spouses.  However, the results reported are contradictory, 
with some reporting that patients and spouses experience similar levels of distress, 
others reporting that patients experience higher levels of distress than spouses, and yet 
others reporting that spouses experience higher levels of distress than patients.  The 
diversity of results in this area has led to little advance in the specification of 
mechanisms, development of theory, or empirical exploration of mediator and 
moderator variables.  The role of patient versus partner has been confounded with 
gender.  In fact, in studies of ‘mixed’ cancer patients, results are often discussed without 
reference to gender.  A meta analysis of 43 studies with sample sizes of at least 20 
couples clarified the contradictions by finding a significant effect for women reporting 
more distress than men, regardless of whether the woman was the patient or the partner 
(Hagedoorn, Sanderman, Bolks, Tuinstra, & Coyne, 2008).  
Another correlate of patient and spouse distress is type of cancer (Baider and 
De Nour, 1988).  Levels of distress are likely to be affected by factors such as prognosis 
of the particular cancer and its impact on everyday life.  The research carried out in this 
thesis involves only ovarian cancer patients (who are all female) and there are therefore 
no confounding factors due to type of cancer or gender.  Ovarian cancer has a poor 
prognosis, and research has shown that many patients experience significant levels of 
psychological distress (see Chapter 2).  There is very little research on partners of 
ovarian cancer patients.  However, it is expected that many experience significant levels 
of distress, partly because the disease has a poor prognosis, and partly because of the 
impact on sexual functioning and fertility, which is likely to be particularly important 
for younger couples.   
Patient distress does not appear to differ between studies of patients assessed 
alone and studies of couples.  Those who do not have a partner may have alternative 
sources of support whereas those who have a partner may not always get the support 
they need (Hagedoorn et al., 2000b). Some studies have compared couples coping with 
cancer to community samples.   Hagedoorn et al. (2000a) reported higher levels of 
distress among women in couples coping with cancer than women in healthy couples.  
However, these differences in distress tended to decrease over time (Hinnen, 
Hagedoorn, Sanderman, & Ranchor, 2007).  Comparisons with gender specific norms  
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reveal a modest elevation in distress in couples coping with cancer.  However, this 
finding should be treated with caution as differences between American and Israeli 
norms on the Brief Symptom Inventory are larger than differences between couples 
coping with cancer and the community (Hagedoorn et al., 2008).  Having established 
that women experience more distress than men, it is now important to understand the 
correlates and predictors of psychological distress in couples experiencing a diagnosis 
of cancer. 
3.4 Correlates/ Predictors of Psychological Distress and Quality of Life in Patients 
 
Correlates of psychological distress in ovarian cancer are discussed in Chapter 2. 
This section therefore focuses on relationship related correlates of distress in patients, 
with particular reference to female patients.  When experiencing elevated mood 
disturbance and trauma symptoms, most people turn to their partners for increased 
support.  The support of a partner increases motivation to seek more aggressive 
treatment and have better health habits, and may buffer women coping with the 
psychological stresses and physiological changes of disease progression.  
3.4.1 Marital satisfaction 
 Poor marital satisfaction at the time of diagnosis is closely related to future 
distress, whereas perception of inadequate intimacy and support during stressful times is 
closely related to mood disturbance.  Higher levels of marital quality have been 
associated with less anxiety and depression (Hannum, Giese Davis, Harding, & 
Hatfield, 1991; Pettingale, Burgess, & Greer, 1988) and better quality of life (Swensen 
& Fuller, 1992) across a variety of cancers.   
However, marital status is sometimes used as an index of social support without 
assessing the extent to which partners in the relationship perceive their marriage as 
supportive.  This is important as research discussed later in this chapter has shown that 
negative aspects of close relationships are better predictors of quality of life than 
positive aspects.   Giese Davis, Weibel, and Spiegel (2000), in a study of 125 metastatic 
breast cancer patients (57% married), found no differences in levels of mood 
disturbance between married and single women, and between women with partners 
involved in the study, and partners not involved in the study. However, married patients 
who rated their relationship as having greater cohesion and expression were less 
distressed.  
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3.4.2 Coping Strategies 
Several studies have assessed patient and partner use of coping strategies, and 
their relation with patient distress.  Evidence from small cross sectional studies suggests 
that spouse coping is related to quality of life (Zacharias, Gilg, & Foxall, 1994) and 
marital satisfaction (Ptacek, Ptacek, & Dodge, 1994), with self blame, emotional 
venting and wish fulfilling fantasy being highlighted as particularly maladaptive 
strategies (Zacharias et al., 1994).  Examining this issue in more detail, Ben Zur, Gilbar, 
& Lev (2001) found that high psychological distress and low psychosocial adjustment 
were related to high levels of emotion focused coping in both patients and spouses. In 
particular, emotional ventilation, denial and reliance on religion by the spouse were 
related to patient psychological distress and poor psychosocial adjustment.  Such 
reactions may be perceived by the wife as indicating helplessness and therefore lack of 
support.  Since this was a cross sectional study, it is not possible to be clear about the 
direction of causality: high levels of distress may prevent efficient use of problem 
focused coping by both spouses.  Alternatively, spousal distress may be dependent on 
patient distress and coping.  Nevertheless, these findings suggest that if spouse coping 
influences patients’ distress, interventions to reduce more maladaptive emotion focused 
coping may be effective in reducing psychological distress in patients and spouses.  
3.4.3 Social support in the context of the marital relationship 
When researching social support in the context of the marital relationship, one 
important issue to consider is the amount of support sought by the patient, and 
disclosure of concerns to the partner.  Harrison, Maguire, & Pitceathly (1995) in a study 
of 520 recently diagnosed cancer patients found that men tended to name only one 
confidant, their spouse, whereas women had a wider circle of family and friends to 
whom they confided information about their cancer.  Based on this finding, it is 
expected that improvements in marital communication will lead to greater 
improvements in quality of life in partners than in female patients, who may be less 
dependent on their spouses for emotional support.  Nevertheless, spouse support may 
have a significant impact on patient psychological distress.  Several studies found that 
spouse support was related to lower levels of distress in cancer patients, across a variety 
of diagnoses (Baider, Ever Hadani, Goldzweig, Wygoda, & Peretz, 2003; Northouse, 
Dorris, & Charron Moore, 1995). 
Given the strong relation between spouse support and patient distress, and the 
lack of spouse support in some couples, it is important to examine whether support from  
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friends/ family can compensate for poor partner support.  Pistrang and Barker (1995), in 
a study of 113 breast cancer patients in adjuvant treatment, found that helpfulness of 
disclosures to partners was significantly correlated with well being even among those 
who had a good helping relationship with someone else, showing that a poor partner 
helping relationship was a risk factor in the psychological response to breast cancer.  
However, patients were required to report on their helping relationship with one person, 
rather than their overall social network.   More recent research has suggested that 
support from family and friends may compensate for unsupportive partner responses by 
reducing maladaptive coping and counteracting self appraisals that result from partner 
unsupportive behaviours.  For example, Helgeson, Cohen, Schulz, and Yasko (2000) 
found that a peer discussion group was helpful for breast cancer patients who lacked 
support from their partners.  Manne et al. (2003) found that among women with breast 
cancer who reported low family and friend support, partner unsupportive behaviours 
were indirectly related to patient distress via increased patient avoidance and reduced 
coping efficacy, whereas among those with high levels of family and friend support, 
partner unsupportive behaviours had a direct relation with patient distress.  This 
research suggests that interventions to reduce partner unsupportive behaviours may be 
effective in reducing patients’ distress, but the type of interventions required may differ 
depending on the level of family and friend support the patient has. 
It is also important to investigate the pattern of spouse support across different 
phases of treatment, as this may vary according to the demands of the situation.  The 
erosion hypothesis holds that social support declines over time as a stressor becomes 
chronic and members of the social network become tired and overwhelmed by the 
individual’s need for support.  This idea has been supported by evidence suggesting that 
support remains high in the first month post surgery, but then decreases over the 
following few months (Bolger, Foster, Vinokur, & Ng, 1996).  This appears to be the 
case whether the support is emotional (Northouse, 1988) or instrumental (Neuling & 
Winefield, 1988).  Bolger et al. (1996) found that an increase in physical impairment 
was associated with a relative increase in support, but that an increase in emotional 
distress was associated with a decrease in support provision.  This is important, as it 
suggests that distressed cancer patients are not receiving the support they require.  
Overall, the evidence addressed here suggests that more spouse support is related to 
reduced patient distress, but that support from other family and friends may compensate 
for poor spouse support.  However, overall support appears to decrease as time since  
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diagnosis increases, suggesting that individuals several months post diagnosis may be 
more at risk of distress than those who are newly diagnosed.  However, if the spouse is 
experiencing significant levels of distress, he/ she is less likely to be able to provide 
support to the patient.  The following section therefore addresses correlates of distress 
in the spouse. 
 
3.5 Correlates/ predictors of psychological distress in the spouse 
 
A cancer diagnosis can have a considerable impact on the patient's spouse, who 
is burdened with many difficulties including uncertainty about treatment outcome (Coe 
& Kluka, 1988; Zahlis & Shands, 1991), a sense of helplessness and isolation, providing 
care and support (both instrumental and emotional) to the ill partner (Zahlis & Shands, 
1991), shifting of role responsibilities and disruption in social and recreational life 
resulting from the partner’s disability (Zahlis & Shands, 1991), coping with the 
partner’s emotional distress (Northouse, 1989) and need for information and support 
from medical professionals (Coe and Kluka, 1988).  These stressors place the healthy 
spouse at risk of greater psychological distress and physical disorders.  As an indication 
of the greater impact of a cancer diagnosis on spouses relative to other family members, 
Cassileth, Lusk, Brown, and Cross (1985), in a study of relatives of cancer patients, 
found that spouses reported greater mood disturbance on the Profile of Mood States 
than other relatives.  Research has shown that spouses have elevated levels of distress 
during the initial phase of treatment, and recurrent and late stages of the disease 
(Blanchard, Albrecht, & Ruckdeschel, 1997).  This is important because the spouse is a 
key source of social support for the patient, and elevated levels of distress may interfere 
with his/ her ability to provide emotional and practical support to the patient.  
Therefore, understanding factors that contribute to spouse distress can lead to ideas for 
ways to reduce this distress, and thereby improve both spouse and patient quality of life.   
Patient physical impairment appears to be associated with spouse distress (Ell, 
Nishimoto, Mantell, & Hamovitch, 1988; Northouse et al., 1995).  Perceived social 
support may be another important factor (Baider et al., 2003; Northouse, Mood, 
Templin, Mellon, & George, 2000). It may be that spouses fail to make their needs for 
support known.  If this is the case, an intervention asking spouses to write about the 
impact of their partners’ cancer on their lives may prompt them to seek help and/or 
discuss their needs with the ill partner and could constitute a covert method for spouses  
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to “legitimately” seek help.   Northouse et al. (1995) also found a significant correlation 
between partner health problems and psychological distress in the partner, suggesting 
that this should be taken into account when examining the impact of illness on couples.  
In a longitudinal study, Northouse et al. (2000) found that baseline role problems and 
level of marital satisfaction were the best predictors of role adjustment in spouses one 
year post surgery.  Baseline emotional distress had a significant direct effect on 
emotional distress at one year follow up, suggesting that emotional distress may remain 
a problem for a significant minority and early identification is therefore crucial.   
 
3.6 Correlations between patient and partner distress 
 
Studies have assessed the correlation between patient and spouse distress, and 
factors that modify such reactions.  Correlations have been found between patient and 
spouse distress (Fang, Manne, & Pape, 2001; Northouse et al., 2000), patient 
psychological distress and spouse reports of marital quality (Fang et al., 2001), patient 
and spouse quality of life (Chen, Chu, & Chen, 2004), and spouse depression and 
patient quality of life (Nijboer, Triemstra, Tempelaar, Sanderman, & van den Bos, 
1999).  Such correlations have been reported longitudinally, over multiple assessments 
and across several types of cancers.  Segrin et al. (2005), addressing this issue in a 
longitudinal study of distress in dyads of women with cancer and close others (children, 
friends, intimate partners) reported significant correlations over time, and similar 
trajectories in distress within dyads.  However, these trajectories could have been tied to 
trajectories in the course of the woman’s active treatment, such that both members of 
the couple experienced more distress when the woman was being treated.  The evidence 
reviewed here suggests that partners’ distress reactions appear to be closely linked, a 
finding that has been supported by two reviews (Hagedoorn et al., 2008; Manne, 1998).  
Hagedoorn et al. (2008), in a meta analysis, found a correlation between patients’ and 
partners’ distress of .29, which was not moderated by gender.  However, there was 
significant heterogeneity across studies, with some finding no such correlations at some 
time points (Baider, Koch, Esacson, & De Nour, 1998), and others finding significant 
correlations only for certain genders (Baider, Perry, Holland, Sison, & Kaplan De Nour, 
1995).  Although contradictory, these findings suggest that the ways in which couples 
adapt to their situation and respond to the stress created by illness may in some cases be 
influenced by the gender of the patient and spouse.  In this context, it is important to  
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note that concordance between patient and partner distress fluctuates considerably – 
according to Northouse et al. (2000), correlations in psychological adjustment between 
couples where the woman had breast cancer varied from 33% agreement for baseline 
emotional distress to 57% for role problems at 1 year post diagnosis.  However, 
distressed couples tended to remain distressed over time.  Gustavsson Lilius, Julkunen, 
Keskivaara, and Hietanen (2007), after finding that patient and partner distress and 
sense of coherence were related at 14 month follow up, though not baseline, suggested 
that the reactions of one partner to the disease affected the other partner’s reactions, and 
over time the psychological status of patients and partners increases in similarity. 
Overall, there are several questions that need to be explored further: how distress 
is transmitted, whether there are gender differences in transmission and communication 
of distress, and whether improvement in the psychological condition of one partner 
would be transmitted to the other.  Further, it is important to examine adjustment across 
the course of cancer i.e., diagnosis, treatment, post treatment, as different time periods 
may be associated with specific psychological processes.   The answers to these 
questions have important implications for the development of psychological 
interventions. Nevertheless, the evidence suggests that interventions designed to help 
reduce distress and manage negative emotions in patients may also be useful in 
alleviating spouse distress, as patient and spouse distress appear to be at least 
moderately correlated.   
 One issue that should be examined in this context is the role of information 
exchange, as that may provide reassurance and uncertainty reduction, particularly to the 
spouse.  Bar Tal, Barnoy, and Zisser (2005) found that female patients attributed greater 
information needs to spouses than the spouses expressed, and relied heavily on 
perception of their own knowledge when assessing their spouse’s knowledge, which 
was not accurate.  This suggests the importance of good communication between 
partners – if the patient has an inaccurate understanding of their partner’s knowledge,  
mis communication is more likely to occur.  Evidence suggests that female partners 
have a more accurate understanding of their husbands’ experience with prostate cancer 
than male partners do of their wives’ experience with breast cancer (Carlson, Ottenbreit, 
St Pierre, & Bultz, 2001).  Thus, it is hypothesized that the current study will provide a 
context for improving couple communication, by enabling each partner to reflect on 
their story regarding the woman’s ovarian cancer, and thus acting as a springboard for 
the couples to discuss the illness and thereby reach a common understanding of it.  In  
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support of this idea, Skerrett (2003) has shown that in counselling sessions for couples 
where one partner has a chronic illness, requiring each partner to tell their illness story 
provides couples with an insight into the different narratives they may have about the 
illness, and thus aids them in reaching a common understanding.   
 
3.7 Impact of cancer on the marital relationship 
 
The correlations observed between patient and partner distress suggest that 
distress in one partner may negatively impact on the marital relationship.  However, the 
empirical evidence needs to be reviewed.  Research assessing the impact of cancer on 
the marital relationship is therefore assessed here.  However, it is important to note that 
the patients in the research reported here were not assessed until after their diagnosis.  A 
true assessment of the impact of cancer on the marital relationship can only be gained 
by assessing the couple prior to the patient’s cancer diagnosis.  Retrospective ratings of 
marital satisfaction have been strongly correlated with perceptions of subsequent 
marital satisfaction, and a longer period of time spent on chemotherapy has been 
associated with worse marital satisfaction in women with breast cancer (Lichtman, 
Taylor, & Wood, 1987).  Overall, the evidence suggests that a cancer diagnosis or 
recurrence may lead to communication difficulties in a significant minority of couples, 
particularly when patient reports are taken into account, even if their marital satisfaction 
does not differ from the norm (Hoskins, 1995; Lichtman et al., 1987).  Patient reported 
problems include the husband’s failure to talk about cancer related issues, and patients’ 
need for more opportunities to express fears about cancer recurrence (Lichtman et al., 
1987).  However, it is important to note that cancer does not always lead to marital 
dissatisfaction.  For example, Kuijer, Buunk, and Ybema (2001) found that cancer 
patients and partners are as satisfied with their relationships as healthy couples.   The 
evidence suggests that at least 40% of cancer patients report that their relationship has 
become closer compared to pre diagnosis (Dorval et al., 2005; Swensen & Fuller, 
1992).  
 
3.8 Effects of positive partner support and negative responses on patient distress 
 
The evidence addressed above suggests that emotional support provided by 
spouses and greater marital satisfaction are associated with general psychological  
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adjustment.  This is particularly important, since support provided by partners may not 
be compensated for by other sources of support (Helgeson & Cohen, 1996).  Further, 
there is a positive relationship between spousal support and marital satisfaction in both 
healthy couples and couples in distress (Abbey, Andrews, & Halman, 1995).  Active 
engagement, which includes involving the patient in discussions, and inquiring about 
how they feel and what help they need, has been positively associated with marital 
satisfaction (Kuijer, Ybema, Buunk, & DeJong, 2000).  
However, partners can display a variety of unsupportive responses to a diagnosis 
of cancer, including excessive worry/ pessimism, underestimating the severity of the 
illness, avoiding/ withdrawing from the patient, criticizing the way the patient is coping 
with the illness, conveying lack of interest in patient concerns, changing the topic when 
the partner is talking about the cancer experience and behaving in an unkind manner, 
either intentionally or unintentionally (Manne, Taylor, Dougherty, & Kemeny, 1997).  
The evidence suggests that critical and avoidant responses from husbands of female 
cancer patients are associated with both distress and well being, whereas perceived 
support is associated only with well being (Manne et al., 1997; Vinokur & Vinokur 
Kaplan, 1990).  These findings are important as they mean that those most in need of 
spousal support are least likely to receive it.   
Unsupportive responses may have a stronger association with psychological 
distress than supportive responses, as they impact on coping strategies (Lepore, Ragan, 
& Jones, 2000).  This idea is based on cognitive processing theory, which holds that 
successful processing of an event can occur through sharing thoughts/ concerns.  If 
individuals feel constrained in attempts to talk about their experience with others, they 
may be more likely to engage in avoidance, which may then lead to intrusive thoughts.  
In support of this hypothesis, Manne (1999), in a longitudinal study of 129 married 
individuals with cancer (87 female) found that intrusive thoughts were associated with 
greater spouse avoidance, and that individuals who perceived their partner as critical 
and/or avoidant of cancer discussion were more upset by intrusive cancer related 
thoughts.   Overall, this evidence suggests that perceived spouse negative behaviours 
are significantly associated with patient distress.  The impact of one of the most 
common negative spouse behaviours, protective buffering, on patient distress will now 
be examined in more detail. 
3.8.1 Protective Buffering 
One of the most extensively studied negative behaviours performed by spouses  
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is protective buffering.  This consists of hiding concerns, denying worries, concealing 
discouraging information and preventing the patient from thinking about their cancer, 
and is a commonly used strategy, particularly among spouses of patients with lower 
physician rated life expectancy (Manne et al., 1997).  However, it has been associated 
with more distress in male survivors of myocardial infarction (Coyne & Smith, 1991).  
Research on cancer patients has shown that protective buffering is viewed as unhelpful 
(Lichtman et al., 1988), is related to increased distress in women reporting low levels of 
marital satisfaction (Manne et al., 1997), and is associated with lower marital quality in 
patients experiencing high levels of psychological distress, and those with high levels of 
physical impairment (Hagedoorn et al., 2000b).  The relation between protective 
buffering and marital quality is particularly strong for patients experiencing high levels 
of physical impairment, possibly because physical limitations are more noticeable.  It is 
likely that protective buffering impacts so negatively on patient psychological 
adjustment because it undermines feelings of control.   
3.8.2 Determinants of negative responses 
Given the association between partner negative responses and patient distress, it 
is important to understand why partners interact in such ways, so that interventions can 
be developed to reduce negative responses.  Several studies on determinants of 
protective buffering have been carried out.  Partners tend to use more protective 
buffering if they are more distressed (Coyne & Smith, 1991; Hinnen et al., 2007), and 
score higher in neuroticism (Hinnen et al., 2007).  In addition, Hinnen et al. (2007) 
found that among those scoring low in neuroticism, less distress was associated with 
more active engagement over time, whereas there was no such relation for those scoring 
high on neuroticism.  Thus, neuroticism and distress are both risk factors for less active 
engagement.  Although neuroticism is a fairly stable variable, interventions to reduce 
distress may be effective at increasing active engagement.  Written disclosure may help 
to increase active engagement by providing a context for the partner to think about his 
wife, or may reduce his distress, which may then lead to discussion between the couple, 
and could subsequently reduce patients’ distress also. 
3.8.3 Moderators of the impact of negative responses 
Manne et al. (1997) found that physical impairment moderated the relation 
between spouse withdrawal and patient well being, such that among those with less 
impairment, spouse withdrawal was associated with lower well being, whereas among 
those who were more physically impaired, withdrawal was not associated with patient  
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well being.  This finding suggests that as the magnitude of their illness increases, 
patients may attend less to the responses of others.  For those with more impairment, 
higher levels of spouse support were associated with more distress.   While seemingly 
counter intuitive, these results suggest that if the patient experiences more disability 
imposed by the illness, significant others are more likely to respond negatively.  This 
can be explained with reference to the caregiver stress model (Pearlin, Mullan, Semple, 
& Skaff, 1990) which holds that a primary stressor (i.e. limitations in the patient’s 
ability to complete daily activities) may lead to a secondary stressor (role strain 
associated with constriction of social and recreational activities) for the caregiver.  
Manifestations of stress in spouses may increase as the patient becomes more impaired, 
and could result in withdrawal from the ill partner and criticism of their way of coping 
with the illness.   
However, patients’ attitude to negative responses may partially depend on the 
quality of the relationship.  Manne, Alfeiri, Taylor, and Dougherty (1999) found that 
patients with cancer who reported low marital satisfaction reported more negative 
spouse behaviours, but that there was no direct link between patient functional 
impairment and spouse negative affect.  However, among those high in marital 
satisfaction, patient functional impairment was related to spouse negative affect both 
directly and indirectly through interference in spouse activity.   Partners experiencing 
less marital satisfaction may have had fewer supportive exchanges with their spouse in 
the past, and therefore be less willing to provide assistance to the patient.  Also, partners 
with low marital quality may be distancing themselves from their ill spouse, such that 
they do not react emotionally to the spouse’s morbidity.  However, it is unclear whether 
these results would generalize to significantly maritally distressed couples – 76% of 
those in the low marital satisfaction group were not considered to be maritally 
distressed.  Also, the quality of the marital relationship before the onset of illness could 
not be assessed prior to the diagnosis of cancer.  Furthermore, patient related variables 
were not assessed – if the patient was irritable or hostile (possibly due to increased 
physical symptoms), this may have elicited criticism from their spouse.    
3.8.3.1 Moderators of the impact of protective buffering 
Manne et al. (2007a) found that increases in protective buffering by partners 
were associated with increases in distress only among patients who rated their 
relationships as more satisfactory.  Partners were more likely to hide their negative 
feelings and avoid conflict than patients, probably because they had more motivation to  
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shield the ill partner from additional stress.  Protective buffering led to more distress 
over time for the person engaging in it, which is in line with research that hiding 
concerns and less disclosure is detrimental to mental health (Pennebaker & Susman, 
1988).   Written disclosure may therefore be beneficial as it provides a stimulus for 
couples to discuss issues relating to the illness.  Protective buffering by the patient was 
significantly related to more patient distress, possibly because the healthy spouse needs 
to know the patient’s emotional needs and concerns in order to provide support.   
3.8.4 Positive support and coping: relations with patient distress 
Given the significant relation between spouse negative behaviours and patient 
psychological distress, it is important to understand ways to enhance positive social 
support.  There are several ways in which positive social support exchanges can occur.  
First, advice and guidance may alter harmful and/or threatening appraisal of a situation 
to more benign appraisal, if realistic in the context of cancer.  Second, open 
communication can provide a safe context for patients to discuss their concerns.  Manne 
et al. (2004c), in a study of 162 women with breast cancer and their partners, found that 
patients experienced more posttraumatic growth than their partners over a period of 18 
months post diagnosis if their partners were above average in emotional expression.  
They suggest that interventions should facilitate engagement in affective expression, 
which is the case in the GDP.  Third, partners can help identify adaptive coping 
strategies by providing feedback about the efficacy of particular coping efforts, and 
provide a positive evaluation of coping (Holahan & Moos, 1987).  Manne, Pape, Taylor, 
and Dougherty (1999) in a cross sectional study, found that positive reappraisal coping 
mediated the relation between spouse support and psychological well being.  
Conversely, avoidant coping mediated the relation between spousal criticism/ avoidance 
and psychological distress.  Unsupportive behaviours may damage the individual's 
perceptions of mastery/ control, possibly because they are detrimental to appraisals of 
coping efficacy.  This is important because higher perceived control over the 
consequences of cancer has been associated with lower psychological distress 
(Thompson, Sobolewshubin, Galbraith, Schwankovsky, & Cruzen, 1993).   
Manne & Glassman (2000) found that more perceived negative spouse 
behaviours were associated with lower coping efficacy, less perceived control over 
medical and emotional aspects of treatment, and greater use of avoidant coping (which 
was associated with higher levels of distress).  Conversely, higher levels of coping 
efficacy were associated with less psychological distress.  Furthermore, coping efficacy  
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and avoidance mediated the association between spouse negative behaviours and 
psychological distress.  A further longitudinal study showed that avoidant coping 
mediated the relation between unsupportive partner behaviour and patient distress 
(Manne, Ostroff, Winkel, Grana, & Fox, 2005).  These findings help suggest ways in 
which perceived negative spouse behaviours may impact on patient coping.  When the 
spouse is overtly critical or shows a lack of interest in the patient's concerns, this may 
lead to increased avoidance.  Fewer opportunities to vent concerns are associated with 
attempts to avoid thinking about cancer and/or dealing with feelings about it, and 
therefore reduced opportunity to accomplish cognitive processing.  Further, if the 
spouse is not available to talk or gives negative feedback, patients may evaluate coping 
efforts regarding the demands of their cancer in a more negative light.   Therefore, it is 
recommended that clinical interventions involve partners, particularly those who are 
rated by patients as unsupportive.  The current research aims to reduce perceived 
negative spouse behaviours by using an intervention to moderate appraisal of the cancer 
in both patients and their partners.  Writing about the cancer enables individuals to 
reflect on their appraisal of it, and may lead to them being more open about it.  In this 
way, if the partner changes his/her appraisal of the cancer, this may lead to reduced 
psychological distress in the patient.  However, the evidence here is based on 
questionnaires.  It is important to understand the type of spouse utterances that are 
perceived as negative, so interventions can be developed to reduce such utterances. 
 
3.9 In-depth analysis of couple communication 
 
The inability to communicate openly within a marital relationship may lead to 
physiological distress, increased illness and further compromise immune functioning 
(Kiecolt Glaser & Newton, 2001).   Although questionnaires are the mostly commonly 
used method of assessing patient and spouse behaviours, they do not provide an insight 
into the nature of couple communication (Baider & Kaplan De Nour, 2000).  This 
section therefore addresses the relation between partner responses and patient distress in 
detail. 
3.9.1 Informal helping relationships 
Pistrang and Barker (1995) looked at the quality of informal helping 
relationships (dyadic communication where one partner is experiencing emotional 
distress and the other attempting to alleviate that distress) in women recently diagnosed  
 
64 
with breast cancer.  Patients who reported their partner as being more helpful reported 
less distress.  Partner empathy was positively correlated with helpfulness, but negatively 
correlated with partner withdrawal.  However, there was no relation between partner 
criticism and partner withdrawal, possibly because criticism was sometimes 
experienced positively, as a sign of partner engagement.  However social support 
research often fails to address what social support consists of when it occurs between 
two people, or include the perspectives of both members of the dyad (Pistrang, Barker, 
& Rutter, 1997).  Pistrang et al. (1997) used tape assisted recall (where a recording of 
the conversation is played back to the participants, and they are asked a series of 
questions about it) to examine conversations with three couples in which the woman 
had recently been diagnosed with breast cancer.  This revealed that lack of empathy/ 
change of focus from the helper (partner) was seen as unhelpful, whereas the helper 
responding to the essence of the discloser’s (patient’s) concerns was seen as helpful.  
The main issue regarding this type of analysis is ecological validity – the only way to 
determine whether conversations are typical of how the partners talk is by patient 
report.  Another limitation is that reports of helpfulness from patients may be positively 
biased to enable maintenance of a positive image of the relationship.   
3.9.2 Large-scale observational study 
The study carried out by Pistrang et al. (1997) discussed communication in only 
three couples.  In order to gain more generalizable insights into communication patterns 
in dyads, Manne et al. (2004b) carried out an observational study where 148 couples in 
which the woman had breast cancer had to participate in two ten minute discussions, 
one of a cancer related issue and a one of a mutually agreed relationship problem.  
Patients experienced higher levels of both general and cancer specific distress if partner 
self disclosure was less likely to follow patient self disclosure.  One important model 
for understanding these findings is the interpersonal process model of intimacy (Reis & 
Shaver, 1988).  According to this model intimacy is a process where one person 
expresses important self relevant feelings and information to another person, and as a 
result of the other’s response, comes to feel understood, validated and cared for.  The 
key components include self disclosure and the speaker interpreting the listener’s 
statements as responsive.  According to this model, both patient disclosure and spouse 
disclosure predict perceived partner responsiveness, which predicts intimacy.  Manne et 
al. (Manne et al., 2004a) found that in support of this model, findings based on spouse 
self report revealed that perceived partner responsiveness mediated the association  
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between patient self disclosure and intimacy.  However, findings based on patient report 
also revealed a direct association between perceived spouse disclosure and intimacy.  
Disclosure by the ill partner may not set the tone for perceived intimacy due to high 
general levels of self disclosure by patients.  Importantly, there was a very strong 
association between perceived responsiveness and intimacy, and in both the general and 
cancer related topics, greater intimacy was associated with patient self disclosure being 
followed by partner self disclosure.  However, the laboratory nature of the discussion 
may have changed intimacy processes, and there were no pre morbid measures of 
intimacy, or control group of healthy couples.   
3.9.3 Cancer-related discussion 
In the observational studies patients did not report the frequency of cancer 
related discussions in general.  Even in close relationships, cancer is not necessarily 
discussed frequently (Boehmer & Clark, 2001).  As discussed above, protective 
buffering has been associated with more distress in female patients (Manne, Alfieri, 
Taylor, & Dougherty, 1999) and lower marital satisfaction in distressed patients 
(Hagedoorn, Buunk, Kuijer, Wobbes, & Sanderman, 2000a).  Certainly, qualitative 
interviews with couples in which one partner has breast cancer have demonstrated that 
couples who discuss the cancer openly tend to view it as a couple related stressor, 
which enhances coping, whereas couples where one or other partner avoids discussing 
the cancer tend to view it as an individual stressor (Kayser, Watson, & Andrade, 2007; 
Skerrett, 1998).  Further, avoidance of discussing the cancer tends to spread to other 
family members (Kayser et al., 2007). Relationship awareness (thinking about the 
impact of the disease on the partner and the relationship (Badr & Acitelli, 2005), 
authenticity (honest self disclosure) and mutuality (ability to empathize), appeared to be 
important in the coping process.  The evidence from these studies points to the 
importance of open communication about the illness within couples in promoting a 
united outlook and thus enhancing its manageability.   
Examining this issue in more depth, Manne et al. (2006), in a longitudinal study, 
found that more mutual constructive communication (discussion of issues, expression of 
feelings, understanding of views, feeling that the issue has been resolved) was 
associated with lower levels of distress and higher relationship satisfaction in patients at 
nine month follow up.  Conversely, more avoidance of discussing problems and more 
use of demand withdraw communication (where one partner pressed the other to talk 
about a problem, and the other withdrew) was associated with higher levels of distress  
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and lower levels of relationship satisfaction in patients.  Cancer related relationship 
communication did not change significantly over nine months, indicating that couples 
experiencing communication difficulties are in need of interventions.  The transition to 
survivorship poses relationship related challenges which continue to require couples to 
negotiate solutions together.  However, the lack of change in cancer related relationship 
communication over time may be because maladaptive strategies are infrequently used, 
or because couples rated how frequently they used each strategy when they encountered 
an issue rather than the overall use of each strategy.  The finding that demand withdraw 
communication was maladaptive among non maritally distressed couples dealing with a 
medical stressor, indicates that interventions to help improve couple communication and 
adjustment to illness may benefit a significant percentage of couples.  Two major 
limitations of this study include that relationship communication prior to diagnosis and 
general, non cancer related communication among couples were not assessed.    
 
3.10 Interventions for couples facing cancer 
 
The previous section attempted to identify communication patterns that were 
associated with psychological adjustment in patients.  Taken together, these results 
suggest that open communication and partner empathy are associated with improved 
adjustment in patients, whereas greater use of avoidance and withdrawal by partners are 
associated with higher levels of distress in patients.  Interventions for couples 
experiencing a cancer diagnosis are now discussed, in order to assess their 
methodology, quality and effectiveness.  Martire, Lustig, Schulz, Miller, and Helgeson 
(2004), in a meta analysis of psychosocial interventions for chronic illness which 
involved families (five on cancer patients), found reduced depressive symptoms in 
spouses, but no effect on anxiety.  Interventions that focused on relationship issues led 
to a reduction in depressive symptoms in patients, possibly through helping the spouse 
to be more supportive and less critical of the patient.  Also, spouse participation may be 
considered an act of support.  A further meta analysis of twelve studies has 
demonstrated that couple focused interventions are more effective than interventions for 
patients alone (Martire, 2005).  This evidence suggests that intervention studies for 
individuals with chronic illness should involve partners where possible. 
Very few intervention studies for cancer patients have involved both members of 
the couple, and the majority of those suffered from several methodological flaws.   
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However, a few good quality studies are discussed below. 
One important theory that may explain adjustment to cancer is equity theory 
(Walster, Walster, & Berscheid, 1978), which holds that when relationships are out of 
balance, both partners feel inequitably treated.  A serious illness leads to a change in the 
balance of give and take between partners   as patient contributions to the relationship 
decrease, their rewards increase, whereas the opposite is true for the spouse.  The lack 
of equity may remain long after the necessity for it has ended.  In healthy couples, lack 
of equity is associated with lower relationship satisfaction.  Kuijer, Buunk, and Ybema 
(2001) found that cancer patients and healthy partners who perceived themselves as 
underbenefited reported less satisfaction with their relationships when the patient 
experienced few physical limitations.  These studies suggest that inequity in couples 
may partly account for the impact of a cancer diagnosis. 
Kuijer, Buunk, de Jong, Ybema, and Sanderman (2004) tested this idea by 
carrying out a randomized controlled trial where couples were assigned to a biweekly, 
CBT oriented counselling programme focusing on the exchange of social support and 
help or a wait list control group.  The intervention led to a decrease in perceptions of 
inequity in both patients and partners, which was directly related to improvements in 
relationship quality and remained at 3 month follow up.  However, although distress 
decreased in patients and remained stable to follow up, the intervention had no effect on 
partner distress, possibly because the partners were still worried about their spouses.  
One major limitation was that this study had a small sample of 59, which meant it was 
not possible to study gender differences.  Furthermore, couples experiencing marital 
dysfunction unrelated to cancer were excluded, which limits the generalisability of the 
findings.   
One school of thought holds that better patient adjustment may increase partner 
support, whereas patient distress may increase partner withdrawal and negativity.  
Couples’ individual responses to stress interact, and their social support is mutual.  
Effective couple coping develops through empathic communication which develops 
emotional connection and a shared realistic and positive appraisal of stress.  Scott, 
Halford and Ward (2004), found that an intervention designed to focus on helping 
couples to cope conjointly with the cancer and support each other (CanCOPE) led to 
improved couple focused coping with the cancer and reduced partner withdrawal in 
response to patient communication (as assessed by a 10 minute video where the couple 
discussed the patient’s cancer) post intervention and at six month follow up, in 94  
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couples where the women had early stage breast or gynaecological cancer.  
Psychological distress, avoidance and sexual problems reduced in patients, but there 
were no significant benefits for their partners.  However, those who did not complete 
the study reported lower levels of relationship satisfaction, and may have dropped out 
due to poor partner support and poor adjustment to their cancer.  This study has been 
commended by Manne and Andrykowski (2006) as being one of the best trials of recent 
years, meeting 16/21 of the Consort guidelines, and with a 94% participation rate.  
However, Coyne and colleagues (Coyne, Lepore, & Palmer, 2006a) criticized it on the 
grounds that the level of effort made by the researchers in this trial to recruit 
participants and deliver the intervention would not be feasible in general practice.  For 
example, the intervention was home based and tailored to the schedules and preferences 
of the women and their husbands.   
Manne et al. (2005) carried out a randomized controlled trial comparing six 
sessions of couple focused communication and coping skills (CG), with an emphasis on 
the psychological impact of cancer on the couple and relationship, and enhancing 
communication and support, to usual care on adjustment to early stage breast cancer in 
238 couples.  The rate of acceptance was only 33%.  However, 19/21 CONSORT 
guidelines were met.  Intention to treat analyses showed that CG led to significant 
reductions in depression and anxiety relative to usual care and had a greater impact on 
distress and positive well being among women who rated their partners as unsupportive 
pre intervention.  (Manne, Ostroff, & Winkel, 2007) found that those who began the 
couple focused group intervention with higher levels of emotional processing 
(attempting to explore the meaning of cancer and come to an understanding of their 
emotions) and emotional expression regarding their reactions to cancer experienced 
lower levels of depressive symptoms at follow up.  Thus, asking participants to express 
emotions was beneficial for individuals who naturally select emotional expression to 
cope with stressors.  Similarly, those who are more emotionally expressive may be more 
likely to benefit from written disclosure (Stanton et al., 2000).  However, such effects 
are unlikely to be as strong, as written disclosure is carried out in a less engaging and 
less interpersonal context.  Overall, evidence from well designed studies suggests that 
interventions with a focus on couple related communication may be effective in 
reducing distress in patients, and improving couple communication.  However, uptake 
rates tend to be low, possibly due to the level of commitment required from the couple.  
The current study therefore tests the effectiveness of written disclosure, a brief  
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intervention which can be carried out at home with minimal inconvenience, but may 
nevertheless stimulate couple communication regarding the cancer. 
 
3.11 Methodological issues 
 
There are a number of methodological issues to consider when conducting 
research with couples, which are discussed below.  These may account for the 
contradictory results to date. 
3.11.1 Recruitment - sample size and rate of uptake 
Although sample size is important for sufficient power, it is equally important to 
consider the rate of uptake, which has not been reported in many studies (Hagedoorn et 
al., 2008), and is especially low among individuals with advanced stage cancer 
experiencing active medical treatment.  Spouse refusal is generally higher than that of 
patients.  However, it is difficult to determine whether refusal is due to the patient, 
spouse, or both partners.  This is particularly important, as couples experiencing higher 
levels of marital conflict/ difficulties may be less likely to participate in such studies, 
and could be those most in need of interventions.   Patients are likely to refuse to 
participate in research if they believe their partner will not cooperate, and it is not 
therefore possible to compare patient and partner response rates (Manne, 1994).  In 
some studies, partners were not asked to participate until the patients had given consent 
(Hagedoorn et al., 2008).  In the current study, patients will be provided with the option 
to participate alone if their partners are not interested, which enables comparison of 
patient and partner response rates.   
3.11.2 Study design 
The majority of the studies to date have been cross sectional.  Although the 
issue of dropout increases in longitudinal studies, such research is necessary in order to 
understand how patient and spouse distress vary and reciprocally affect each other 
across the course of the cancer journey and predict patient outcomes.  This is 
particularly important as longitudinal studies often only present data for couples who 
have completed all assessments, leading to a biased sample.  Intention to treat analyses 
will therefore be carried out in the current research. 
3.11.3 Type of cancers studied 
Most studies have been carried out on breast cancer patients and their husbands,  
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and it remains uncertain whether these results can generalize to other cancers. This is 
important as a high percentage of ovarian cancer patients are diagnosed with advanced 
stage disease     Hagedoorn et al. (2008) note a lack of attention to cancers with poorer 
prognoses.  However, breast cancer research can to some extent be generalized to 
ovarian cancer, a disease which has been under researched.  In addition to breast cancer, 
a number of studies have been carried out on patients with ‘mixed’ cancer diagnoses.  
The conclusions that can be drawn from such studies are limited, particularly since 
patient and partner characteristics and medical details such as current treatment, 
duration of treatment, frequency, and additional treatments are not often recorded 
(Hagedoorn et al., 2008).  In future studies, it is necessary to specify criteria for sample 
selection, diagnosis, and stages of illness, select a variety of sociodemographic 
variables, and analyse refusals and dropouts.  All these factors have been taken into 
account in the current study.  Furthermore, it focuses solely on ovarian cancer, a disease 
which affects only women. 
3.11.4 Assessment 
Self report is the main method of assessment in studies of couples experiencing 
cancer. In recent years there has been a shift from assessing psychopathology to 
assessing psychological distress, and studies have found more evidence of non 
pathological levels of distress in physically ill patients (Baider & Kaplan De Nour, 
2000).  The most common measures are the Symptom Checklist 90 and the Brief 
Symptom Inventory.  The current research assesses perceived stress and quality of life.  
Perceived stress was considered to be an appropriate way of assessing current distress.  
However, low scores on a distress measure do not indicate satisfaction with life, and it 
was therefore decided to assess quality of life as a primary endpoint.  With regard to 
spouse support, many studies have used different measures, making comparisons 
limited.  In fact, there are many aspects of marital relationships that are not addressed in 
the chronic illness literature, and for the purpose of the research in this thesis, four items 
were developed to assess illness related marital communication. 
Self report scales have been administered by interview, mail and telephone.  
Baider and Kaplan de Nour (2000) recommend the use of interviews for in depth 
insight into patients’ psychological state and response to their illness.  However, since 
the current research recruited from a wide geographical area, and many of the patients 
had advanced stage cancer, it was decided to send out questionnaires patients could 
complete at home.  
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3.12 Conclusions 
This chapter addressed the impact of a cancer diagnosis on couples.  The key 
findings are summarized below.  First, women experience more distress than men, 
whether they are the patient or the spouse.  Second, the main factors associated with 
patients’ psychological distress are marital satisfaction, use of emotion focused coping 
by their partners and partner support (which may be compensated for by support from 
friends, though).  Third, similar factors are associated with psychological distress in 
spouses, with the addition of levels of patient and spouse physical symptoms.  Fourth, 
there is a small correlation between patient and spouse distress.  Fifth, perceived spouse 
negative behaviours have a greater impact on patient well being than perceived positive 
behaviours.  Negative behaviours that are particularly detrimental for patient well being 
include protective buffering (especially in individuals experiencing high levels of 
marital satisfaction), and withdrawal from cancer related discussion, both of which are 
used by partners reporting higher levels of distress.  On the other hand, partner empathy 
and engagement with patient concerns are positively associated with patient well being.  
Finally, interventions involving cancer patients and their partners have tended to show 
positive effects, but the few well designed studies involved procedures that would be 
too time consuming to implement widely.  Hence, it is important to test the 
effectiveness of brief interventions.   
The evidence reviewed in this chapter suggests that couples reporting both low 
and high levels of marital satisfaction may benefit from written disclosure, as it 
provides a context to openly discuss the patient’s illness and its impact on their lives.  
Following a pilot study to test the feasibility of carrying out a written disclosure 
intervention with ovarian cancer patients (Chapter 5), the effectiveness of written 
disclosure as a stand alone intervention for couples will be tested (Chapters 6 8).    
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Chapter Four: Written disclosure: Evidence for effectiveness, theory and methodology 
4.1 Introduction 
 
     The previous chapters have demonstrated that many ovarian cancer patients 
and partners of cancer patients experience significant levels of distress, and identified 
individual and couple related correlates of distress in ovarian cancer patients and their 
partners.  Given that the current research is a randomized controlled trial assessing the 
effectiveness of written emotional disclosure, this chapter assesses the current evidence 
of its benefits for physical and psychological health.  The results of three meta analyses 
are discussed, the most recent of which found a significant effect size and identified a 
number of moderators.  As the current research assesses the effectiveness of guided 
written disclosure in women with ovarian cancer and their partners, the rationale for 
using guided rather than standard writing is addressed, and previous studies assessing 
the effectiveness of written disclosure in patients with a variety of chronic illnesses are 
summarized and discussed, with particular attention given to studies on cancer patients.  
Studies on written disclosure in the context of relationships are summarized and 
discussed.  The current research aims to test two theories developed to explain the 
beneficial effects of written disclosure: the cognitive adaptation hypothesis and the 
social interaction hypothesis, and these theories are therefore critically evaluated.  
However, other competing theories are also evaluated, including the original theory (the 
emotional inhibition hypothesis) and the exposure/ emotional processing hypothesis, to 
set the context.  Finally, methodological issues in carrying out a randomized controlled 
trial assessing the effectiveness of written disclosure are discussed, to justify the 
procedure used in the current study.   
 
4.2 Introduction 
 
There is a variety of evidence to show that traumatic events are associated with 
increased likelihood of mental and physical health problems (e.g., Kartha et al., 2008).  
However, the majority of individuals who experience a trauma do not develop post 
traumatic stress disorder (PTSD) symptoms (Keane, 1998; Wortman & Silver, 1989).  
Evidence suggests that not disclosing traumatic events to a social network is associated 
with elevated risk of illness (Cole, Kemeny, Taylor, & Visscher, 1996; Ullrich,  
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Lutgendorf, & Stapleton, 2003).  Related to this, there is considerable evidence 
indicating that repressive coping (avoidance of negative affect) is associated with worse 
health (Niaura, Herbert, McMahon, & Sommerville, 1992), and some psychological 
interventions encouraging expression of thoughts and feelings have been associated 
with reductions in stress (Spiegel, Bloom, & Yalom, 1981).  From the above evidence it 
is possible to extrapolate that writing about thoughts and feelings related to traumatic 
events may lead to improved health.  This may happen because the act of repression is 
associated with increased stress, or because writing enables the individual to habituate 
to aversive emotional stimuli.   
 
4.3 Written Disclosure – evidence for health effects 
 
Numerous studies have shown a positive effect of writing about trauma on 
health.  Originally, Pennebaker and Beall (1986) found that writing about traumatic 
events led to reduction in healthcare centre visits and fewer physical health complaints 
in healthy students.  This result has since been replicated in a wide variety of 
populations, and the evidence suggests that writing about important personal 
experiences for 15 minutes per day over three days brings improvements in mental and 
physical health, across age, gender, culture and social class (Pennebaker & Seagal, 
1999). Writing has similar results to psychotherapy in healthy participants (Esterling, 
L'Abate, Murray, & Pennebaker, 1999).  Smyth (1998), in a meta analysis of 13 
randomized controlled trials assessing the effectiveness of written disclosure (mainly on 
healthy students), found the mean weighted effect size to be Cohen’s d = .47., which 
was significant at p < .0001, with a fail safe N of 117, and concluded that writing about 
trauma leads to improved health, and psychological, physical and general functioning.  
Two variables moderated the effect size, the length of time between writing sessions (1 
week led to greater effect than 1 day) and gender (males showed more change in 
response to written disclosure than females).   
   Writing may yield its positive effects by leading to greater cognitive change, 
understanding of the problem, and awareness of alternative explanations for the event 
(Esterling et al., 1999). This suggests a cognitive mediation for the beneficial effects of 
written disclosure. However, in a recent meta analysis, Meads, Lyons, and Carroll 
(2003) criticize Smyth’s meta analysis, on the grounds that first, he excluded four 
randomized controlled trials that were available, and second, the results were  
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aggregated across wide ranging categories, meaning that the results of trials and 
outcome measures were largely incompatible, and thus the overall effect size was not 
easy to interpret quantitatively in relation to benefits that emotional disclosure may 
bring about. Finally, this earlier meta analysis included only 13 trials. Meads et al.’s 
analysis included 61 trials assessing the effectiveness of written disclosure across a 
variety of populations, with numerous unpublished trials with null results, and they 
concluded that there is no or little effect of writing about trauma, and further studies 
need to be carried out to establish the true effects. 
However, until recently, many such interventions have been unstructured.  
Typically, participants are instructed to write about the most traumatic experience of 
their lives and describe their deepest thoughts and feelings (Smyth & Helm, 2003).  
More recently, Frattaroli (2006), in a meta analysis of 146 randomized controlled trials 
assessing the effectiveness of written disclosure across a variety of populations, found a 
mean effect size of 0.075, which was significant at p = 3 * 10
9.  Although this effect 
size is smaller than previous meta analyses, it did include a number of unpublished 
studies, which are more likely to have null findings.  This high quality, comprehensive 
review was published in a peer reviewed journal, and there has been an exponential 
increase in the literature in recent years.  Such a small effect size points to the existence 
of moderators.  Based on theory regarding cognitive processing of trauma, one 
hypothesized moderator is type of instructions given (cognitive processing or standard).  
Although Frattaroli (2006) did not find a significant effect for cognitive processing 
instructions, they were used in only six studies, compared to 110 studies that used 
standard instructions.  Of the three studies in this meta analysis that compared 
cognitive processing and standard instructions, two (possibly underpowered), found no 
differences, and Broderick, Stone, Smyth, and Kaell (2004), who used a larger sample, 
found a significant effect for using cognitive processing instructions.  More large scale 
studies assessing the effectiveness of guided writing are therefore needed.  The current 
research therefore aimed to assess the effectiveness of the Guided Disclosure Protocol 
(GDP) (Duncan & Gidron, 1999) which is discussed below. 
4.3.1 The Guided Disclosure Protocol 
Duncan and Gidron (1999) developed the GDP, where participants are required 
to write in a structured way about a trauma, for 15 minutes per day over 3 days.  The 
content and theoretical basis for this form of writing are discussed below.  On day 1, 
participants are asked to describe the event in chronological order, without expression  
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of emotions, and to write the causal links between what happened.  It is likely that this 
increases comprehensibility.  Foa, Molnar, and Cashman (1995) found that describing a 
rape chronologically predicted better prognosis.  This may be because memories of 
trauma are fragmented and intrusive, because they may be encoded in a somato sensoric 
and affective limbic (amygdala) memory mode (Shin et al., 2004; Van der Kolk & 
Fisler, 1995).  Linguistically labelling emotionally negative stimuli reduces amygdala 
activity and increases prefrontal cortex (PFC) activity, whereas processing such stimuli 
in an affective and sensory manner alone increases amygdala activity (Hariri, 
Bookheimer, & Mazziotta, 2000).  Elevated amygdala activity, and reduced prefrontal 
cortex activity have been correlated with increased severity of PTSD symptoms (Shin et 
al., 2004).  Thus, disclosing the event chronologically may help individuals to process 
the event cognitively and fit it into the framework of their lives.   
   On day 2, participants are asked to describe their thoughts and feelings at the 
time of the event in words, and whether the event affected their life, to increase their 
insight about it.  The precise verbal labelling and processing of unpleasant emotions 
may first reduce amygdala activity and increase PFC activity (Hariri, Bookheimer, & 
Mazziotta, 2000), thus enabling cognitive restructuring, and together with describing the 
event’s impact on their lives, this allows individuals to think about the event more 
explicitly, and thus reflect on what they have learned from the event, and how they have 
developed as a result of it.  In support of this idea, Pennebaker and Francis (1996) 
showed that participants who used more insight words when disclosing trauma 
experienced greater health benefits.   
On day 3, participants are required to write how they currently think and feel 
about the event, and reflect on what they would do in the future if they encountered a 
similar event.   This enables them to consider coping strategies and to undergo self 
regulation, which is likely to enhance the effectiveness of the intervention   recent 
research suggests that written disclosure may be more effective for those with good 
physiological self regulation.  In a study of bereaved adults, O’Connor, Allen, and 
Kazniak (2005) found that within the disclosure group, higher first session repiratory 
sinus arrhythmia (an indicator of vagal control of the heart) was related to a better 
outcome.  This could reflect greater vagal withdrawal during disclosure induced 
sympathetic arousal, possibly leading to a faster desensitisation response later.  
Gidron et al. (2002) found that the GDP reduced visits to general practitioners (GPs) 
in frequent attendees, an effect that was maintained at a 15 month follow up.  This  
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contrasts with a study by Schilte et al. (2001), which found that typical non guided 
writing did not reduce GP visits in frequent attendees.  However, it is not possible to 
compare Schilte et al.’s (2001) study directly with other writing studies, since the 
writing in that study was a summary of two 45 minute one to one sessions with a GP 
who invited participants to disclose important events in their life.  Duncan et al. (2007) 
found that the GDP reduced PTSD symptoms in parents of children with cancer.  
However, this finding needs to be treated with caution, as this study was based on a 
sample of only 8 parents, and it therefore utilized an AAB design as opposed to a 
randomized controlled trial.  The GDP has also improved sense of coherence in 
individuals writing about a controllable event, possibly because it raises their awareness 
of a sense of control in their lives (Arden Close, Gidron, & Duncan, 2005).  However, 
at the moment there is only tentative support for the effectiveness of cognitive 
processing instructions.  Gidron et al. (2002) had a small sample, which reduces 
generalizability of their results.  More large scale studies assessing the effectiveness of 
the GDP are therefore required. 
In a study examining the impact of cognitive processing instructions, Lutgendorf 
and Antoni (1999) found a decrease in levels of intrusive thoughts one week following 
completion of the writing, but no changes in avoidance.  Greater involvement in the 
disclosure and more negative mood arousal were associated with greater insight by the 
end  of  the  session.    They  suggest  that  written  disclosure  may be  more  effective  in 
stimulating  changes  in  cognitive  processing  for  those  who  ruminate  about  their 
problems, and that high levels of intrusive thoughts at study entry may have relevance 
to populations dealing with traumas such as life threatening diagnoses.  The participants 
in the current research are patients with ovarian cancer, which has a poor prognosis, or 
their spouses.  The fact that they have joined a support group suggests a willingness to 
engage with their illness, and it is therefore expected that levels of avoidance will be 
low. 
4.3.2 Written disclosure in chronic illness 
  Originally, many written disclosure studies were carried out on healthy students.  
However, results of these studies have limited relevance for individuals with life 
threatening illnesses outside their contribution to theory.  Therefore, this section focuses 
on studies of written disclosure carried out on people with physical illness.  The 
majority of such studies have been carried out in individuals with rheumatoid arthritis, 
asthma and fibromyalgia, which are chronic, rather than life threatening.  Nevertheless,  
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such studies provide valuable insights into methodological issues, and can be compared 
to cancer when addressing the impact of the illness on lifestyle, and the impact of 
writing on illness specific measures. 
Several studies have been carried out on individuals with rheumatoid arthritis 
(RA) (Broderick, Stone, Smyth, & Kaell, 2004; Danoff Burg, Agee, Romanoff, Kremer, 
& Strosberg, 2006; Kelley, Lumley, & Leisen, 1997; Smyth, Stone, Hurewitz, & Kaell, 
1999; Wetherell et al., 2005).  Those considered to be most relevant to the current study 
are discussed in detail.  Kelley et al. (1997) required their participants to talk into a tape, 
as RA causes difficulty with writing.  Disclosure led to reductions in physical 
dysfunction and affective disturbance from baseline to three month follow up, and 
larger increases in negative affect after disclosure (possibly caused by recalling and 
experiencing affective memories, and thus suggesting a greater depth of processing) 
were correlated with greater improvement in joint condition.  However, the participation 
rate was low, suggesting that many patients may be reluctant to engage in such research 
  perhaps only those accepting or capable of deeper emotional processing remained in 
the study.  Smyth et al. (1999) found that written disclosure led to improvements in 
forced expiratory volume in patients with asthma and improvement in overall disease 
activity in patients with RA.  Interestingly, health improvements in the trauma writing 
group were not mediated by quality of sleep, substance use, medication use, affect, 
stressful experiences or social contact with others (Stone, Smyth, Kaell, & Hurewitz, 
2000), possibly because the variables were measured over an inadequate time frame, 
there was inadequate statistical power to detect small changes in potential mediators, or 
other variables mediated the effect of writing on clinical outcomes.   
Hamilton West and Quine (2007) found that written disclosure led to 
improvements in functional status at 3 month follow up in patients with ankylosing 
spondylitis (similar to rheumatoid arthritis), which were related to word usage.  
Improvement in disease activity was associated with an increase in use of positive 
emotion words, and a decrease in the use of sadness/ depression words.  Improvement 
in functional status was associated with a decrease in sadness/ depression words, an 
increase in tentative words, and a decrease in certainty words.  Improvements in 
psychological health were associated with a questioning approach characterised by a 
move away from the use of words relating to certainty and towards the use of words 
relating to tentative possibilities.  This evidence highlights the importance of assessing 
word usage as a potential moderator of improvement.    
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Broderick et al. (2004) compared standard writing with enhanced meaning 
writing (similar to the GDP – individuals were required to consider a traumatic event in 
a comprehensive, integrated way, and relate it to effects and changes in their beliefs and 
life views), and had two control groups, one for time management writing, and one for 
attention.  Those in the enhanced meaning group showed an improvement in disease 
activity relative to the other groups at 4 6 month follow up.  However, only 49% of 
those who volunteered to participate completed the task, and the results were non 
significant when intention to treat analyses were carried out.  These results suggest that 
further research should be carried out in order to identify who benefits from writing.  
Broderick, Junghaenel, and Schwartz (2005) carried out a study of written disclosure in 
fibromyalgia patients.  The writing in this study followed a format similar to the Guided 
Disclosure Protocol, with the only difference being that on the first day, participants 
were required to use emotional expression and cognitive reappraisal after they had 
retold the story factually.  Written disclosure led to decreases in pain and depression, 
and an increase in psychological well being, whereas the control groups (a neutral 
writing group, and a usual care group), worsened on all measures.  The effect sizes were 
similar to those found in pharmaceutical clinical trials.  Thus, evidence from this study 
suggests that the GDP could benefit people with chronic illness.   
Very  few  studies  have  been  carried  out  on  patients  with  life threatening 
illnesses.  Petrie, Fontanilla, Thomas, Booth, & Pennebaker (2004) in a study of patients 
with HIV, found that written disclosure led to an immediate reduction in viral load, 
which was followed by increases in the CD4+ lymphocyte count over the following six 
months,  compared  to  no  change  in  the  control  group.    They  suggest  that  written 
disclosure may lead to a reduction in catecholamine/cortisol elevations that result from 
an unresolved stressor, and may therefore be more useful for those who are socially 
isolated and lack a close confidant.  In support of this view, Esterling, Antoni, Kumar & 
Schneiderman (1990) found that repressors who wrote expressively had higher levels of 
Epstein Barr virus after writing.  In the current study, it is expected that the intervention 
will  provide  an  opportunity  for  partners  to  disclose  concerns  in  a  non threatening 
environment. 
Nine studies of written disclosure in clinical populations were reviewed in a 
meta analysis (Frisina, Borod, & Lepore, 2004).  The mean weighted effect size was d = 
.19, which was significant at p <.05.  Further analyses found the effect to be significant 
for physical health outcomes, but not psychological health outcomes.  However, the  
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reasons given for excluding several studies were unclear.  Further, the review failed to 
include several relevant articles.  Thus, only limited conclusions can be drawn.   
 
4.3.3 Written disclosure in cancer patients 
It is important to note that the underlying response to writing may vary across 
patient groups.  As there are very few studies per patient group, it is difficult to 
determine if the medical characteristics of samples or small procedural differences are 
responsible for the varying impact of written disclosure (Harris, Thoresen, Humphreys, 
& Faul (2005).  To illustrate this, Smyth et al. (1999) found improvement by two weeks 
in patients with asthma, whereas for patients with rheumatoid arthritis there was a clear 
improvement only after four months.  However, to date, only five studies have looked at 
written disclosure in cancer patients.  These studies are discussed in detail in Table 5, 
and quality assessed based on the number of CONSORT guidelines (developed to 
assess the quality of randomized controlled trials) they met (Moher, Schulz, & Altman, 
2001). 
First, possible reasons for some pertinent results reported in Table 5 are 
addressed, in order to put them in context. The lack of positive outcomes in Walker et 
al. (1999) may have been due to low statistical power and failure to assess physical 
outcomes, which generally show more robust effects than psychological outcomes 
(Frisina et al., 2004). Further, positive mood was close to ceiling level, meaning that it 
was not possible to detect improvement.  The results from this study should not 
therefore be taken as evidence that written disclosure is not helpful for cancer patients.  
Zakowski et al. (2004) suggested that a possible mechanism for their findings regarding 
avoidance and social constraint is that written disclosure provided the participants with 
a stimulus to begin speaking more effectively and with less distress about their 
emotions, whereas high levels of social constraints may have been associated with 
continued cognitive avoidance of cancer related thoughts and stimuli in the control 
group at follow up.  Avoidance may be detrimental in the long term, because it prevents 
the individual from confronting and processing threat and possibly acting to solve it.  
Based on these findings, the current study aims to reduce avoidance by asking both the 
woman and their partner to write about her cancer, which may then enable them to 
discuss it more openly. 
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Table 5: Studies of written disclosure in cancer patients 
 
Study  Sample 
population 
(size) 
Design  Findings  CONSORT 
score 
( /22) 
(Walker, 
Nail, & 
Croyle, 
1999)  
Breast cancer 
patients 
completing 
radiotherapy 
(44) 
T: Write deepest 
thoughts and feelings 
about cancer 
C: Usual care 
No effect on any of the 
measures 
11 
(Rosenberg 
et al., 2002) 
Prostate cancer 
patients (30) 
T: Write about 
deepest thoughts and 
feelings regarding 
cancer 
C: Usual care 
Reduced pain 
Trend towards improvement in 
health care utilization 
12 
(de Moor et 
al., 2002)  
Stage IV renal 
carcinoma 
patients (42) 
T: Write about cancer 
C: Write about health 
behaviours 
Improved sleep (Pittsburgh 
Sleep Quality Index) (4, 6, 8 
and 10 wk follow ups) 
13 
(Zakowski, 
Ramati, 
Morton, 
Johnson, & 
Flanigan, 
2004) 
New diagnosis 
of prostate/ 
gynaecological 
cancer (13.5% 
ovarian) (104) 
T: Write about parts 
of cancer experience 
they found hard to 
share with others 
C: Describe daily 
activities non 
emotionally 
T: Decrease in distress (BSI) if 
high levels of social constraint 
(Compared to increased 
symptoms and avoidance in 
among those with high social 
constraint in control group) 
 
12 
(Stanton et 
al., 2002)  
Women with 
Stage I/ II 
breast cancer 
within 20 
weeks of 
completing 
treatment (60) 
T1: Write about 
deepest thoughts and 
feelings regarding 
breast cancer 
T2: Write about 
positive thoughts and 
feelings regarding 
cancer 
C: Write facts about 
cancer 
Decrease in physical 
symptoms 
Fewer medical appointments 
for cancer related morbidity 
Decrease in distress if low 
cancer related avoidance 
Both treatment conditions 
beneficial 
20 
 
The implications of the extent to which the studies in Table 5 met CONSORT 
guidelines are now discussed, in order to assess the strength of the evidence and how 
this affects the conclusions that can be drawn.  Both Walker et al. (1999) and Rosenberg 
et al. (2002) failed to meet requirements related to randomization and blinding, which  
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have been shown to impact seriously on trial outcomes.  However, since these studies 
found few significant results and are more like pilot studies, due to small sample size, 
these results are unlikely to significantly bias scientific opinion.  Similarly, de Moor et 
al. (2002) defined their study as a pilot study and note that their results need further 
exploration.  Further, this study had some strengths   effect sizes were reported and the 
method of randomization was explained.  The study by Zakowski et al. (2004) however, 
suffers from several serious flaws   requirements related to randomization and blinding 
were not met, and the findings were reported in a way that led readers to believe process 
variables were primary outcomes.  The lack of significant results was glossed over.  
This was possible as trial protocols are not published for written disclosure studies.  
Further, pre post differences in distress within the intervention group were smaller than 
initial differences between the intervention and control groups (Coyne, Lepore, & 
Palmer, 2006b).  However, the fifth study (Stanton et al., 2002) was well designed, with 
the main limitations being the number of primary outcomes, and failure to mention the 
start and end dates of the study. 
Overall, only limited conclusions can be drawn from the research assessed 
above, due to small sample sizes, and failure to report details of randomization and 
blinding.  Further, there were considerable differences between the studies regarding 
type of cancer investigated, writing content and outcomes, which limit the extent to 
which they can be compared.  Nevertheless, positive findings from a high quality study 
(Stanton et al., 2002) provide an impetus for further studies testing the efficacy of 
written disclosure in cancer patients.  The evidence for assessing the efficacy of written 
disclosure in couples is now addressed. 
 
4.3.4 Written disclosure in the context of relationships 
Although traumatic events are often interpersonal, the research literature tends to 
emphasize intrapersonal processes and consequences.  The occurrence of a traumatic 
event to someone may have important implications for his/her partner.  However, the 
written disclosure literature has mainly considered people in isolation, although there 
are some exceptions.  Snyder, Gordon, and Baucom (2004) carried out a study of 
written disclosure in couples where one partner had experienced an extramarital affair.  
Treatment led to decreases in depression and PTSD related symptoms, reductions in 
state anger and global marital distress, decreases in negative assumptions, and increases 
in forgiveness towards the partner for affected/hurt spouses.  The effect sizes were  
 
82 
moderate to large, exceeding the average for effective marital therapies not targeting 
affair couples.  However, here the written disclosure was carried out as part of a 
structured intervention with a therapist, whereby the partners were required to write 
letters to each other.   Thus, it is not clear whether written disclosure facilitated the 
other interventions or required the other treatment components to achieve its benefits.  
Further, it is not clear what individual relationship processes moderated or mediated the 
effects of written disclosure.  
Other studies, despite addressing relationship processes, have only involved one 
member of the couple.  For example, Slatcher and Pennebaker (2006) found that among 
undergraduates who had been in a committed heterosexual relationship for an average 
of 1.3 years, those who wrote their deepest thoughts and feelings about their current 
romantic relationship were significantly more likely to still be dating their partners at 
three month follow up, relative to those who wrote about their daily activities.  Analysis 
of instant messages before and after the writing, and at three month follow up revealed 
that both members of the couples increased the use of positive emotion words in their 
text messages at similar rates, even though only one member had participated in the 
expressive writing manipulation.  It appears that the effects of writing transferred to the 
non participant partners, possibly through changes in the way in which the participant 
interacted with them after the intervention.  Lepore and Greenberg (2002) found that 
among members of couples who had experienced a relationship break up approximately 
six months previously, those who wrote their thoughts and feelings about the 
relationship were more likely to reunite with their ex partner, and felt significant 
decreases in resentment towards their ex partner, guilt over the break up, and symptoms 
of intrusions and avoidance at 15 weeks follow up.  In contrast, the control participants, 
who were told to develop rational arguments about impersonal topics, experienced 
higher levels of intrusive thoughts and avoidance, which were associated with increases 
in upper respiratory symptoms.   
Overall, the few studies available suggest that writing is beneficial with regard 
to feelings about romantic relationships.  There are several differences between the 
studies discussed above and the current research – they were carried out on 
undergraduates, who had been in relationships for a much shorter period of time, they 
involved only one member of the couple, and the writing focused on the relationship. 
The current research will require both partners to write and will focus on the wife’s 
cancer. Nevertheless, the evidence suggests that writing leads to positive benefits for  
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couples, possibly initiated through changes in the way in which the member of the 
couple who participated in the expressive writing intervention interacts with his/her 
partner, following reflection on their relationship.  Although the participants in the 
current research will not be required to write about their relationship, diagnosis and 
treatment of cancer in women impacts heavily on male partners (Baider & De Nour, 
1999) and may have led to changes in marital interactions.  Writing may provide a 
framework for couples to explore issues surrounding the diagnosis and how it has 
impacted on their relationship, thereby reducing any constraint they may previously 
have felt regarding such issues. 
 
4.4 Theory: Why does written disclosure work? 
 
Several theories have been developed to explain the positive outcomes following 
written disclosure.  These include the emotional inhibition hypothesis, the cognitive 
adaptation hypothesis, the exposure/emotional processing theory and the social 
interaction hypothesis.   
4.4.1 Emotional inhibition hypothesis 
According to the emotional inhibition hypothesis, those who inhibit their 
emotions may be more prone to physical impairments and disease than if they are 
emotionally expressive (Cohen & Herbert, 1996).  Inhibited anger and hostility have 
been linked to hypertension and CHD (Barefoot, Larsen, von der Lieth, & Schroll, 
1995).  Also, emotional inhibition may be linked to cancer progression (Garssen, 2004).  
Suppression of emotion increases sympathetic activation (Gross, 1998), and chronic 
sympathetic activation (caused by increased stress) leads to adverse physical and 
psychological outcomes, particularly infectious illnesses (Cohen & Williamson, 1991).  
Pennebaker (1989) hypothesised that disclosure may lead to reduction in stress, and thus 
improved immune functioning and health.  In support of this hypothesis, written 
disclosure has led to improvement in immune function i.e., proliferation of T helper 
cells, antibody response to the Epstein Barr virus (Esterling, Antoni, Fletcher, 
Margulies, & Schneiderman, 1994), immune response to hepatitis B vaccinations 
(Petrie, Booth, Pennebaker, Davison, & Thomas, 1995), and enhanced wound healing 
(Weinman, Ebrecht, Scott, Walburn, & Dyson, 2008). 
However, there is no evidence that decreases in inhibition mediate the 
relationship between writing about traumatic events and improved health.  For example,  
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Greenberg and Stone (1992) found no differences in reported health or physician visits 
at two month follow up between those writing about undisclosed and previously 
disclosed traumas.  In addition, Greenberg, Wortman, and Stone (1996) found that 
writing about deep emotions regarding imaginary traumas produces the same effects as 
writing about deep emotions related to experienced traumas.    Further, evidence 
suggests that emotional expression and cognitive assimilation may be more effective 
than emotional expression only (Ullrich & Lutgendorf, 2002).  Overall, the evidence 
does not provide support for the emotional inhibition hypothesis.  It is therefore 
necessary to explore other theories to explain the beneficial effects of written disclosure. 
4.4.2 Cognitive adaptation hypothesis 
The cognitive adaptation hypothesis holds that processing of a traumatic 
experience requires changing of existing schemas (Janoff Bulman, 1992).  According to 
this hypothesis, information processing regarding specific events is guided by schemas 
that are relatively stable.  Affectively overwhelming experiences interfere with the 
cognitive integration of traumatic events to an inner model, and may result in the 
storage of memory as sensory perceptions/obsessional ruminations/behavioural 
ruminations without integration into mental schemas.  Since such memories lack 
linguistic components, they cannot be effectively communicated or organized 
(Horowitz, 1986).     
Horowitz (1986) hypothesised that resolution of a traumatic event is 
characterized by alternating cycles of intrusion and avoidance.  According to this 
model, avoidance protects individuals from being overwhelmed by their emotions.  
However, intrusions, which lead to continual activation of the nervous system and HPA 
axis, pave the way for the assimilation of new information.  These alternating cycles 
allow disturbing information to be assimilated and worked through in manageable 
doses.  Being able to confront a stressful event that has been avoided increases the 
chance of resolution of that event.  Decreased avoidance leads to a change in cognitive 
emotional processing, and decreased intrusive thoughts lead to a greater sense of 
integration with the stressful event.  Activation of relevant cognitive emotional schemas 
accompanied by new information incompatible with previously existing cognitive 
affective schemas brings about psychological change.  Reprocessing may involve 
returning to traumatic memory repeatedly in attempts to achieve integration with the 
existing mental schema, which is necessary for complete recovery.  Cognitive change  
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requires the integration of thoughts and feelings.  Once the meaning of the event makes 
sense, the emotional effects associated with it are more manageable.   
According to the cognitive adaptation hypothesis, written disclosure may 
provide a context for the controlled activation of trauma schemas enabling the logical 
restructuring of illogically stored memories into a coherent narrative (Lutgendorf & 
Antoni, 1999; Pennebaker, 1997; Smyth & Pennebaker, 1999; Smyth, True, & Souto, 
2001).  The facing of avoided topics in a nonthreatening context helps individuals 
reorganize and integrate thoughts and feelings related to the experience, thereby leading 
to resolution of the traumatic event and to improved physical health (Lutgendorf & 
Antoni, 1999).  In support of this idea, decreasing disorganization is associated with 
improvements in narratives from the victims of personal trauma during exposure 
treatment (DeSavino et al., 1993), and predicts better prognosis (Foa et al., 1995).  
However, many people may require specific instructions on how to order their 
memories and reflect on how the event impacted on their life, as in the GDP.   
     In order to explore these hypotheses further, it is important to look at the 
correlations between words used in the writing tasks and benefit gained from writing, as 
this may provide insight into the process by which improvements take place.  
Pennebaker and Francis (1996) found that use of more positive emotion words and a 
moderate number of negative emotion words were associated with improved health 
outcomes.  Those who use very few negative emotion words may be repressive copers, 
whereas those who use high numbers of negative emotion words may be high in 
neuroticism.  Further, Pennebaker, Mayne, and Francis (1997) suggest that labelling 
emotions reduces the perceived intensity of the experience, and increases sense of 
control over affective experiences, thereby aiding in integrating emotional reactions into 
the general understanding of a traumatic event.  Studies on relations between content 
analyses and outcomes support the variability between participants and the need to 
guide participants, to maximize benefits from writing. 
Health improvements have been associated with an increase in causal and 
insight words over the three days, suggesting that some participants are constructing a 
story over time whose elements were meaningfully linked, following reflection 
(Pennebaker & Francis, 1996; Pennebaker, Mayne, & Francis, 1997). Such organization 
of narratives may have led to health improvements.  Those who use high levels of 
cognitive words throughout the writing may enter the study with a preconceived 
explanation of their emotional experience.  However, the evidence is correlational –  
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changes in language may be affected by other mechanisms.  Also, in many studies, there 
is cognitive and/or linguistic change in the absence of physical/ psychological 
improvements.  In order to test this theory, Smyth et al. (2001) carried out a study with 
three groups – control, narrative, and listing the event in a fragmented way.  This study 
included only one session because it was thought that more sessions would lead the 
fragmented experimental group to form a narrative.  The hypothesis that intrusions 
would be reduced by the narrative was not supported – the narrative group experienced 
higher levels of avoidant thinking following the writing.  However, multiple sessions 
may be required for increases/improvements in narrative function, as they provide the 
individual with an opportunity to habituate to the traumatic memory over several days 
and perhaps achieve reorganisation and greater insight into the event.  Alterations in 
narrative may underlie cognitive and physical benefits from written disclosure.  In 
support of this idea, Greenberg et al. (1996) found that a single writing session led to 
increases in avoidant thinking.   
Lutgendorf and Antoni (1999) found that moderate emotion and a high level of 
involvement in the disclosure process (from detached to having emerging insight) was 
associated with positive outcomes.  Similarly, an increased level of insight, 
understanding and involvement has been associated with better immune functioning 
post disclosure (Esterling et al., 1994).  However, a moderate level of reflection appears 
to be optimal.  Suedfeld and Pennebaker (1997), found that in the essays from 
Pennebaker et al. (1988), scores closer to the median level of complexity were 
associated with greater improvements in health, which may have been indicative of 
allowing enough resources to analyze and come to terms with their memories of 
severely negative experiences.  Higher levels of complexity may have been 
characteristic of brooding, obsessive rumination, or an attempt to process an 
unnecessarily large amount of information.   
However, it is necessary to address the nature of cognitive complexity in order 
to understand it fully.  In order to do this, Creswell et al. (2007) analysed the essays 
written by the cancer patients in Stanton et al. (2002) for self affirmation, defined 
cognitive processing plus discovery of meaning.  They suggest that cognitive processing 
alone can be construed as rumination, whereas cognitive processing combined with 
discovery of meaning (enhanced appreciation for life and recognition of its fragility as a 
result of a traumatic event) is characteristic of successful reconciliation to the traumatic 
event.  In support of this idea, self affirmation mediated the effects of writing on  
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reductions in physical symptoms, whereas cognitive processing alone had no effects.  
This evidence suggested an independent psychological pathway by which writing leads 
to health benefits. However, the writing groups were not compared – the mediation may 
have been carried by positive correlations in the group writing about perceived benefits 
of breast cancer.  Nevertheless, as a possible mechanism for this pathway, Creswell et 
al. (2007) suggest that expressive writing may have buffered the stress associated with 
writing about cancer related thoughts and feelings.  Such reduced defensiveness may 
have enhanced efforts at maintaining involvement during writing and facilitated efforts 
to work through difficult cancer related thoughts and feelings.   
Park and Blumberg (2002) assessed cognitive appraisal of the event 
(uncontrollability, threat, stressfulness, intrusions, avoidance) prior to writing, on the 
last day and four months later.  They hypothesised that the cognitive model would be 
supported if a positive outcome was associated with change in appraisal of the event.  
However, although appraisal improved from pre writing to follow up for the disclosure 
group, there were no improvements in self reported emotional and physical health.  
Admittedly, it is difficult to measure cognitive changes   content analysis may not 
necessarily be able to capture the nuances of cognitive restructuring important for 
positive change.  Alternatively, cognitive changes may be an outcome of successful 
exposure, rather than a prerequisite of positive health outcomes in written disclosure.  
Overall, there is some evidence suggesting that cognitive processing is associated with 
improved health.  However, this relation appears to be complex, and requires further 
exploration, particularly of the self affirmation findings.   
4.4.3 Exposure/ emotional processing theory 
Alternatively, the positive effects as a result of written disclosure may be 
explained by the exposure/emotional processing theory.  Watson, Gaind, and Marks 
(1972) found that in phobic clients, exposure to fearful stimuli promoted physiological 
and psychological habituation, leading to a reduction in the fear response over time.  
Exposure reduces fear by activating the fear structure through exposure to feared stimuli 
and providing corrective information about the stimuli, responses and meanings (Foa & 
Kozak, 1986).  Written disclosure allows the individual to be exposed to aversive 
conditional stimuli (memories) and other cues that were previously avoided.  Repeated 
exposure to these adverse stimuli through several writing sessions may allow for the 
extinction of negative emotional associations (UCS CS associations), or activate the 
fear structure and provide corrective information, thereby leading to beneficial outcome.   
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Thus, written disclosure may overcome the tendency to avoid or suppress distressing 
memories/ emotions/physiological sensations.   
In support of this hypothesis, research has shown that disclosure is associated with 
greater salivary cortisol reactivity and more self reported arousal in response to the first 
writing session, relative to controls, whereas this difference is not observed at 
subsequent sessions.  These findings hold across both women with moderate levels of 
PTSD symptom severity (Kloss and Lisman, 2002), and trauma survivors with high 
levels of psychological distress (Sloan & Marx, 2004a).  Disclosure in these studies led 
to reductions in PTSD symptoms and depressive symptoms.  Importantly, in Kloss and 
Lisman’s (2002) study, greater physiological activation in response to the first session 
was significantly associated with these improvements.  However, the participants were 
only followed for four weeks – effects may diminish over time.  Further, the 
physiological measure is sensitive to novelty – the disclosure participants may not have 
shown physiological reactivity to the second and third writing sessions because the 
procedure was no longer novel, although the self reports suggested this is unlikely.    
Thus, these studies provide some support for the exposure theory.  However, in the 
instructions, participants were allowed to choose the topic to write about, whereas Foa 
and Rothbaum (1998) stated that exposure to the same traumatic experience/ memory is 
critical for extinction/ habituation, an idea that has been supported by both case studies 
(Sloan & Marx, 2006) and experimental studies (Bernard, Jackson, & Jones, 2006).   
Support for this hypothesis was also reported by Sloan, Marx, Epstein, & 
Lexington (2007) who found that emotional expression (writing with as much emotion 
and feeling as possible) was more effective than insight and cognitive assimilation 
(focusing on what the event meant and how it changed their lives, and challenging 
dissonant thoughts), leading to fewer depressive symptoms, physical health complaints 
and PTSD symptoms at one month follow up.  Importantly, the relation between 
experimental condition and changes in PTSD symptoms was fully mediated by changes 
in self reported arousal.  These results showed a link between confronting emotions 
related to the event and improvements in physical and psychological symptoms.   
  Alternatively, the extinction of negative emotions may be achieved through 
constant elicitation of intense negative affect, regardless of the eliciting stimulus.  
Watson, Gaind, and Marks (1971), found that in individuals with a phobia, exposure to 
stimulus specific cues and fear specific cues were equally effective at reducing anxiety 
when the clients were subsequently confronted with stimuli related to their phobia.   
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According to this theory, the beneficial effects of written disclosure may be partly due 
to response related habituation.  Emotional expression in a safe context such as written 
disclosure should attenuate negative affective and physiological responses to stress 
related stimuli through repeated exposure (Bootzin, 1997).  Habituation may lead to 
decreases in emotional arousal between sessions.  In support of this idea, Greenberg et 
al. (1996) found no difference in health centre visits at follow up between students who 
wrote about past personal traumas and those who wrote about imaginary traumas.   
Finally, as evidence to support this theory, there should be changes in posttraumatic 
stress symptoms following written disclosure.  This has been supported by a reduction 
in intrusive thoughts and images in some studies (Kloss & Lisman, 2002; Sloan & 
Marx, 2004a), but other studies have shown no effect.  However, methodology has 
varied across studies: some used small samples, meaning that there may have been 
insufficient power to examine outcome effects; some used a single writing session, 
which may have been inadequate to extinguish negative emotions; and length of time 
until follow up has varied.  The final point is important because Nishith, Resick, and 
Griffin (2002) found that during a course of treatment, female rape victims increased in 
trauma related avoidance prior to improving.  Also, the study populations have varied 
widely: some have been individuals seeking treatment, and some have been college 
students either randomly selected or pre selected based on their trauma history.  The 
presence and severity of psychological symptoms varied considerably across these 
populations – written disclosure may work best with low to moderate levels of 
symptoms.  Alternatively, there may be individual differences in ability to 
chronologically structure disclosed memories, which may influence arousal systems and 
also account for part of the effects of repeated self exposure via writing.  However, the 
GDP may reduce these differences, since individuals are given guidance on how to 
structure their writing, based on cognitive neuroscience principles.  
4.4.4 Social interaction hypothesis 
When people write about traumatic experiences, they are writing about social 
issues (Pennebaker, 2004).  Rime, Mesquita, Philippot, and Boca (1991) suggest that 
social sharing is important in processing and resolving trauma.  One theory holds that 
written disclosure is beneficial because it results in changes in social and linguistic 
behaviours, leading to increased social connections (Pennebaker & Graybeal, 2001)).  
In support of this idea, Pennebaker, Barger, and Tiebout (1989) asked Holocaust 
survivors to talk about their experiences during and immediately following WWII.   
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These emotionally charged interviews were videotaped and a copy of the videotape was 
given to the participants.  Although prior to the interviews, 70% of the participants had 
not talked to anyone about the Holocaust, at follow up interviews several weeks later, 
almost all the participants had viewed the videotapes twice, and shown them to at least 
three others.  Giving these testimonies led to changes in the ways these participants 
related to others and thought about their pasts, and to important health benefits (reduced 
physician visits in the months post interview), even though 40 years had passed since 
the traumatic event.  Pennebaker and Graybeal (2001) suggest that talking about 
personal experiences helps people in several ways.  First, talking helps the person to 
come to a cognitive understanding of their traumatic experiences, partly because others 
may put forward more adaptive cognitive perspectives regarding the event.  Second, 
talking alerts others to the person’s psychological state, enabling him/her to remain 
socially tied to others.  Written disclosure may help to break down social constraints, 
thereby providing individuals with a stimulus to talk more about emotions related to 
traumatic experiences (cf. Zakowski et. al, 2004).  Finally, people may actually disclose 
traumatic memories differently after writing about them, perhaps with greater insight 
and less chaos, which may be less socially deterring to others.  Certainly, most 
respondents to surveys report the need to share their feelings with others following a 
traumatic event (Rime, Philippot, Boca, & Mesquita, 1992), and disclosure of trauma 
helps to resolve stressful experiences.   
   However, many traumatic experiences are never disclosed.  Pennebaker and 
Susman (1988) found that across a wide range of traumas varying in social 
acceptability, at least 20% of the respondents did not confide the event to others.  
Henderson, Davison, Pennebaker, Gatchel, and Baum (2002), in a study of 272 breast 
cancer patients, found that although over half reported at least a moderate desire to talk 
with others about their cancer, one third reported that they preferred not to discuss it 
with anyone in their social network.  Factors related to increased disclosure included 
more severe disease, younger age and being more optimistic.  Although this study was 
retrospective, meaning that recall of disclosure may have been biased, it nevertheless 
provides insight that disclosure is a coping strategy used in an attempt to develop new 
insights, find significance in the experience of cancer, and seek and obtain emotional 
and instrumental support.  Those who are more optimistic may anticipate greater 
receptivity from potential disclosure targets, have interpersonal communication  
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pathways characterized by relatively high levels of collaboration and trust, and have the 
ability to find personal growth in trauma, factors that may increase social sharing.  
  Often, since there are no clear social norms for talking about traumatic 
experiences, friends or even family are unsure about how to respond to disclosure of a 
traumatic event following the trauma.  Further, although disclosing traumatic events 
may be associated with psychological and physiological benefits, including drops in 
skin conductance (Pennebaker et al., 1989), watching/hearing about emotional events is 
associated with adverse biological changes, such as increased skin conductance (Shortt 
& Pennebaker, 1992).  However, it is important to clarify how levels of social support 
vary following a traumatic event and its disclosure.  Pennebaker, Colder, and Sharp 
(1990), in a study of 40 bereaved parents attending support groups, found that in the 
first 2 4 weeks after their children’s deaths, their friends and acquaintances were very 
helpful, but then interactions became stilted.  To explore post trauma interaction in 
more detail, Pennebaker and colleagues have examined mass social reactions to large 
scale upheavals, including the Loma Prieta Earthquake of October 1989 and the Gulf 
War (Pennebaker & Harber, 1993).  Social reactions to the events were similar: people 
talked and thought about them at very high levels during the first two weeks following 
the event; then there was then a significant drop in talking about the event, but thinking 
about it remained at high levels and self reports of physical symptoms, anxiety and 
arguments increased; and by eight weeks following the event, thinking and talking 
about it were both at relatively low levels.  The first shift appeared to be primarily due 
to social constraint – from 2/3 weeks after the events onwards, people reported that 
while they would like to talk about their own experiences, they would not like to hear 
stories about others’ experiences.  After a certain amount of time, individuals do not 
wish others to discuss their feelings about a catastrophe.   
With regard to an individual upheaval, lack of interest is particularly hard for the 
traumatized person, because the event affects them maximally, and the desire to talk 
about the event remains much greater for them over a much longer period of time than 
for individuals in their support network.  If trauma related thoughts are not validated by 
others, people are more likely to consider them inappropriate or abnormal.  Thus, social 
constraints may interfere with the ability to process traumatic events (Lepore, Silver, 
Wortman, & Wayment, 1996), by increasing arousal.   
However, amount of talking is not simply a function of desire to talk, but also 
depends on the receptiveness of the social network, relative success of cognitive  
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processing of the loss, and degree of emotional recovery.  Although on one level trauma 
victims would be better off by not inhibiting themselves so much, encouraging people 
to stop inhibiting themselves may adversely affect their social networks.  Written 
disclosure may therefore be effective as an intervention because it enables people to 
release their deepest thoughts and feelings to an ‘implicit audience’ without hostile 
reactions.  This may then enable them to interact with others in a more positive way, 
since they experience lower levels of distress and may have greater self control.  
However, this theory has only been tested in a handful of studies.  Kim (2008) in a 
study on bilingual students who wore a computerized tape recorder (EAR) for two days, 
found that those who were required to switch between writing in their native and 
acquired languages talked more and spent more time in dyadic interactions at one month 
follow up than those who wrote in a single language and control participants.  Other 
studies have shown that participants in written disclosure studies are likely to talk about 
their traumatic experience more frequently post disclosure than pre disclosure (Kovac 
& Range, 2000; Schoutrop, Lange, Hanewald, Davidovich, & Salomon, 2002).  
However, to date, there is mixed support for this theory – Frattaroli (2006) in a meta 
analysis, found that emotional writing did not lead to greater likelihood of discussing 
the event, and although it was more likely to improve social relationships, this effect  
was small, based on a small number of studies, with a fail safe N of 2.  It appears that 
further research is required.   
Alternatively, writing may provide an alternative way to cope with stress, and a 
new understanding of stressful experiences. In support of this idea, Langens and Schuler 
(2005) found that written disclosure led to lower levels of negative mood at follow up 
in individuals high in fear of rejection, even after controlling for neuroticism, possibly 
by compensating for the impaired capacity to down regulate negative mood caused by 
diminished perceptions of social support.  Similarly, Gortner, Rude, and Pennebaker 
(2006) found that expressive writing led to reductions in depressive symptoms at 6 
month follow up in individuals high in suppression who had experienced elevated levels 
of depressive symptoms in the past.   
4.4.4.1 Implicit audience 
Brody and Park (2004) suggest that participants are writing for an ‘implicit 
audience.’  Sharing may promote an implicit sense of accountability and a desire to talk.  
To date, the two studies which allowed participants to retain the writing found no effect 
(Ames et al., 2005; Broderick et al., 2004).  As the writing was not monitored, it is  
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possible that the participants did not follow the instructions (i.e., they may have taken 
breaks in the middle of the writing, or done it only for a few minutes).  Radcliffe, 
Lumley, Kendall, Stevenson, & Beltran (2007) found that writing shared with 
researchers led to reduced interpersonal sensitivity, depression, and avoidance, whereas 
private disclosure led to reductions in avoidance only.  When writing with an audience 
in mind, the participants may have either processed the stressor more fully, or written 
about secrets. Alternatively, they may have chosen to write about more difficult 
stressors/ conflicts.  However, this would not be possible to test ethically, as it would 
involve the use of deception in a supposedly ‘private writing’ group.  
  Pennebaker (2004) puts forward factors that should be taken into account during 
the stages in the interval between the written disclosure intervention and outcome.  
Initially, there are cognitive changes – the individuals have to label, structure and 
organize the event, present information in a linguistic structure often for the first time, 
to an implicit audience and themselves.  It is often difficult to understand this stage and 
determine whether it is associated with long term health.  There are also immediate 
emotional changes such as habituation and extinction, which may reduce the impact of 
thoughts surrounding the trauma.  However, it is also difficult to link this stage to long 
term physical health.  Thinking less about the trauma enables the individual to devote 
his/her thoughts to other issues.  Alternatively, Lepore (1997) suggests that the 
immediate emotional arousal associated with writing dissipates over time, leading to 
fewer emotionally charged thoughts about the writing topic within weeks.    
Further studies exploring the experiences of participants in writing studies are 
necessary, in order to gain insight into how benefit might occur.  To date, however, only 
one study has addressed this issue.  Byrne Davis et al. (2006) reported on the 
experience of a sub sample of the participants in Wetherell et al.’s (2005) study of 
written emotional disclosure in rheumatoid arthritis (nine intervention, six control).  
Several processes of improvement appeared to be taking place – finding resolution by 
reliving and releasing emotions and focusing on ability to cope after the trauma.  The 
intervention appeared to be most beneficial for participants who reported that they did 
not usually discuss the issues with others.  Those who reported the greatest benefit had 
worse mood and higher levels of disease at baseline.  Men were reluctant to discuss 
their experiences of disclosure, and did not report the process as valuable.   
Overall, the written disclosure paradigm is complex – Sloan and Marx (2004) 
suggest that it is possible that a combination of theories may underlie the beneficial  
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effects associated with it. They recommend that multiple models be examined 
simultaneously.  The main study assesses the cognitive adaptation hypothesis, since the 
GDP was developed based on research regarding cognitive processing of trauma, and 
the social interaction hypothesis, since couples are participating in the intervention, and 
it will be possible to test whether their communication changes following the 
intervention. 
4.5 Methodological issues 
4.5.1 Efficacy versus effectiveness 
Broderick et al. (2004) highlight the distinction between efficacy and 
effectiveness trials.  Efficacy trials involve evaluating novel treatments in rigorously 
controlled laboratory settings.  Inclusion/ exclusion criteria are strict and rigorously 
applied.  Effectiveness research involves testing of such treatments in real world 
settings.  This is important as efficacy research is often carried out at the cost of external 
validity, and may not represent the range of patients, health care providers and settings 
observed in clinical practice.  Individuals self selected into research trials may be more 
motivated and ready for change.  Further, research settings may elicit positive 
expectations from the participants, and furnish attention to the patient that may optimize 
the treatment outcome.  Effectiveness issues include treatment generalizing to all 
patients and contexts, treatment feasibility in terms of implementation, acceptance, and 
evaluation of costs and benefits.  However, it is often difficult to deliver a specified 
intervention in a form consistent with the laboratory version, and make it sufficiently 
appealing to motivate patient participation.   
In the current research, due to ethical considerations, recruitment letters will be 
sent only to patients who have given consent to be contacted by third parties.  Further, 
the participants are members of an ovarian cancer support group, and therefore may be 
more motivated to participate in research studies than patients with ovarian cancer who 
are not members of support groups (Grande, Myers, & Sutton, 2006).  Also, writing 
time will be monitored in order to test the effectiveness of writing for a particular period 
of time.  These features of the design are typical of an efficacy study.  On the other 
hand, the inclusion criteria have been kept very broad, and the writing will be carried 
out at home, as it is easy and inexpensive to implement.  It could be argued, therefore, 
that to a certain extent the current research assesses effectiveness as well as efficacy.  
Further, since written disclosure has never been tested on patients with ovarian cancer, 
or on couples as a stand alone intervention, the current research is exploratory.    
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4.5.2 Home-based versus lab-based studies 
Home based studies eliminate restrictions caused by limited physical space, 
increase flexibility, and allow access to a broader range of participants.  Also, at home 
participants undergo exposure to the event in their natural environment, which could 
facilitate the process of integrating the event into their lives.  However, in such studies 
experimenter control is reduced, and it is therefore not possible to verify that 
participants have been provided with adequate care during the experiment (Sheese, 
Brown, & Graziano, 2004). One major issue to consider is limited control over the 
surroundings where the participants carry out the writing.  This is important because, 
according to Pennebaker (1994), participants should write in an isolated setting, to 
enable the individual to concentrate and engage in higher order cognitive processing.  
To illustrate how this may impact on the results, Schwartz and Drotar (2004) found no 
effect of writing on adult caregivers of children with a chronic illness, who started the 
writing while staying with their children in hospital.  A high level of cognitive and 
emotional demand may have meant the participants were unable to engage fully in and 
habituate to the response of writing, and therefore would have been unlikely to gain 
sense of mastery and control over emotional responses, making cognitive restructuring 
unlikely.  These issues have some relevance to the present study – research has shown 
that a diagnosis of cancer in women is a highly stressful experience for their 
husbands/partners (Baider & De Nour, 1999).  However, in the current study the 
participants will be advised to write in a quiet place, and will not be distracted by 
unfamiliar surroundings.   
  At home, there is also limited control over the extent to which the participants 
follow instructions regarding when they should write and for how often/long.  For 
example, Sheffield, Duncan, Thomson, and Johal (2002) found that the absence of 
contact during the intervention meant there was reduced adherence to the task 
instructions.  A method of controlling for this, which will be used in the main study, is 
to telephone the participants prior to writing, remind them to find a quiet room and 
write for 15 minutes, and then telephone them again after 15 minutes to tell them to stop 
writing (Zakowski et al., 2004).  Writing at home means it is possible to recruit 
participants from a wide geographical area, and inconvenience to the participants is 
reduced, which is extremely important when recruiting people with a chronic illness, 
such as cancer.  For example, Wetherell et al. (2005) in a home based study on  
 
96 
rheumatoid arthritis patients, provided participants with the opportunity to talk instead 
of write and to take breaks, since RA causes difficulty with writing.  This enabled 
recruitment of patients with varying severities of the illness.   Furthermore, Frattaroli’s 
(2006) meta analysis found larger effect sizes for psychological health in studies where 
participants wrote at home, possibly because participants felt more comfortable and 
relaxed, and therefore engaged more with the topic.  Overall, it is necessary to adapt 
methodological issues to health, logistic and ethical issues when researching patients 
with chronic illnesses. 
4.5.3 Time period over which the writing is spread and length of time for writing 
A meta analysis by Smyth (1998) suggested that effect sizes were larger when 
writing sessions were separated by one week.  However, Sheese et al. (2004) found no 
differences between writing once a week for three weeks, and writing over three 
consecutive days – both groups improved equally on self reported health and sick days 
relative to a control  group that wrote about non emotional topics.  Further, Pennebaker 
(1994) recommends the use of consecutive sessions, based on the observation that once 
people have started a writing study they tend to think about it every possible moment. 
Therefore, in the studies which follow, the participants will be required to write over 
three consecutive days.  The time given for writing generally varies from 15 to 20 
minutes per day.  In the current study, the participants were given 15 minutes to write, 
as it was thought that 20 minutes would be too long for the control group to remain 
engaged.  Recent research has shown that writing for two minutes is effective in 
reducing physical symptoms in healthy undergraduates (Burton & King, 2008), 
suggesting that 15 minutes is unlikely to be too short. 
4.5.4 Instructions given to the control group 
     Generally, participants in the control group are asked to write about neutral, non 
emotional topics.  This controls for experimenter contact and expectations.  However, 
one major issue with this is that of dropout due to lack of engagement with the task.  
Although a randomized controlled trial is the only way to prove beyond doubt that 
benefits are due to an intervention, benefits in a number of studies may have been due to 
deterioration in the control group following writing about trivial/ meaningless topics, or 
suppressing their thoughts and feelings, so it is important to select engaging control 
topics that are perceived as relevant (Danoff Burg et al., 2006).  To engage participants 
emotionally in the task, in a study of written disclosure in patients with chronic pelvic 
pain, Norman, Lumley, Dooley, and Diamond (2004) asked the control group to write  
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about pleasant events they had experienced.  However, such control groups may be too 
similar to the writing intervention, in that emotions are also invoked. Therefore, a 
standard control group, where participants are required to write about what they did the 
previous day, will be used in the present study.  Further, because husbands/partners will 
write about their wife’s diagnosis and treatment of cancer, it was decided that the 
control group would write about what their wives did the previous day, in order to 
control for husbands thinking about their wives.    
4.5.5 Typing or writing 
Brewin and Lennard (1999) reported participants who typed used fewer negative 
affect words, whereas those who wrote in longhand disclosed more.  However, such 
studies generally take place in the lab, meaning that all individuals are required to write 
in longhand.  Here, since participants were writing at home, it was decided to give them 
the option to type or write, to make them feel more relaxed. 
4.5.6 Interaction with the participants 
Pennebaker (1994) advises interacting in a warm and caring yet serious manner with 
participants.  In his studies, they are asked ‘warm up questions’ at the initial meeting.  
Following an overview of the study, where its importance is stressed, the participants 
meet with the lead investigator for the remaining writing instructions.  Following 
termination, they meet with the experimenter for debriefing and to talk about the study 
and their reactions to it.  It has been suggested that these repeated interactions with a 
warm, experimenter may contribute to improvement in emotional disclosure 
participants.  Rogers, Wilson, Gohm, & Merwin (2007) found that expressive writing 
participants assigned to a warm experimenter rated their essays as more revealing of 
emotion and more personal, and were more likely to think about the study and the 
topics, but experienced more distress at one week than those assigned to a cold 
experimenter.  However, the follow up was very short – written disclosure often causes 
an upsurge in negative affect immediately following completion, but benefits in the long 
run.  Interactions with a warm experimenter may be more beneficial in the long term.  
In the current research, the instructions will be given according to a protocol.  However, 
I will be available to chat with the participants following each writing session, should 
they have issues they wish to discuss, and will thank them after every session.  Further, 
I will already have established a rapport with the participants by telephoning them to 
take background details, and will have been willing to answer their queries/ listen to 
them.  
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4.5.7 Outcomes 
The CONSORT guidelines require clearly defined primary and secondary 
outcome measures to be reported.  Current regulations require trial protocols to be 
registered at the point of starting a clinical trial, with clearly defined outcome measures.  
However, to date very few studies have done this.  An inflated sense of the efficacy of 
interventions is presented, due to a variety of factors including post hoc selection of 
measures that put the efficacy of the intervention in the best light possible, recasting 
past trials with null effects as positive in subsequent publications, and post hoc dropping 
of patients from analyses who are likely to show the least positive benefit from having 
been randomized to an intervention (Coyne et al., 2006b).  Several studies have put 
forward this ‘confirmatory bias’ (Antoni et al., 2001; Classen et al., 2001; Zakowski et 
al., 2004).  The investigators should be prepared to judge the efficacy of an intervention 
based on effects on pre specified outcomes.  The current research has two clearly 
defined outcomes – overall quality of life and perceived stress.  Secondary outcomes, 
hypothesized to be process variables, include intrusive thoughts and marital 
communication.  Further, all analyses, whether pre specified or exploratory, should be 
reported.  Often, trials are stopped based on positive results in interim analyses of data, 
rather than attainment of a predetermined sample size.  For the current research, sample 
size will be clearly defined, based on a power calculation.   
4.5.8 Length of follow-up 
It is important to ensure that the time course of benefits is charted, in order to 
understand whether an intervention leads to improvements in the short term, and 
whether such improvements are maintained long term.  One month may be too short for 
benefits to appear.  On the other hand, longer term follow ups are needed, as 
interventions with lack of benefit beyond 3 months may not be cost effective.  Gillis, 
Lumley, Mosley Williams, Leisen, and Roehrs (2006), in  a study of at home written 
emotional disclosure in 72 women with fibromyalgia, found improvements in sleep, 
global health,  healthcare utilization and physical disability at three months, relative to 
the control group, whereas the only outcome that improved at one month was sleep 
quality.  The delay of these benefits indicates that time was required for change, which 
may have reflected continued emotional processing, extinction of negative emotion, 
changes in cognitions regarding self and others, and decisions to communicate and 
approach relationships differently.  On the other hand, Broderick et al., (2005) found  
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that effects of written disclosure in fibromyalgia were weakened by 10 months.  
However, the time course of effects may vary by illness population.  In the pilot study, 
the follow up will only be one month following the completion of the final intervention, 
as its main aim is to assess the feasibility of the intervention.  However, the main study 
includes follow ups at 3 and 6 months, to see whether the GDP leads to short term 
benefits, and whether these benefits are maintained in the long term.  A one month 
follow up was considered to place extra burden on patients, and provide limited further 
information. 
4.5.9 Randomization 
The CONSORT guidelines require details of how the random allocation 
sequence is generated and implemented, and by whom the allocation sequence, 
enrollment and assignment to groups is carried out.  This is important, as researchers 
may otherwise assign participants based on their suitability for the intervention.  
Random allocation sequences should be generated using an impartial method, such as a 
computer program.  However, since this may lead to group differences in small trials, it 
is acceptable to use stratification, whereby participants are randomized after being split 
based on a significant demographic/ clinical measure.  As the main study aims at a 
sample of 80 100 participants, stratification will be used after consulting the research 
team and considering variables of prognostic importance.  Once the sequence has been 
defined, it should be concealed from the researcher prior to assigning participants to 
their groups, as inadequate allocation concealment can inflate effect sizes (Schulz, 
Chalmers, Hayes, & Altman, 1995).  This can be done using number containers or a 
central telephone.  In the current study, details of assignment will be placed in 
numbered envelopes, which will be kept in a locked drawer to which the principal 
researcher does not have a key, and opened by another researcher once the participant 
has been given a number.  It is also important to know who generated the allocation 
sequence, who enrolled participants, and who assigned participants to their groups.  
Ideally, these tasks should be carried out by different researchers, in order to minimize 
bias.  One limitation of the current study is that it will be carried out by a single 
researcher, due to economic constraints.  However, the allocation sequence will be 
destroyed once it has been generated, which minimizes the possibility of significant 
bias.  
 
100 
 
4.5.10 Blinding 
Ideally, participants, those administering the interventions, and those assessing 
the outcomes should be blind to group assignment, in order to reduce bias.  Blinding of 
participants is important, as knowledge of group assignment may influence responses to 
the intervention.  In line with ethical considerations, participants will be informed that 
there are two groups.  However, they will not be informed about which task the 
intervention is, and which the control group assignment is.  One major limitation is that 
this study is being carried out by a single researcher, who cannot therefore be blind to 
condition – this increases the possibility of performance bias.  However, the booklet 
clearly explains how to carry out the task, and the researcher will use a pre written 
script, and time every call to 15 minutes by setting an alarm.  Lack of blinding is not 
expected to increase the possibility of observer bias, as the outcomes are all self 
reported and the questionnaires are completed at home, apart from CA 125, which is 
measured by the patients’ consultants, who are not aware of the study.  Therefore, the 
risk of bias is considered to be minimal.  Further, the return questionnaires will be 
addressed to my supervisor, who has had no contact with the participants. 
 
4.6 Conclusions 
 
To date, there is some evidence for the beneficial effects of written disclosure in 
cancer patients.  However, written disclosure has mainly been carried out on individuals 
in isolation, and very few studies have tested the effectiveness of guided writing.  
Possible theories to explain the beneficial effects of written disclosure include the 
cognitive adaptation hypothesis, the exposure/ emotional processing hypothesis, and the 
social interaction hypothesis.  There are also several methodological issues that need to 
be taken into account when planning a writing intervention.  The first study aims to test 
the feasibility of the written disclosure paradigm combined with half an hour of stress 
management over the telephone in ovarian cancer patients.  The reasons for including 
the stress management will be discussed in Chapter 5.  The second study aims to test the 
effect of guided written disclosure concerning the diagnosis and treatment on stress and 
quality of life in women with ovarian cancer and their partners.  Hypothesized 
mechanisms for change include reductions in intrusive thoughts and greater insight 
(assessed by percentages of insight and causality words) in order to test the cognitive  
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model, and changes in social interaction (assessed by a marital communication 
questionnaire) to test the social interaction hypothesis.  This study will therefore extend 
the written disclosure paradigm to partners, and focus on a relatively unstudied 
population.  
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Chapter Five: Pilot Study: The effects of written disclosure and stress management on 
perceived stress and quality of life in women with ovarian cancer 
 
This chapter discusses the pilot study.  The rationale behind the stress 
management intervention is explained.  The aims and hypotheses are stated, the method 
is described, and the results are reported.  Findings, limitations, and implications for 
future research are discussed. 
5.1 Introduction 
The main background to this study is discussed in Chapters 1 4.  For sake of 
brevity and comprehensiveness, only the background concerning the rationale behind 
the stress management intervention is provided here. 
          Several studies have demonstrated that use of positive approach coping is 
associated with greater well being in gynaecological cancer, whereas avoidant coping 
(behavioural disengagement) is associated with worse outcomes (reported in Chapter 
two).  Avoidant coping may be ineffective in dealing with long term stressful situations 
because it only addresses the immediate emotional response, not providing the 
individual with tools to manage the stressor (Mishel et al., 2002).  Greater use of 
avoidant coping in relation to breast cancer has been related to lower levels of one year 
survival, which reinforces this idea (Epping Jordan, Compas, and Howell (1994)).  
Given such evidence, it is plausible to assume that interventions that increase use of 
positive approach coping and reduce use of disengagement may be effective in reducing 
distress and improving quality of life in ovarian cancer.  
The Guided Disclosure Protocol (GDP) (Duncan & Gidron, 1999) discussed in 
Chapter 4, may not be sufficient for reducing distress because although it encourages 
appraisal of a stressful event, it does not teach alternative coping strategies. Thus, 
cancer patients may require additional guidance in stress management related 
approaches, to teach problem focused coping and relaxation techniques.  
Many stress management interventions have had a positive impact on cancer 
patients.  For example, Antoni et al. (2001) found that a 10 week cognitive behavioural 
stress management programme reduced the prevalence of depressive symptoms and 
increased benefit finding in breast cancer patients.  However, since the writing consisted 
only of three 15 minute sessions, it was decided that a similar period of time would be 
appropriate for the stress management session, because its main aim was to enhance any  
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benefits brought about by writing.  Further, an intervention requiring a significant time 
commitment was believed to place considerable response burden on the participants, 
many of whom had been diagnosed with advanced stage cancer.   
As evidence that brief interventions can be effective, Lekander, Furst, Rotein, 
Hursti, and Fredrikson (1997) found that three sessions of relaxation training led to 
increased lymphocyte numbers and higher proliferative responses to ConA in patients 
undergoing chemotherapy for ovarian cancer.  Andersen (2002), in a review, concluded 
that many interventions have shown positive benefits for at least a subgroup of 
participants.  Therefore, it was decided to add a 30 minute stress management session 
over the telephone, focusing on the use of problem focused coping in controllable 
situations and emotion focused coping in uncontrollable situations.  This was based on 
the ‘Goodness of Fit’ hypothesis, suggested by Lazarus and Folkman (1984) that 
problem focused coping is more effective in controllable situations, whereas emotion 
focused coping is more effective in uncontrollable situations.  This theory was 
supported by evidence from Forsythe and Compas (1987) who found a high level of 
symptoms when there was a poor fit between appraisal and coping strategy (trying to 
change uncontrollable stressors), but a low level of symptoms when there was a good fit 
between appraisal and coping strategy. 
5.2 Aims and Hypotheses 
     This study, then, aimed to examine the effects of written disclosure and stress 
management on measures of well being in patients with ovarian cancer. Overall, I 
hypothesized that the GDP and stress management intervention would lead to reduced 
perceived stress and intrusions, greater use of problem focused coping and reduced use 
of behavioural disengagement, and improved quality of life in women with ovarian 
cancer.  I further hypothesized that improvement in levels of intrusive thoughts and 
perceived stress, and quality of life would be mediated by increase in use of problem 
focused coping and reduction of use of behavioural disengagement.  I further 
hypothesized that improvements were expected to occur only due to the intervention, 
not due to passage of time or exposure to tests, and it was therefore decided to use an 
AAB design.  I further hypothesized that the improvement would not differ according to 
the order in which the interventions were carried out.  However, it was possible that the 
first intervention would influence the way in which the participants experienced the 
second intervention.  For example, if they did the stress management first, they could  
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then write about coping strategies on Day 3 of the writing.  Therefore, there were two 
groups, to test for an order effect of the interventions. 
 
5.3 Method  
5.3.1 Design and Procedure 
This pilot study was carried out to examine the combined effectiveness of 
written disclosure and stress management, and to investigate whether there was an order 
effect of the interventions.  It used an AAB matched prospective design, since there was 
no control group.  Patients with ovarian cancer who were interested in participating 
contacted the researcher by telephone or e mail.  After 8 participants had contacted the 
researcher, the participants were randomly assigned to either stress management first or 
written disclosure first, after matching for time since diagnosis and treatment.   Each 
group of eight participants was divided into two.  For each group of four participants, 2 
slips marked ‘Writing first’ and 2 slips marked ‘Stress management first’ were put into 
a box.  For each participant, the researcher drew a slip from the box.  The researcher 
then posted an informed consent form and the questionnaires to the participants, 
enclosing a stamped self addressed envelope.  A month after the initial questionnaires 
had been received, the questionnaires plus the first intervention (either written 
disclosure or the stress management booklet, depending on which group the participant 
was assigned to) were sent out.  The participants were required to complete the second 
questionnaires before taking part in the intervention.  Two weeks after the first 
intervention was completed, the second intervention was sent out.  A month after this 
was received, the final questionnaire was sent out.   
 
5.3.2 Participants 
The participants were 27 members of the UK ovarian cancer charity Ovacome. 
Originally, the study was advertised in their quarterly newsletter.  From this, six people 
contacted the researcher to express an interest in participating.  Further, I gave a brief 
presentation at the Ovacome members’ day, and eight people approached me to express 
an interest in participating.  Letters were then sent out to 39 members of Ovacome who 
had participated in a previous study the research team had run, and 13 people contacted 
me indicating willingness to participate.  Further letters were sent out to a sample of 
Ovacome members living in the south (near Southampton university) who had ticked a 
box indicating willingness to be contacted by third parties when they joined Ovacome,  
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and eight people contacted me expressing willingness to participate.  Thus, originally 35 
people were recruited.  However, two people who had been disease free for nearly 10 
years since diagnosis felt the questionnaires irrelevant to them, and thus decided not to 
participate. One person withdrew from the study before participating, due to ill health.  
One person died soon after completing the initial questionnaires.  A further two dropped 
out after completing one intervention, due to ill health.  One person was unable to 
complete the follow up due to ill health.  One person did not return the follow up, and 
repeated telephone calls to her were not answered.  Thus, the final sample consisted of 
27 participants.    Since this was a pilot study and limited psychological research had 
been done on this population, inclusion criteria were limited to having had a diagnosis 
of ovarian cancer, being able to read and write English, and being in good enough 
health to complete the study. 
 
5.3.3 Background information 
Background information was collected about the participants’ age, cancer stage 
at diagnosis, time since diagnosis, time since treatment, type of treatment received, 
highest level of education completed, alcohol and cigarette intake, type and frequency 
of exercise, and frequency of relaxation (i.e., deep breathing exercises/ progressive 
muscle relaxation).  This was assessed by a 5 point Likert scale ranging from 1 (not at 
all) to 5 (5 times per week or more).  Follow up data was collected about frequency of 
relaxation (see Appendices F and K). 
 
5.3.4 Measures 
The  measures  used  were  completed  at  both  baselines  and  at  follow up  (see 
Appendices, F, G and K).   
5.3.4.1 Brief COPE   
The Brief Coping Orientation to Problems Experienced (COPE) (Carver, 1997) 
assesses dispositional and situational abilities to cope with stress.  The Brief COPE 
contains two items from each subscale.  Items are measured on a 4 point self report 
scale from 0 (I haven’t been doing this at all) to 4 (I’ve been doing this a lot).  For this 
study, the subscales of active coping, positive reframing, acceptance, emotional support, 
and behavioural disengagement were used, since previous studies i.e., Lutgendorf et al. 
(2002a), have shown active coping and positive reframing to be associated with better 
health, but behavioural disengagement to be associated with worse health.  This was  
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deemed to be the most appropriate coping scale for use with a clinical population – 
normative data was collected from survivors of a hurricane, whereas other measures of 
coping have been based on student samples.  
5.3.4.2 Perceived Stress Scale 
The Perceived Stress Scale (Cohen & Williamson, 1988) is a 10 item self report 
scale measuring the extent to which individuals felt able to cope with stress in their lives 
during the past month.  Items are rated on a 5 point scale from 0 (never) to 4 (very 
often).   Normative data for this was collected from a sample of 2,387 people who 
completed a telephone interview.  Cronbach’s alpha was found to be .78, indicating 
good reliability.  Scores were moderately related to responses on other measures of 
perceived stress, and numbers of life events experienced within the past year.  Scores 
were also related to self reported physical illness and utilization of health services.  In 
this study, Cronbach’s alpha ranged from 0.88 to 0.91, indicating good reliability.  This 
was considered a suitable measure of appraisal of current stress levels, which the 
intervention aimed to reduce and correlates correlates highly with anxiety scales.  This 
scale has been used with a wide variety of populations.   
5.3.4.3 Impact of Event Scale-Revised   
The IES R (Weiss & Marmar, 1997) was developed to parallel the DSM IV 
criteria for PTSD, and consequently includes three subscales of intrusions, avoidance 
and hyperarousal.  It is a self report measure designed to assess current subjective 
distress for any specific life event.  Items are rated on a 5 point scale from 0 (not at all) 
to 4 (extremely).  For this study, the intrusions subscale (revised version) was used (8 
items).  
In a study of four different population samples, internal consistency for the 
intrusions subscale ranged from 0.87 to 0.92 (Weiss & Marmar, 1997).  Test retest 
correlation coefficients ranged from 0.57 to 0.94.  It has been shown to detect changes 
in clinical status over time, and to be sensitive to differences in response to traumatic 
events as a function of severity.  With regard to content validity, the original intrusions 
subscale (one item was added for the IES R), had a high endorsement of up to 85%.  
The intrusions subscale was used in this study as it was hypothesised that reductions in 
intrusive thoughts would indicate changes in cognitive restructuring and less need to 
inhibit unpleasant memories following the written disclosure intervention, and this scale 
has been used widely with cancer patients.  Further, several studies have shown that 
intrusive thoughts longitudinally predict levels of anxiety and depression (Epping  
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Jordan et al., 1999; Hipkins et al., 2004).  Cronbach’s alpha in this study ranged from 
0.84 to 0.88, indicating good reliability.   
5.3.4.4 Functional Assessment of Cancer Therapy-Ovarian   
The FACT O (Basen Engquist et al., 2001) is a self report scale that was 
developed to measure quality of life in people with ovarian cancer.  There are four 
subscales that are relevant to any chronic illness (physical well being, social/ family 
well being, emotional well being, functional well being), and one scale specific to 
ovarian cancer (additional concerns).  For this study, the physical well being, social/ 
family well being, emotional well being and additional concerns subscales were used.  
Each item is rated on a 5 item scale from 0 (not at all) to 4 (very much).  There are 
seven items in the physical well being subscale, seven items in the social/ family well 
being subscale, 6 items in the emotional well being subscale, and 12 items in the 
additional concerns subscale.   
Normative data was based on 232 outpatients with ovarian cancer (Basen 
Engquist et al., 2001).  Follow ups were carried out at one week, to assess test retest 
reliability, and at two months, to assess sensitivity to changes in performance status.  
Internal consistency and test retest reliability were greater than 0.80 for the physical, 
emotional, and functional subscales, and for the FACT O total score, indicating very 
good reliability, and ranged from 0.70 to 0.80 for the social well being and ovarian 
cancer specific scales, indicating satisfactory reliability.  FACT O scores were 
significantly correlated with other measures of quality of life, physical symptoms, 
anxiety, depression and family functioning as expected.  FACT O scores were sensitive 
to differences in performance status and whether the person was under active treatment 
or not, and the functional and social well being and ovarian cancer specific subscales 
were also sensitive to differences in disease stage.  Change in performance status at two 
months follow up was associated with an overall change in FACT O subscales.  
Assessing quality of life is now viewed as being of primary importance in randomized 
controlled trials, and the FACT has been used in the majority of studies focusing on 
both gynaecologic cancer patients in general, and ovarian cancer patients.  In this study, 
Cronbach’s alpha ranged from 0.86 to 0.90 for the physical well being subscale, 
indicating good reliability, from 0.79 to 0.85 for the social well being subscale, 
indicating good reliability, from 0.62 to 0.80 for the emotional well being subscale, 
which raises some concern, and from 0.57 to 0.69 for the ovarian cancer specific 
subscale, indicating quite low reliability.    
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5.3.5 Writing intervention 
     This study used the Guided Disclosure Protocol, developed by Duncan and Gidron 
(1999), and tested in Gidron et al. (2002).  The researcher telephoned the participants a 
few days after sending out the writing task, to ask if they had any questions about the 
task, and remind them about it.  The participants were asked to reflect on their diagnosis 
and treatment of ovarian cancer, by writing for 15 minutes per day over three days, at 
home in a quiet room free from distractions.  There were three parts to the writing.  On 
Day 1, they were asked to describe the event in chronological order, in a ‘journalistic 
manner’, without expressing their emotions.  On Day 2, they were asked to describe 
their thoughts and feelings at the time of the event (to enhance cognitive processing and 
verbal labelling of sensory and affective responses), and whether it affected their life (to 
enhance self reflection and insight).  On Day 3, they were asked to describe how they 
currently thought and felt about the event (to enhance perspective taking), and how they 
would cope with similar events, should they be encountered in the future (to enhance 
self regulation).  The full protocol is presented in Appendix J.   
The writing was analysed by the computer programme Linguistic Inquiry and 
Word Count (Pennebaker, Francis, & Booth, 2001), to see whether use of affective 
(positive and negative emotion) and cognitive (insight) words in the written disclosure 
tasks were related to improvement on the psychological measures.  Pearson correlations 
were carried out to see the relations between the change in the main psychological 
variables from baseline to follow up, after controlling for baseline levels of these 
variables and affective and cognitive words used on days 2 and 3 of the writing. 
5.3.6 Stress Management Intervention 
     I designed the stress management intervention, and it was checked by and pilot 
tested on my supervisor.  It was also pilot tested on one of the support staff in the 
Ovacome office, a nurse who had had training in counselling, and was experienced in 
dealing with Ovacome members.  The topics covered included problem focused coping 
(problem solving), emotion focused coping (deep breathing exercises) and assertiveness 
when communicating with doctors, with a focus on tailoring coping strategies to the 
situation. In addition to the session, a booklet explaining the main points was sent out to 
the participants, for reference during the intervention (see Appendix I).  
I telephoned the participants a few days after sending out the booklet, to arrange 
a convenient time for them to take part in the programme (approximately 30 minutes  
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over the telephone), and to remind them to first complete the questionnaires, and to 
have the booklet available for the stress management session.   
I telephoned the participants at a previously agreed time, to carry out the stress 
management session.  After introducing myself, I explained about the different types of 
coping strategies that could be used depending on whether the situation was controllable 
or uncontrollable.  I then invited the participant to choose a controllable problem they 
wished to work on, and to try to solve it according to cognitive behavioural principles.  
I then asked the participant to give examples of uncontrollable situations, and taught the 
participant a method of deep breathing.  Finally, I gave the participant some advice on 
being assertive with their doctor (i.e., asking if there were alternative treatments with 
less toxicity).  I delivered the intervention following an intensive course on Stress 
Management at the Centre for Stress Management in London, UK.  The protocol for 
this intervention is presented in Appendix H. 
 
5.3.7 Data Analysis 
The data was analysed using SPSS for Windows (version 12).  Since this was an 
exploratory study, it was decided to conduct a number of analyses, despite awareness 
that this could increase the risk of Type 1 error.  The aim was to see whether there was 
an improvement from baseline to follow up, such that conditions differed in relation to 
the various psychological measures only at follow up.  To determine the effects of the 
intervention on the outcome variables, repeated measures mixed analyses of variance 
(ANOVA) were conducted, with group (GDP first, SM first) being the between subjects 
factor and time (first baseline, second baseline, follow up) being the within subjects 
factor.  Where appropriate, disease stage was entered as a covariate.  Significant effects 
of time were followed up with planned contrasts comparing the first and second 
baseline, and the first baseline and the follow up, in order to see where the differences 
occurred. A non significant result when comparing first and second baseline coupled 
with a significant result when comparing first baseline and follow up was taken as 
evidence that the improvement was due to the interventions.   
5.4 Results 
5.4.1 Participant characteristics: 
     The mean age of the participants was 56.1 (range 33 to 72).  The majority of the 
participants had advanced stage disease (Stage I: 4, Stage II: 4, Stage III: 16, Stage IV: 
3). Demographic characteristics of the groups are presented in Table 6.    
 
110 
 
Table 6. Baseline demographic information as a function of group  
 
  Stress Management First 
Mean (SD) 
Writing First 
Mean (SD) 
Age   58.17 (8.68)  54.64 (9.40) 
Time since diagnosis 
(months) 
35.75 (13.1)  40.71 (29.1) 
Time since treatment 
(months) 
17.42 (13.4)  25.07 (27.7) 
Exercise   3.25 (1.06)  4.21 (0.89) 
Alcohol consumption 
(units per week) 
4.10 (3.31)  5.0 (3.63) 
Relaxation   2.17 (1.02)  2.14 (0.66) 
Smoke  0  Yes   2, No – 12 
Disease stage  Early – 42%, Advanced – 
58% 
Early – 21%, Advanced – 
79% 
 
Independent samples T tests were carried out on the continuous demographic 
variables.  These showed that the groups were well matched with regard to age, time 
since diagnosis and treatment, alcohol consumption, and frequency of relaxation.  
However, the writing first group did significantly more exercise than the stress 
management first group.  However, since this was a pilot study, with a small sample, it 
was decided not to include exercise as a covariate.  Chi square tests were carried out in 
relation to the categorical demographic variables of disease stage and tobacco 
consumption.  No significant differences were found between the groups.  For the 
ANOVAs, disease stage was controlled for if it correlated with change in scores from 
baseline to follow up.  One participant in the stress management first group had to be 
excluded from the analyses, because personal communication revealed that she 
completed Day 3 of the writing approximately one month after Day 2.  All results are 
reported in Table 7. 
 
5.4.2 Quality of Life 
5.4.2.1 Physical 
Initial examination of the data revealed high levels of skewness and kurtosis at 
second baseline.  A reflect and logarithm transformation improved the fit of the data to 
a normal distribution, and therefore all statistical tests were carried out on the 
transformed data.  Since Pearson correlations revealed that change in physical quality of  
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life from first baseline to follow up was correlated with disease stage (r =  .421, p = 
.04), stage was included as a covariate in all subsequent analyses.  There was a 
significant effect of time on physical quality of life: (F (2, 46) = 3.32, p = .05), but no 
main effect of group (F (1, 23) = 1.49, p = .24), and no group by time interaction (F (2, 
46) = 1.21, p = .31).  Planned contrasts revealed no significant differences from first 
baseline to second baseline (F (1, 24) = .87, p = .77); but a trend towards significant 
differences from first baseline to follow up (F (1, 24) = 2.92, p = .10).  Examination of 
effect sizes revealed a small effect for the writing first group, but no effect for the SM 
first group. 
5.4.2.2 Social 
There was no effect of time on social quality of life (F (2,48) = 2.05, p = .14), no 
effect of group (F (1,24) = .62, p = .44) and no group by time interaction (F (2, 48) = 
.98, p = .38).  However, examination of effect sizes revealed a small to medium effect 
for the writing first group only. 
5.4.2.3 Emotional 
   There was no effect of time on emotional quality of life (F (2, 48) = .26, p = 
.77), no effect of group (F (1, 24) = .995, p = .33) and no group by time interaction (F 
(2, 48) = .04, p = .96).  Examination of effect sizes revealed no effect for either group. 
5.4.2.4 Ovarian-cancer specific concerns 
There was no effect of time on ovarian cancer specific concerns (F (2, 48) = .90, 
p = .41), no effect of group (F (1, 24) = .19, p = .67), and no group by time interaction 
(F (2, 48) = 1.00, p = .38).  However, examination of effect sizes revealed a small effect 
for the writing first group. 
5.4.3 Coping 
With regard to coping, it was decided to analyse only the ‘active coping’ and 
‘behavioural disengagement’ subscales, to reduce the probability of Type 1 error.  
Active coping was considered to be the best example of problem focused coping, and 
behavioural disengagement was considered to be the best example of an ineffective 
strategy, based on previous research (Lutgendorf et al., 2002a). 
5.4.3.1 Active coping 
The mean at baseline was very close to ceiling level.  Examination of histograms 
of the data revealed severe negative skewness at all time points.  A reflect and inverse  
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transformation was attempted, but this did not reduce the skewness and kurtosis values.  
Therefore, this data was analysed using non parametric statistics.  The Friedman test 
revealed no significant differences in scores between the three time points  
(χ2 = 1.50, p =.47). 
5.4.3.2 Behavioural disengagement 
The mean at baseline was very close to ceiling level.  Examination of histograms 
of the data revealed severe negative skewness at all time points.  As a reflect and 
inverse transformation did not reduce skewness and kurtosis, this data was analysed 
using non parametric statistics.  The Friedman test revealed no significant differences in 
scores between the three time points (χ2 = 1.14, p = .57). 
 
5.4.4 Intrusive thoughts 
     Close examination of the data revealed high levels of skewness at follow up.  A 
square root transformation reduced levels of skewness and kurtosis, resulting in the data 
being more normally distributed.  Therefore, all statistical analyses were carried out on 
the transformed data.  Pearson correlation revealed that change in levels of intrusive 
thoughts from first baseline to follow up was not correlated with disease stage (r =  .05, 
p = .83), and therefore it was decided not to include disease stage as a covariate in 
subsequent analyses.  There was a significant effect of time on levels of intrusive 
thoughts (F (2, 48) = 5.07, p = .01), but no effect of group (F (1, 24) = .37, p = .56) and 
no group by time interaction (F (2, 48) = 1.65, p = .20).  Paired t tests revealed that 
there were significant differences from first baseline to follow up (t (25) = 2.87, p = 
.008), but not from first baseline to second baseline (t (25) = .42, p = .68).  These results 
are displayed in Figure 1.  Examination of effect sizes revealed a medium to large effect 
for the writing first group and a small to medium effect for the SM first group. 
5.4.5 Perceived Stress 
Pearson correlation revealed that change in levels of perceived stress from first 
baseline to follow up was not correlated with disease stage (r =  .03, p = .91).  There 
was a significant effect of time (F (2, 48) = 5.97, p = .005), but no effect of group (F (1, 
24) = .24, p = .63), and no group by time interaction (F (2, 48) =. 89, p = .42).  Paired 
T tests revealed that there were significant differences from first baseline to follow up (t 
(25) = 3.32, p = .003), but not from first baseline to second baseline (t (25) = 1.6, p =  
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.12).   These results are reported in Figure 2.  Examination of the effect sizes revealed a 
large effect for the writing first group and a small effect for the SM first group. 
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Figure 1. Effects of the GDP plus stress management on intrusive thoughts 
 
0
5
10
15
20
25
1st baseline 2nd baseline Follow-up
Time
P
e
r
c
e
i
v
e
d
 
s
t
r
e
s
s
SM first 
Writing first
 
 
Figure 2. Effects of the GDP plus stress management on perceived stress 
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Table 7. Effects of written disclosure and stress management on psychological variables  
 
Variable  Group  First 
baseline  
Mean (SD) 
Second 
baseline  
Mean (SD) 
Follow up  
Mean (SD) 
Effect size 
Cohen’s D 
(1
st 
baseline to 
follow up) 
Physical QoL  Writing 
first 
22.07 (6.02)  22.93 (6.40)  23.93 (5.18)  .32 
  SM first  21.41 (5.68)  21.58 (6.05)  21.50 (5.83)  .02 
  Overall  21.77 (5.76)  22.31 (6.16)  22.81 (5.52)  .18 
Social QoL  Writing 
first 
15.93 (4.05)  16.14 (4.54)  17.64 (4.91)  .38 
  SM first  18.33 (5.50)  17.33 (6.23)  18.33 (4.54)  0 
  Overall  17.04 (4.83)  16.69 (5.30)  17.96 (4.66)  .21 
Emotional QoL  Writing 
first 
14.86 (5.95)  14.79 (4.63)  15.29 (5.04)  .07 
  SM first  16.58 (3.20)  16.17 (2.72)  16.67 (2.64)  .03 
  Overall  15.7 (4.87)  15.4 (3.86)  15.9 (4.10)  .04 
Ovarian  cancer 
specific 
concerns 
Writing 
first 
36.64 (5.37)  37.50 (5.17)  38.21 (5.65)  .29 
  SM first  37.0 (6.21)  35.75 (5.31)  37.0 (5.59)  0 
  Overall  36.81 (5.66)  36.69 (5.21)  37.65 (5.54)  .16 
Active coping  Writing 
first 
6.64 (1.55)  6.93 (0.92)  7.0 (1.47)   
  SM first  6.25 (1.54)  6.08 (1.70)  6.42 (1.31)   
  Overall  6.46 (1.53)  6.54 (1.36)  6.73 (1.40)   
Behavioural 
disengagement 
Writing 
first 
6.93 (1.44)  6.64 (1.78)  7.07 (1.21)   
  SM first  7.58 (1.16)  7.67 (0.65)  7.58 (0.90)   
  Overall  7.23 (1.34)  7.12 (1.45)  7.31 (1.09)   
Perceived 
stress 
Writing 
first 
20.86 (6.20)  18.64 (5.44)  16.57 (6.02)  .70 
  SM first  18.33 (7.32)  18.0 (6.52)  16.33 (7.32)  .27 
  Overall  19.69 (6.72)  18.35 (5.85)  16.46 (6.51)  .48 
Intrusive 
thoughts 
Writing 
first 
13.14 (6.94)  11.57 (7.04)  9.0 (6.78)  .60 
  SM first   9.42 (4.58)  10.42 (4.85)  8.0 (3.54)  .34 
  Overall  11.42 (6.15)  11.57 (6.04)  8.54 (5.45)  .50 
 
Since there were no changes in coping, the reductions in levels of intrusive 
thoughts and perceived stress were not due to changes in coping, and therefore no 
mediation analyses were carried out. 
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5.4.6 Relaxation 
A paired T test revealed that the participants reported doing significantly more 
relaxation at follow up compared to first baseline (t (25) =  4.46, p < .001).  Whereas 
the baseline mean was 2.15, indicating that the majority of participants did relaxation 
once a week or less, the follow up mean was 3.27, indicating that the majority of 
participants did relaxation once or twice a week.  However, bivariate correlations 
(controlling for frequency of relaxation at baseline) revealed that increases in frequency 
of relaxation were not related to improvements in levels of perceived stress (r = 0.15, p 
= .48), intrusive thoughts (r = .08, p = .71), quality of life (r = .05, p = .80) or 
behavioural disengagement  
(r = .25, p = .22).  However, there was a trend towards a relation between increase in 
frequency of relaxation and improvements in active coping (r = .38, p = .06). 
 
5.4.7 Content analyses of the writing 
     Content analyses were carried out to see the percentages of affective (positive and 
negative emotion words) insight, and causality words used on Days 2 and 3 of the 
writing, using Linguistic Inquiry and Word Count  (Pennebaker et al., 2001).  Reduction 
in perceived stress was correlated with greater use of affective words in general (r =  
0.42, p = .03) and greater use of negative emotion words (r =  0.42, p = .03) on Day 2.  
Reduction in intrusive thoughts was correlated with greater use of negative emotion 
words (r =  0.37, p = .06) and greater use of anxiety/ fear words (r =  0.40, p = .05) on 
Day 2.  Reduction in levels of perceived stress was correlated with greater use of 
cognitive words in general (r = 0.40, p = .04), and greater use of causality words (r =  
.57, p = .002) on Day 3. 
 
5.5 Discussion 
 
The results partially supported the hypotheses.  Perceived stress and intrusive 
thoughts decreased from baseline to post test, but not from first to second baseline, 
indicating that the intervention was successful in reducing distress in patients with 
ovarian cancer.  Effect sizes were large for the writing first group and small for the SM 
first group.  These improvements appeared to be related to the words used on Days 2 
and 3.  This offers tentative support for the cognitive processing hypothesis of written 
emotional disclosure, and the importance of emotional labelling.  It is important to note 
that frequency of relaxation did not affect outcomes.  Reflecting on how they currently  
 
116 
felt about their diagnosis and treatment and how they were now able to cope with 
similar situations (as required on Day 3) may have helped participants to put the event 
into perspective and to self regulate.  The precise verbal labelling and processing of 
unpleasant emotions reduces arousal, thereby aiding in integrating emotional reactions 
into the general understanding of a traumatic event (Pennebaker et al., 1997), and may 
reduce amygdala activity and increase PFC activity (Hariri et al., 2000).  In support of 
this hypothesis, increased use of negative emotion words was related to greater 
reduction in levels of intrusive thoughts. 
There was also a trend towards improvement in physical quality of life from first 
baseline to follow up.  However, since this improvement was not related to words used 
on Day 2 or Day 3, it is not possible to say with any degree of certainty which part of 
the intervention was responsible for it.  Examination of the effect sizes revealed small 
effects for physical quality of life, social quality of life and ovarian cancer specific 
concerns, in the writing first group only.   Writing prior to talking have may influenced 
participants’ willingness to disclose information in the stress management session, by 
reducing their distress and increasing their self control, in line with the social 
interaction hypothesis (Pennebaker & Graybeal, 2001), and particularly the ‘implicit 
audience’ theory (Brody & Park, 2004).  However, since the writing first group reported 
higher levels of stress and intrusive thoughts and worse social quality of life at baseline, 
these results should be interpreted with caution.  Finally, with regard to the FACT O, 
there were no effects on emotional quality of life.  Examination of the items revealed 
that they were similar to those assessing clinical levels of depression, such as the CES 
D (Radloff, 1977), whereas the presence of clinical levels of distress was not a 
requirement for participation.   
Problem focused coping improved very little, and change in coping was not 
related to improvements in other outcomes.  This suggests that the mechanism by which 
improvement occurs is not increased use of problem focused coping.  However, an 
increase in active coping was correlated with an increase in frequency of relaxation, 
suggesting that participants who did more relaxation may have also used more problem 
focused coping in controllable interventions.  Further research is needed to examine 
moderators of the efficacy of cognitive behavioural stress management.  However, due 
to the small sample, these results should be interpreted with caution.  Alternatively, 
there are several other explanations for the lack of improvement in coping.  First, 
problem focused coping was close to ceiling level in this population, leaving little room  
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for improvement.  The study population were members of a support group, and thus 
may have been more likely to use adaptive coping strategies than the general population 
with ovarian cancer (Grande et al., 2006).  Second, the measures may not have targeted 
outcomes with sufficient sensitivity – it may have been more appropriate to ask 
participants if they used more problem focused coping in specific controllable 
situations, and more emotion focused coping in specific uncontrollable situations, such 
as when waiting for CA 125 test results, as this causes considerable anxiety (Parker et 
al., 2006).  Third, the stress management intervention may not have been sufficient for 
improvements in this population.  Although participants increased the amount of 
relaxation they did from baseline to follow up, which suggested that they had engaged 
with the programme, and reported that they liked it, this was not related to improvement 
on any of the outcome measures, except active coping, which was close to ceiling level 
at baseline.  There are several possible reasons for this result.  First, it only took 30 
minutes over the telephone – many such interventions take several months, with an 
hourly meeting every week.  Therefore, it may not have been long enough to bring 
about lasting change.  Second, it was carried out by a research student who had no 
formal training in counselling.  However, since there were no follow ups in between the 
interventions (partly to decrease response burden, and partly because the full 
intervention package was deemed necessary for maximum benefit), it is not possible to 
conclude definitively which part of the intervention was responsible for improvements.   
 
5.5.1 Limitations 
   This study had several limitations.  First, although the participants were told to 
write for 15 minutes per day over three days, this was not directly monitored.  Although 
personal communication suggested that most participants followed the instructions, it 
would be advisable to monitor this directly in future studies, by telephoning the 
participants before and after they write.  Second, the participants were only followed up 
at one month – a longer follow up may have revealed greater improvement, and would 
have provided information about maintenance of benefits.  This is particularly relevant 
with regard to CA 125, which will be recorded in the main study – patients are tested 
more regularly when they are on chemotherapy, whereas those who have been disease 
free for several years are tested once every three or six months.  Third, the sample size 
was quite small, which increased the likelihood of the results being skewed by 
participants with extreme scores.  Further, it was not possible to test for U shaped  
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relations – this is important because writing at a moderate level of complexity is related 
to greater improvement at follow up (Suedfeld & Pennebaker, 1997).  Fourth, the 
questionnaires were returned to the principal researcher, which may have increased the 
likelihood of observer bias.  However, the differential effects between the writing first 
and SM first groups suggest that this is unlikely to be the only reason for the positive 
outcomes.  Finally, the participants in this study were members of a support group, so 
not necessarily representative of the general population with ovarian cancer.  However, 
since this intervention has never been carried out on ovarian cancer patients before, the 
main aim was to see whether it could reduce psychological distress – a search of the 
literature revealed that only seven psychological interventions have been tested on 
ovarian cancer patients.  If the intervention was found to be beneficial, it would need to 
be replicated on a more representative sample.   
Given that this study suggested that benefit obtained was mainly due to the 
writing, the main study aims to test the effects of written disclosure as a stand alone 
intervention on ovarian cancer patients and their partners, using a larger sample, and 
with a longer term follow up.  The introduction and method for the main study are 
presented in Chapter 6.  
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Chapter Six: The effect of guided written disclosure on distress and quality of life in 
women with ovarian cancer and their partners: A randomized controlled trial: Aims and 
Method 
6.1 Introduction 
The previous chapters have identified several important findings.  First, many 
patients with ovarian cancer experience significant levels of distress.  Second, 
psychological interventions could be beneficial for a large proportion of patients who 
desire them.  Third, partners of cancer patients also experience significant levels of 
distress.  Fourth, partners’ distress and couple communication are significantly 
associated with psychosocial adjustment in both patients and partners.  Fifth, written 
emotional disclosure has been effective in improving health in patients with chronic 
illnesses, and improving psychological outcomes in studies targeting relationship 
processes.  Further, evidence suggests it may be effective in improving health outcomes 
in cancer patients.  The pilot study found that word usage on days 2 and 3 of the GDP 
was associated with benefits in patients with ovarian cancer.  However, the effects of 
the GDP on the well being of patients and spouses of women with ovarian cancer have 
not been tested.  This study therefore aims to assess the effectiveness of the GDP in 
reducing distress and improving quality of life in women with ovarian cancer and their 
partners.  Before conducting research, it is important to have explicitly defined 
hypotheses, in order to test theoretical models, ensure that interventions are expected to 
be effective, and reduce the risk of Type I error.  This chapter therefore starts by 
outlining the aims and hypotheses of the main study, and the rationale for these. 
  6.2 Hypotheses 
6.2.1 Primary Outcomes 
6.2.1.1 Aim 1: To evaluate the effectiveness of the GDP compared to control 
writing in reducing distress and improving quality of life in ovarian cancer patients and 
their partners 
To the best of my knowledge, there are no reported RCTs assessing the effects 
of written emotional disclosure as a stand alone intervention for couples or as an 
intervention for couples where one partner has a chronic illness.  Furthermore, very few 
studies have tested the effectiveness of guided writing.  The purpose of the current 
research was to test the effectiveness of writing about the diagnosis and treatment of the 
patient’s cancer according to the GDP in reducing distress and improving quality of life  
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in women with ovarian cancer and their partners, compared to writing about what the 
patient did the previous day, which was selected in order to control for experimenter 
contact, expectations, and the partner thinking about their wife. 
In terms of primary outcomes, it was hypothesized that:  
•  Couples who wrote about the patient’s diagnosis and treatment following the 
GDP for 15 minutes a day over three days would demonstrate significantly 
greater improvements in quality of life and reductions in perceived stress at 
three month follow up when compared to couples who wrote about what the 
patient did the previous day, for 15 minutes a day over three days. 
•  Improvements for the GDP group would be maintained at six months 
 
6.2.2 Secondary Outcomes 
6.2.2.1 Aim 2: To evaluate the effectiveness of the GDP in reducing visits to 
health professionals in ovarian cancer patients 
Previous written disclosure studies have found significant reductions in visits to 
health professionals in healthy students (Smyth, 1998), using the GDP (Gidron et al., 
2002) and in cancer patients (Stanton et al., 2002).  As effects of writing in chronic 
illness are stronger for physical than psychological health outcomes (Frisina et al., 
2004), the current study aimed to investigate the effectiveness of the GDP in reducing 
visits both to consultants/ GPs and to alternative therapists.  Since ovarian cancer is 
often diagnosed at a late stage, following several misdiagnoses, this tends to impair 
patients’ trust in their GPs, leading them to explore alternative therapies. 
It was hypothesised that: 
•  Patients in the GDP group would show significant reductions in visits to GPs/ 
consultants and visits to alternative therapists  at three month follow up, relative 
to those in the control group 
•  These benefits would be maintained at six month follow up. 
 
6.2.2.2 Aim 3: To see whether the GDP reduces CA 125 levels 
CA 125 is a tumour marker with high prognostic value in ovarian cancer (Bast et 
al., 1983).  Preliminary evidence suggests that dispositional optimism is a significant 
predictor of CA 125 (de Moor et al., 2006).  However, the relation between 
psychological factors and CA 125 has been investigated in very few studies.  Given that  
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psychiatric disorders are associated with worse survival post diagnosis (von Georgi et 
al., 2002), the current study aimed to see whether the GDP would lead to improvements 
in CA 125. 
It was hypothesized that: 
•  CA 125 would be lower for patients in the GDP group at three month follow up, 
relative to the control group.   
•  These benefits would be maintained at six month follow up. 
6.2.3 Aim 4: To examine potential mediators of the efficacy of the GDP 
Evidence has suggested that written emotional disclosure is effective in improving 
physical and psychological health.  However, the reason for its beneficial effects is 
unclear, although several mechanisms have been hypothesised.  This study aimed to see 
whether the cognitive processing hypothesis or the social interaction hypothesis was 
more effective in explaining the benefits brought about by the GDP. 
It was hypothesised that: 
•  The GDP would lead to reductions in levels of intrusive thoughts and distress about 
the illness, and improvements in both general and illness related communication 
relative to the control group at three month follow up, and these benefits would be 
maintained at six month follow up. 
•  The GDP would lead to improvements in quality of life and reductions in perceived 
stress through reductions in levels of intrusive thoughts and distress about the 
illness, in line with the cognitive processing hypothesis. 
•  The GDP would lead to improvements in quality of life and reductions in perceived 
stress through improvements in both general and illness related couple 
communication, in line with the social interaction hypothesis. 
6.2.4 Aim 5: To identify factors associated with treatment outcomes 
  One objective of the present study was to evaluate potential predictors and 
moderators of improvements in quality of life and perceived stress.  Specific illness 
variables, baseline levels of some secondary outcome measures, change in levels of 
some of the secondary outcomes, and aspects related to the actual intervention were 
selected as potential predictors, moderators and moderated mediators based on clinical 
or theoretical rationales.  A moderator can be defined as a variable that influences the 
strength of the relation between an independent and a dependent variable (in this 
context, the relation between group and quality of life/ perceived stress).   Moderated  
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mediation occurs when the process by which treatment leads to the outcome depends on 
the value of a moderator variable (Muller, Judd, & Yzerbyt, 2005).  Thus, it enables 
understanding of the conditions under which mediation may occur.  Although such 
analyses have often been dismissed as “fishing,” Kraemer, Wilson, Fairburn, and Agras 
(2002) are of the view that ‘There has recently been growing recognition ...that 
carefully and expertly performed hypothesis generating activities are necessary to foster 
stronger hypotheses for the next generation of hypothesis testing studies and to provide 
the background information necessary to design such powerful studies’ (p 882). Thus, 
although not all the moderators or moderated mediators are directly related to the study 
aims, they were considered important in order to generate theoretically relevant 
information through enhancing understanding of those for whom the intervention 
worked and the processes by which it did so (Hinshaw, 2007). 
  In Chapter 2, having recurrent ovarian cancer was not conclusively associated 
with quality of life or distress.  Nevertheless, given that recurrence means the disease is 
incurable, and thus individuals who have experienced a recurrence face different 
stressors from those who have not, it was important to assess if recurrence status had an 
impact on the primary outcomes, partly to clarify for whom the GDP might be effective.  
Moderation analysis was considered a more appropriate way to assess this than 
sensitivity analysis, as over half the sample had experienced a recurrence. 
  Given that one expected outcome of the research was improvements in marital 
communication, it was expected that the GDP might be more effective for those who 
could be classified as less satisfied with regard to marital communication.  Also, based 
on research regarding communication and psychosocial outcomes (i.e., Manne et al., 
2006), it was expected that those who improved more with regard to illness related 
couple communication would benefit more from the GDP, and thus change in illness 
related communication was selected as a potential moderated mediator.  According to 
the cognitive processing hypothesis, it was expected that those who improved more with 
regard to intrusive thoughts would benefit more from the GDP, and thus change in 
intrusive thoughts was selected as a potential moderated mediator.  Finally, given that 
previous research has demonstrated that partner distress is associated with worse 
outcomes for the patient (i.e., Northouse et al., 1995), the current study aimed to assess 
whether partners’ intrusive thoughts predicted or moderated the primary outcomes. 
One predictor was chosen that related to aspects of the actual intervention: views 
about the intervention.  It was important to assess if those who liked the intervention  
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benefited, as this would suggest that the GDP could be offered to those who viewed it 
positively.  
6.2.5 Aim 6: To identify whether word usage was related to treatment outcomes 
Previous research has shown correlations between word usage and health 
improvements (Pennebaker et al., 1997; Danoff Burg et al., 2006), which have been 
related to cognitive processing.  In line with the cognitive processing hypothesis, it was 
expected that: 
•  Participants in the GDP group would use more emotion, insight and causality words 
on days 2 and 3 of the writing than the control group. 
•  Use of emotion, insight and causality words would be related to improvements in 
the primary outcomes. 
6.2.6 Aim 7: To identify whether participants in the GDP group reported talking and 
thinking more about the writing at follow-up relative to the control group 
  According to the social interaction hypothesis, written disclosure changes the 
way in which participants interact with others, leading to increased discussion of the 
traumatic event (Pennebaker & Graybeal, 2001).  Such increased discussion of the event 
is likely to be related to thinking more about it. It was therefore hypothesized that: 
•  Participants in the GDP group would report thinking and talking more about what 
they wrote, relative to those in the control group 
6.2.7 Aim 8: To evaluate whether patient and partner improvement were correlated 
In the current study, both women with ovarian cancer and their partners wrote about 
the woman’s diagnosis and treatment of ovarian cancer.  Since it was expected that 
writing about the woman’s illness would provide a context for couples to discuss the 
illness, and possibly help them arrive at a shared understanding of how to cope with it, 
it was hypothesized that within the GDP group, patient and partner improvement on the 
primary and secondary outcomes from baseline to three month follow up would be 
correlated, whereas such correlations would not be significant for the control group. 
6.2.8 Aim 9: To see whether discrepancy in communication moderated the effects of the 
primary outcomes 
The majority of the hypotheses have focused on each individual member of the 
couple.  However, research has suggested that congruence between couples may be an 
important influence on psychological adjustment (Sagy & Antonovsky, 1992).  The 
current study aimed to test this by assessing first, whether discrepancy with regard to  
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both general and illness related couple communication was related to levels of the 
primary outcomes of perceived stress and quality of life at baseline, and second, if these 
results were significant, whether change in discrepancy from baseline to three month 
follow up moderated the effects of group on quality of life and perceived stress. 
6.3 Method 
The study was a randomized controlled trial in which the Guided Disclosure 
Protocol (GDP) (Gidron et al., 2002) for written emotional disclosure was compared to 
control writing.  The study was approved by the School of Psychology Ethics 
Committee, University of Southampton. 
The study followed the Consolidated Standards of Reporting Trials 
(CONSORT) guidelines for designing and reporting the results of RCTs (Moher et al., 
2001).  Participants who were eligible and had provided informed consent were 
randomized to writing for 15 minutes a day over three days, either about the patients’ 
diagnosis and treatment in a structured way (the GDP) or about what the patient did the 
previous day (control).  The control condition was designed to control for experimenter 
contact, expectations, and the partner thinking about the patient, and has been used in a 
number of written disclosure studies. 
6.3.1 Random assignment, concealment and blinding 
Prior to commencement of the study, the program www.randomization.com was 
used to generate a table indicating assignment to groups.  This was carried out twice, as 
patients were stratified based on whether they had had a recurrence since their initial 
diagnosis, in order to increase the probability of obtaining two equivalent groups with 
regard to prognosis.  Randomization was then carried out separately for patients with 
and without a recurrence. As the sample was quite small, randomization was done in 
blocks of ten.  Following this, opaque envelopes were numbered and the appropriate 
condition was written on a slip inside each envelope.  The random numbers table was 
then destroyed, and the envelopes kept in a locked cabinet to which the principal 
researcher did not have access.  Following return of the initial questionnaire, each 
couple was given a number based on the order in which they had entered the trial, and 
this number corresponded with a numbered envelope.  An independent administrator 
who was not connected with the project then opened the cabinet, opened the appropriate 
envelope, and told me which condition the participant was assigned to, after which I put 
the appropriate task in an envelope and sent it to the participant.  
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As this study was carried out by a single researcher, double blinding was not 
possible.  However, several other measures were taken to reduce bias.  First, the 
questionnaires were returned to my supervisor, who had had no contact with the 
participants and was unaware of their group allocation, in order to reduce the risk of 
measurement bias.  Also, the outcomes were assessed by self report questionnaires, 
which the participants filled in at home in their own time, except for CA 125, which 
was measured by consultants who were unaware of the study and later self reported by 
patients.  Second, although I telephoned the participants to tell them when to start and 
stop writing, the instructions were clearly stated on the writing booklet, and I timed the 
writing in order to reduce the risk of performance bias.  The participants were not 
informed about group assignment. They were merely told in the consent form that a 
certain type of writing had been shown to benefit health in a variety of illnesses, and 
that they would be asked to write about events in either an emotional or a non emotional 
way. 
6.3.2 Participants 
The participants were recruited from Ovacome, a UK charity for patients with 
ovarian cancer.  Initially, the study was advertised in the Ovacome newsletter, and 
interested participants were invited to contact me for further information.  Once the 
advertisement had been placed, letters were sent out to 530 patients who had given prior 
consent to be contacted by third parties, with the title ‘Mrs’ to maximize recruitment of 
couples, at four time points between May 2006 and June 2007, informing them about 
the study and inviting them to participate.  Interested individuals were invited to write 
their name and telephone number on a slip which was returned to me in an attached 
stamped addressed envelope.  Those who were not interested were requested to fill in a 
slip where they could tick one of four boxes indicating the reason why from ‘I am not 
interested’, ‘I am too busy’ or ‘I am not feeling well’ or ‘Other (please specify where 
possible)’.  This procedure was carried out in order to determine reasons for non 
participation where possible.  Those who had further questions were invited either to e 
mail me or contact me via the Ovacome office.   
I telephoned those individuals who had indicated their willingness to participate, 
thanked them for returning the slip and asked if they had any questions about the study, 
and asked several screening questions in order to ensure that they met the inclusion 
criteria and could be randomized accurately. These questions covered the treatment the 
patient received when she was diagnosed, whether she had received any treatment since  
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(for stratification purposes), time since initial diagnosis, and whether the patient’s 
husband/ partner would be willing to participate.  Once eligibility had been determined, 
I took the patient’s address and posted out the initial questionnaire. 
The inclusion criteria were:  
•  A definite diagnosis of ovarian cancer. 
•  No more than five years since last treatment.  During this period individuals are seen 
by their consultant once every six months or more, and their CA 125 level is tested 
at each visit.   
The exclusion criteria were:  
•  Being unable to speak, read or write English. 
•  Being under 18 years old.   
The inclusion criteria for spouses were: 
•  Having a partner with ovarian cancer with whom they lived full time. 
All those who agreed to participate were sent the initial questionnaire and a 
consent form.  Questionnaires were returned in stamped addressed envelopes to my 
supervisor.  Upon receipt of the initial questionnaire, I sent out the writing task, and 
telephoned the couple several days later to arrange mutually convenient times for them 
to do the writing.  On each day of the writing, I telephoned the participant at a mutually 
agreed time, to tell him/her to start writing, and again after 15 minutes to tell him/her to 
stop writing.  After completing the third day of the writing, participants were thanked 
for their involvement in the task and requested to return the writing to the supervisor in 
the attached stamped addressed envelope.  Follow up questionnaires were sent out after 
three and six months and returned to my supervisor, who had had no contact with the 
participants.  Once the final questionnaire had been received from both partners, the 
couple was sent a debriefing form. 
6.3.3 Writing Protocol 
In the treatment group, the couples wrote about the patient’s diagnosis and 
treatment for 15 minutes a day over three days within one week.  Couples were required 
to write on the same days, but not at the same times (although a number of couples 
chose to do so).  If both members of the couple chose to write at the same time, I spoke 
to only one member of the couple (whoever answered the telephone), but if they chose 
to write at separate times, I spoke to each member of the couple separately.  In the 
control group, the patients wrote about what they did the previous day, and the partners 
wrote about what their partner did the previous day, in order to control for the partner  
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thinking about the patient. As in previous trials, this controls for experimenter contact 
and expectations, and for the effects of being required to write.  Participants were asked 
to find a quiet place free from distractions, and were told not to worry about grammar, 
spelling or sentence structure, and to write continuously for the entire time.   
The GDP protocol was as follows:  On Day 1 of the study, the participants were 
asked to describe the diagnosis and treatment chronologically, and to describe what 
caused what, without mentioning their emotions.  Day 2 was divided into two parts.  
First, the participants were required to describe how they felt and what they thought at 
the time of the diagnosis.  Second, they were required to write about the impact that 
their diagnosis and treatment had had on their lives, and whether it had caused them to 
change priorities.  On Day 3, they were required to describe how they currently felt and 
thought about the diagnosis and treatment, whether their thoughts and feelings now 
were the same as at the time of diagnosis, and whether they would be able to cope with 
similar situations better because they had experienced it. The protocols for both 
conditions are included in Appendices R and S.  
6.3.4 Assessments and Measures: Background Demographic and Biomedical 
Information 
Demographic information was collected at baseline about age, occupation, 
highest level of education completed, marital status and length of time married.  
Medical information about cancer stage at diagnosis, time since diagnosis, time since 
last treatment, whether the participant had received surgery, chemotherapy (with drugs 
received mentioned if known) and radiotherapy, number of courses of chemotherapy, 
and whether the participant was currently undergoing treatment and if so what, were 
obtained by self report.  In addition, at each follow up participants were asked if they 
were currently undergoing treatment and if so what.  In addition, information was 
collected at baseline about whether the participant smoked and if so how many 
cigarettes per day, whether they drank alcohol and if so how many units per week, and 
how often they exercised per week, which was answered on a five point scale from ‘5 
times a week or more’ to ‘Never’ (see Appendix P). 
6.3.5 Outcome measures 
Assessments included self report measures which were collected in 
questionnaire form, and an objective measure of disease progression which was 
collected by self report and later confirmed by oncologists who were unaware of the 
study.  Data based on these measures was collected at each time point.  
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The primary outcome measures were quality of life measured by the Functional 
Assessment of Cancer Therapy – Ovarian (FACT O) (Basen Engquist et al., 2001) or 
the Functional Assessment of Cancer Therapy – General Population (FACT GP) (Cella 
et al., 2003) and perceived stress measured by the Perceived Stress Scale (PSS) (Cohen 
& Williamson, 1988).  Hypothesized mediators of improvement in the GDP group 
included cancer related intrusive thoughts (IES) (Weiss & Marmar, 1997), marital 
communication, both general (ENRICH Couple Scales – Communication Subscale; 
Fowers & Olson, 1989) and illness related (four items developed for the purpose of this 
study), use of positive and negative emotion words on Days 2 and 3 of the study (LIWC 
2007; Pennebaker, Booth, & Francis, 2007), and extent to which participants had talked 
and thought about the event following the study.  Other secondary outcomes included 
emotional representations of the illness (IPQ R; Moss Morris et al., 2002), CA 125 
level, visits to the GP/ consultant and visits to alternative therapists.  Assessment was 
completed as baseline (see Appendix P), three months follow up (see Appendix T) and 
at six month follow up (see Appendix V). 
6.3.5.1 Primary Outcomes 
  The FACT O (Basen Engquist et al., 2001) was used to assess quality of life.  
This is the most widely used measure of quality of life in ovarian cancer research, thus 
permitting comparison with other studies (see Chapter 2). Full justification for use of 
this scale is presented in Chapter 5.  There are four subscales that are relevant to any 
chronic illness (physical well being, social/ family well being, emotional well being, 
functional well being), and one scale specific to ovarian cancer (additional concerns).  
For this study, the physical, social and functional well being subscales were used.  The 
ovarian cancer specific concerns scale and the emotional well being subscales had low 
reliability in the pilot study, so were not utilized. 
There are seven items in the physical well being subscale, six or seven items in 
the social/ family well being subscale (one optional item, assessing satisfaction with sex 
life, was excluded from this study, as first, it was considered to address a different issue 
compared to the other questions, and second, approximately 25% of participants failed 
to answer it), and seven items in the functional well being subscale.  Each item is rated 
on a 5 item scale from 0 (not at all) to 4 (very much).  Details about the reliability and 
validity of this scale are presented in Chapter 5.  In the current study, Cronbach’s Alpha 
for the overall scale ranged from .88 to .91, indicating good reliability.  All subscales 
showed similar levels of internal consistency across the three time points.  For the  
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individual scales, Cronbach’s alpha ranged from .88 to .91 for the physical well being 
scale, from .82 to .89 for the social well being scale, and from .85 to .88 for the 
functional well being scale.  
  The partners completed the FACT GP, an equivalent scale for assessing quality 
of life in the general population.  Using a scale with the majority of the same questions 
meant that patient and partner improvement could be compared.  As for the patients, the 
physical, social and functional well being scales were used.  There are 6 items in the 
physical well being subscale, 5 items in the social/ family well being subscale, and 6 
items in the functional well being subscale.  An internet survey completed by 1078 
participants from the general population demonstrated good convergent and divergent 
validity, and Cronbach’s alpha was higher than 0.70, across the subscales (Cella et al., 
2003).  In the current study, Cronbach’s alpha for the overall scale ranged from .81 to 
.84, indicating good reliability.  For the individual subscales, Cronbach’s alpha ranged 
from .75 to .78 for the physical well being subscale, indicating adequate reliability, 
from .77 to .80 for the social well being subscale, indicating adequate reliability, and 
from .80 to .85 for the functional well being subscale, indicating good reliability.  
To assess levels of stress, both patients and partners completed the PSS (Cohen 
& Williamson, 1988).  As mentioned in Chapter 5, this scale has good reliability and 
validity.  It was considered an appropriate measure for the current population, as levels 
of distress in physically ill patients are generally non pathological.  Improvements on 
this scale were demonstrated in the pilot study, which were related to percentages of 
negative emotion and causality words used on days 2 and 3, indicating that written 
emotional disclosure may be effective in reducing perceived stress and that changes in 
the PSS are sensitive to the GDP.  In the current study, Cronbach’s alpha ranged from 
.90 to .91 for patients, and from .87 to .89 for partners, indicating good reliability. 
6.3.5.2 Secondary Outcomes 
    Both patients and partners completed the IES R (Weiss & Marmar, 
1997).  Patients completed it with regard to their cancer, and partners completed it with 
regard to their partners’ cancer.  Psychometrics and rationale for use of this scale are 
described in Chapter 5.  In the current study, Cronbach’s alpha ranged from .91 to .92 
for patients, and from .90 to .92 for partners, indicating good reliability.  
  Both patients and partners completed the emotional representations scale of the 
Illness Perception Questionnaire – Revised (Moss Morris et al., 2002).  This 
questionnaire, which has good reliability and validity, was used as an alternative to the  
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FACT O emotional quality of life scale, which had low reliability in the pilot study, as 
it was considered to more accurately capture the emotional response to the cancer.  The 
patients completed it with regard to their cancer, and the partners completed it with 
regard to their partners’ cancer.  This scale consists of six items which are answered on 
a 5 point scale from ‘strongly disagree’ to ‘strongly agree,’ and is scored so that higher 
scores indicate more emotional distress in relation to the illness.  One item is reverse 
scored.  Sample items include ‘I get depressed when I think about my cancer’ and ‘My 
cancer makes me feel angry.’  In the current study, Cronbach’s alpha ranged from .88 to 
.90 for patients, and from .84 to .86 for partners, indicating good reliability.   
Both patients and partners completed the ENRICH Couple Scales 
communication scale, which assesses marital communication (Fowers & Olson, 1989).  
This measure was used as it specifically assessed communication, in line with the social 
interaction hypothesis regarding written emotional disclosure, which is evaluated in the 
current research.  This scale consists of ten items which are answered on a 5 point 
Likert scale from 1 ‘Disagree Strongly’ to 5 ‘Agree Strongly.’ Six items are reverse 
scored.  Sample items include ‘I can express my true feelings to my partner’ and ‘When 
we are having a problem, my partner often refuses to talk about it’ (reverse scored).  
The scale is scored so that higher scores indicate better marital communication.  A study 
of 15, 522 individuals (7621 couples) demonstrated a Cronbach’s alpha of .86.  Test 
retest reliability data over a period of 4 weeks was .86, based on a sample of 115 
individuals (Olson & Olson, 2000). Results from a discriminant analysis based on the 
ENRICH marital inventory indicated that satisfied and dissatisfied couples could be 
discriminated with 85 95% accuracy, a finding that was highly relevant for the 
communication subscale (Fowers & Olson, 1989).  Cronbach’s alpha in this study 
ranged from .89 to .91 for patients, and from .87 to .91 for partners, indicating good 
reliability. 
  Research has shown that when one member of a couple has cancer, 
communication regarding the illness is significantly correlated with relationship quality 
(see Chapter 4).  However, a search revealed no questionnaire specifically designed to 
assess illness related marital communication, so it was decided to create a brief measure 
assessing this.  The items cover two main domains: how comfortable the individual felt 
about discussing the illness with their partner and their impression of their partner’s 
willingness/ reluctance to discuss the illness.  These domains are explored from both the 
patient’s and the partner’s perspective.  This measure consists of four items which can  
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be answered on a 5 point Likert scale from 1 ‘Disagree strongly’ to 5 ‘Agree strongly,’ 
with the wording edited so that the questions can apply to either the patient or the 
partner.  Higher scores indicate better communication.  Items include ‘It is hard for me 
to express feelings about my illness to my partner’ (for patients, reverse scored), and ‘I 
feel comfortable discussing issues related to her illness with my partner’ (for partners).  
Cronbach’s alpha ranged from .80 to .85 for patients, indicating good reliability, and 
from .72 to .80 for partners, indicating adequate to good reliability.  Reading ease is at 
Flesch Kincaid grade level 7 (Microsoft Word Readability Statistics).  Convergent 
validity was demonstrated by significant correlations with the Enrich couple scales 
communication subscale for patients and partners; concurrent validity was demonstrated 
by significant correlations with social quality of life in patients and partners, and with 
intrusive thoughts and emotional representations of the illness in patients only; test 
retest reliability over a period of three to six months was demonstrated in both patients 
and partners in the control group; and predictive validity was demonstrated in the 
control group by significant correlations between illness related communication at 
baseline and emotional representations of the illness at three month follow up for 
patients, and between illness related communication at baseline and social quality of 
life at three month follow up for partners.  This scale is presented as the final four items 
assessing communication (see Appendices P and Q). 
Utilization of health care was assessed by asking participants how often they had 
visited their GP or a consultant for illness, injury or checkup; an alternative therapist for 
illness, injury or regular treatment; or self treated with over the counter remedies or 
alternative medicine in the preceding 3 months.  Previous research on written disclosure 
has shown stronger effects for physical than psychological health outcomes, and this 
study aimed to see whether these results could be replicated.  Ovarian cancer patients 
are often diagnosed with advanced stage disease, following misdiagnoses by their GPs, 
which can impair the patient provider relationship, and lead to patients becoming 
interested in complementary therapies.  It was therefore decided to obtain information 
about visits to alternative therapists as well as GP visits. 
CA 125 is a tumour marker with high prognostic value in ovarian cancer (see 
Chapter 1).  Since a previous study found that optimism significantly predicted CA 125 
at the end of treatment (de Moor et al., 2006), this study aimed to see whether similar 
improvements in CA 125 levels could be obtained. Data about CA 125 level and date of 
last CA 125 test were obtained by self report.  However, following an amendment to  
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approval from the ethics committee, patient consent was obtained for letters to be 
written to consultants requesting confirmation of the self reported CA 125 (see 
Appendices Y Z).  The correlation between self report and consultant report was 0.995, 
indicating that these self reports were highly reliable. 
6.3.5.3 Linguistic analysis of the writing 
The writing texts were analysed using the computer program Linguistic Inquiry 
and Word Count (LIWC) 2007 (Pennebaker et al., 2007).  This counts numbers of 
words for a variety of language categories, and reports percentages of words in each 
category, as well as total word count.  In order to do this, all handwritten texts were 
typed, and all typewritten texts were scanned and checked against the original text.  The 
LIWC analysis served two purposes.  First, it was a manipulation check, to see whether 
the GDP group used more positive and negative emotion, insight and causality words 
than the control group on Days 2 and 3.  Second, it aimed to see whether percentages of 
positive emotion, negative emotion and causality words used on Days 2 and 3 were 
related to improvements in the GDP group. 
 
6.3.5.4 Post-writing questions. 
Each day, the participants were given several questions to answer immediately 
post writing.  (Pennebaker, 1994).  On days 1 and 2, these questions asked how personal 
the writing was, how revealing they were of emotions, how much the individual had 
told others about the topic they wrote about, how much they had wanted to tell someone 
about what they wrote, and how much they had actively held back from telling someone 
about what they wrote.  On day 3, questions were asked about how personal the essays 
were, how revealing of emotions they were on days 2 and 3, how much they had told 
others about the topic they wrote about and held back from telling someone about the 
topics they wrote about.  They were also asked about the extent to which they had 
thought about the study since it began, the extent to which they had thought about the 
topics since the beginning of the study, and the extent to which they thought about the 
topics they wrote about prior to the study.  These questions were answered on a scale 
from 1 ‘not at all’ to 7 ‘a great deal.’ They served two purposes.  The questions 
regarding how personal and how revealing of emotions the essays were, and the extent 
to which the participants had thought about the study and the topics acted as a 
manipulation check, to see if the GDP group had engaged more with their essays than 
the control group.  The other questions were based on the social interaction hypothesis,  
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which holds that written disclosure can lead to increased social interaction following a 
traumatic event.  At the follow ups, the participants were asked how much they had 
thought about what they wrote, and how much they had talked to someone about what 
they wrote.  It was hypothesized that self report of talking more at follow up would 
mediate improved outcomes. 
6.3.5.5 Follow-up questions. 
At the final follow up, the participants were asked whether they would 
recommend the writing to others, and whether they thought they were in the 
intervention or control group.  These questions were designed to assess the acceptability 
of the intervention, and the effectiveness of blinding the participants to condition. 
6.3.6 Sample Size Determination 
The sample size calculation for this study was based on the results from the pilot 
study for perceived stress, which is one of the primary outcomes in the current study.  A 
calculation based on the difference between the means at first baseline and follow up 
for the ‘writing first’ group in the pilot study revealed an effect size of 0.70.  With 80% 
power and p<.05, using two tailed tests, it was calculated that the current study needed 
32 participants per group to complete the intervention in order to obtain a significant 
effect.  However, since this estimate was generous, it was decided to recruit 
approximately 50 participants per group.  This calculation was based on the perceived 
stress results as it was assumed that quality of life would improve more over a longer 
time period. 
6.3.7 Statistical analyses 
First, to determine the success of randomization, the GDP and control groups 
were compared on baseline demographic and biomedical variables, using T tests for 
continuous variables, and chi square for categorical variables.  Any variable found to 
differ between groups at baseline was added as a covariate in subsequent analyses.  
Second, the writings in the GDP and control groups were compared for use of positive 
and negative emotion, insight and causality words on days 2 and 3 using T tests.  Also, 
the extent to which the participants considered their writing to be personal and revealing 
of emotions was compared across the GDP and control groups, using T tests, in order to 
assess engagement with the task. 
To determine whether the GDP led to improved quality of life and reduced 
perceived stress relative to the control group, 2 by 3 mixed ANOVAs were used, with  
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group (GDP or control) as the between subjects factor, and time (baseline, 3 month or 6 
month) as the within subjects factor.  Mixed ANOVAs were used as they provided an 
opportunity to compare changes over time in the GDP and control groups.  It was 
hypothesized that there would be a group by time interaction indicating improvement in 
the GDP group relative to the control group at three and six months follow ups.  If such 
interactions occurred, changes were examined from baseline to each follow up point 
using planned contrasts, to determine the group in which time had had an effect.   
Similar 2 by 3 ANOVAs were carried out for the process variables of intrusive 
thoughts, marital communication and illness related marital communication.  When 
these were also found to be significant, mediation analyses were carried out using the 
Sobel test (Preacher & Hayes, 2004) in order to determine whether the improvements in 
the outcome variables were fully or partially mediated by the improvements in the 
process variables.  Pearson correlations were carried out in order to determine whether 
percentages of positive emotion, negative emotion, insight and causality words were 
related to changes in outcomes from baseline to each follow up.  Significant 
correlations were followed up with multiple regressions in order to test for moderation.  
Level of the outcome variable at follow up was entered as the DV, level of the outcome 
variable at baseline was entered on the first step, and the percentage of i.e. positive 
emotion words used was entered on the first step.  The CA 125 results were 
dichotomized based on a clinical cut off of 35 (Bast et al., 1983), and analyzed using 
nonparametric tests, since they were initially highly skewed. 
Intraclass correlations were carried out in order to determine whether patient and 
partner improvement were correlated.  These analyses were hypothesized to provide 
insight into whether improvements were couple related or individually based. 
  Moderation and moderated mediation analyses were carried out based on 
hypotheses regarding subsets of individuals who might be expected to benefit more 
from the intervention and mechanisms by which benefits were expected to occur.  
Although the main aim of randomized controlled trials is to minimize between group 
differences at baseline, and determine if the intervention is efficacious for the 
population as a whole, it is also important to identify moderators (Sherman et al., 2004).  
As discussed in section 6.2.4, identification of moderators and moderated mediators 
serves two main purposes.  Clinically, it is important for clinicians to be aware of who 
benefits from interventions, so they know to whom to offer therapies.  Theoretically, it  
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provides a greater understanding of the theoretical underpinnings of specific 
interventions and their processes. 
The presence of moderators and moderated mediators was tested in the 
following way.  For dichotomous variables, 3 (time) ×2 (group) ×2 (moderator variable) 
ANOVAs were used, with the moderator as a between subjects factor.  For continuous 
variables, hierarchical multiple regressions were used.  The primary outcome at three 
months (quality of life or perceived stress) was the dependent variable.   It was decided 
to focus on outcomes at three months, as improvements were expected to be most likely 
to occur over this period.  The measure of the primary outcome at baseline and other 
relevant covariates were entered in the first step, and group, the moderator, and the 
interaction term of group × the z score value of the moderator was entered in the third 
step. The moderator/moderated mediator was centred in order to reduce 
multicollinearity.  Hypothesized illness related moderators included experience of a 
recurrence.  Hypothesized moderators/ moderated mediators related to the social 
interaction hypothesis included change in illness related couple communication (since 
the GDP might have been expected to benefit couples who were experiencing problems 
discussing the patient’s illness) and marital communication at baseline. Hypothesized 
moderated mediators related to the cognitive processing hypothesis were changes in 
levels of intrusive thoughts (as improvements are indicative of having worked through 
the event – see Chapter 4).  Other moderators included partners’ intrusive thoughts at 
baseline and whether participants would recommend the intervention. 
Finally, sensitivity analyses, excluding participants based on certain factors, 
were carried out in order to see whether these factors impacted on the results.  It was 
decided to check whether the couple completing the intervention together or separately 
would influence the results, and thus couples who had completed the intervention 
separately were excluded from these analyses. 
  Analyses were carried out on both the intention to treat and the completers’ 
samples.  The intention to treat sample consisted of all participants who were assigned 
to each group, regardless of whether they experienced the intervention.  The analysis on 
the intention to treat sample tested the benefit that could be expected from offering the 
intervention in practice.  Missing values were replaced with participants’ baseline 
values of the measures.  The analysis on the completers’ sample tested the efficacy of 
the intervention for those who received it and remained alive to experience the benefits. 
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Chapter Seven: The effect of guided written disclosure on perceived stress and quality 
of life: A randomized controlled trial   Results 
 
The following chapter reports the analyses and subsequent results for each 
hypothesis.  Section one describes preliminary analyses carried out to screen the data.  
In sections two, three and four participant flow and baseline characteristics of the 
couples are described.  Section five focuses on the inter relationships between baseline 
factors.  Section six addresses whether the participants would recommend the 
intervention, and the effectiveness of blinding.  Sections seven and eight describe the 
fidelity checks: word usage by group, and the post writing questions. Sections nine, ten 
and eleven describe the outcome data for primary and secondary outcomes.  Section 
twelve describes the findings on predictors and moderators of the primary outcomes.  
Sections thirteen and fourteen describe the correlations between word usage and change 
in the outcomes, and levels of thinking and talking about the writing at follow up.  The 
final section discusses couple related factors: correlations between patient and partner 
improvement and communication discrepancy as a correlate of outcome. 
 
7.1 Data Screening and preliminary analyses 
 
Statistical analyses were performed using SPSS for Windows (version 15). Prior 
to analysis all variables were examined using the SPSS explore function.  Most 
variables did not have missing values.  If under 25% of the data from a particular scale 
were missing, the scores were replaced with the means of the other items.  This 
happened in two cases out of the entire sample.  If over 25% of the data from a 
particular scale were missing, the data were treated as missing for the completers 
analyses, and replaced with the previous observation for the intention to treat analyses. 
The data were examined for normality of sampling distributions, linearity and 
homogeneity of variance.  These examinations revealed that skewness and kurtosis were 
less than 1 for most variables, indicating that the assumption of normality was met.  
However, three of the variables had extreme levels of skewness and kurtosis – CA 125 
level, doctor visits, and visits to alternative therapists.  Transformations were attempted, 
but did not normalize the data.  It was therefore decided to dichotomize the CA 125 
results using the clinical cut off of 35 u/ml (Bast et al., 1983).  Briefly, a score above 35  
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u/ml is indicative of a possible recurrence, whereas a score below 35 u/ml is within the 
normal range for the general population.  Similarly, as only one third of the participants 
had visited an alternative therapist at any time point, these results were dichotomized 
based on whether the patients had visited an alternative therapist or not.  However, the 
variable of doctor visits could not be dichotomized, so it was analysed using non 
parametric tests. 
All statistical analyses were two tailed and a 5% significance level was 
maintained throughout the analyses.  Two types of analyses were carried out: 
completers and intention to treat.  Intention to treat analyses are recommended as they 
include all randomized participants in the groups to which they were allocated, 
regardless of whether they completed the intervention (Hollis & Campbell, 1999).  Such 
analyses indicate the effectiveness of a new treatment, should it be implemented in 
practice, and control for non compliance and differential dropout between conditions.   
However, given that, one of the main reasons for attrition in the current research was 
patient death, whereas the current research did not claim to enhance survival, 
completers analyses were also carried out.  
There is a lack of consensus about how missing responses should be handled in 
intention to treat analysis.  However, one of the most commonly used methods is the 
‘last observation carried forward’ method (Hollis & Campbell, 1999), which was used 
in this study.  For participants who withdrew from the study without completing the 
intervention, or before the three month follow up, three month follow up scores on the 
questionnaire measures were obtained by substituting the missing data with their scores 
obtained at baseline.  Similarly, for the participants who dropped out between three and 
six month follow up, six month follow up scores were obtained by substituting the 
missing data with their scores obtained at the three month follow up.   
 
7.2 Participant Flow 
 
  Figure 3 shows the flow of participants through the trial.  Three hundred and 
thirty six respondents returned a slip or contacted the researcher indicating receipt of the 
letter.  It is important to note that the Ovacome database is not based on hospital 
records, but updated by members and their families.  A number of those who did not 
respond to the initial letter may have been in hospital, died, moved away or been 
ineligible to participate.  Of those who responded, 203 expressed interest in the study,  
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and 141 couples were found to be eligible.   Reasons for ineligibility included being 
single (28 participants), and too long since their last treatment (34 participants).  Of 
these 141 couples, 102 completed baseline measures and were randomized   the 
intention to treat sample.  This represents a response rate of 102/141 (72.3%).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Flow of participants through the trial  
Assessed for eligibility (203) 
Excluded (n= 79) 
•  Not meeting inclusion criteria 
(62) 
•  Patient refused to participate (0) 
•  Partner ill/ not interested (17) 
Lost to follow-up (n= 2) 
•  Woman died (2) 
 
Discontinued intervention (1) 
Husband withdrew (1) 
GDP (n= 53) 
Couple received intervention (44) 
Couple did not receive intervention (2) 
•  Woman too ill (1) 
•  Woman not interested (1) 
Partner did not receive intervention (n=7) 
•  Not interested (7) 
Lost to follow-up (n= 4) 
•  Woman died (3) 
•  Partner failed to return 
questionnaire (1) 
Discontinued intervention (1) 
•  Couple withdrew (1) 
Control (n= 49) 
Couple received allocated intervention 
(44) 
Couple did not receive intervention (2) 
•  Couple not interested (1) 
•  Woman died (1) 
Partner did not receive intervention (2) 
Analyzed (for intention to treat) (49) 
Allocation 
Analysis 
Follow Up  
Enrollment 
Randomized 
Returned initial questionnaire (102) 
•  Couple not interested (12) 
•  Partner ill/ not interested (5) 
•  Woman died: (2) 
•  Woman too ill (4) 
Follow Up   Lost to follow-up (n= 2) 
•  Woman too ill (1) 
•  Failed to return questionnaire (1) 
Lost to follow-up (n=2) 
•  Woman died (1)    
•  Failed to return questionnaire 
(1) 
Replied to invitation (336) 
Analyzed (for intention to treat) (53) 
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Of the 102 couples that were randomized, 13 (12.7%) dropped out without 
writing.  Reasons for dropout included that the partner did not wish to write (GDP: 7 
cases; Control: 2 cases), the patient was not interested (GDP: 1 case, Control: 1 case), 
the woman was too ill (GDP: one case) and the woman died (Control: one case).  A 
further 12 (11.8%) failed to complete one or both of the follow up assessments.  
Reasons for this included the patient dying (GDP: 2 cases; Control: 4 cases), the patient 
being too ill (GDP: 1 case), the couple withdrawing from the study (Control: 1 case); 
the partner withdrawing from the study (GDP: 1 case), and failure to return the 
questionnaire, by the partner (Control: 1 case) and the couple (GDP: 1 case; Control: 1 
case).  Thus, 77 couples (75.5% of those randomized) completed the intervention.  
Completers analyses were carried out on these participants, in order to determine the 
effectiveness of the intervention.  However, since the moderation analyses were carried 
out between baseline and three month follow up, they included all participants who 
remained in the study to that date (81 couples; 79.4%).  In addition, even if the partner 
withdrew from the study, the patient usually did not do so.  Thus, the overall response 
rate for patients was 88/102 (86.3%), and the moderation analyses for patients included 
92 couples (90.2%). 
7.3 Baseline demographic characteristics of participants 
 
Baseline demographic and disease related characteristics of patients randomized 
to the GDP and control groups are reported in Table 8.  The mean age of participants 
was 55.1 years.  The average time since diagnosis across both groups was 37.8 months, 
and average time since last treatment was 15.1 months.  Approximately 2/3 of the 
patients (63.7%) were diagnosed with advanced stage disease.  Thirteen patients 
(12.7%) were undergoing treatment at the time of recruitment, and 45 (44.1%) had 
experienced a recurrence of the cancer since their initial diagnosis.  Among those who 
completed at least one follow up assessment, 44 of those who had not had a recurrence 
remained disease free, and 10 had a recurrence during the study.  All but eight patients 
had had surgery.  The median number of courses of chemotherapy experienced was one 
(range 0 5).  Participants had been married/ cohabiting for 27.08 years on average.  
Thirty two patients (19.6%) had a tertiary education.  Thirty seven (36.3%) were 
employed. 
There were no between group differences with regard to the health behaviours of 
exercise, smoking and alcohol consumption.  On average, patients exercised 1 2 times  
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per week or more.  The average level of alcohol consumption was five units per week, 
which is well below limits recommended for the general population.  Only seven (7%) 
of the sample smoked.    
  
Table 8: Baseline demographic and illness characteristics and health behaviours of the 
patients  
  GDP (n=53)  Control 
(n=49) 
Statistical comparison 
Age (Mean, SD)  53.02 (10.30)  57.39 (8.09)  t = 2.32 (p=.02)* 
Disease stage:       
I  12  11  Pearson χ
2 = 3.89 
(p=.27) 
II  4  10   
III  30  24   
IV  7  4   
Time since diagnosis in months 
(Mean, SD) 
43.29 (34.05)  31.54 (21.22)  t =  2.09 (p=.04)* 
Time since last treatment in 
months (Mean, SD) 
16.40 (19.44)  13.65 (15.34)  t =  .78 (p=.44) 
Currently having treatment  7  6  Pearson χ
2 = .02 (p=1) 
Had a recurrence   26  19  Pearson χ
2 = 1.09  
(p=.32) 
Number of courses of 
chemotherapy (Mean, SD) 
1.85 (1.35)  1.53 (0.96)  t =  1.36 (p=.18) 
Had surgery  51  43  Pearson χ
2 = 2.52  
(p=.15) 
Had radiotherapy  6  5  Pearson χ
2 = .03 (p=1) 
Length of time married/ living with 
partner in years (Mean, SD) 
25.67 (13.66)  28.62 (10.98)  t = 1.11 (p=.27) 
Highest level of education:       
Less than secondary school  16  21  Pearson χ
2 = 1.92  
(p=.38) 
Secondary school/ technical 
qualification 
18  15   
University education  19  13   
Employment status:       
Employed  23  14  Pearson χ
2 =2.42 
(p=.15) 
Retired/ homemaker  30  35   
Exercise (Mean, SD)  3.28 (1.32)  3.09 (1.21)  t=  .10 (p= .92) 
Smoke  4  3  Pearson χ
2 =.39 (p=.58) 
Alcohol units per wk (Mean, SD)  5.21 (6.06)  5.09 (5.44)  t=  .77 (p= .45) 
*p<.05  
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Baseline demographic characteristics of the partners are reported in Table 9.  
Across the whole sample, the mean age of the partners was 57.8 years.  Thirty six 
participants (41.9%) had a tertiary education.  Fifty nine participants (57.8%) were 
employed.   
 
Table 9: Baseline demographic characteristics of partners  
  GDP (n=53)  Control 
(n=49) 
Statistical comparison 
Age (Mean, SD)  55.34 (10.92)  60.43 (9.22)  t = 2.33 (p=.02) 
Highest level of education:       
Less than secondary school  11  10  Pearson χ
2 = .15 
(p=.93) 
Secondary school/ technical 
qualification 
14  15   
University education  17  19   
Employment status:       
Employed  24  35  Pearson χ
2 = 3.04 
(p=.11) 
Retired  25  18   
 
Comparisons were made to determine whether the two groups were equivalent 
with regard to demographic and biomedical characteristics.  Differences were tested 
using independent samples T tests for continuous data, and chi square analysis for 
categorical data.  Results showed that the two groups did not differ significantly in 
terms of disease stage, time since treatment, whether they were currently having 
treatment, numbers having experienced a recurrence, number of courses of 
chemotherapy, time married, educational level and employment status.  However, there 
were significant differences in age and time since diagnosis between the groups.  
Participants in the GDP group were significantly younger than those in the control 
group, and it was longer since their initial diagnosis.  Because of this, age and time 
since diagnosis were added as covariates in all subsequent analyses.  In addition, it was 
expected that having treatment at retest would influence the results, so this was also 
included as a covariate in subsequent analyses.  Similarly, although partners did not 
differ between the groups with regard to educational level and employment status, those 
in the GDP group were significantly younger than those in the control group.   
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7.4 Characteristics of baseline outcome measures 
7.4.1 Primary Outcomes 
The GDP and control groups were compared on their quality of life (FACT O: 
patients; FACT GP: partners) and perceived stress scores at baseline.  These results are 
reported in Tables 10 and 11.  For patients, there were no statistically significant 
differences between the two groups at baseline on quality of life, but the GDP group 
experienced higher levels of perceived stress than the control group.  For partners, there 
were no statistically significant differences at baseline on perceived stress, but the GDP 
group experienced worse quality of life than the control group.  Comparisons of the 
subscales showed that these differences were due to partners in the GDP group 
reporting worse social and functional quality of life.  The overall perceived stress scores 
reported in this sample (Patients: 16.99, SD=8.13; Partners: 14.40, SD= 7.03) were 
higher than those reported for the general population (13.02) (Cohen & Williamson, 
1988).  Patients’ scores on the FACT O subscales were slightly lower than the means 
reported in the validation study (Physical: 22.25; Functional: 20.94; Social (7 item 
scale): 23.33) (Basen Engquist et al., 2001) indicating that patients in this sample were 
slightly less satisfied with their quality of life.  The mean score for partners on the 
FACT GP (74.0 %) was similar to that of a representative sample of 1400 people from 
the general population (Cella et al., 2003). 
7.4.2 Secondary Outcomes 
As shown in Tables 10 and 11, independent samples T tests revealed no 
differences between the GDP and control groups at baseline with regard to intrusive 
thoughts and emotional representations of the illness.  In addition, for patients, there 
were no differences at baseline with regard to marital communication and illness related 
couple communication.  Further, Mann Whitney U tests showed no differences between 
groups at baseline with regard to visits to GPs/ consultants and visits to alternative 
therapists.  However, for partners, the GDP group scored lower at baseline with regard 
to marital communication and illness related couple communication.  
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Table 10: Baseline characteristics for outcome measures   patients (means are presented 
with standard deviations in brackets unless otherwise specified)  
  GDP (n=53)  Control (n=49)  Statistical comparison 
Quality of Life (FACT O)        
Physical  21.30 (5.62)  21.51 (5.99)  t = .18 (p= .86) 
Social  17.81 (4.97)  19.57 (4.18)  t = 1.94 (p= .06) 
Functional  18.52 (6.16)  18.94 (5.69)  t = .35 (p= .73) 
Overall  57.64 (13.40)  60.02 (11.32)  t = .96, (p= .34) 
Perceived Stress   18.57 (8.05)  15.25 (7.94)  t =  2.08 (p= .04)* 
Intrusive thoughts   11.62 (7.81)  9.82 (7.52)  t =  1.19 (p=.24) 
Marital communication   34.79 (9.01)  37.10 (7.87)  t = 1.37 (p=.17) 
Illness related 
communication  
13.64 (3.86)  14.39 (3.76)  t = .99 (p= .33) 
Emotional representations   19.70 (5.64)  18.69 (6.13)  t =  .86 (p= .39) 
Visits to GP/ consultant 
(Median, range) 
2 (10)  1 (12)  Mann-Whitney U 
Z =  .57 (p= .57) 
Visits to alternative therapists 
(Median, range) 
0 (36)  0 (13)  Mann-Whitney U 
Z =  .45 (p = .65) 
*p<.05 
 
Table 11: Baseline characteristics for outcome measures – partners (means are 
presented with standard deviations in brackets) 
  GDP (n=53)  Control (n=49)  Statistical comparison 
Quality of Life (FACT GP)        
Physical   20.57 (3.18)  21.69 (3.40)  t = 1.73 (p= .09) 
Social  9.60 (3.37)  11.49 (3.52)  t = 2.76 (p= .007)** 
Functional  14.15 (4.68)  17.59 (4.92)  t = 3.62 (p < .001)** 
Overall  44.32 (8.19)  50.78 (8.60)  t = 3.88 (p < .001)* 
Perceived Stress   15.43 (6.84)  13.29 (7.13)  t =  1.55 (p= .12) 
Intrusive thoughts   9.15 (7.17)  8.60 (6.73)  t =  .39 (p= .69) 
Marital communication   35.15 (8.15)  39.14 (6.92)  t = 2.66 (p= .009)** 
Illness related 
communication  
14.77 (3.54)  16.35 (2.61)  t = 2.57 (p= .012)* 
Emotional representations   22.13 (4.68)  20.98 (4.99)  t =  1.20 (p=.23) 
*p<.05, **p<.001 
 
Concerning levels of intrusive thoughts regarding the cancer, no group 
differences were observed.  Thirty six patients (35%) and 29 partners (29%) scored  
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above the cut off of 12 (Creamer, Bell, & Failla, 2003) indicating possible caseness of 
PTSD with regard to the intrusive thoughts criterion. 
Concerning emotional representations of the cancer, no group differences were 
found.  Patients scored higher than the mean of 19.75 reported for chronic pain patients 
(Moss Morris et al., 2002), indicating more distress in relation to their illness, and the 
mean score for partners was similar to the mean reported for chronic pain patients, 
indicating similar levels of distress. 
There were no group differences with regard to marital communication for the 
patients.  However, partners in the GDP group scored lower than those in the control 
group, indicating worse marital communication.  Both patients (35.90) and partners 
(37.07) scored higher than the mean of 31.6 based on a sample of 21, 501 married 
couples (Fowers & Olson, 1989), which indicates that they had better marital 
communication.  Based on cut off scores, 19 patients (18.6%) and 16 partners (15.7%) 
would be considered to be dissatisfied with regards to marital communication.  
Concerning illness related couple communication, there were no group differences with 
regard to the patients, but partners in the GDP group scored lower than those in the 
control group, indicating less satisfaction with illness related couple communication.  
Patients reported similar levels of satisfaction for general (3.59) and illness related 
communication (3.50), when the mean item scores were compared.   Partners also 
reported more satisfaction with illness related communication (3.88) than general 
communication (3.71). 
Visits to GPs/ consultants and alternative therapists over the preceding three 
months (for illness, injury and regular treatment combined) did not differ between the 
GDP and control groups.  These results were compared using Mann Whitney U tests as 
the data was skewed (a high percentage of the patients reported not visiting GPs/ 
consultants or alternative therapists at all).  The range for visits to alternative therapists 
was particularly large, as some people visited alternative therapists for weekly 
treatments. 
Overall, the evidence from independent samples T tests and chi square tests 
showed that the patients were equivalent with regards to most of the baseline 
demographic, medical and outcome characteristics.  Out of 23 variables, differences 
were found on only three (age, time since diagnosis and perceived stress).  However, the 
randomization appeared to be less successful with regard to the partners.  Out of six  
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partner specific variables, differences were found on three (quality of life, marital 
communication, and illness related couple communication).   
7.5 Correlations between the primary outcomes and other factors at baseline 
7.5.1 Background demographic and biomedical variables 
Pearson product moment correlations were calculated to assess the degree to 
which quantitative demographic and illness variables were associated with the primary 
outcome measures (quality of life, perceived stress) at baseline.  Point biserial 
correlations were used for dichotomous variables and Spearman correlations for the 
other categorical data.  These results are presented in Tables 12 and 13.  
 
Table 12: Correlations between the primary outcomes and background biomedical, 
demographic and health behaviour variables – patients 
Variable  Type of Correlation  Quality of 
Life 
Perceived 
Stress 
Age  Pearson correlation  .13   .17 
Disease stage  Spearman correlation   .02  .14 
Time since diagnosis  Pearson correlation   .001  .003 
Time since treatment  Pearson correlation  .02  .05 
Having treatment  Point-biserial correlation   .10   .07 
Had a recurrence  Point-biserial correlation  .07   .09 
No of courses of 
chemotherapy 
Pearson correlation   .09   .01 
Had surgery  Point-biserial correlation   .002   .07 
Had radiotherapy  Point-biserial correlation   .10   .11 
Time married  Pearson correlation  .01   .06 
Level of education  Spearman correlation  .05  .03 
Employment status  Point-biserial correlation   .06   .05 
Exercise  Pearson correlation  .10  .05 
Smoking   Point-biserial correlation   .02   .05 
Units of alcohol/ wk  Pearson correlation  .17   .18 
 
For patients, none of the baseline demographic and illness variables were 
significantly correlated with the primary outcome variables at baseline.  Correlation 
coefficients were generally small, ranging between  .18 and .17, with p values >.05.  
For partners, correlations ranged from  .25 to .35.  The majority of p values were >.05.  
However, there were significant correlations between patients’ disease stage and 
partners’ perceived stress, patients’ time since diagnosis and partners’ quality of life, 
patients being on treatment and partners’ perceived stress, patients having had a 
recurrence and partners’ quality of life and perceived stress, number of courses of 
chemotherapy patients had had and partners’ quality of life and perceived stress, and  
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educational level and quality of life.  These findings suggested that partners experienced 
more perceived stress when the patient was diagnosed with more advanced stage 
disease, was on treatment, had had a recurrence, and had had more courses of 
chemotherapy.  Partners experienced better quality of life when the patient had been 
diagnosed more recently (in most cases these patients had not experienced a 
recurrence), had not had a recurrence, had had fewer courses of chemotherapy, and 
when they were more educated. 
 
Table 13: Correlations between the primary outcomes and background biomedical and 
demographic variables – partners 
Variable  Type of Correlation  Quality of 
Life 
Perceived 
Stress 
Age  Pearson correlation  .13  .03 
Disease stage  Spearman correlation   .04  .22* 
Time since diagnosis  Pearson correlation   .23*  .12 
Time since treatment  Pearson correlation   .13   .11 
Having treatment  Point-biserial correlation   .04  .24* 
Had a recurrence  Point-biserial correlation  .25*   .32** 
No of courses of 
chemotherapy 
Pearson correlation   .22*  .35** 
Had surgery  Point-biserial correlation  .01   .04 
Had radiotherapy  Point-biserial correlation  .03   .02 
Time married  Pearson correlation  .12  .02 
Level of education  Spearman correlation  .04  .09 
Employment status  Point-biserial correlation  .24*   .09 
*p<.05, **p<.001 
 
7.5.2 Correlations between the primary and secondary outcome variables 
Pearson product moment correlations were calculated to assess the degree that 
secondary outcome variables were linearly related to the primary outcome variables of 
quality of life and perceived stress.  Point biserial correlations were calculated for the 
dichotomized variables of CA 125 and visits to alternative therapists.  These results are 
reported in Tables 14 and 15.   
Pearson product moment correlations showed that for patients, all the secondary 
outcome variables except visits to alternative therapists and CA 125 level were 
significantly correlated with perceived stress and quality of life.  For partners, all the 
secondary outcomes were significantly correlated with perceived stress and quality of 
life. 
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Table 14: Correlations between the primary and secondary outcome variables   patients 
Variable  Quality of Life  Perceived Stress 
Intrusive thoughts   .50**  .71** 
Emotional representations of the 
cancer 
 .50**  .68** 
Marital communication  .40**   .38** 
Illness related communication  .31**   .22* 
Visits to GPs/consultants   .36**  .30** 
Visits to alternative therapists  .02  .06 
CA 125   .09  .05 
*p<.05, **p<.001 
 
Table 15 : Correlations between the primary and secondary outcome variables   partners 
Variable  Quality of Life  Perceived Stress 
Intrusive thoughts   .31**  .49** 
Emotional representations of the 
cancer 
 .23*  .52** 
Marital communication  .57**   .31** 
Illness related communication  .47**   .40** 
*p<.05, **p<.001 
 
7.6.1 Effectiveness of blinding and acceptability of the intervention 
7.6.1.1 Effectiveness of blinding 
  In order to determine the effectiveness of blinding, participants were asked 
whether they thought they were assigned to the intervention or control group.  Among 
patients, 20 of the control participants thought they were in the control group, three 
thought they were in the intervention group, and 17 were not sure.  Six of the GDP 
participants thought they were in the intervention group, 21 thought they were in the 
control group, and 19 were not sure.  Pearson chi square revealed that these numbers 
were not significantly different between groups (χ
2 = .72, p=.69), indicating that 
blinding of participants was successful for patients.  Among partners, 15 of the control 
participants thought they were in the control group, eight thought they were in the 
intervention group, and 12 were not sure.  Ten of the GDP participants thought they 
were in the intervention group, 11 thought they were in the control group, and 18 were 
not sure.  Pearson chi square revealed that these numbers were not significantly  
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different between groups (χ
2 = 1.83, p=.40), indicating that blinding was also successful 
for partners.  Interestingly, a number of participants assigned to the GDP thought they 
were in the control group, as they were not given feedback on their writing tasks.  
Overall, these results suggest that blinding was successful. 
 
7.6.1.2 Acceptability of the intervention 
  No participants in the GDP group reported any adverse effects of the 
intervention.  Seven partners in the GDP group (13.2%) did not feel comfortable 
completing the intervention and therefore withdrew from the study without doing so.  
There was one participant in the control group who reported distress from completing 
the questionnaires, and therefore withdrew from the study at three month follow up.   
For patients, 32 (69.6%) of the GDP group said they would recommend the 
intervention and 14 (30.4%) said they would not, whereas 18 (45%) of the control group 
said they would recommend the intervention, and 22 (55%) said they would not.  
Pearson chi square revealed that this difference was statistically significant (χ
2 = 5.31, 
p=.029), indicating that patients in the GDP group were more likely to recommend the 
writing than those in the control group.  For partners, 22 (56.4%) of the GDP group said 
they would recommend the intervention and 17 (43.6%) said they would not, whereas 
20 (57.1%) of the control group said they would recommend the intervention and 15 
(42.9%) said they would not.  Pearson chi square revealed that this difference was not 
statistically significant (χ
2 = .004, p=1.00) indicating that partners in the GDP group 
were no more likely to recommend the intervention than those in the control group.  
Overall, the GDP appeared to be received more positively by patients than their 
partners.   
 
7.7Word Usage across the three days 
7.7.1 Comparing word usage across groups 
Percentages of positive emotion, negative emotion, insight, and causality words 
were computed for each day of writing, using Linguistic Inquiry and Word Count 
(LIWC; Pennebaker et al., 2007).    This had two purposes.  First, it served as a 
manipulation check, to see whether participants in the GDP group used more affect and 
cognitive words than those in the control group.  In order to do this, percentages of 
words used for each category were compared between the groups using T tests.  These  
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results are reported in Tables 16 and 17.  Overall, both patients and partners in the GDP 
group used more positive emotion, negative emotion, insight and causality words on 
days 2 and 3 relative to the control group.  In addition, participants in the GDP group 
used more negative emotion and insight words, and fewer positive emotion words on 
day 1 relative to the control group.  This indicated that the experimental manipulation 
was successful on days 2 and 3, but that participants in the GDP group found it difficult 
to describe the diagnosis and treatment without reference to emotions. 
 
Table 16: Percentages of word usage categories across groups – patients (means are 
presented with standard deviations in brackets) 
Word Category   GDP (n=49)  Control (n=47)  Statistical 
comparison 
Day 1       
Word Count   359.98 (97.17)  326.72 (107.62)  t =  1.59 (p=.12) 
Positive emotion   1.18 (0.70)  2.44 (1.45)  t = 5.36 (p<.001)** 
Negative emotion   1.47 (0.95)  0.68 (0.85)  t =  4.30 (p<.001)** 
Insight   2.70 (1.21)  0.91 (0.79)  t =  8.62 (p<.001)** 
Causality   0.82 (0.55)  0.99 (0.67)  t = 1.37 (p=.18) 
Day 2       
Word Count   376.33 (93.40)  325.40 (104.66)  t =  2.52 (p=.014)* 
Positive emotion   2.99 (1.43)  2.00 (1.17)  t =  3.70 (p<.001)** 
Negative emotion   3.02 (1.02)  0.81 (0.56)  t =  13.24 (p<.001)** 
Insight   3.92 (1.32)  1.08 (0.94)  t =  12.12 (p<.001)** 
Causality   1.68 (0.81)  0.90 (0.63)  t =  5.25 (p<.001)** 
Day 3       
Word Count   356.33 (107.02)  345.68 (133.66)  t =  .43 (p=.67) 
Positive emotion   3.43 (1.78)  2.45 (1.50)  t =  2.94 (p=.004)** 
Negative emotion   2.53 (1.13)  0.85 (0.76)  t =  8.59 (p<.001)** 
Insight   4.18 (1.17)  1.14 (0.90)  t =  14.29 (p<.001)** 
Causality   1.65 (0.83)  0.96 (0.62)  t =  4.55 (p<.001)** 
*p<.05, **p<.01  
 
150 
Table 17: Percentages of word use categories across groups – partners (means are 
presented with standard deviations in brackets) 
Word Category   GDP (n=44)  Control (n=44)  Statistical comparison 
Day 1       
Word Count   300.32 (114.95)  227.64 (98.69)  t =  3.18 (p=.002)** 
Positive emotion   1.29 (1.07)  2.14 (1.65)  t = 2.85 (p=.006)** 
Negative emotion   1.79 (1.18)  0.29 (0.37)  t =  8.04 (p<.001)** 
Insight   2.54 (1.19)  0.77 (0.76)  t = 8.31 (p<.001)** 
Causality   1.09 (0.80)  1.11 (0.94)  t = .12 (p=.91) 
Day 2       
Word Count   281.77 (89.76)  229.89 (99.39)  t =  2.57 (p=.012)* 
Positive emotion   3.09 (1.50)  1.77 (1.34)  t =  4.34 (p<.001)** 
Negative emotion   2.95 (1.30)  0.60 (0.72)  t =  10.51 (p<.001)** 
Insight   3.62 (1.27)  0.94 (0.84)  t =  11.70 (p<.001)** 
Causality   2.20 (1.25)  0.84 (0.75)  t =  6.17 (p<.001)** 
Day 3       
Word Count   256.70 (103.13)  243.77 (108.22)  t =  .57 (p=.57) 
Positive emotion  3.60 (1.47)  1.81 (1.20)  t =  6.27 (p<.001)** 
Negative emotion   2.48 (1.23)  0.68 (0.74)  t =  8.32 (p<.001)** 
Insight   3.74 (1.65)  1.21 (1.03)  t =  8.61 (p<.001)** 
Causality   1.80 (1.17)  0.82 (0.75)  t =  4.68 (p<.001)** 
*P<.05, **p<.01 
7.8 Post-writing questions 
  After each writing session, the participants answered questions regarding their 
essays.  On days 1 and 2, these questions covered how personal and revealing of 
emotions the essays were, how much they had told other people about what they had 
written, how much they had wanted to tell others about what they wrote, and how much 
they had actively held back from telling others about what they wrote.  On the final day, 
the questions related to all three days of the writing.  They covered how personal and 
revealing of their emotions the participants considered the essays to be, how much they 
had told other people about what they had written, how much they had actively held 
back from telling others about what they had written, how much they had thought about 
the study since it began, how much they had thought about the topics they wrote about 
since the beginning of the experiment, and the degree to which they thought about the 
topics they wrote about before the experiment began.  All the items were answered on a  
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seven point Likert type scale from 1 (not at all) to 7 (a great deal).  These results are 
presented by group in Tables 18 and 19.   
 
Table 18: Post writing questions – patients (means are presented with standard 
deviations in brackets 
  GDP (n=49)  Control (n=47)  Statistical 
comparison 
Day 1:       
Personal   5.86 (1.55)  4.51 (2.07)  t=  3.59 (p =.001)** 
Revealing of emotions  3.31 (2.16)  2.40 (1.84)  t=  2.21 (p =.03)* 
Told others  5.22 (1.99)  2.13 (1.75)  t=  8.07 (p<.001)** 
Wanted to tell others  4.82 (2.10)  2.28 (1.65)  t=  6.61 (p<.001)** 
Held back from telling others  2.69 (2.07)  2.49 (2.20)  t=  .47 (p=.64) 
Day 2:       
Personal   6.59 (0.91)  4.49 (2.03)  t=  6.50 (p<.001)** 
Revealing of emotions  5.82 (1.39)  2.68 (1.81)  t=  9.49 (p<.001)** 
Told others  4.10 (1.98)  2.28 (1.65)  t=  4.89 (p<.001)** 
Wanted to tell others  4.78 (2.06)  2.32 (1.82)  t=  6.18 (p<.001)** 
Held back from telling others  3.61 (2.08)  2.00 (1.84)  t=  4.03 (p<.001)** 
Overall:       
Personal   6.37 (1.05)  4.49 (2.09)  t=  5.51 (p<.001)** 
Revealing of emotions  5.84 (1.39)  2.83 (1.81)  t=  9.10 (p<.001)** 
Told others  4.18 (1.94)  2.23 (1.68)  t=  5.24 (p<.001)** 
Held back from telling others  3.55 (1.98)  2.47 (2.09)  t=  2.61 (p=.01)* 
Thought about study  4.09 (1.69)  3.50 (1.85)  t=  1.33 (p=.19) 
Thought about writing topics 
since study began 
4.85 (1.71)  3.7 (1.98)  t=  2.79 (p=.007)** 
Thought about topics before 
study began 
4.53 (1.54)  2.87 (1.83)  t=  3.94 (p<.001)** 
 *p<.05, **p<.01 
 
These analyses are based on the participants who completed the writing and returned it 
to the researcher (GDP: n=49; Control: n=47).  Two participants in the GDP group and 
two participants in the GDP group did not complete the writing.  In the GDP group, the 
writing from one patient was lost in the post, and another participant failed to return it. 
As expected, Table 18 shows that the patients in the GDP group viewed their 
essays as more personal and revealing of emotions across all three days.  This was the 
case even on Day 1, when the GDP group were required to describe the diagnosis and  
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treatment factually, without reference to emotions.  In addition, participants in the GDP 
group reported having told others more about what they had written and holding back 
more from telling others about what they had written.  Also, the GDP group reported 
having thought more about the writing topics both before the study began and since it 
began.  However, the GDP group were not more likely than the control group to have 
held back from telling others about what they had written on Day 1 (when they 
described the factual details of their diagnosis and treatment), although the difference 
held for the other two days, nor were they more likely than the control group to have 
thought about the study since it began.   
 
Table 19: Post writing questions – partners (means are presented with standard 
deviations in brackets) 
  GDP (n=44)  Control (n=44)  Statistical 
comparison 
Day 1:       
Personal   5.50 (1.65)  4.39 (2.15)  t=  2.73 (p=.008)** 
Revealing of emotions  3.48 (2.26)  1.84 (1.26)  t=  4.20 (p<.001)** 
Told others  4.43 (2.40)  1.23 (0.64)  t=  8.57 (p<.001)** 
Wanted to tell others  4.43 (2.31)  1.59 (1.11)  t=  7.37 (p<.001)** 
Held back from telling others  2.59 (1.96)  1.98 (1.99)  t=  1.46 (p=.15) 
Day 2:       
Personal   6.39 (0.84)  4.16 (2.28)  t=  6.08 (p<.001)** 
Revealing of emotions  5.50 (1.23)  2.18 (1.50)  t=  11.36 (p<.001)** 
Told others  3.55 (1.99)  1.25 (0.84)  t=  7.04 (p<.001)** 
Wanted to tell others  3.77 (2.23)  1.36 (0.61)  t=  6.91 (p<.001)** 
Held back from telling others  3.32 (2.08)  1.80 (1.69)  t=  3.77 (p<.001)** 
Overall:       
Personal   6.09 (1.18)  3.95 (2.26)  t =  5.56 (p<.001)** 
Revealing of emotions  5.64 (1.12)  2.61 (1.74)  t=  9.68 (p<.001)** 
Told others  3.70 (1.92)  1.41 (0.95)  t=  7.10 (p<.001)** 
Held back from telling others  3.16 (2.02)  2.32 (2.11)  t=  1.91 (p=.06) 
Thought about study  3.29 (1.86)  2.19 (0.79)  t=  2.87 (p=.007)** 
Thought about writing topics 
since study began 
4.39 (1.71)  2.26 (1.26)  t=  5.29 (p<.001)** 
Thought about topics before 
study began 
4.11 (1.91)  2.07 (1.73)  t=  4.13 (p<.001)** 
*p<.05, **p<.01  
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As expected, Table 19 shows that the partners in the GDP group viewed their 
essays as more personal and revealing of emotions across all three days.  This was the 
case even on Day 1, when the GDP group were required to describe their diagnosis and 
treatment factually, without reference to emotions.  In addition, participants in the GDP 
group reported having told others more about what they had written and greater desire 
to tell others what they had written about.  Also, the GDP group reported having 
thought more about the writing topics both before the study began and since it began, 
and having thought more about the study since it began.  However, the GDP group were 
not more likely than the control group to have held back from telling others about what 
they had written on Day 1 (when they described the factual details of their diagnosis and 
treatment) or overall, though they were on Day 2.  Overall, these results demonstrated 
that both patients and partners had followed the instructions as required, except with 
regard to writing without emotions on Day 1. 
 
7.9 Results for the RCT outcome data: repeated measures ANOVA 
 
  The RCT evaluated the efficacy of guided written emotional disclosure (the 
GDP) about the patients’ diagnosis and treatment of ovarian cancer for improving 
quality of life and perceived stress in women with ovarian cancer and their partners.  
The primary outcome measures and the continuous secondary outcome measures were 
analysed using 2 (group) by 3 (time) repeated measures ANOVA. These analyses were 
carried out for both patients and partners.  In each of these cases, the independent 
variable (IV), group, included two levels: GDP and control.  Covariates included the 
patient’s age, time since diagnosis, and whether the patient had undergone treatment 
since participating in the intervention.  Since it was hypothesized that benefits from the 
intervention would be greater for patients if their partners completed the intervention 
also, completers’ analyses consisted only of couples where both partners completed the 
intervention.  Intention to treat analyses are reported separately.  The categorical 
outcome measures of CA 125 and visits to alternative therapists were dichotomized and 
analysed using Pearson chi square tests.  Visits to GPs/consultants were highly skewed.  
However, as over 80% of the sample had visited their GP or consultant at least once, it 
was not appropriate to dichotomize it.  These results were therefore analysed using the 
Mann Whitney U test.  
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The 2 (group) by 3 (time) repeated measures ANOVAs evaluated the effects of 
group, time and group by time interactions.  When significant, the group by time 
interaction effect was examined further by using a priori within subjects’ contrasts 
comparing each time point to the previous one.  Repeated contrasts were used to assess 
when change occurred by comparing three month follow up data with the baseline 
scores, and to assess if treatment gains were maintained by comparing the six month 
follow up data to the three month follow up data.   In order to understand the group in 
which change occurred, these analyses were carried out separately for each group.  
Finally, to understand the influence of disease progression on follow up results, 
sensitivity analyses were conducted to examine the effect of recurrence status on the 
outcome measures. 
  Before conducting the outcome analyses, tests were conducted in order to assess 
whether the assumption of sphericity was met.  Sphericity refers to the equality of 
variances of the differences between levels of the repeated measures factor.  It is 
considered to be present when the difference between each pair of scores has equal 
variance (Field, 2005).  Sphericity was measured using Mauchly’s test.  A significance 
level of less than p= .05 indicates that the condition of sphericity is violated.  In such 
cases, the Greenhouse Geisser correction was used in order to produce a valid F ratio. 
 
7.10 Results for the primary outcomes 
 
The primary outcome measures included quality of life (the FACT) and perceived 
stress (the PSS).   
7.10.1 Quality of Life 
7.10.1.1 Group Means 
Two (group) by 3 (time) repeated measures ANOVAs were conducted to 
determine whether there were any statistically significant group by time effects on 
quality of life.  The dependent variable was quality of life measured at each of the three 
time points.  The group means across time for both patients and partners are presented 
in Table 20, with higher scores indicating better quality of life.  Figures 4 and 5 are 
graphs indicating changes in quality of life over time for patients and partners.  There 
were no group by time interaction effects.  For patients, effect sizes (Cohen’s d) for the 
GDP group were  0.21 from baseline to three month follow up and  0.19 from baseline  
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to six month follow up.  For partners, effect sizes for the GDP group were 0.15 from 
baseline to three month follow up and  0.03 from baseline to six month follow up. 
 
Table 20 : Quality of Life Scores for both groups – patients and partners 
Group  Baseline 
(Mean, SD) 
Three month 
follow up  
(Mean, SD) 
Six month 
follow up  
(Mean, SD) 
Repeated 
measures 
ANOVA 
F                    p 
Patients:         
GDP  58.87 (12.53)  56.00 (15.30)  56.30 (14.96)  df (2, 140) 
Control  60.13 (11.06)  60.26 (11.77)  60.26 (12.58)  F = 2.34    .10 
Partners         
GDP  45.75 (7.40)  46.86 (7.61)  45.50 (7.63)  df (1.81, 119.53) 
Control  50.94 (8.99)  49.57 (8.53)  49.11 (8.90)  F = 2.52      .09 
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Figure 4: Mean quality of life scores across time for patients 
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Figure 5: Mean quality of life scores across time for partners 
 
7.10.1.2 Quality of Life: Sensitivity Analyses 
  Sensitivity analyses were conducted to examine whether changes in factors 
unique to the ovarian cancer patients and their partners in this study had an impact on 
quality of life outcome.  In the current study, only one such analysis was carried out.  
The couples were informed that they could either complete the intervention at the same 
time or at different times.  Eleven couples completed the intervention separately (seven 
in the control group and four in the GDP group).  Sensitivity analyses were conducted 
with regard to quality of life, whereby these 11 couples were excluded from the 
analysis.  For patients, a 2 (group) by 3 (time) repeated measures ANOVA revealed 
similar results to the analyses for all completers – the group by time interaction was 
non significant (F (2, 126) = 2.97, p=.06).  For partners, the results were similar to the 
analyses conducted on all completers – the group by time interaction was non 
significant (F (1.80, 106.21) = 1.77, p=.18).  Thus, sensitivity analyses indicated that in 
this sample of ovarian cancer patients and their partners, allowing couples to complete 
the intervention separately did not appear to have a significant impact on the overall 
outcome for patients or partners. 
 
7.10.1.3 Quality of Life: Intention to treat analyses 
The CONSORT guidelines (Moher et al., 2001) recommend that intention to 
treat analyses are carried out, in order to understand the impact an intervention will have 
in practice.  In the current study, these were not the primary analyses, as although the  
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RCT did not aim to improve survival, a major reason for attrition was patient death.  
Furthermore, since written disclosure has not been tested as a stand alone intervention 
for couples, this study aimed to test the effectiveness of completing the intervention and 
possible mechanisms for this effect.  Nevertheless, in order to ascertain the viability of 
future research into this topic, intention to treat analyses were carried out.  These 
analyses revealed similar results to the completers’ analyses with regard to interactions.  
For patients, the group by time interaction was non significant (F (2, 168) = 2.56, 
p=.08).  For partners, the group by time interaction was non significant (F (1.75, 
145.45) = 1.30, p = .28).  These results suggest that the GDP has no effect on patients’ 
or partners’ quality of life. 
7.10.2 Perceived Stress 
7.10.2.1 Perceived Stress: Group Means 
Two (group) by 3 (time) repeated measures ANOVAs were conducted to 
determine whether there were any statistically significant group by time effects on 
perceived stress.  The group means across all three time points for patients’ and 
partners’ levels of perceived stress are presented in Table 21, with higher scores 
indicating more stress.  As shown in Figures 6 and 7, which are graphs indicating 
changes in perceived stress over time, there was no group by time interaction effect for 
perceived stress in patients or partners. For patients, effect sizes (Cohen’s d) for the 
GDP group were  0.11 from baseline to three month follow up and  0.10 from baseline 
to six month follow up. For partners, effect sizes for the GDP group were  0.30 from 
baseline to three month follow up and  0.21 from baseline to six month follow up. 
 
Table 21 : Perceived stress scores for both groups – patients and partners 
Group  Baseline 
(Mean, SD) 
Three month 
follow up  
(Mean, SD) 
Six month 
follow up  
(Mean, SD) 
Repeated 
measures 
ANOVA 
F                    p 
Patients:         
GDP  18.10 (7.70)  18.95 (7.68)  18.85 (7.74)  df (2, 140) 
Control  14.17 (7.67)  15.09 (6.92)  16.23 (7.82)  F = .38          .68 
Partners         
GDP  15.13 (6.69)  17.13 (6.52)  16.45 (6.19)  df (2, 136) 
Control  12.29 (6.92)  12.40 (6.36)  13.29 (7.68)  F = 1.20        .30 
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7.10.2.2 Perceived Stress: Sensitivity analyses 
Sensitivity analyses were conducted to examine whether changes in factors unique to 
the ovarian cancer patients and their partners in this study had an impact on perceived 
stress. In the current study, eleven couples completed the intervention separately (seven 
in the control group and four in the GDP group).  Sensitivity analyses were conducted 
with regard to perceived stress, whereby these 11 couples were excluded from the 
analysis.  For patients, a 2 (group) by 3 (time) repeated measures ANOVA revealed 
similar results to the analyses for all completers – the group by time interaction was 
non significant (F (2, 126) = .52, p=.59).  For partners, the results were similar to the 
analyses conducted on all completers – the group by time interaction was non 
significant (F (1.81, 110.25) = .82, p=.43).  Thus, allowing couples to complete the 
intervention separately did not appear to have a significant effect on the outcome for 
patients or partners. 
7.10.2.3 Intention-to-treat analyses 
  Intention to treat analyses were carried out with regard to the perceived stress 
scores.  For patients, the results were similar to the completers’ analyses.  There was no 
group by time interaction (F (2, 168) = .30, p=.74).  For partners, the results were 
similar to the completers’ analyses.  There was no group by time interaction (F (2, 168) 
= 2.18, p=.12).  Overall, these results suggest that the GDP had no impact on perceived 
stress in either patients or partners when the full sample was taken into consideration.   
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Figure 6 : Mean perceived stress scores across time for patients  
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Figure 7 : Mean perceived stress scores across time for partners 
 
7.11 Results for the secondary outcomes 
7.11.1 Social Interaction Hypothesis 
  Two secondary outcomes were assessed with regard to the social interaction 
hypothesis: marital communication and illness related couple communication.   
7.11.1.1 Social interaction hypothesis – group means 
The group means across all three time points for patients’ and partners’ marital 
communication in general and illness related couple communication are presented in 
Table 22, with higher scores indicating better communication.  Figures 8 11 are graphs 
indicating changes in communication over time for patients and partners.  Two (group) 
by 3 (time) repeated measures ANOVAs were conducted to determine whether there 
were any statistically significant group by time effects on communication.  The 
dependent variables were marital communication and illness related couple 
communication measured at each of the three time points.   
With regard to the patients, there was no group by time interaction with regard 
to marital communication (F (2, 142) = 1.50, p=.23) or illness related couple 
communication (F (1.83, 129.91) = .11, p=.88).  With regard to partners, there was no 
group by time interaction with regard to marital communication (F (2, 134) = .21, 
p=.81) or illness related couple communication (F (2, 134) = 1.58, p=.21).  These 
results are reported in Table 15, and depicted in Figures 6 9. For patients, effect sizes 
(Cohen’s d) for marital communication for the GDP group were  0.10 from baseline to 
three month follow up and  0.07 from baseline to six month follow up.  For partners,  
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effect sizes for marital communication for the GDP group were  0.04 from baseline to 
three month follow up were and  0.09 from baseline to six month follow up.  For 
patients, effect sizes for illness related couple communication for the GDP group were 
0.10 from baseline to three month follow up and 0.12 from baseline to six month 
follow up.  For partners, effect sizes for illness related couple communication for the 
GDP group were  0.10 from baseline to three month follow up and  0.08 from baseline 
to six month follow up. 
 
Table 22 : Means and standard deviations of social interaction hypothesis variables for 
both groups – patients and partners 
Variable  Group  
 
Baseline 
 
3 month 
follow up 
6 month 
follow up 
Marital communication         
Patients  GDP  35.05 (9.26)  34.15 (9.06)  34.43 (9.18) 
  Control  36.00 (8.02)  37.33 (7.04)  37.67 (8.04) 
Partners  GDP  35.65 (7.81)  35.32 (8.71)  34.92 (8.57) 
  Control  38.91 (7.44)  38.46 (8.31)  37.69 (8.22) 
Illness related couple 
communication 
       
Patients  GDP  13.63 (4.10)  14.00 (3.72)  14.10 (3.62) 
  Control  13.58 (3.65)  14.39 (3.27)  14.28 (3.34) 
Partners  GDP  14.65 (3.58)  14.30 (3.79)  14.38 (3.45) 
  Control  16.20 (2.71)  14.86 (3.43)  15.26 (3.27) 
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Figure 8: Mean marital communication scores across time for patients  
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Figure 9: Mean marital communication scores across time for partners 
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Figure 10: Mean illness related couple communication scores across time for patients 
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Figure 11: Mean illness related couple communication scores across time for partners 
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7.11.1.2 Social interaction hypothesis: intention-to-treat analyses 
  Intention to treat analyses were carried out on the variables of marital 
communication and illness related couple communication.  With regard to general 
marital communication, the results were similar to the completers’ analyses for both 
patients and partners.  There was no group by time interaction in patients (F (2, 168) = 
1.62, p=.20) or in partners (F (2, 168) = .48, p=.60).  With regard to illness related 
communication, the results were similar to the completers analyses   there was no group 
by time interaction for patients (F (1.72, 144.53) = .77, p=.45), or for partners (F (2, 
168) = 2.44, p=.09).  In summary, there was no effect of the GDP on general marital 
communication or illness related couple communication in patients or partners.   
7.11.2 Cognitive Processing Hypothesis 
Two secondary outcomes were assessed with regard to the cognitive processing 
hypothesis: intrusive thoughts related to the cancer, and emotional representations of the 
cancer.   
7.11.2.1 Cognitive Processing Hypothesis: Group Means  
The group means across all three time points for patients’ and partners’ levels of 
intrusive thoughts and emotional representations of their illness are presented in Table 
23, with higher scores indicating higher levels of intrusive thoughts/ more distress.  
Figures 12 to 15 are graphs indicating changes in illness related intrusive thoughts and 
levels of distress over time for patients and partners.  Two (group) by 3 (time) repeated 
measures ANOVAs were conducted to determine whether there were any statistically 
significant group by time effects on intrusive thoughts and emotional representations of 
the illness.  These analyses were carried out for both patients and partners.  The 
dependent variables were cancer related intrusive thoughts and emotional 
representations of the illness measured at each of the three time points.   
  With regard to the patients, there was no group by time interaction for intrusive 
thoughts (F (2, 142) = .035, p=.97) or emotional representations of the illness (F (2, 
142) = .48, p=.62).  With regard to partners, there was no group by time interaction for 
emotional representations of the illness (F (1.78, 121.32) = .11, p=.88).  However, there 
was a significant group by time interaction for intrusive thoughts (F (2, 134) = 3.29, 
p=.04).  Planned contrasts of the interaction effect revealed that there was a significant 
group by time interaction between baseline and three month follow up (F (1, 72) = 7.14, 
p=.009) but that there was no group by time interaction between three month follow up  
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and six month follow up (F (1, 67) = .10, p=.75), indicating that the change occurred 
between baseline and three months.  The effect of time from baseline to three months 
was significant for the GDP group (F (1, 39) = 6.92, p=.012) but not for the control 
group (F (1, 38) = .32, p=.57), indicating that this difference was due to an increase in 
levels of intrusive thoughts in the GDP group between baseline and the three month 
follow up.  For patients, effect sizes (Cohen’s d) for intrusive thoughts for the GDP 
group were 0.03 from baseline to three month follow up and  0.07 from baseline to six 
month follow up.  Effect sizes for emotional representations of the illness for the GDP 
group were  0.05 from baseline to three month and 0.06 from baseline to six month 
follow up.  For partners, effect sizes for intrusive thoughts for the GDP group were  
0.27 from baseline to three month follow up and  0.33 from baseline to six month 
follow up.  This contrasts with effect sizes of 0.11 from baseline to three month follow 
up and 0.08 from baseline to six month follow up. For emotional representations of the 
illness, effect sizes for the GDP group were 0.13 from baseline to three month follow 
up and 0.09 from baseline to six month follow up. 
 
Table 23: Means and standard deviations of cognitive processing hypothesis variables 
for both groups – patients and partners 
Variable  Group   Baseline 
 
3 month 
follow up  
6 month  
follow up  
Intrusive thoughts         
Patients  GDP  10.90 (7.46)  10.68 (8.00)  11.40 (7.59) 
  Control  8.92 (6.96)  9.06 (6.55)  9.36 (6.90) 
Partners  GDP   8.14 (5.95)  9.95 (7.49)  10.24 (6.92) 
  Control  8.54 (6.59)  7.86 (6.28)  8.03 (6.21) 
Emotional representations of 
the illness 
       
Patients  GDP  19.45 (5.36)  19.70 (5.27)  19.10 (5.63) 
  Control   18.58 (5.81)  18.17 (5.41)  18.56 (5.27) 
Partners  GDP  21.71 (4.69)  21.13 (4.50)  21.26 (5.07) 
  Control  21.14 (4.35)  20.17 (4.96)  20.60 (4.89) 
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Figure 12: Levels of intrusive thoughts across time for patients 
 
 
0
2
4
6
8
10
12
Baseline 3 mth 6 mth
Time
I
n
t
r
u
s
i
v
e
 
t
h
o
u
g
h
t
s
Control
GDP
 
Figure 13: Levels of intrusive thoughts across time for partners 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Emotional representations of the illness – patients 
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Figure 15: Emotional representations of the illness – partners 
 
7.11.2.2. Intention-to-treat analyses – cognitive processing hypothesis 
Intention to treat analyses were carried out with regard to the variables of 
emotional representations of the illness and intrusive thoughts.  For emotional 
representations of the illness, the results were similar to the completers’ analyses.  There 
was no group by time interaction in patients (F (2, 168) = 0.80, p=.45) or partners (F (2, 
168) = 0.35, p=.69).  For intrusive thoughts, the results were similar to the completers’ 
analyses.  There was no group by time interaction in patients (F (2, 168) = 0.46, p=.63).  
However, there was a significant group by time interaction in partners (F (2, 168) = 
3.76, p=.03), which occurred between baseline and three months (F (1, 84) = 7.00, 
p=.01), but not between three months and six months (F (1, 84) = .57, p=.45).   
In summary, there was no differential effect of the GDP versus control writing 
on emotional representations of the illness.  There was no effect of the GDP on intrusive 
thoughts in patients, but it led to increased intrusive thoughts in partners relative to the 
control group.   
7.11.3 Secondary Outcomes: Visits to Health Professionals 
Visits to health professionals for the preceding three months were assessed at 
each time point.  These were divided into visits to GPs/consultants and visits to 
alternative therapists.  Both these variables had high levels of skewness and kurtosis at 
baseline, which were not influenced by transformations.  As 67 of the participants had 
not visited an alternative therapist at baseline, it was decided to dichotomize this 
variable.  Chi square analyses were then conducted to determine whether significantly 
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fewer patients visited an alternative therapist at follow up in the GDP group relative to 
the control group.  These results, which are reported in Table 24, revealed no significant 
group differences at any time point. 
 
Table 24: Number of patients who had visited an alternative therapist at each time point, 
by group 
Visits to alternative therapists  GDP   Control   Chi square analysis 
(df = 1) 
Baseline (n, %)  17 (32%)  15 (32.6%)  χ
2 = .003, p=1.00 
Three month follow up (n, %)  18 (37.5%)  15 (36.6%)  χ
2 = .008, p=1.00 
Six month follow up (n, %)  17 (37%)  13 (31.7%)  χ
2 = .26, p=.66 
 
The variable of GP visits could not be transformed or dichotomized 
appropriately, so non parametric tests (Mann Whitney U) were used to compare the 
groups at each time point.  As shown in Table 25, there were no significant group 
differences at any time point. 
 
Table 25: GP/consultant visits at each time point, by group 
GP visits  GDP   Control   Statistical analysis 
(Mann Whitney U) 
Baseline (median, range)  2 (0 10)  1 (0 12)  Z =  .57, p=.57 
Three month follow up 
(median, range) 
2 (0 7)  2 (0 13)  Z =  1.10, p=.27 
Six month follow up (median, 
range) 
2 (1 8)  2 (0 9)  Z =  1.29, p=.20 
 
7.11.4 Secondary Outcomes: CA 125 
Since the CA 125 data was highly skewed, it was decided to dichotomize it 
based on the clinical cut off of 35 U/ml (Bast et al., 1983).  Categorical CA 125 levels 
did not differ between groups at baseline.  Chi square analyses were conducted to 
determine whether the percentage of patients with CA 125 levels above 35 U/ ml 
differed between the groups at each follow up.  Not all participants had this data at each 
time point, so these analyses are not based on the full sample, and should be considered 
as exploratory.  As shown in Table 26, these results revealed no significant group 
differences at any time point.  
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Table 26: Categorical CA 125 levels at each time point and results of chi square 
analysis 
CA 125 > 35 U/ml  GDP (n, %)  Control (n, 
%) 
Chi square analysis 
Baseline (n, %)  12 (23%)  14 (29%)  χ
2 = .48, p=.50 
Three month follow up (n, %)  15 (37.5%)  12 (37.5%)  χ
2 = 0, p=1.00 
Six month follow up (n, %)  15 (48%)  13 (43%)  χ
2 = .16, p=.80 
 
7.12 Mediators and Moderators 
7.12.1 Mediators of change 
Mediators identify mechanisms through which an intervention brings about 
positive change.  One of the aims of this study was to investigate potential mediators of 
the effectiveness of the GDP in reducing distress and improving quality of life in 
ovarian cancer patients.  However, there was no group by time interaction for any of the 
primary outcomes, so no tests for potential psychosocial mediators were carried out. 
7.12.2 Moderators of change in quality of life and perceived stress and conditional 
indirect effects 
Another objective was to evaluate potential moderators of the primary outcomes 
of perceived stress and quality of life in ovarian cancer patients and their partners.  
Hypothesised possible illness related moderators included the presence of a recurrence.  
Hypothesised psychosocial moderators included baseline marital communication (which 
was categorised based on published norms) and partners’ levels of intrusive thoughts at 
baseline,.    Other moderators included participants’ views of the intervention (based on 
a question asking whether they would recommend it to others) and recurrence status.  
Since it was also considered important to address the process by which improvements 
may have occurred for some of the population, change in levels of intrusive thoughts 
and change in illness related communication were selected as potential moderated 
mediators, based on the original theoretical hypotheses (Muller et al., 2005)).  Change 
scores are generally used in mediation analysis (Baron & Kenny, 1986).  However, as 
discussed in Chapter 6, moderated mediation implies mediation for some people or in 
some contexts.  In the current research, as there was no theoretical basis for selecting 
further moderators the change scores were treated as moderators in these analyses.  This 
was considered more appropriate than splitting the sample based on their change scores 
and running mediation analyses on each half, as it accounted for the full range of  
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variability in the change scores.  Since it was expected that any change would occur 
mainly between baseline and three months, and any effects demonstrated were present 
at three months but not six months, these analyses were carried out between baseline 
and three months.   
Possible moderators and moderated mediators were analysed in two ways.  
Categorical variables were analysed using a 2 (moderator variable, i.e., recurrence) by 2 
(group) ANOVA, controlling for baseline levels of the primary outcome (perceived 
stress or quality of life), with levels of the primary outcome at three months as the DV.  
Continuous variables (partners’ levels of intrusive thoughts at baseline plus the 
hypothesized moderated mediators (conditional indirect effects)) were analysed using 
hierarchical multiple linear regressions.  This is considered to be a better method than 
categorising outcomes based on a median split, as it takes into account variability in the 
moderator.  In these regressions, the primary outcome in question at three months (i.e., 
quality of life) was entered as the DV and level of the primary outcome at baseline, was 
entered as a predictor on the first step, followed by intervention group, the z score of the 
moderator variable and the interaction term of group by the z score of the moderator 
variable on the second step.  Results for the dichotomous moderator variables are shown 
in Tables 27 and 28, and results for the continuous moderator/ moderated mediator 
variables are shown in Tables 29 and 30.   
 
Table 27: Analysis of variance for the dichotomous predictor/ moderator variables – 
quality of life 
Predictor/ Moderator    F  p 
Recurrence   Patients  .03  .86 
  Partners  .09  .76 
Recurrence*Group  Patients  .005  .94 
  Partners  .006  94 
Marital communication  Patients  2.83  .10 
  Partners  2.59  .11 
Marital communication* Group  Patients  .09  .77 
  Partners  .66  .42 
Recommend intervention  Patients  .58  .45 
  Partners  1.28  .26 
Recommend intervention*Group  Patients  4.81  .03* 
  Partners  .20  .66 
*p<.05 
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Table 28: Analysis of variance for the dichotomous predictor/ moderator variables – 
perceived stress 
Predictor/ Moderator    F  p 
Recurrence   Patients  6.12  .02* 
  Partners  .92  .34 
Recurrence*Group  Patients  .002  .97 
  Partners  1.67  .20 
Marital communication  Patients  .96  .33 
  Partners  .12  .73 
Marital communication* Group  Patients  .64  .43 
  Partners  .10  .75 
Recommend intervention  Patients  2.44  .12 
  Partners  .25  .62 
Recommend intervention*Group  Patients  1.19  .28 
  Partners  .03  .87 
*p<.05 
 
Table 27 shows that for patients, views about the intervention moderated the 
effect of group on quality of life.  In the GDP group, there was no effect of views of the 
intervention on quality of life at three month follow up, whereas in the control group, 
those who said they would not recommend the intervention reported better quality of 
life at three month follow up.  These results are depicted in Figure 16.  Having recurrent 
ovarian cancer was a significant predictor of perceived stress, such that those who had 
had a recurrence reported lower levels of perceived stress at follow up.  However, no 
significant interaction was obtained between this predictor and group.   
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Figure 16: Views about the intervention as a moderator of the effect of group on quality 
of life  
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Results for the continuous variables revealed that change in intrusive thoughts 
predicted quality of life at three month follow up in partners (see Table 29).  The 
partner’s levels of intrusive thoughts at baseline and change in illness related 
communication moderated the effects of the GDP on quality of life in patients (see 
Tables 29 and 30).  Change in intrusive thoughts predicted levels of perceived stress at 
three month follow up in patients and partners.  It also moderated the effects of the 
GDP on perceived stress in patients.  These results are explained below, with reference 
to graphs where appropriate.   
 
Table 29: Hierarchical multiple regression for the continuous predictor/ moderator/ 
moderated mediator variables – quality of life 
Predictor/ Moderator/moderated 
mediator 
  B  SE B  β  t  p 
Partner intrusive thoughts  Patients   .43  .22  .24   1.97  .052 
  Partners  .17  .10  .17  1.69  .10 
Partner intrusive 
thoughts*Group 
Patients  .63  .28  .24  2.28  .03* 
  Partners   .08  .14   .06   .61  .55 
Change in intrusive thoughts  Patients   .27  .19   .13   1.40  .16 
  Partners   .43  .15   .27   2.91  .005** 
Change in intrusive 
thoughts*Group 
Patients   .32  .29   .10   1.10  .28 
  Partners   .08  .21   .03   .36  .72 
Change in illness related 
communication 
Patients  .09  .32  .03  .29  .77 
  Partners   .13  .30   .05   .45  .66 
Change in illness related 
communication*Group 
Patients  1.17  .52  .20  2.27  .03* 
  Partners  .25  .41  .06  .61  .55 
*p<.05, **p<.001 
 
The interaction effect of change in illness related communication by group was 
significant in predicting quality of life at three month follow up.  The interaction 
explained an additional 2.3% of the variance in quality of life (F (1, 85) = 5.16, p=.03).  
To explore this relationship further, quality of life was plotted against change in illness 
related communication for each group (see Figure 17).  Predicted values for quality of 
life were obtained by using the following equation (Aiken & West, 1991):  
“Ŷ = (b1 + b3Z) X + (b2Z + b0)” 
Ŷ stands for the predicted value of quality of life at three month follow up.  X stands for 
group (coded as 0 (control) and 1 (GDP)), and Z stands for the z score for change in 
illness related communication for the mean, one standard deviation above and one  
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standard deviation below the mean. The unstandardized regression coefficients (B) for 
the constant, group, change in illness related communication and the interaction are 
represented by b0, b1, b2 and b3 respectively.  The equation was summed with the 
unstandardized regression coefficient for quality of life at baseline.  The total product 
was converted from a z score to give the actual quality of life score.   
  
Table 30: Hierarchical multiple regression for the continuous predictor/moderator 
variables – perceived stress 
Predictor/Moderator/moderated 
mediator 
  B  SE B  β  t  p 
Partner intrusive thoughts  Patients  .15  .13  .14  1.17  .24 
  Partners   .03  .12   .03   .25  .80 
Partner intrusive 
thoughts*Group 
Patients   .30  .17   .19   1.75  .08 
  Partners   .002  .16   .002   .01  .99 
Change in intrusive thoughts  Patients  .47  .11  .39  4.31  <.001** 
  Partners  .43  .18  .30  2.44  .02* 
Change in intrusive 
thoughts*Group 
Patients   .43  .16   .24   2.66  .009** 
  Partners   .16  .25   .08   .66  .51 
Change in illness related 
communication 
Patients  .14  .20  .07  .71  .48 
  Partners  .28  .33  .12  .86  .39 
Change in illness related 
communication*Group 
Patients   .28  .32   .08   .87  .39 
  Partners   .49  .45   .15   1.09  .28 
*p<.05, **p<.01 
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Figure 17: Change in illness related communication as a moderator of the effects of 
group on quality of life – patients 
 
  For the control group, there was no impact of change in illness related 
communication on quality of life at three month follow up, whereas for the GDP group, 
quality of life was better if illness related communication improved, and worse if 
illness related communication worsened.  Thus, improvements in illness related 
communication mediated the effect of group of quality of life in some of the patients in 
the GDP group. 
Partner intrusive thoughts at baseline moderated the effects of group on patients’ 
quality of life at three month follow up.  This interaction explained an additional 2.5% 
of the variance in quality of life (F (1, 84) = 5.19, p=.03).  To explore this relationship 
further, quality of life was plotted against partner intrusive thoughts at baseline for each 
group, following the equation, and summing it with the unstandardized regression 
coefficient for quality of life at baseline.  These results are depicted in Figure 18.   
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Figure 18: Partners’ intrusive thoughts as a moderator of the effects of group on quality 
of life patients 
 
For the control group, quality of life at three month follow up worsened 
considerably as partner intrusive thoughts increased.  However, for the GDP group, 
quality of life improved as partner intrusive thoughts increased.  Finally, in partners, 
change in intrusive thoughts predicted quality of life at three month follow up, such that 
if intrusive thoughts decreased, quality of life also improved.    
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Change in intrusive thoughts predicted levels of perceived stress at three month 
follow up in patients, such that if there was a decrease in intrusive thoughts, perceived 
stress stayed the same, whereas if levels of intrusive thoughts increased, levels of 
perceived stress also increased.  However, the interaction between change in intrusive 
and group was significant in predicting quality of life at three month follow up.  This 
interaction explained 3% of the variance in perceived stress (F (1, 84) = 7.07, p=.009).  
To explore this relationship further, perceived stress was plotted against change in 
intrusive thoughts for each group, using the equation described earlier.  The equation 
was summed with the unstandardized regression coefficient for perceived stress at 
baseline (see Figure 19).    
   For the control group, an increase in intrusive thoughts was associated with 
higher levels of perceived stress at three month follow up, whereas for the GDP group, 
although perceived stress was marginally lower if intrusive thoughts decreased, there 
was no effect on perceived stress if levels of intrusive thoughts remained constant or 
increased.  Thus, for some of the patients in the control group, an increase in intrusive 
thoughts mediated an increase in perceived stress.  Finally, for partners, change in 
intrusive thoughts predicted levels of perceived stress at three month follow up.  Results 
were similar to those for patients: a decrease in levels of intrusive thoughts was 
associated with perceived stress remaining constant, whereas if levels of intrusive 
thoughts increased, levels of perceived stress also increased. 
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Figure 19: Change in intrusive thoughts as a moderator of the effects of group on 
perceived stress – patients 
  
 
174 
7.13 Correlations between word usage and improvements on the primary and 
secondary outcomes 
Previous studies have found that word usage is related to improvements in the GDP 
group.  This was therefore assessed in the current study.  It was hypothesized that 
greater use of positive and negative emotion, insight and causality words (indicative of 
reflection and emotional processing) would be related to improvements in the GDP 
group from baseline to three month follow up, for both patients and partners.   
In order to assess this, partial correlations were carried out between change in the 
primary and secondary outcomes of quality of life, perceived stress, marital 
communication, illness related couple communication, intrusive thoughts and emotional 
representations of the illness from baseline to three month follow up and the word usage 
categories of positive emotion, negative emotion, insight and causality words on days 2 
and 3, controlling for baseline score on the outcome in question.  In order to reduce the 
possibility of Type 1 error, the percentages of words used on days 2 and 3 were 
combined.   
The results for patients are presented in Table 31.  Increased use of positive 
emotion words on days 2 and 3 were associated with reductions in perceived stress and 
improvements in illness related couple communication from baseline to three month 
follow up.  In addition, reduced use of negative emotion words was associated with 
reductions in perceived stress from baseline to three month follow up.  The results for 
partners are presented in Table 32.  Increased use of positive emotion words was 
associated with improvements in illness related couple communication from baseline to 
three month follow up. In summary, these results indicate that word usage had a 
significant influence on outcomes within the GDP group. 
  
Table 31: Correlations between word usage on days 2 and 3 and change in the primary 
and secondary outcomes from baseline to three months   patients 
Change in outcome variable 
(baseline to three months) 
Positive 
emotion 
Negative 
emotion 
Insight   Causality 
Quality of Life (FACT O)  .03  .02  .10  .003 
Perceived Stress   .31*  .32*  .14   .27 
Intrusive thoughts  .03  .06   .11  .06 
Emotional representations   .16  .07   .15   .15 
Marital communication  .22   .08  .24  .03 
Illness related communication  .32*   .15  .12  .14  
 
175 
* p<.05 
 
Table 32: Correlations between word usage on days 2 and 3 and change in the primary 
and secondary outcomes from baseline to three months – partners 
Change in outcome variable 
(baseline to three months) 
Positive 
emotion 
Negative 
emotion 
Insight   Causality 
Quality of Life (FACT O)   .03  .14   .02   .06 
Perceived Stress  .20  .10   .003   .07 
Intrusive thoughts   .06  .03   .13  .07 
Emotional representations  .02  .03   .08  .12 
Marital communication   .01  .08  .02   .07 
Illness related communication  .33*  .01   .12   .08 
*p<.05 
7.14 Thinking and talking about the writing at follow-up 
At each follow up, participants were asked to evaluate how much they had 
thought about what they had written and talked with others about what they had written 
since participation in the intervention, on a scale from 1 to 7.  These results are reported 
in Tables 33 and 34.  Overall, levels of thinking and talking about the writing post 
intervention were very low for both groups.  Patients in the GDP group were 
significantly more likely to report thinking more about what they had written at three 
months, and significantly more likely to report talking about what they had written at 
six months.  For partners, those in the GDP group reported thinking and talking about 
the intervention more at three months, but there were no group differences at six 
months.   However, even the significant differences were very small. 
 
Table 33: Group differences with regard to thinking and talking about the writing at 
follow up – patients (means are presented with standard deviations in brackets) 
  GDP   Control  Statistical 
comparison 
Three month follow up:        
Think   2.54 (1.29)  1.90 (1.03)  t =  2.57 (p=.012)* 
Talk   1.56 (1.05)  1.33 (0.53)  t =  1.33 (p=.19) 
Six month follow up:       
Think   2.59 (1.41)  2.12 (1.47)  t =  1.51 (p=.14) 
Talk   1.65 (1.04)  1.27 (0.63)  t =  2.05 (p=.04)* 
*p<.05  
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Table 34: Group differences with regard to thinking and talking about the writing at 
follow up – partners (means are presented with standard deviations in brackets) 
  GDP   Control  Statistical 
comparison 
Three month follow up:        
Think   2.48 (1.45)  1.60 (0.98)  t =  3.16 (p=.002)** 
Talk   1.68 (1.12)  1.25 (0.49)  t =  2.20 (p=.03)* 
Six month follow up:       
Think   2.28 (1.34)  2.08 (1.20)  t =  0.67 (p=.50) 
Talk   1.41 (0.68)  1.31 (0.82)  t =  0.60 (p=.55) 
*p<.05, **p<.01 
7.15 Couple-related outcomes 
7.15.1 Correlations between patient and partner improvement 
It was hypothesised that when couples participated in the intervention together, 
their improvements would be correlated.  Intraclass correlations were used in order to 
assess correlations between patient and partner change on the primary and secondary 
outcomes from baseline to three month follow up, as this was the period when most 
improvements were expected to occur.  Intraclass correlations were considered to be 
more appropriate than Pearson correlations as they measure dependence among 
observations and are sensitive to mean difference.  Following this, Fischer’s z test was 
used to test whether the correlations were significantly different.  These results are 
reported in Table 35. 
In the control group, correlations between patient and partner change from 
baseline to three months were significant for the variables for perceived stress, intrusive 
thoughts, emotional representations of the illness and quality of life, supporting the idea 
that patient and partner distress are correlated.    However, comparison of these 
correlations between the GDP and control groups revealed that they were significantly 
different only for quality of life and emotional representations of the illness.  Further, 
there was a highly significant correlation between patient and partner change in illness 
related couple communication in the GDP group.  Although this was not significantly 
different to the control group, it suggested that the GDP may have influenced the way in 
which couples discussed the patient’s illness.    
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Table 35: Intraclass correlations between patient and partner change from baseline to 
three month follow up for the primary and secondary outcomes and comparison of 
group differences 
Variable  GDP  
 
Control   Difference 
Perceived stress  r=.50 (p=.02)*  r=.45 
(p=.04)* 
χ
2 =.08 (p=.78)
   
Intrusive thoughts  r=.33 (p=.11)  r=.52 
(p=.01)* 
χ
2  =.96 (p=.33) 
Emotional representations  r= .61 (p=.93)  r=.49 
(p=.02)* 
χ
2  =28.67 
(p<.001)** 
Quality of life  r= .45 (p=.87)  r=.44 
(p=.04)* 
χ
2  =16.93 
(p<.001)** 
Communication  r=.24 (p=.20)  r=.12 (p=.35)  χ
2  = .29 (p=.59) 
Illness related communication  r=.60 (p=.003)**  r=.26 (p=.17)  χ
2  =3.19 (p=.07) 
*p<.05, **p<.01 
7.15.2 Discrepancy between couples 
7.15.2.1 Absolute discrepancy at baseline 
It was hypothesised that discrepancy between couples regarding general and 
illness related communication would be related to levels of distress and quality of life.  
In order to test this, the partner’s score at baseline was subtracted from the patient’s 
score at baseline, and the absolute value of the discrepancy was calculated.  Pearson 
product moment correlations were then used to calculate the linear relation between 
absolute discrepancy in marital communication and illness related communication and 
the primary outcomes of perceived stress and quality of life.  These results are reported 
in Table 36. 
 
Table 36: Correlations at baseline between absolute communication discrepancy and the 
primary outcomes 
Absolute discrepancy 
variable 
QoL   
patients 
QoL partners  PSS 
patients 
PSS partners 
Marital communication   .15   .14  .12  .15 
Illness related 
communication 
 .09  .01  .18  .15 
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There was no relation between discrepancy in either marital communication in 
general or illness related communication and the primary outcomes of perceived stress 
and quality of life in either patients or partners.  This indicated that the other partner’s 
levels of satisfaction with communication did not influence quality of life or levels of 
distress. 
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Chapter Eight: Discussion of the main study 
8.1 Introduction 
  This thesis investigated the effects of guided written disclosure on perceived 
stress and quality of life in women with ovarian cancer and their partners.  To date there 
are no known studies of written disclosure for couples with chronic illness, and very 
few studies assessing the effectiveness of guided written disclosure.  Furthermore, most 
studies have had very short follow ups.  The pilot study indicated that written disclosure 
was acceptable to women with ovarian cancer, and together with brief stress 
management it may have led to significant reductions in perceived stress and intrusive 
thoughts at one month follow up.  The main study followed CONSORT guidelines as 
far as possible, and included a six month follow up to determine if any benefits were 
maintained over time.  Inclusion of secondary outcomes relevant to the population in 
question enabled investigation as to whether the GDP had any effect on tumour marker 
levels and visits to alternative therapists.  In addition, this study aimed to facilitate 
understanding of the mechanisms responsible for benefit following written emotional 
disclosure, by comparing two theories: the cognitive processing hypothesis and the 
social interaction hypothesis. 
The previous chapter described the results of the main study with regard to 
baseline characteristics of the couples, inter relationships between baseline factors, 
impressions of the intervention and the effectiveness of blinding, the outcome data for 
the primary and secondary outcomes, predictors and moderators/ moderated mediators 
of the primary outcomes, the relation between word usage and outcomes in the GDP 
group, the post writing questions and thinking and talking about the writing, 
correlations between patient and partner improvement, and communication discrepancy 
as a moderator of outcome.  In this chapter, the results relating to each of these 
categories are discussed in the context of the literature described in the introductory 
chapters of this thesis.  The final chapter attempts to account for differences between the 
pilot study and the main study, addresses the theoretical and clinical implications of 
these findings, examines the limitations of the research, and suggests future directions 
for research. 
8.2 Baseline characteristics of the couples 
  Approximately two thirds of the participants were diagnosed with advanced 
stage disease.  This is consistent with the demographics of ovarian cancer in the general  
 
180 
population (Pan et al., 2004).  The mean age of participants in this study was 55, which 
is slightly younger than that of 59 for the general population of ovarian cancer patients 
(Barber, 1993).  However, given that younger people are generally more likely to 
participate in psychological intervention studies (Manne et al., 2007; Scott et al., 2004), 
this was expected.  Almost all participants had had chemotherapy, and all but eight had 
had surgery, whereas very few had had radiotherapy, reflecting the NICE 
recommendations (National Institute of Clinical Excellence, 2003) of cytoreductive 
surgery where feasible followed by six cycles of chemotherapy.  Thus, the majority of 
participants had experienced the same stressors regarding treatment, although they may 
have differed with regard to the magnitude of these stressors.  Half the sample had 
recurrent ovarian cancer.  Although this is lower than the percentage of patients with 
ovarian cancer who will eventually develop a recurrence (Pan et al., 2004), some of the 
participants had only just finished their initial chemotherapy.  In fact, ten of the 
participants had their first recurrence during the study, which was expected as they had 
been diagnosed with advanced stage disease.  The participants had been married for 27 
years on average, indicating that the majority were in fairly stable relationships.  
Approximately one third of the patients were employed.  Some had passed the 
retirement age, which until recently was 60 years of age for women, and some took 
early retirement due to having had multiple recurrences.  On the whole, the participants 
reported high levels of health behaviours.  Only seven participants smoked, and the 
mean consumption of alcohol was 5 units per week, which is well below the upper 
recommended limit of 14 units for women.   
  The GDP and control groups were not significantly different in terms of any of 
the demographic factors assessed except age and time since diagnosis, with GDP 
participants being younger and having had longer time since diagnosis.  Because of this, 
age and time since diagnosis were controlled for in all analyses. 
8.3 Baseline outcome measures 
For the patients, there were no differences between the GDP and control groups 
with regard to any of the primary outcomes except for perceived stress (the GDP group 
reported higher levels of stress than the control group) and no differences with regard to 
any of the secondary outcomes.  However, partners in the GDP group reported worse 
quality of life and less satisfaction with marital communication and illness related 
couple communication than those in the control group.  Because of this, all findings 
related to these factors were interpreted with caution.  Levels of perceived stress were  
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higher than those in the general population (Cohen & Williamson, 1988).  As outlined 
in Chapter 1, ovarian cancer patients have to cope with a number of stressors including 
misdiagnoses prior to treatment, surgery, combination chemotherapy and the risk of 
recurrence.  Consequently, living with ovarian cancer, particularly if recurrent, can be 
highly stressful for patients and their significant others.  Quality of life for patients was 
lower than in the validation study for the FACT O (Basen Engquist et al., 2001).  
Patients undergoing active treatment and those with advanced stage disease were 
underrepresented in that study, unlike in the present study.  However, quality of life in 
partners was similar to that of the general population (Cella et al., 2003). 
Secondary outcome measures indicated that intrusive thoughts were lower than 
in the general population for both patients and partners (Creamer et al., 2003), and 
therefore not a problem for most participants.  However, approximately one third of the 
sample experienced high levels of intrusive thoughts.  This finding is concurrent with 
previous research indicating that high levels of distress are present only in a subset of 
ovarian cancer patients (Kornblith et al., 1995; Norton et al., 2004). The mean score for 
emotional representations of the illness was higher than that reported for chronic pain 
patients (Moss Morris et al., 2002).  Ovarian cancer often has a poor prognosis, and fear 
of a recurrence is one of the main concerns affecting patients (Ferrell et al., 2003), 
possibly manifested here by high levels of distress about the illness.  Chronic pain, 
while disabling, is unlikely to be terminal.  Satisfaction with marital communication 
was higher than for a general population sample (Fowers & Olson, 1989) – less than 
20% of the participants could be classified as maritally distressed with regard to 
communication.  Similar findings have been reported in other studies of couples 
(Manne, 1999, Baider, 2003) as maritally distressed couples are less likely to agree to 
participate in such research.  It is also possible that a cancer diagnosis may improve 
marital communication in some cases (Schover, 2004). 
Approximately one third of the sample had visited an alternative therapist in the 
three months prior to participating in the intervention.  This reflects the high usage of 
alternative therapies among ovarian cancer patients following diagnosis, as diagnostic 
delays tend to impair their relationships with their GPs (Evans et al., 2006). This could 
also reflect fear or mistrust in the mainstream medical system among some patients.  
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8.4 Inter-relationships between baseline factors 
8.4.1 Relation between baseline demographics and primary outcomes 
  None of the baseline demographic factors and illness severity factors were 
significantly correlated with quality of life or perceived stress.  With regard to perceived 
stress, this agrees with previous research with regard to recurrence status (Donovan et 
al., 2002) and being on active treatment (Boscaglia et al., 2005), but is in contrast to 
previous studies on ovarian cancer and other cancers, which have found a link between 
age, disease stage and time since diagnosis and psychological distress (see Arden Close, 
Gidron & Moss Morris, in press for a review). However, it is important to note that the 
Perceived Stress Scale used here assesses levels of stress in everyday life, which may be 
less likely to differ across age groups than clinical levels of distress.  The relation 
between disease stage and quality of life would probably be stronger if it was 
categorized as early or advanced, rather than broken down into four stages.  However, 
too few cases in the current study had early stage cancer.  The relation between a longer 
time since diagnosis and reduced distress is likely to be stronger in individuals who 
have not experienced a recurrence (Arden Close, Gidron, & Moss Morris, in press) but 
half the sample in the current study had had a recurrence.  The relation between having 
radiotherapy, length of time married, employment status, levels of exercise, smoking 
and units of alcohol consumed per week and levels of distress has not been addressed in 
previous studies of ovarian cancer patients.  Thus, my null findings cannot be compared 
to the findings of others. 
With regard to quality of life, the lack of any relation with demographic factors 
is in conflict with the finding reported in Chapter 2 that evidence from previous studies 
found a strong association between older age and better quality of life and between 
being on active treatment and worse quality of life.  However, previous findings of a 
relation between age and quality of life did not hold for social well being (Guo et al., 
2004; Miller et al., 2002), and the scale used in the current study consisted of only 
physical, social and functional well being subscales.  Furthermore, the relation between 
age and quality of life was in the expected direction, but of very small magnitude.  The 
relationship between length of time married, smoking, alcohol intake and quality of life 
has not previously been addressed in ovarian cancer patients.  Thus, my null findings 
cannot be compared to the findings of others. 
However, in partners, longer time since diagnosis was associated with worse 
quality of life, the patient having had a recurrence was associated with better quality of  
 
183 
life and less perceived stress, more courses of chemotherapy were associated with worse 
quality of life and more perceived stress, the patient being on treatment was associated 
with more perceived stress, and more advanced stage disease was associated with more 
perceived stress.  These correlations were small in magnitude.  As mentioned above, the 
relation between time since diagnosis and psychological factors can only be assessed 
after recurrence status has been taken into account.  The findings regarding recurrence 
status and partners’ well being are surprising.  It may be that a worse prognosis draws 
couples closer together (cf. Schover, 2004), or that patients with a poorer prognosis are 
less likely to explain the details of their diagnosis and treatment to their partners.  
Another possible explanation for these findings is that patients who had not experienced 
a recurrence had finished treatment more recently, and were still recovering from the 
side effects of their treatment, which affected their partners.  However, the findings 
regarding numbers of courses of chemotherapy was expected as it is a stressor that is 
likely to impact on partners’ social and functional quality of life.   Similarly, the patient 
being on active treatment increases the number of stressors the partner has to deal with 
in his daily life.  Finally, more advanced stage disease is associated with a worse 
prognosis, and partners are well aware of this relation, which may cause them more 
stress. 
8.4.2 Relationships between primary and secondary outcomes 
  The secondary outcomes of intrusive thoughts, emotional representations of the 
illness, marital communication and illness related couple communication were 
significantly correlated with perceived stress and quality of life in both patients and 
partners.  The correlations of intrusive thoughts and emotional representations of the 
illness with worse quality of life and more perceived stress were particularly strong for 
patients, which is constant with previous literature (Epping Jordan et al., 1994; Hipkins 
et al., 2004).  Patients often experience high levels of distress with regard to their 
illness, which impacts negatively on their ability to enjoy life and the levels of stress 
they experience in everyday life.  The correlations were less strong for partners, but 
nevertheless indicated that distress about the illness is a significant factor affecting 
partner quality of life and distress.  These correlations indicate that the hypothesis that 
improvements in these outcomes would mediate improvements in the primary outcomes 
is plausible.  The relations of marital communication and illness related communication 
with perceived stress and quality of life were stronger for partners than patients.  This 
may be because women are more likely to have additional sources of support, whereas  
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the spouse tends to be the main confidant for men (Harrison et al., 1995).  This is 
particularly true with regard to illness related communication.  These correlations 
indicate that the hypothesis that improvements in communication would mediate 
improvements in the primary outcomes is plausible, particularly for men. 
Visits to GPs and consultants were associated with increased perceived stress 
and worse quality of life in patients.  Such visits may cause a disruption to everyday life 
or could result from increased stress.  Further, people are more likely to visit health 
professionals when they are feeling ill, and their quality of life is therefore low.  
However, visits to alternative therapists and CA 125 levels were not associated with 
perceived stress and quality of life in patients.  Many ovarian cancer patients are 
interested in alternative therapies, regardless of prognosis, and view them as a means 
towards maintaining a healthy lifestyle (Bishop, Yardley, & Lewith, 2006).  A higher 
CA 125 level is a strong indication of a recurrence.  However, many of the participants 
were leading active lives and felt no symptoms even if their cancer had recurred.   
8.5 Effectiveness of blinding and acceptability of the intervention 
  The results indicated that only one third of participants were able to accurately 
classify whether they were assigned to treatment or control.  This difference was 
particularly pronounced for patients – only 10% of the GDP group thought they were 
assigned to the intervention.  Many participants had thought that they would receive 
feedback on their writing, even though the consent form had explicitly outlined the 
study.  This is important as expectations of benefit have been associated with 
improvement in randomized trials (Turner et al., 2002).  Thus, any negative effects of 
the GDP may have been because many in the GDP group did not expect an effect of the 
condition to which they were assigned, or since they did not receive their expected 
feedback. 
  Overall, written disclosure was considered acceptable – there were no 
complaints about the writing among those who completed it.  Some of the partners did 
not wish to do the writing upon seeing the first question, so withdrew without 
completing it.  This indicates that it would be safe to implement written disclosure as an 
intervention to be completed at home. 
Approximately two thirds of the patients and over half the partners in the GDP 
group said they would recommend the intervention, indicating that the GDP was viewed 
positively by a significant number of participants.  Previous research has revealed 
individual differences in who benefits from written disclosure (Frattaroli, 2006; Norman  
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et al., 2004).  However, the question about recommendation was answered on a yes/ no 
basis.  Asking this question on a scale from 1 to 7 would have provided more sensitivity 
into impressions of the intervention.  In addition, requiring comments from all 
participants would have provided more insight into the acceptability and perceived 
benefit of written disclosure.   
8.6 Word usage across the three days 
  Usage of positive emotion, negative emotion, insight and causality words were 
compared across the groups.  This served as a manipulation check on whether the GDP 
group had adhered to the instructions and engaged with the task as presented.  As 
expected, both patients and partners in the GDP group had used significantly more 
positive emotion, negative emotion, insight and causality words than the control group 
on days 2 and 3, indicating that they had adhered to the instructions.  However, patients 
and partners in the GDP group had also used more negative emotion words than the 
control group on day 1, when they were required to describe the event without reference 
to emotions.  This is extremely difficult to do when describing a traumatic event.  The 
GDP group had been partially successful in following the instructions, though   the 
percentage of negative emotion words used on day 1 was considerably lower than on 
days 2 and 3.  The GDP group used more negative emotion words on day 2, when they 
were required to write about how they thought and felt at the time of the event, how it 
had changed their lives, and the meaning it had had for them, and more positive emotion 
words on day 3, when they were required to write about how they think and feel now, 
and whether they would be able to cope with similar events better.  Usage of insight and 
causality words was high across both days. 
8.7 Post-writing questions 
  After each day of writing, the participants were required to answer several 
questions.  These questions were used as a manipulation check on the degree to which 
participants had engaged with their essays.  With regard to days 1 and 2 and overall, 
both patients and partners in the GDP group considered their essays to be more personal 
and more revealing of emotions than those in the control group.  This indicated that the 
GDP group had experienced difficulty in following the instructions on day 1, when they 
were required to describe the diagnosis and treatment without reference to emotions.  
However, the GDP group considered their essays to have been more revealing of  
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emotions on day 2 than on day 1, which indicated that they had attempted to follow the 
instructions on day 1.   
The GDP group were more likely than the control group to have told others and 
to have wanted to tell others about what they had written.  Also, with regard to day 2, 
the GDP group were more likely than the control group to have held back from telling 
others about what they had written about.  However, this difference was not present on 
Day 1.  This was probably because on day 1 the GDP group were required to describe 
the patient’s diagnosis and treatment of ovarian cancer, which consisted mainly of 
medical facts that the participants had probably told others previously.  Overall, the 
difference between groups was significant for patients and approached significance for 
partners.  This difference may have been because patients were more likely to have been 
asked questions about their illness than their partners were, or because partners may 
have been less likely to wish to discuss the cancer.  It is possible that participants may 
have talked about the illness in a more factual manner prior to undergoing the GDP, 
while this may have shifted to a more emotional and cognitive manner after the GDP. 
In addition, the GDP group reported having thought more about the writing 
topics than the control group both since the study began and before the study began, 
which indicated that they were dealing with personally meaningful topics and had 
engaged with their essays.  Finally, the partners in the GDP group reported having 
thought more about the study since it began, compared to the control group, whereas the 
patients did not.  Examination of the scores revealed that this was due to patients 
engaging more in the study than partners, regardless of the group to which they were 
assigned.  Overall, these results indicated that the GDP group had adhered to the 
instructions and engaged with the study while participating in it.  Thus, any failure to 
find significant differences at follow up was unlikely to have been due to lack of 
involvement in the study or misunderstanding the instructions. 
8.8 Aim one: Evaluate the effectiveness of the GDP compared to control writing in 
reducing distress and improving quality of life 
  The primary aim of this study was to see whether the GDP would lead to 
improvements in perceived stress and quality of life in ovarian cancer patients and their 
partners at three month follow up, relative to the control group and whether these 
results were maintained at six month follow up.  However, the results indicated that 
there was no effect of the GDP on quality of life or perceived stress in patients or 
partners.  Similar results were found when intention to treat analyses were carried out,  
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and when sensitivity analyses excluding couples who had completed the intervention 
separately were carried out.  These results indicated that the findings were robust.  The 
GDP therefore had no effect on any of the primary outcomes.  These findings agree 
with a meta analysis by Frisina et al. (2004), which found a non significant effect size 
for the efficacy of written disclosure in improving psychological outcomes in patients 
with chronic illness. Similarly, four of the five previous studies on written disclosure in 
cancer patients, three of which involved unsupervised writing at home (Rosenberg et al., 
2002; Walker et al., 1999; Zakowksi et al., 2004) have found no effects on 
psychological outcomes for the overall sample, and limited effects for physical 
outcomes.  It may be that written disclosure, which can be viewed as a type of problem 
focused coping, is ineffective for dealing with uncontrollable stressors (Folkman & 
Lazarus, 1984). The patients in Stanton et al.’s (2002) study, which found positive 
effects of writing about the cancer on physical symptoms and medical appointments, 
had just completed treatment for early stage breast cancer, and were at low risk of 
recurrence.  Ten participants had their first recurrence during the study, which is likely 
to have increased their stress levels and worsened their quality of life.  In addition, the 
participants were supervised while writing, which may have meant they were less likely 
to be distracted.  Alternatively, the cancer may not have been a prominent stressor in the 
lives of the 44 patients who had not experienced a recurrence and remained disease free 
throughout the study.  For these patients, choosing their own topics to write about may 
have brought about greater improvements.  Although it is not possible to compare the 
current study directly with previous studies, as it used guided rather than standard 
writing, the evidence to date suggests that writing about their illness may not be 
effective for the majority of cancer patients.  Written emotional disclosure has not 
previously been tested in partners of patients with chronic illness.  However, the results 
from the current study echo those of Schwartz and Drotar (2004), who found no benefit 
of written disclosure for parents of children with chronic illness. As in that study, the 
partners in the present study may have experienced too many cognitive and emotional 
demands to fully engage in the writing – greater involvement has been associated with 
positive outcomes (Lutgendorf & Antoni, 1999).  Although the partners wrote at home 
and were not therefore distracted by unfamiliar surroundings, they may still have been 
unable to concentrate, particularly since the GDP and completing the questionnaires 
would have increased the prominence of the illness in their thoughts, at the expense of  
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engaging in the writing.  Alternatively, the partners may have benefited more from 
choosing their own topics to write about.   
8.9 Aim two: Evaluate the effectiveness of the GDP compared to control writing in 
improving the secondary outcomes  
8.9.1 Social interaction hypothesis outcomes 
There was no effect of the GDP on marital communication or illness related 
couple communication for patients or partners.  These results do not provide support for 
the social interaction hypothesis.  There could be several reasons for these results.  First, 
communication may have been close to ceiling level at baseline.  This idea is supported 
by the fact that less than 20% of the full sample were found to be maritally distressed 
with regard to communication – the GDP may lead to improved communication in 
couples who are less satisfied with their communication, provided partners agree to 
participate in such studies.  In this context, the effect of moderators will be addressed 
later.  Second, in order for illness related communication to improve, couples need to 
discuss the illness.  Informal discussions revealed that some of the couples did not 
discuss the writing tasks.  Finally, although the couples were implicitly provided with a 
context to discuss the illness, they were not given training in communication skills.  
This may be necessary for improvements in illness related communication. 
8.9.2 Cognitive processing hypothesis outcomes 
  There was no effect of the GDP on intrusive thoughts or emotional 
representations of the illness in patients.  For partners, there was no effect of the GDP 
on emotional representations of the illness, but intrusive thoughts increased in the GDP 
group from baseline to three month follow up relative to the control group.  These 
results do not provide support for the cognitive processing hypothesis.  Among couples 
where the woman has breast cancer, very few have reported discussing the illness 
regularly (Boehmer & Clark, 2001).  Writing about the illness may therefore have 
forced the partners to reflect in depth about an issue they might avoid examining in 
detail, and may rarely discuss with their partners, and thus may have increased their 
awareness of the vulnerability of their partners, leading to an increase in intrusive 
thoughts.  Previous written disclosure studies have not assessed emotional 
representations of the illness, but effect sizes for written disclosure in chronic illness 
tend to be  small for psychological outcomes (Frisina et al., 2004).  Previous written 
disclosure studies have found reductions in intrusive thoughts in members of couples  
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who have experienced a relationship breakup (Lepore & Greenberg, 2002), individuals 
with PTSD symptoms (Schoutrop et al., 2002), and healthy students (Lutgendorf & 
Antoni, 1999).  However, there have been no effects on intrusive thoughts in patients 
with chronic illness (Frisina et al., 2004).  This may be because chronic illness is a 
concurrent stressor that cannot be forgotten about, particularly for individuals who 
experience a recurrence.   
8.9.3 Visits to healthcare professionals 
  There was no effect of the GDP on visits to alternative therapists or visits to 
GPs/ consultants.  Visits to GPs were unlikely to change for two reasons.  First, as 
ovarian cancer can be asymptomatic in the early stages, patients are highly vigilant for 
symptoms, and will visit health professionals even for minor ailments.  Second, many 
ovarian cancer patients have lost confidence in their GPs following numerous 
misdiagnoses, and have become more involved in alternative therapies, which they view 
as an active means of maintaining a healthy lifestyle (Bishop et al., 2006).  These 
outcomes may be more affected by personality factors such as neuroticism or by stable 
coping styles such as information seeking. 
8.9.4 CA 125 
  Finally, there was no effect of the GDP on CA 125 levels at follow up.  For this 
result to be put in context, it must be noted that a number of the participants did not 
report their CA 125 level at each time point, meaning that there were very small 
numbers for these analyses.  Furthermore, CA 125 was not tested at the time point of 
each assessment, as patients reported this data with regard to their last visit to their 
consultant, which may have been any time within the previous three months.  This 
meant that these results could not be accurately mapped on to each time point.  Also, the 
44 patients who had not had a recurrence and remained disease free reported low CA 
125 levels at each time point.  This meant that there were a limited number of patients 
whose CA 125 levels could potentially be influenced by the intervention.   However, 
these findings were viewed as exploratory, since longitudinal relations between 
dispositional optimism and CA 125 have previously been found (de Moor et al., 2006).  
CA 125 levels would need to be assessed at the time of each assessment for firmer 
conclusions to be drawn.  Alternatively, written disclosure may be insufficient to 
change stable traits, which previous research has shown to be more strongly related to 
CA 125 levels than current psychological well being (de Moor et al., 2006).  
 
190 
8.10 Aim three: Examine the efficacy of potential mechanisms or mediators of the 
efficacy of the GDP 
  Since there were no effects of the GDP on quality of life or perceived stress, and 
calculation of effect sizes revealed minimal change, it was decided not to test for 
mediators.  However, a number of potential predictors, moderators and moderated 
mediators of possible benefits from emotional writing were examined.  The results 
regarding these variables are discussed below. 
  For patients, views about the intervention moderated the effects of the GDP on 
quality of life, such that in the GDP group, there was no effect of views of the 
intervention on quality of life, whereas in the control group, those who said they would 
not recommend the writing reported better quality of life at three month follow up than 
those who said they would.  This result indicates that viewing the GDP positively does 
not influence effectiveness.  Similarly, there was no moderating effect of views of the 
intervention on quality of life in partners.  Also, marital communication at baseline did 
not moderate the effects of group on quality of life or perceived stress at follow up in 
patients or partners.  This may have been due to the low percentage of couples reporting 
dissatisfaction with marital communication at baseline.  Similarly, the presence of a 
recurrence at baseline did not moderate the effects of group on quality of life or 
perceived stress at follow up in patients or partners.  This indicates that having recurrent 
ovarian cancer did not affect outcomes.  However, patients who had recurrent ovarian 
cancer reported lower levels of perceived stress.  Although counter intuitive, this may 
be because some of the participants who did not have recurrent ovarian cancer at 
baseline experienced a recurrence between baseline and three month follow up, whereas 
many of those with recurrent ovarian cancer had been living with their condition for 
several years, and had therefore developed strategies for dealing with general and 
illness related stressors. 
  In patients, the partner’s levels of intrusive thoughts at baseline moderated the 
effects of group on quality of life such that in the control group, patients reported worse 
quality of life at three month follow up if their partner experienced higher levels of 
intrusive thoughts at baseline, whereas in the GDP group, patients reported better 
quality of life at three month follow up if their partners experienced higher levels of 
intrusive thoughts at baseline.  Thus, the GDP may have buffered the longitudinal effect 
of partner intrusive thoughts on patient quality of life.  The finding from the control 
group is in line with previous research on ovarian cancer patients (Jalal, 2004).  The 
GDP may have increased patients’ awareness of the distress the illness has caused their  
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partner (possibly due to discussing their reflections on it as a couple) and enabled them 
to reframe partner distress as concern, thus reducing its impact on patients’ quality of 
life.  It is also possible that the GDP reduced the negative effects of partners’ intrusive 
thoughts on the couple, which then manifested in improved quality of life in patients.  
Also, there was an interaction effect between change in illness related communication 
and group in predicting quality of life, such that in the GDP group, if illness related 
communication improved, this improvement mediated the relation between group and 
improved quality of life at three month follow up, whereas in the control group there 
was no effect of change in illness related communication on quality of life.  Thus, if the 
GDP enhanced illness related communication, it was beneficial for quality of life.  This 
evidence provides support for the social interaction hypothesis in some individuals.  
This means that further research needs to be carried out to understand demographic and 
psychological factors associated with change in illness related communication 
following the GDP.  In partners, change in intrusive thoughts predicted quality of life at 
three month follow up, such that if they decreased, quality of life also improved.  These 
findings add to the evidence base suggesting a negative correlation between intrusive 
thoughts and quality of life (Lewis et al., 2001; Manne et al., 2004). 
In patients, there was an interaction between change in intrusive thoughts and 
group in predicting perceived stress, such that in the control group, if intrusive thoughts 
increased, this increase mediated the relation between group and perceived stress at 
three month follow up, whereas in the GDP group there was no effect of an increase in 
intrusive thoughts on levels of perceived stress.  Thus, the GDP may have buffered the 
effect of increased intrusive thoughts on levels of perceived stress.  The GDP may have 
helped participants to put their cancer into perspective, and deal with intrusive thoughts 
more effectively, by providing a strategy for addressing them. This finding can be 
related to the instructions of the GDP.  The precise verbal labelling and processing of 
unpleasant emotions may reduce amygdala activity and increase prefrontal cortex 
activity, thus enabling individuals to think about the event more explicitly (Hariri et al., 
2000).  Experience from participating in the GDP may thus provide individuals with a 
strategy to think about intrusive thoughts more explicitly, and reflect on them.  
Interviews with participants in written disclosure studies are required to explore this 
idea further (cf. Byrne Davis et al., 2006).   Change in intrusive thoughts also predicted 
levels of perceived stress at three month follow up, such that if they decreased, levels of 
perceived stress also decreased.  In partners, change in intrusive thoughts predicted  
 
192 
levels of perceived stress at three month follow up, such that if they decreased, levels of 
perceived stress also decreased. 
8.11 Correlations between word usage and improvements in the primary and secondary 
outcomes 
  For the GDP group, correlations between percentage of positive emotion, 
negative emotion, insight and causality words used across days 2 and 3 of the writing 
and improvements in the primary and secondary outcomes from baseline to three month 
follow up were tested.  For patients, reductions in levels of perceived stress were 
associated with use of fewer negative emotion words and more positive emotion words.  
To recap, on day 2 there are two parts to the writing.  In the first part, participants are 
required to describe how they felt and what they thought at the time of the event.  In the 
second part, they are required to describe the meaning the event had for them and 
whether it has caused them to change priorities.  On day 3, participants are required to 
write how they think and feel about the event now, whether their thoughts and feelings 
differ from those they had at the time of the event, and whether they think they would 
be able to cope with similar situations better because they experienced that event.  It is 
likely that the results related to word usage relate mainly to the second part of day 2, 
and the whole of day 3.  Thinking of any benefits brought about by the cancer (as 
indicated by increased use of positive emotion words), may have helped the patients to 
accept it, and thus view cancer related difficulties as more manageable, or even as an 
opportunity rather than a threat.  In addition, a positive view of how they coped with the 
illness may have increased their ability to deal with stressors.  However, those who 
viewed the illness with anger may have been less able to deal with difficulties in their 
everyday life, due to concentrating more on the anger.   
Improvements in illness related couple communication were also associated 
with greater use of positive emotion words for both patients and partners.  In this case, 
use of positive emotion words may also have been indicative of benefit finding.  The 
opportunity to reflect on how they currently thought and felt about the event could have 
provided the participants with more insight into the context surrounding their illness, 
which may have influenced the way in which they disclosed it to their partners 
(Pennebaker et al., 1989; Schoutrop et al., 2002).  In support of these ideas regarding 
mechanisms by which word usage led to improvement, Antoni et al. (2001), found that 
cognitive behavioural stress management led to increases in benefit finding for early 
stage breast cancer patients.  Similarly, Stanton et al. (2002) found that writing about  
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positive thoughts and feelings regarding the cancer led to health benefits for women 
with early stage breast cancer.  Editing the instructions to require reference to positive 
emotions on days 2 and 3 may lead to greater improvements at follow up.  
Alternatively, there may be individual differences with regard to use of positive emotion 
words that are responsible for these improvements.  For example, individuals higher in 
dispositional optimism may be more likely to use positive emotion words.  Controlling 
for dispositional optimism is required to test the relation between use of positive 
emotion words and improvements following writing. 
Finally, for partners, improvements in quality of life were associated with 
increased use of words indicating sadness.  Use of such words may have been indicative 
of greater insight regarding the stresses and problems their partner had suffered, which 
may have enabled them empathize with their partners more, or to view their own quality 
of life as better in comparison. The latter explanation is similar to the phenomenon of 
response shift, whereby people modify their expectations of what is necessary to 
achieve good quality of life as their health worsens (Lutgendorf et al., 2002).   
8.12 Thinking and talking about the event 
  Levels of thinking and talking about the writing post intervention were very low 
for both groups.  The majority of participants reported talking about what they had 
written about ‘not at all’ or ‘not very much’ in the six months post intervention.  Levels 
of thinking about the event were slightly higher, but still low.  Patients in the GDP 
group reported thinking about the event more at three months and talking about it more 
at six months, relative to the control group.  Partners in the GDP group reported 
thinking and talking about the event more at six months, relative to the control group.  
However, these differences mainly reached significance because of the small standard 
deviations.  Research has shown that higher levels of disclosure are longitudinally 
associated with better health (Pennebaker et al., 1989).   However, disclosing about an 
event is not simply a function of desire to talk, but depends also on the individual’s 
social network (Pennebaker & Harber, 1993).  However, the questions regarding talking 
about the writing may not have effectively targeted the desired outcome or been 
sufficiently specific.  Since couples participated in the intervention, it may have been 
more appropriate to ask the participants how much they had talked about the writing 
with their spouse or partner.  
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8.13 Correlations between patient and partner improvement 
  Intraclass correlations were carried out to examine correlations between 
improvement in patients and partners from baseline to three month follow up for the 
GDP and control groups.  For the control group, these correlations were significant for 
perceived stress, cancer related intrusive thoughts, emotional representations of the 
illness and quality of life.  These results indicated that patient and partner distress tend 
to be related over time, in agreement with previous research (Hagedoorn et al., 2008).  
However, these findings do not provide information into the way distress is transmitted 
between couples.  Although for the GDP group, this correlation remained only for 
perceived stress, further analyses revealed that the correlations differed significantly 
between the groups only for quality of life and emotional representations of the illness. 
For these variables, the correlations within the GDP group were negative, suggesting 
that patients and partners in the GDP group were influenced differently by the 
intervention with regard to these factors.  However, the correlation for illness related 
couple communication tended to be significantly different between the GDP and control 
groups, indicating that the GDP had influenced illness related communication in both 
members of the couple, possibly by triggering more discussion of the patient’s illness 
between the couple.  Informal discussions with some of the patients post writing 
revealed that they had talked about the diagnosis and treatment with their husbands after 
the first writing day, which they considered had enabled them to understand each 
other’s side of the story.  However, this information was anecdotal.  Asking each 
participant whether they had discussed the illness with their partners post writing would 
have enabled objective testing of these ideas. 
8.14 Discrepancy between couples 
  Correlations between discrepancy in marital communication and illness related 
couple communication and levels of the primary outcomes of quality of life and 
perceived stress at baseline were carried out.  These results revealed no relation between 
these factors, indicating that concordance with partners with regard to levels of 
satisfaction with communication was not important for well being – the individual’s 
level of satisfaction with communication was more important.  Thus, if the individual 
was satisfied with communication with his/ her partner, he/ she experienced better well 
being. 
    Overall, there was no main effect of the GDP on quality of life or 
perceived stress.  However, a number of moderators and moderated mediators of the  
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effects of the GDP on the primary outcomes were identified in patients.  These included 
views of the intervention, change in illness related communication, change in intrusive 
thoughts and the partners’ levels of intrusive thoughts at baseline.  For the GDP group, 
improvements appeared to be related to use of positive emotion words.  General 
theoretical and clinical implications of the research are discussed in Chapter 9.  
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Chapter Nine: General Discussion 
 
The current research was designed to test the efficacy of the GDP compared to 
control writing in reducing distress and improving quality of life in women with ovarian 
cancer and their partners.  There were no main effects of the GDP on these outcomes or 
the secondary outcomes.  However, several moderators and moderated mediators were 
identified.  Following a comparison of the pilot study and the main study, this chapter 
focuses on general clinical and theoretical implications.  Limitations and implications 
for future research are addressed, and final conclusions are drawn. 
 
9.1 Comparison of the pilot study and the main study 
 
The pilot study found large positive effect sizes with regard to perceived stress 
and intrusive thoughts, particularly for the group that wrote emotionally first.  However, 
there was no effect of the GDP on perceived stress or intrusive thoughts in the main 
study.  The effects in the pilot study may have reflected a general tendency to improve 
over time, since there was no control group.  However, an AAB design was used, and 
the effect sizes were considerably larger for the ‘writing first’ group than for the ‘stress 
management first’ group, suggesting that there was at least some effect of the 
intervention order.  Further, as the tendency in the main study, which had a control 
group, was for the patients to remain the same or get worse over time, this is unlikely.   
An alternative explanation for the findings from the pilot study is that it also 
included thirty minutes of stress management over the telephone.  Originally, it was 
concluded that the improvements were due to the writing, since there were significant 
correlations between word usage on days 2 and 3 and improvement in the GDP group, 
and the ‘writing first’ group improved more than the ‘stress management first’ group, 
whereas increased relaxation at follow up was not related to improvement.  However, 
the process of writing followed by talking (even if not necessarily about the writing 
topic) may have been partly responsible for the improvements.  The value of writing 
prior to talking in therapy has been previously demonstrated (Snyder et al., 2004).  
Since participants were not assessed following each component of the intervention, it 
was not possible to test the effects of each component.  Alternatively, the participants in 
the pilot study may have benefited from being able to do the writing at any time they 
pleased, and for as long as they needed.  In the main study, I telephoned the participants  
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to tell them to start writing, and again after 15 minutes to ask them to stop writing.  
Although this was necessary to ensure that the participants followed instructions, it did 
constrain them – many said 15 minutes was not long enough to describe their diagnosis 
and treatment.  Alternatively, the stronger effects found in the pilot study compared to 
the main study may have been due to non specific factors such as increased attention 
paid to the participants.  However, since the effect sizes were much larger for the 
‘writing first’ group than the ‘stress management first’ group, increased contact time is 
unlikely to have been the only reason for the differential outcomes. 
 
9.2 Theoretical implications 
 
  The findings of this study have contributed to the theoretical understanding of 
reasons and revealed some circumstances when written disclosure may be beneficial.  A 
number of issues were raised in the introductory chapters on the role of demographic, 
psychosocial and communication related factors as correlates of distress and quality of 
life in ovarian cancer patients and their partners, and on the lack of knowledge of 
mechanisms of improvement in written disclosure.  These areas are reviewed here. 
9.2.1 Demographic correlates of distress and quality of life 
The evidence from this research suggests that demographic and illness related 
factors are not significant correlates of distress and quality of life in women with 
ovarian cancer.  However, a number of illness related factors were related to increased 
levels of perceived stress and worse quality of life in partners.  These findings suggest 
that partners may be in greater need of support or psychosocial interventions if their 
wives are diagnosed with advanced stage disease, and while their wives are on 
treatment. 
9.2.2 Psychosocial correlates of distress and quality of life 
  The systematic review on correlates of psychosocial distress in ovarian cancer 
suggested that intrusive thoughts regarding the cancer were associated with increased 
levels of distress, and the excluded studies provided support for this relation.  The 
findings from this study support the evidence for a relation between increased levels of 
intrusive thoughts and both higher levels of perceived stress and worse quality of life in 
ovarian cancer patients.  Such correlations were found at baseline.  In addition, 
longitudinal relations between an increase in levels of intrusive thoughts from baseline  
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to three month follow up and higher levels of perceived stress at three month follow up 
were demonstrated for the control group only.  Similarly, emotional representations of 
the illness that were indicative of increased distress were associated with increased 
perceived stress and worse quality of life at baseline.  Findings for partners were 
similar.  These findings suggest that increases in levels of intrusive thoughts may be one 
mechanism by which a cancer diagnosis leads to worsening in quality of life and 
increased distress.  Intrusive thoughts are one of the symptoms present in post traumatic 
stress disorder.  They reflect an inability to control thoughts about a stressor and process 
it, thus increasing the presence of the stressor in individuals’ lives. 
  The relation between couple communication and quality of life has been 
assessed in very few studies (Manne et al., 2006).  The research here supports evidence 
suggesting the importance of couple communication for quality of life.  Better marital 
communication and illness related couple communication were associated with less 
distress and better quality of life at baseline in both patients and partners, though, 
interestingly, the correlations were stronger for partners.  This is in line with previous 
research that men are more likely to name their partner as their sole confidant (Harrison 
et al., 1995).  In addition, improvements in illness related communication were 
associated with better quality of life at follow up for patients in the GDP group.  Further 
research is needed to clarify the direction of this relation for partners and for general 
communication in patients – the evidence suggests that in women, poor marital 
satisfaction causes increased depression, whereas in men, depression leads to worse 
marital satisfaction (Fincham, Beach, Harold, & Osborne, 1997).  Finally, discrepancy 
in communication was not significantly associated with distress or quality of life, 
suggesting that the individual’s own perceptions of communication are more important 
in predicting well being than levels of concordance with their partners regarding 
communication.  Similarly, Sagy and Antonovksy (1992) found that consensus as 
defined by absolute discrepancy with regard to sense of coherence was not associated 
with couple adjustment to retirement – among incongruent couples, the higher score 
was a better predictor of retiree adaptation.  Thus, preliminary evidence suggests that 
couple concordance is not a significant predictor of well being in either partner. 
9.2.3 Cognitive processing hypothesis 
This study did not provide support for the cognitive processing hypothesis.  
There was no effect of the GDP on intrusive thoughts and emotional representations of 
the illness in patients or partners in the main study.  Also, there was no relation between  
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use of insight and causality words on days 2 and 3 of the writing and improvements in 
any of the outcomes.  This may be because a number of the participants had already 
processed and come to terms with the event.  In support of this idea, very few 
participants experienced high levels of intrusive thoughts.  Alternatively, confronting 
emotions relevant to the event may be more important than reflection – Sloan et al. 
(2007) demonstrated that emotional expression was more effective than insight and 
cognitive assimilation in reducing depressive symptoms, PTSD symptoms and physical 
health complaints.  Alternatively, written disclosure interventions may be too brief to 
enable adequate processing of a traumatic event, as such events may affect core beliefs 
and therefore require cognitive behavioural therapy to be addressed fully (Westbrook, 
Kennerly, & Kirk, 2007).  Another explanation is that the measures used in the current 
study were not sensitive to changes in cognitive processing in the study population, as 
the majority of participants would not have been classified as having clinical levels of 
PTSD with regard to the intrusive thoughts criterion, and were too close to ‘floor’ level 
with regard to intrusive thoughts.  Although there were improvements in levels of 
intrusive thoughts in the pilot study, these may have partly been due to the opportunity 
to discuss a problem with a nonjudgmental outsider (in the stress management session), 
or the knowledge of appropriate situations to do relaxation (i.e., when seeing the 
consultant for checkups).  Any improvements in cognitive processing may not 
necessarily have been due to the writing.  In support of this idea, a major reason for the 
efficacy of cognitive behavioural therapy is that it provides patients with skills to deal 
with specific situations (Westbrook et al., 2007).  Overall, these findings indicate that 
changes in cognitive processing were not the main reason for any beneficial effects of 
written disclosure in the current study.  However, studies comparing guided and 
standard disclosure are required to test this issue further. 
9.2.4 Social interaction hypothesis 
   This study provided tentative support for the social interaction hypothesis.  
Although there was no effect of the GDP on couple communication, improvements in 
illness related communication in patients were associated with better quality of life at 
three month follow up in the GDP group.  These findings suggested that the GDP had 
changed the way in which some patients discussed their illness with their partners, 
possibly by providing a covert method to enable them to discuss it with their partners.  
However, this was not the case for all patients, suggesting that changes in illness related 
communication may have been moderated by an unexplained third variable, such as  
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emotional expressiveness.  In support of this idea, Manne et al. (2007) found that 
emotional expression and emotional processing moderated the effects of a couple 
focused group intervention on depression.  Participants in the GDP group did not report 
talking more about what they wrote at three month follow up than those in the control 
group.  However, this question did not address how often patients discussed the topic 
with their partners in the period immediately post intervention.  Also, it may have been 
more effective to ask both the GDP and control group to rate how often they had 
discussed the illness with others at follow up and how it was discussed.  As further 
evidence in support of the social interaction hypothesis, the correlation between patient 
and partner change with regard to illness related couple communication was significant 
only in the GDP group, and tended to be significantly different to the correlations in the 
control group.  These results suggest that the GDP may have led to similar changes in 
illness related couple communication in patients and partners, and made couples more 
concordant, possibly because it provided a context for them to discuss the illness and its 
impact on their lives.  However, couple communication was not assessed in the best 
way possible.  It could have been assessed directly by requiring participants to wear the 
electronically activated recorder (EAR) (Kim, 2008), or to have participated in lab 
discussions of illness related issues before and after the intervention.  Such methods, 
although beyond the budget of the current study, would be recommended for future 
research.  Also, asking participants about the extent to which they had held back about 
discussing the illness at each follow up might have provided more information on the 
extent to which they had disclosed the topic post intervention.   
9.2.5 Alternative explanations for the benefits 
In patients, increased use of positive emotion words and reduced use of negative 
emotion words on day 2 were associated with reductions in perceived stress at three 
month follow up.  Also, in both patients and partners, increased use of positive emotion 
words was associated with improvements in illness related communication at three 
month follow up.  Although preliminary, these findings suggest that reflecting on 
benefits brought about by the illness may be beneficial.  Certainly, there are a number of 
studies suggesting that benefit finding is associated with lower distress, more positive 
mood, and greater well being (Lechner, Carver, Antoni, Weaver, & Phillips, 2006), and 
improved family relationships and greater love for partners (Andrykowski, Brady, & 
Hunt, 1993).  Expressive writing may increase emotion processing and subsequent 
benefit finding, and cognitive restructuring may increase positive reframing and  
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decrease pessimistic appraisals, as demonstrated by increased use of positive emotion 
words.  Certainly, cognitive behavioural stress management has led to increases in 
benefit finding in cancer patients (Antoni et al., 2001; McGregor et al., 2004).  
Particularly on Day 2 of the writing, participants are required to describe how they felt 
and what they thought at the time of the event, which facilitates emotion processing, 
and to reflect on the meaning of the event and whether it caused them to change 
priorities, which may facilitate cognitive restructuring.  Thus, greater use of positive 
emotion words may have indicated enhanced restructuring of the event.   
However, demographic and/or personality characteristics may have influenced 
use of positive emotion words – more optimistic people are more likely to see positive 
effects of negative events.  Higher levels of optimism at baseline have been 
longitudinally associated with more benefit finding in breast cancer patients (Lechner et 
al., 2006), and Cameron and Nicholls (1998) found that in healthy students, standard 
emotional writing led to a reduction in clinic visits only among optimists.  However, 
this would need to be tested further by altering the instructions on days 2 and 3 to 
require use of positive emotion words and comparing the effects of the altered 
instructions with the standard GDP instructions, or by assessing e.g.., dispositional 
optimism at baseline in order to examine the relation between word usage and those 
factors and the moderating role of optimism.  Although a few studies have demonstrated 
benefits of writing about positive thoughts and feelings (i.e., Stanton et al., 2002), this 
area requires further exploration.   
The GDP buffered the effect of increased intrusive thoughts on perceived stress 
in patients.  Thus, although it did not reduce intrusive thoughts, it reduced the impact of 
intrusive thoughts on levels of distress.  Writing about their diagnosis and treatment 
may have enabled the patients to reflect on how they coped successfully with their 
diagnosis and treatment, and therefore enhanced their self efficacy for dealing with 
distressing thoughts about the cancer.  Assessing self efficacy for addressing cancer 
related distress would provide an objective test of this relation.  Also, the GDP changed 
the relation between partners’ intrusive thoughts and quality of life in patients, such that 
increased partner intrusive thoughts were associated with better quality of life in 
patients in the GDP group.  The GDP may have led to cognitive restructuring of the 
diagnosis and treatment in partners so as to increase the controllability of their intrusive 
thoughts, thus reducing patients’ distress.  Alternatively, it may have provided patients 
with insight into their partners’ strategies for dealing with cancer related distress, thus  
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enabling them to interpret partner responses such as withdrawal as indicative of 
increased distress rather than lack of concern.  Assessing the impact of partners’ 
unsupportive responses (Manne & Schnoll, 2001) on quality of life both at baseline and 
follow up would enable testing of this hypothesis. 
9.3 Clinical implications 
 
  The findings of this thesis have important clinical implications.  The main study 
has demonstrated that guided written disclosure is not effective at reducing perceived 
stress and improving quality of life in women with ovarian cancer and their partners, 
and in fact led to an increase in levels of intrusive thoughts in partners at three month 
follow up.  This suggests that written disclosure is not an effective intervention for 
ovarian cancer patients and their partners.  However, posthoc several moderators were 
identified, suggesting that it may be effective for some patients.  Importantly, the 
evidence suggests that the GDP can be carried out safely at home – no participants in 
the GDP group reported any adverse effects as a result of the intervention.  Previous 
home based studies of written disclosure for chronic illness have reported similar results 
(i.e., Broderick et al., 2004).  Thus, if further research identifies patients for whom it is 
effective, it would be possible to offer the GDP as an optional intervention for patients 
to complete in their free time. 
  With regard to patients, several moderators were identified.  These are discussed 
in the context of clinical implications of the results.  One interesting moderator was 
partners’ intrusive thoughts at baseline.  Higher levels of intrusive thoughts in partners 
were associated with worse patient quality of life at follow up in the control group, but 
better patient quality of life in the GDP group.  This result indicates that partners’ 
distress can impact on patient quality of life, and suggests that the GDP may buffer the 
impact of partner distress on patient quality of life, by enabling patients to reframe 
partner distress as indicative of concern.  Further research needs to be carried out to 
explore this in more depth and understand whether partner participation in written 
disclosure studies is necessary for patients to experience this buffering effect – 
distressed partners may be less likely to agree to participate in the GDP.  Within the 
GDP group, improvements in illness related communication were associated with better 
quality of life at three month follow up in patients.  Further research is needed to 
determine demographic and personality related predictors of change in illness related 
communication, in order to understand who may benefit from the GDP, so that  
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providers can offer it to the patients for whom it would be most appropriate.   Either 
way, these results suggest that finding ways of improving couple communication may 
improve quality of life in ovarian cancer patients.  Finally, the GDP buffered the effects 
of intrusive thoughts on perceived stress, suggesting that it may provide a method for 
reducing perceived stress in individuals experiencing high levels of intrusive thoughts. 
A possible explanation for this result is that describing the event chronologically and 
expressing emotions in words helped patients to process the event and deal with 
intrusive thoughts more effectively, in line with the cognitive processing basis on which 
the GDP was developed.  Further research is required to examine whether the GDP is 
effective in a sample of individuals experiencing high levels of intrusive thoughts 
combined with high levels of perceived stress.     
The fact that the GDP increased levels of intrusive thoughts in partners suggests 
that it was not beneficial for them.  Writing about the illness may therefore have forced 
the partners to reflect in depth about an issue they rarely examined in detail or dealt 
with differently.  While intrusive thoughts have been viewed as a step in cognitive 
processing of a traumatic event, such in depth examination of the diagnosis and 
treatment may not have been necessary for all the partners.  This evidence suggests that 
the GDP cannot be recommended for all partners of patients with cancer.  However, 
across the full sample, if intrusive thoughts decreased, quality of life improved and 
levels of perceived stress decreased.  Therefore, further research is required to examine 
moderators of change in levels of intrusive thoughts following the GDP in partners, in 
order to identify those who may benefit from it, and to determine ways to reduce 
intrusive thoughts in male partners of cancer patients.  This is particularly important, as 
no moderators were identified for partners. 
The current research assumed that writing about the diagnosis and treatment of 
the patient’s cancer would provide an opportunity for the couples to discuss it in a non 
threatening context.  Discussion with the patients post intervention revealed that some 
had talked about their diagnosis and treatment with their partners, which may have 
enabled them to come to a joint understanding of the impact of cancer on their lives.  
While not obtained in a standardized manner, this evidence suggests that further 
research to examine whether the GDP is effective in the context of therapy for couples 
coping with chronic illness (cf. Skerrett, 2003) is warranted, as writing prior to 
discussing the illness may help break down social constraints and enhance disclosure of 
the event (Pennebaker et al., 1989; Schoutrop et al., 2002; Zakowski et al., 2004).  The  
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results of the pilot study tend to suggest that introducing writing prior to verbal 
meetings may be helpful. 
  A number of the participants in the main study reported that fifteen minutes was 
not long enough for them to describe the details of their diagnosis and treatment.   To 
solve this problem, if the GDP was implemented in practice, patients could be 
recommended to write until they had completed the details of their diagnosis and 
treatment, on day 1.  Importantly, there were no differences between couples who 
completed the writing at the same time and at different times.  This finding suggests that 
there is no need to recommend couples to complete the writing at the same time. 
 
9.4 Limitations and future directions 
9.4.1 Methodological limitations 
  When interpreting the findings of this research, there are a number of 
limitations that need to be considered.  First, for ethical reasons, no demographic 
information was collected about those who refused to participate, which meant it was 
not possible to compare characteristics of responders and non responders.  Although 
those invited to participate in the study were provided with the opportunity to tick a box 
indicating reasons for refusal to participate, not all did so.  Therefore, it was not 
possible to accurately gauge the recruitment rate – a number of the non responders may 
not have been eligible to participate, or may have died, as the only means of updating 
the charity database is notifications from patients and their families.  However, this 
study was a first of its kind, and research on the effectiveness of written disclosure for 
the general population of ovarian cancer patients would need to be carried out before 
the GDP could be implemented in practice.  Therefore, this does not seriously affect the 
conclusions that can be drawn from this study, it only questions its generalisability.  
The sample for the main study may have been underpowered to detect small to 
medium effects.  The power analysis was based on an anticipated large effect size, 
following previous studies using the GDP (i.e., Gidron et al., 2002; Duncan et al., 
2007).  Previous research has found smaller effect sizes for written disclosure in cancer 
patients (Stanton et al., 2002), suggesting that a larger sample may have been required 
to demonstrate significant effects.  However, the effect sizes for the majority of the 
measures were extremely small, suggesting that lack of power was not the reason for the 
non significant results.  Nevertheless, the study was powered for outcome rather than 
moderation, and these findings should therefore be viewed as exploratory.  Related to  
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this, a number of moderation and moderated mediation analyses were carried out, thus 
increasing the risk of Type I error.  Also, the participants were a heterogeneous group 
with regard to time since diagnosis.  This variability limited the conclusions that could 
be drawn from the research.  In particular, regarding participants with advanced stage 
disease, it was difficult to determine whether improvements were independent of 
disease progression. Further large scale studies focusing only on patients with early 
stage or only on those with recurrent disease are required in order to determine the 
influence of disease progression on outcomes or partly rule out its effects.   
According to CONSORT guidelines, generation of the allocation sequence, 
enrolment of participants and assignment to groups should ideally be carried out by 
different researchers.  In the main study, these tasks were carried out by a single 
researcher.  However, the allocation sequence was destroyed once opaque sealed 
envelopes had been created, and these envelopes were kept in a locked cabinet to which 
the principal researcher did not have access.  Once a participant had been enrolled into 
the trial, another researcher opened an envelope and informed the principal researcher 
the condition to which they were assigned.  Thus, the risk of bias was considered to be 
minimal.  Since the main study was carried out by a single researcher, blinding of the 
researcher during assessment was not possible, which increased the risk of performance 
and observer bias.  However, all items were self reported and participants returned 
questionnaires to the researcher’s supervisor, with whom they had not had contact, 
which minimized the risk of observer bias.  The one measure that was later confirmed 
by doctor records, CA 125, was measured by consultants who were unaware of the 
study.  With regard to performance bias, the instructions were standard and provided in 
a booklet, and each writing session was timed.   
The outcome measures were assessed by self report.  This included outcomes 
such as CA 125 level, visits to GPs/consultants and visits to alternative therapists, which 
are subject to recall, awareness and presentation biases.  This is a significant limitation 
with regard to visits to GPs/ consultants, which can be obtained from medical records.  
However, the significant and very strong correlation between patient reported and 
consultant reported CA 125 levels validated the self reports of CA 125.   Nevertheless, 
assessing CA 125 levels at the time of each questionnaire would have provided a better 
understanding of the impact of the GDP on CA 125 levels.  Further research on this 
topic is required in order to explore the relation between psychological factors and 
tumour progression, as this has been assessed in very few studies (de Moor et al., 2006,  
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von Georgi et al., 2002).  Related to this, medical factors such as disease stage and type 
of treatment were obtained by self report.  Although the CA 125 results suggest that 
these self reports are likely to be highly accurate, it would have been better to validate 
this data against medical records. 
 In the main study, the participants were followed up after three and six months, 
whereas in the pilot study they were followed up at one month.  A follow up at one 
month in the main study would have provided more accurate comparison between the 
studies.  However, it was felt that it would increase response burden, which could 
negatively impact response rate.  Future research would benefit from more follow ups, 
in order to chart the course of change following interventions.  Related to this, one 
major limitation of the pilot study was that participants were not assessed in between 
the writing and stress management, and it was not therefore possible to determine which 
part of the intervention was responsible for improvements.  Another limitation was that 
many statistical tests were performed, thus increasing the risk of Type I error. 
 
9.4.2 Issues to consider in future research   
9.4.2.1 Participant-related issues 
  The participants were members of an ovarian cancer charity, which may have 
influenced the results.  According to Grande et al. (2006) members of support groups 
use more active, adaptive coping strategies and report more control over their cancer 
than patients who are not members of support groups.  Thus, the participants in this 
study may have been more motivated to engage in the study than the general population 
with ovarian cancer.  However, they may also have been less in need of an intervention.  
This highlights a paradox – those most in need of interventions are less likely to be 
receptive to them.  Further research needs to examine reasons for non participation in 
interventions, in order to determine the most appropriate methods of enhancing 
adjustment in women with ovarian cancer and their partners, in couples not seeking 
such participation.   
The participants in this research reported high levels of satisfaction with marital 
communication at baseline – fewer than 20% of the sample would be considered to be 
maritally distressed.  Thus, lack of improvements in communication may have been due 
to a ceiling effect.  It is possible that greater improvements would have been 
demonstrated with couples who had experienced higher levels of distress at baseline.  
However, it is very difficult to convince partners who are not maritally satisfied to  
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participate in research studies.  Related to this, seven of the partners in the GDP group 
withdrew from the study prior to completing the intervention.  In addition, in some 
couples the partners declined to participate in the study.  This raises issues about the 
acceptability of the intervention for partners.  However, the wives of the partners who 
withdrew from the study either had been living with recurrent cancer for several years 
or were almost five years post treatment.  The evidence suggests that the GDP would be 
acceptable to most partners of ovarian cancer patients soon after diagnosis. 
These results were based on a cancer that affects only women.  Although this 
meant that there was no confounding effect of gender on outcome, it limits the extent to 
which the results can be generalised.  This is important, as a meta analysis of written 
disclosure studies demonstrated larger effects for men (Smyth, 1998).  Further research 
is therefore required to determine the effects of writing about cancer and/ or other 
chronic illnesses in couples where the man is the patient.   
9.4.2.2 Areas for further investigation 
There were no effects of the intervention on the cognitive processing measures.  
However, it is difficult to capture changes in cognitive processing.  As an alternative to 
questionnaires, implicit measures of cognitive processing could be used, such as the 
Implicit Association Test (Greenwald et al., 2003).  Such measures may provide a more 
accurate estimate of the degree to which people are experiencing illness related distress 
or hold implicit biases with possible health consequences (Nausheen, Gidron, Gregg, 
Tissarchondou, & Peveler, 2007).  Also with regard to mechanisms of change, the 
current research used the computer program Linguistic Inquiry and Word Count 2007 
(Pennebaker et al., 2007).  However, previous studies have examined the essays in 
detail, in order to understand additional factors influencing outcome (Suedfeld & 
Pennebaker, 1997; Creswell et al., 2007).  Qualitative analysis of the essays could 
provide insights into patient and partner differences, or differences between those who 
improved on the primary and secondary outcomes and those who did not.   
In the main study, the participants answered questions at each follow up about 
how much they had talked to others about what they wrote.  However, given that they 
completed the study with their partners, it may have been more effective to ask them 
about how much they had talked to their partner about what they wrote, and how that 
compared to how much they talked to their partner about it prior to the intervention.  
Since the intervention was completed by the couple, it was expected that it would 
influence their communication with each other.  Couples were assessed for marital  
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communication and illness related couple communication.  These measures were 
chosen as it was expected that the intervention would influence communication rather 
than marital satisfaction in general.  However, a measure of marital satisfaction would 
have enabled direct testing of changes in this variable.  Related to this, the measure of 
illness related couple communication was developed for this study.  Although internal 
consistency was acceptable and good levels of concurrent, convergent, divergent and 
predictive validity were demonstrated, it has not been validated previously.  Further 
research is therefore required to validate this measure.    
  Participants were asked a yes/ no question about whether they would 
recommend the intervention.  However, providing a space for them to describe their 
responses in more detail would have enabled greater insight into patients’ and partners’ 
impressions of the intervention.  In general, more qualitative studies, such as that of 
Byrne Davis et al. (2006) are needed to explore the experiences of participants in 
written disclosure studies.   
  The current research used a guided written disclosure paradigm, which may not 
be the most effective writing paradigm – some participants may have found it too 
structured (although some may have benefited from the guidance provided).  A 
comparison of the GDP and standard writing is needed, to see which type of writing is 
more effective, and/or moderators of the efficacy of each paradigm.  Also, it is 
important to note that the GDP participants were required to write about the patient’s 
illness.  While this is similar to the other written disclosure studies on cancer patients, it 
may not be the most prominent stressor for all participants’, particularly those who were 
diagnosed less recently.  Allowing participants to write about a stressor of their choice 
may have led to greater improvements.  In particular, partners did not experience the 
threat to their lives caused by the diagnosis and treatment, and may have benefited more 
from writing about a stressor they experienced directly.  Although the current research 
aimed to stimulate couple communication, this could be achieved by allowing couples 
to write about a predetermined stressor of their choice.  Further research comparing 
writing about the illness to writing about a stressor of each partner’s choice and a 
stressor of the couple’s choice is required to test this idea. 
9.5 Conclusions 
  Many ovarian cancer patients experience significant levels of distress.  Partners 
of cancer patients also experience significant levels of distress.  However, very few 
interventions have been tested on ovarian cancer patients, and the majority of  
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interventions for cancer patients do not involve their partners.  This thesis 
systematically reviewed the literature on correlates of distress and quality of life in 
ovarian cancer patients, and also reviewed correlates of distress in partners of cancer 
patients to identify correlates of couple communication that lead to increased distress.  
Based on these results, the GDP, which involved writing for fifteen minutes a day over 
three days about the patient’s diagnosis and treatment of ovarian cancer, according to 
standardized instructions, was offered to patients with ovarian cancer and their partners 
  To our knowledge the main study was the first to assess the effectiveness of 
written emotional disclosure as a stand alone intervention for couples.  It was also the 
first study to assess the effectiveness of guided written disclosure in patients with a 
specific chronic illness.  It was the first study to show that guided written disclosure is 
not an effective intervention for all couples with chronic illness.  There were no main 
effects of the intervention on any of the outcomes.  In addition, levels of intrusive 
thoughts increased at three month follow up in partners in the GDP group.   
  This study was also the first to examine two alternative theories of the 
mechanism of improvement following written disclosure: the cognitive processing 
hypothesis and the social interaction hypothesis.  Although there were no positive 
effects overall, change in illness related couple communication and increased use of 
positive emotion words were associated with improvements in quality of life.  Further 
studies are required to understand the factors contributing to these improvements.  In 
addition, the GDP buffered the effects of partners’ intrusive thoughts on patient quality 
of life, such that increased partner intrusive thoughts were associated with better patient 
quality of life, and buffered the effects of intrusive thoughts on perceived stress in 
patients at three month follow up.  Further research is needed to understand the 
mechanisms by which these protective effects of the GDP might occur. 
  The findings from this study are of theoretical and clinical importance.  The 
results have contributed to the knowledge base and understanding of correlates of 
distress and quality of life in ovarian cancer patients and their partners, as well as 
understanding of mechanisms by which written disclosure may lead to benefits in 
physical and psychological health.  Further research is needed to identify those who 
may benefit from written disclosure, in order to increase our understanding of this type 
of intervention and so that it can be offered to people for whom it is likely to be 
effective.    
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Appendices 
Appendix A: Inclusion/ exclusion decision table for full text articles obtained for the 
systematic review 
 
Ref  Article  Included/ 
Excluded 
If excluded, why? 
1  Andersen, B., L. (1995). Quality of life for women with 
gynecologic cancer. Current Opinion in Obstetrics and 
Gynecology, 7, 69 76. 
 
Excluded   Review article 
2  Anderson, B. (1994). Quality of life in progressive ovarian 
cancer. Gynecologic Oncology, 55, S151 S155. 
 
Excluded  Review article 
3  Anderson, B., & Lutgendorf, S. (1997). Quality of life in 
gynecologic cancer survivors. CA: A Cancer Journal for 
Clinicians, 47, 218 225. 
 
Excluded  Review article 
4   Auchincloss, S.S. (1995). After treatment: Psychosocial issues 
in gynecologic cancer survivorship. Cancer, 76, 2117 2224. 
 
Excluded  Review article 
5  Awadalla, A.W., Ohaeri, J.U., Gholoum, A., Khalid, A.O.A., 
Hamad, H.M.A., & Jacob, A. (2007). Factors associated with 
quality of life of outpatients with breast cancer and gynecologic 
cancers and the family caregivers: A controlled study. BMC 
Cancer, 7 (Article no. 102).   
 
Included   
6  Bodurka Bevers, D., Basen Engquist, K., Carmack, C.L., 
Fitzgerald, M.A., Wolf, J.K., de Moor, C. & Gershenson, D.M. 
(2000). Depression, anxiety and quality of life in patients with 
epithelial ovarian cancer. Gynecologic Oncology, 78, 302 308. 
 
Included   
7  Booth, K., Beaver, K., Kitchener, H., O'Neill, J., & Farrell, C. 
(2005). Women’s experiences of information, psychological 
distress and worry after treatment for gynaecological cancer. 
Patient Education and Counseling, 56, 225 232. 
 
Excluded  Only 6/70 
participants had 
ovarian cancer; 
results not 
presented 
separately 
8  Boscaglia, N., & Clarke, D.M. (2007). Sense of coherence as a 
protective factors for demoralisation in women with a recent 
diagnosis of gynaecological cancer. Psycho Oncology, 16, 189 
195. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
9  Boscaglia, N., Clarke, D.M., Jobling, T.W., & Quinn, M.A. 
(2005). The contribution of spirituality and spiritual coping to 
anxiety and depression in women with a recent diagnosis of 
gynecological cancer. International Journal of Gynecological 
Cancer, 15, 755 761. 
 
Included   
10  Canada, A.L., Parker, P.A., de Moor, J.S., Basen Engquist, K., 
Ramondetta, L.M. & Cohen,L. (2006). Active coping mediates 
the relation between religion/spirituality and quality of life in 
ovarian cancer. Gynecologic Oncology, 101, 102 107. 
 
Included   
11  Capelli, G., De Vincenzo, R.I., Addamo, A., Bartolozzi, F., 
Braggio, N. & Scambia, G. (2002). Which dimensions of quality 
of life are altered in patients attending the different gynecologic 
oncology health care settings? Cancer, 95, 2500 2507. 
Included    
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12  Carlsson, M., Strang, P., & Bjurstrom, C. (2000). Treatment 
modality affects long term quality of life in gynaecological cancer. 
Anticancer Research, 20, 563 568. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
13  Carter, J.R. Chen, M.D., Fowler, J.M., Carson, L.F., & Twiggs, 
L.B. (1997). The effect of prolonged cycles of chemotherapy on 
quality of life in gynaecologic cancer patients. Journal of 
Obstetrics and Gynaecology Research, 23, 197 203. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
14  Chan, Y.M., Lee, P.W.U., Fong, D.Y.T., Fung, A.S.M., Wu, 
L.Y.F., Choi, A.Y.Y., Ng, T.Y., Ngan, H.Y.S., & Wong, L.C. 
(2005). Effect of individual psychological intervention in Chinese 
women with gynecologic malignancy: A randomized controlled 
trial.  Journal of Clinical Oncology, 23, 4913 4924. 
 
Included   
15   Chan, Y.M., Ng, T.Y., Ngan, H.Y.S., & Wong, L.C. (2003). 
Quality of life in women treated with neoadjuvant chemotherapy 
for advanced ovarian cancer; A prospective longitudinal study. 
Gynecologic Oncology, 88, 9 16. 
 
Included   
16  Chan, Y.M., Ngan, H.Y., Li, B.Y., Yip, A.M., Ng, T.Y., Lee, 
P.W., Yip, P.S., Wong, L.C. (2001). A longitudinal study on 
quality of life after gynecologic cancer treatment. Gynecologic 
Oncology, 83, 10 19.   
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
17  Chan, Y.M., Ngan, H.Y.S, Yip, P.S.F., Li, B.Y.G., Lau, O.W.K., 
& Tang, G.W.K. (2001). Psychosocial adjustment in gynecologic 
cancer survivors: A longitudinal study on risk factors for 
maladjustment. Gynecologic Oncology, 80, 387 394. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
18  Coleman, R.L. (2005). Depression, correlates of depression, and 
receipt of depression care among low income women with breast 
or gynecologic cancer. Women’s Oncology Review, 5, 227 228. 
Excluded  Ovarian cancer 
results not 
presented 
separately 
19  Costanzo, E.S., Lutgendorf, S.K., Bradley, S.L., Rose, S.L., & 
Anderson, B. (2005). Cancer attributions, distress and health 
practices among gynecologic cancer survivors. Psychosomatic 
Medicine, 67, 972 980. 
 
Excluded  Participants had 
endometrial and 
cervical cancer, not 
ovarian 
20  Costanzo, E.S., Lutgendorf, S.K., Rothrock, N.E., & Anderson, B. 
(2006). Coping and quality of life among women extensively 
treated for gynecologic cancer. Psycho Oncology, 2, 132 142. 
Excluded  Ovarian cancer 
results not 
presented 
separately 
21  Costanzo, E.S., Lutgendorf, S.K., Sood, A.K., Anderson, B., 
Sorosky, J.I. & Lubaroff, D.M. (2005). Psychosocial factors and 
interleukin 6 among women with advanced ovarian cancer. 
Cancer, 104, 305 313. 
 
Included   
22  de Groot, J.M., Mah, K., Fyles, A., Winton, S., Greenwood, S., 
DePetrillo, D., Devins, G.M. (2007). Do single and partnered 
women differ in types and intensities of illness  and treatment 
related psychosocial concerns?  A pilot study.  Journal of 
Psychosomatic Research, 63, 241 245. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
23  de Moor, J.S., de Moor, C.A., Basen Engquist, K., Kudelka, A., 
Bevers, M.W., & Cohen, L. (2006). Optimism, distress, health 
related quality of life, and change in cancer antigen 125 among 
patients with ovarian cancer undergoing chemotherapy. 
Psychosomatic Medicine, 68, 555 562. 
 
Included    
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24  Ding, Y., Zhu, Y.L., & Zhang, M.F. (2007). Quality of life of 
Chinese patients with ovarian malignancies during chemotherapy 
under conditions of no recurrence. Cancer Nursing, 30, 243 251. 
 
Included   
25   Donovan, K.A., Greene, P.G., Shuster, J.L., Partridge, E.E., & 
Tucker, D.C. (2002). Psychosocial well being of women with 
ovarian cancer.  Unpublished manuscript. 
 
Included   
26  Eisemann, M., & Lalos, A. (1999). Psychosocial determinants of 
well being in gynecologic cancer patients. Cancer Nursing, 22, 
303 306. 
Excluded  Participants had 
cervical and 
endometrial cancer, 
not ovarian 
27  Ell, K., Sanchez, K., Vourlekis, B., Lee, P.J., Dwight Johnson, M., 
Lagomasino, I., & Russell, C. (2005). Depression, correlates of 
depression and receipt of depression care among  low income 
women with breast or gynecologic cancer. Journal of Clinical 
Oncology, 23, 3052 3060. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
28   Ersek, M., Ferrell, B.R., Dow, K.H., & Melancon, C.H. (1997). 
Quality of life in women with ovarian cancer. Western Journal of 
Nursing Research, 19, 334 350. 
 
Included   
29  Fasching, P.A., Thiel, F., Nicolaisen Murmann, K., Rauh, C., 
Engel, J., Lux, M.P., Beckmann, M.W., & Bani, R. (2007). 
Association of complementary methods with quality of life and 
life satisfaction in patients with gynecologic and breast 
malignancies. Supportive Care in Cancer, 15, 1277 1284. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
30  Ferrell, B., Cullinane, C.A., Ervine, K., Melancon, C., Uman, 
G.C., & Juarez, G. (2005). Perspectives on the impact of ovarian 
cancer; women’s views of quality of life. Oncology Nursing 
Forum, 6, 1143 1149. 
 
Included   
31  Ferrell, B., Smith, S.L., Cullinane, C.A., & Melancon, C. (2003). 
Psychological well being and quality of life in ovarian cancer 
survivors. Cancer, 98, 1061 1071. 
 
Excluded  Qualitative study 
32  Fitch, M. (2006). Living with ovarian cancer; Perspectives of older 
women. Geriatrics and Aging, 9, 607 612. 
 
Excluded  Qualitative study 
33  22. Fitch, M., Gray, R.E., DePetrillo, D., Franssen, E., & Howell, 
D. (1999). Canadian women’s perspectives on ovarian cancer. 
Cancer Prevention & Control, 3, 52 60. 
 
Excluded  Qualitative study 
34  24. Fitch, M., Gray, R.E., & Franssen, E. (2001). Perspectives on 
living with ovarian cancer: older women’s views.  Oncology 
Nursing Forum, 28, 1433 1442. 
 
Excluded  Qualitative study 
35  23. Fitch, M., Gray, R.E., & Franssen, E. (2000). Women’s 
perspectives regarding the impact of ovarian cancer: implications 
for nursing. Cancer Nursing, 23, 359 366. 
 
Excluded  Qualitative study 
36  Fitch, M., Gray, R.E., & Franssen, E. (2000). Perspectives on 
living with ovarian cancer: young women’s views. Canadian 
Oncology Nursing Journal, 10, 101 108. 
 
Excluded  Qualitative study 
37  Gil, K.M., Gibbons, H.E., Jenison, E.L., Hopkins, M.P., von 
Gruenigen, V.E. (2007). Baseline characteristics influencing 
quality of life in women undergoing gynecologic oncology 
surgery. Health and Quality of Life Outcomes, 5, article no. 25. 
Included    
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38  26. Gioiella, M.E., Berkman, B., & Robinson, M. (1998). 
Spirituality and quality of life in gynecologic oncology patients. 
Cancer Practice, 6, 333 338. 
 
Included   
39  Gotheridge, S.M., & Dresner, N. (2002). Psychological 
adjustment to gynecologic cancer. Primary Care Update for 
Ob/Gyns, 9, 80 84. 
 
Excluded  Review article 
40  Greimel, E.R. & Friedl, W. (2000). Functioning in daily living 
and psychological well being of female cancer patients. Journal 
of Psychosomatic Obstetrics and Gynecology, 21, 25 30. 
 
Included   
41  Greimel, E., Thiel, I., Peitinger, F., Cegnar, I., & Pongratz, E. 
(2002). Prospective assessment of quality of life of female 
cancer patients. Gynecologic Oncology, 85, 140 147. 
 
Included   
42   Guo, Y., Sheng, X J., Liu, Y., & Hua, X F. (2004) Evaluation 
on quality of life for gynecologic cancer patients. Chinese 
Journal of Cancer Research, 16, 292 296. 
 
Included   
43  Hamilton, A.B. (1999). Psychological aspects of ovarian cancer. 
Cancer Investigation, 17, 335 341. 
 
Excluded  Review article 
44  Hipkins, J., Whitworth, M., Tarrier, N., &  Jayson, G. (2004). 
Social support, anxiety and depression after chemotherapy for 
ovarian cancer: A prospective study. British Journal of Health 
Psychology, 9, 569 581. 
 
Included   
45  Hodgkinson, K., Butow, P., Fuchs, A., Hunt, G.E., Stenlake, A., 
Hobbs, K.M., Brand, A., & Wain, G. (2007). Long term survival 
from gynecologic cancer: Psychosocial outcomes, supportive 
care needs and positive outcomes. Gynecologic Oncology, 104, 
381 389. 
 
Included   
46  Hopkins, M.L., McDowell, I., Le, T., & Fung, M.F.K. (2005). 
Coping with ovarian cancer; do coping styles affect outcomes? 
Obstetrical and Gynecological Survey, 60, 321 325. 
 
Excluded  Review article 
47  Houck, K., Avis, N.E., Gallant, J.M., Fuller, A.F., & Goodman, 
A. (1999). Quality of life in advanced ovarian cancer: 
Identifying specific concerns. Journal of Palliative Medicine, 2, 
397 402. 
 
Excluded  Qualitative study 
48  Howell, D., Fitch, M.I., Deane, K.A. (2003). Impact of ovarian 
cancer perceived by women. Cancer Nursing, 26, 1 9. 
 
Excluded  Qualitative study 
49  Kamer, S., Ozsaran, Z., Celik, O., Bildik, O., Yalman, D., 
Bolukbasi, Y., Haydaroglu, A. (2007). Evaluation of anxiety 
levels during intracavity brachytherapy applications in women 
with gynaecological malignancies. European Journal of 
Gynaecological Oncology, 28, 121 124. 
 
Excluded  Participants had 
cervical and 
endometrial 
cancer, not ovarian 
50  Kornblith, A., Thaler, H.T., Wong, G., Vlamis, V., Lepore, J.M., 
Loseth, D.B., Hakes, T., Hoskins, W.J. & Portenoy, R.K. 
(1995). Quality of life of women with ovarian cancer. 
Gynecologic Oncology, 59, 231 242. 
 
Included    
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51  Lakusta, C.M., Atkinson, M.J., Robinson, J.W., Nation, J., 
Taenzer, P.A., & Campo, M.G. (2001). Quality of life in ovarian 
cancer patients receiving chemotherapy. Gynecologic Oncology, 
81, 490 495. 
 
Included   
52  Le, T., Hopkins, L., & Fung Kee Fung, M. (2005). Quality of 
life assessment during adjuvant and salvage chemotherapy for 
advance stage epithelial ovarian cancer. Gynecologic Oncology, 
98, 39 44. 
 
Included   
53   Le, T., Leis, A., Pahwa, P., Wright, K., Ali, K., Reeder, B., 
Hopkins, L., & Fung Kee Fung, M. (2004). Quality of life 
evaluations in patients with ovarian cancer during chemotherapy 
treatment. Gynecologic Oncology, 92, 839 844. 
 
Included   
54  Leake, R.L., Gurrin, L.C., & Hammond, I.G. (2001). Quality of 
life in patients attending a low risk gynaecological oncology 
follow up clinic. Psycho Oncology, 10, 428 435. 
Excluded  Ovarian cancer 
results not 
presented 
separately 
55  Leon Pizarro, C., Gich, I., Barthe, E., Rovirosa, A., Farrus, B., 
Casas, F., Verger, E., Biete, A., Craven Bartle, J., Sierra, J., 
Arcusa, A. A randomized trial of the effect of training in 
relaxation and guided imagery techniques in improving 
psychological and quality of life indices for gynaecologic and 
breast brachytherapy patients. Psycho Oncology, 16, 971 979. 
 
Excluded  Participants had 
cervical and 
endometrial 
cancer, not ovarian 
56  Levine, E.G., & Silver, B. (2007). A pilot study: Evaluation of a 
psychosocial program for women with gynecological cancers. 
Journal of Psychosocial Oncology, 25, 75 98. 
Excluded  Qualitative survey 
57  Liavaag, A.H., Dorum, A., Fossa, S.D., Trope, C., & Dahl, A.A. 
(2007). Controlled study of fatigue, quality of life, and somatic 
and mental morbidity in epithelial ovarian cancer survivors: 
How lucky are the lucky ones? Journal of Clinical Oncology, 
25, 2049 2056. 
 
Included   
58  Lutgendorf, S.K., Anderson, B., Larsen, K., Buller, R.E., & 
Sorosky, J. L. (1999).  
Excluded  Ovarian cancer 
results not 
presented 
separately 
59  Lutgendorf, S.K., Anderson, B., Rothrock, N., Buller, R.E., 
Sood, A.K., & Sorosky, J.I. (2000). Quality of life and mood in 
women receiving extensive chemotherapy for gynecologic 
cancer. Cancer, 89, 1402 1411. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
60   Lutgendorf, S.K., Anderson, B., Sorosky, J.I., Buller, R.E., & 
Lubaroff, D.M. (2000). Interleukin 6 and use of social support 
in gynecologic cancer patients. International Journal of 
Behavioral Medicine, 7, 127 142.  
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
61   Lutgendorf, S.K., Anderson, B., Ullrich, P., Johnsen, E.L., 
Buller, R.E., Sood, A.K., Sorosky, J.I., & Ritchie, J. (2002). 
Quality of life and mood in women with gynecologic cancer: A 
one year prospective study. Cancer, 94, 131 140. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
62  Lutgendorf, S.K., Johnsen, E.L., Cooper, B., Anderson, B., 
Sorosky, J.I., Buller, R.E. & Sood, A.K. (2002). Vascular 
endothelial growth factor and social support in patients with 
ovarian cancer. Cancer, 95, 808 815. 
 
Included    
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63  Lutgendorf, S.K., Sood, A.K.,  Anderson, B., McGinn, S., 
Maiseri, H., Dao, M., Sorosky, J.I., De Geest, K., Ritchie, J. & 
Lubaroff, D.M. (2005). Social support, psychological distress, 
and natural killer cell activity in ovarian cancer. Journal of 
Clinical Oncology, 23, 7105 7113. 
 
Included   
64   Manne, S., Rubin, S., Edelson, M., Rosenblum, N., Bergman, 
C., Hernandez, E., Carlson, J., Rocereto, T. & Winkel, G. 
(2007). Coping and communication enhancing intervention 
versus supportive counselling for women diagnosed with 
gynecological cancers. Journal of Consulting and Clinical 
Psychology, 75, 615 628. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
65  McCorkle, R., Pasacreta, J., Tang, S.T. (2003). The silent killer; 
Psychological issues in ovarian cancer. Holistic Nursing 
Practice, 17, 300 308. 
 
Excluded  Review article 
66  Meden, H., Metz, A., & Monkeberg Tun, E. (1994). Quality of 
life of patients with ovarian cancer after surgery and 
chemotherapy. Onkologie, 17, 50 56. 
Included   
67  Miller, B.E., Pittman, B., Case, D., & McQuellon, R.P. (2002). 
Quality of life after treatment for gynecologic malignancies: A 
pilot study in an outpatient clinic. Gynecologic Oncology, 87, 
178 184. 
 
Included   
68  Miller, B.E., Pittman, B., & Strong, C. (2003). Gynecologic 
cancer patients’ psychosocial needs and their views on the 
physician’s role in meeting those needs. International Journal of 
Gynecological Cancer, 13, 111 119. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
69   Molassiotis, A., Chan, C.W.H., Yam, B.M.C. & Chan, S.J. 
(2000). Quality of life in Chinese women with gynaecological 
cancers. Supportive Care in Cancer, 8, 414 422. 
 
Included   
70  Molassiotis, A., Chan, C.W.H., Yam, B.M.C., Chan, S.J., & 
Lam, C.S.W. (2002). Life after cancer; Adaptation issues faced 
by Chinese gynaecological cancer survivors in Hong Kong. 
Psycho Oncology, 11, 114 123. 
 
Excluded  Qualitative study 
71  Ngan, H.Y.S., Tang, G.W.K., & Lau, O.W.K. (1994). 
Psychosocial study on Hong Kong Chinese women with 
gynecological cancer. Journal of Psychosomatic Obstetrics and 
Gynaecology, 15, 111 117. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
72  51. Norton, T.R., Manne, S.L., Rubin, S., Carlson, J., 
Hernandez, E., Edelson, M.I., Rosenblum, N., Warshal, D. & 
Bergman, C. (2004). Prevalence and predictors of psychological 
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Included 
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ovarian cancer. Journal of Reproductive Medicine, 50, 407 416. 
 
Excluded  Review article 
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Excluded   Review article 
81  Pistrang, N. & Winchurst, C. (1997). Gynaecological cancer 
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Excluded  Ovarian cancer 
results not 
presented 
separately 
83  Rannestad, T., Skjeldestad, F.E.  (2007) Pain and quality of life  
among  long term gynaecological cancer survivors: A 
population based case control study. Acta Obstetrica et 
Gynecologica Scandinavica, 86, 1510 1516. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
84  Rummans, T.A., Frost, M., Suman, V.J., Taylor, M., Novotny, 
P., Gendron,T., Johnson, R., Hartmann, L., Dose, A.M.,  & 
Evans, R.W. (1998). Quality of life and pain in patients with 
recurrent breast and gynecologic cancer. Psychosomatics, 39, 
437 445. 
 
Excluded  Ovarian cancer 
results not 
presented 
separately 
85  Scott, J.L., Halford, W.K., & Ward, B.G. (2004). United we 
stand? The effects of a couple coping intervention on 
adjustment to early stage breast or gynecological cancer. Journal 
of Consulting and Clinical Psychology, 72, 1122 1135. 
 
Excluded  Only 1 participant 
had ovarian cancer 
86  Steginga, S.K., & Dunn, J. (1997). Women’s experiences 
following treatment for gynecologic cancer. Oncology Nursing 
Forum, 24, 1403 1408. 
 
Excluded  Qualitative study 
87  Stevinson, C., Faught, W., Steed, H., Tonkin, K., Ladha, A.B., 
Vallance, J.K., Capstick, V., Schepansky, A., Courneya, K.S. 
(2007). Associations between physical activity and quality of 
life in ovarian cancer survivors. Gynecologic Oncology, 106, 
244 250. 
 
Included    
 
217 
 
88  Sun, C.C., Frumovitz, M., Bodurka, D.C. (2005). Quality of life 
and gynecologic malignancies. Current Oncology Reports, 7, 
459 465. 
 
Excluded  Review article 
89  Sun, C.C., Ramirez, P.T., Bodurka, D.C. (2007). Quality of life 
for patients with epithelial ovarian cancer. Nature Clinical 
Practice Oncology, 4, 18 29.   
 
Excluded  Review article 
90  Stewart, D.E., Wong, F., Duff, S., Melancon, C.H. & Cheung, 
A.M. “What doesn’t kill you makes you stronger”: An ovarian 
cancer survivor survey. Gynecologic Oncology, 83, 537 542. 
 
Included   
91  Tabano, M., Condosta, D., Coons, M. (2002). Symptoms 
affecting quality of life in women with gynecologic cancer. 
Seminars in Oncology Nursing, 18, 223 230. 
 
Excluded  Review article 
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Appendix B: Sources where studies included in systematic review were identified 
 
Included  Articles  Source where article was identified 
1. Awadalla et al. (2007)  Medline; Embase;  
2. Bodurka Bevers et al. (2000)  Medline; Embase 
3. Boscaglia et al. (2005)  Medline; Embase 
4. Canada et al. (2006)  Medline; Embase 
5. Capelli et al. (2002)  In reference list of Pearman (2003) 
6. Chan et al. (2003)  Medline 
7. Chan et al. (2005)  Medline;  
8. Costanzo et al. (2005)  Medline; Embase 
9. de Moor et al. (2006)  Medline; Embase; PsycInfo 
10. Ding et al. (2007)  Medline; Embase; PsycInfo 
11. Donovan et al. (2002)  Dissertation abstract from PsycInfo, 
then personal communication with the 
author 
12. Ersek et al. (1997)  Medline 
13. Ferrell et al. (2005)  Medline 
14. Gil et al. (2007)  Medline 
15. Gioiella et al. (1998)  Medline; Embase 
16. Greimel & Friedl (2000)  Medline; Embase 
17. Greimel et al. (2002)  Medline; Embase 
18. Guo et al. (2004)  Embase 
19. Hipkins et al. (2004)  Medline; Embase; PsycInfo 
20. Hodgkinson et al. (2007)  Medline; Embase 
21. Kornblith et al. (1995)  Medline; Embase 
22. Lakusta et al. (2001)  Medline; Embase 
23. Le et al. (2005)  Medline; Embase 
24. Le et al. (2004)  Medline; Embase 
25. Liavaag et al. (2007)  Medline; Embase 
26. Lutgendorf et al. (2002)  Medline; Embase 
27. Lutgendorf et al. (2005)  Medline 
28. Meden et al. (1994)  Embase  
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32. Norton et al. (2005)  Medline; Embase; PsycInfo 
 
33. Parker et al. (2006)  Medline; Embase 
34. Petersen et al. (2005)  Medline; Embase 
35. Stevinson et al. (2007)  Medline; Embase 
36. Stewart et al. (2001)  Medline; Embase 
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Appendix C: Introductory letter for pilot study (Chapter 5) 
 
 
 
 
Dear   
 
My  name  is  Emily  Arden Close,  and  I  am  a  PhD  student  at  the  Department  of 
Psychology, University of Southampton, working with Dr Yori Gidron.  I am writing to 
request your participation in a study on the effects of writing about significant events 
and  stress  management  over  the  telephone  on  well being.    The  study  is  currently 
advertised in the Ovacome newsletter. 
 
Participation will involve completing questionnaires, writing about significant events 
for  15  minutes  a  day  over  three  days,  and  taking  part  in  a  stress  management 
programme  over  the  telephone  (30  minutes).   Previous  research  has  shown positive 
benefits of both this type of structured writing and stress management training.  It is 
hoped that the results of this research will both benefit other women with cancer and 
further  scientific  knowledge.    All  information  you  provide  will  remain  strictly 
confidential. 
 
If  you  are  interested  in  participating,  or  have  any  questions,  please  contact  me  on 
ejac103@soton.ac.uk / School of Psychology, University of Southampton, Highfield, 
Southampton, SO17 1BJ/ 02380 462 887.   
 
Yours Sincerely, 
 
 
Emily Arden Close  
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Appendix D: Consent form for pilot study (Chapter 5) 
 
The effects of written disclosure and stress management on well-being 
Consent form for research participants 
 
Information sheet 
I am Emily Arden Close, a PhD student at the Department of Psychology, University of 
Southampton.  I am requesting your participation in a study regarding the effects of 
writing about significant events and being given advice on managing stress over the 
telephone on well being.  You will be asked to take part in one of the following 
procedures depending on which condition you are assigned to: 
Condition A 
1)  Complete several questionnaires 
 
2)  (after 1 month) Complete several questionnaires and write about significant events 
for 15 minutes per day over 3 days 
 
3)  (2 weeks later) Take part in a stress management programme over the telephone (30 
minutes). 
 
4)  (1 month later) Complete several questionnaires 
 
Condition B 
 
1)  Complete several questionnaires 
 
2)  (after 1 month) Complete several questionnaires and Take part in a stress 
management programme over the telephone (30 minutes). 
 
3)  (2 weeks later) Write about significant events for 15 minutes per day over 3 days 
 
4)  (1 month later) Complete several questionnaires 
 
Personal information will not be released to or viewed by anyone other than researchers 
involved in this project.  Results of this study will not include your name or any other 
identifying characteristics. 
Your participation is voluntary and you may withdraw your participation at any time.  If 
you have any questions please ask them now, or contact me, Emily Arden Close, at 
ejac103@soton.ac.uk / Department of Psychology, University of Southampton, 
Highfield, Southampton, SO17 1BJ.  
 
223 
Statement of Consent 
I                                                   have read the above consent form.  
          [participants name] 
I understand that I may withdraw my consent and discontinue participation at any time 
without penalty or loss of benefit to myself.  I understand that data collected as part of 
this research project will be treated confidentially, and that published results of this 
research project will maintain my confidentially.  In signing this consent letter, I am not 
waiving my legal claims, rights, or remedies.  A copy of this consent letter will be 
offered to me. 
(Circle Yes or No) 
I give consent to participate in the above study. Yes/ No 
   
Signature                                 Date 
Name     
I understand that if I have questions about my rights as a participant in this research, or 
if I feel that I have been placed at risk, I can contact the Chair of the Ethics Committee, 
Department of Psychology, University of Southampton, Southampton, SO17 1BJ.  
Phone:  (023) 8059 3995.  Further, in the unlikely event that I experience any distress as 
a result of participation in this study, I am aware that the Ovacome helpline can be 
contacted on 02073809589.  
 
224 
 
 
Appendix E: Letter sent with consent form for pilot study (Chapter 5) 
 
School of Psychology 
University of Southampton 
Highfield 
Southampton 
SO17 1BJ 
 
 
 
Dear   
 
My name is Emily Arden Close, and I am a PhD student at the Department of 
Psychology, University of Southampton.  Thank you for agreeing to participate in my 
study, which was advertised in the Ovacome newsletter. 
 
As I mentioned previously, you will be required to complete questionnaires, write about 
significant events (15 minutes per day over 3 days), and take part in a stress 
management programme over the telephone (30 minutes), over a period of three 
months.  Previous research has shown positive benefits of both this type of structured 
writing and stress management training.  It is hoped that the results of this research will 
both benefit other women with cancer and further scientific knowledge.  All information 
you provide will remain strictly confidential. 
 
Please could you now fill in the informed consent form and attached questionnaires, and 
return them to me in the envelope provided as soon as possible.  I will then contact you 
after a month to carry out the intervention.  Your help is greatly appreciated. 
 
As mentioned previously, I can be contacted on ejac103@soton.ac.uk / School of 
Psychology, University of Southampton, Highfield, Southampton, SO17 1BJ/ 02380 
462 887.   
 
Yours Sincerely, 
 
 
Emily Arden Close  
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Appendix F: Questionnaire for first baseline for pilot study 
 
 
 
 
Background Information 
 
 
Date:  
 
Age:  
 
Occupation: 
 
Highest level of education completed: 
 
Marital status:  
 
Cancer stage at diagnosis: 
 
Time since diagnosis: 
 
Time since treatment: 
 
Types of treatment (i.e., chemotherapy – mention drugs received if known, 
radiotherapy, etc.): 
 
Do you smoke: Yes/No 
 
If yes, on average how many per day? 
 
Do you drink alcohol? Yes/ No 
 
If yes, on average how many units per week? 
 
On average, how often do you exercise? 
 
5 times a week   3 4 times a  1 2 times a  Less than   Never 
or more    week     week    once a week 
 
What type of exercise do you do? 
 
On average, how often do you do relaxation (i.e., deep breathing exercises, progressive 
muscle relaxation)? 
 
5 times a week   3 4 times a  1 2 times a  Less than   Never 
or more    week     week    once a week  
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These items deal with ways you've been coping with the stress in your life since you 
were diagnosed with ovarian cancer. These items ask what you've been doing to cope 
with the disease and treatment. Obviously, different people deal with things in different 
ways, but I'm interested in how you've tried to deal with it. Each item says something 
about a particular way of coping. I want to know to what extent you've been doing what 
the item says. How much or how frequently. Don't answer on the basis of whether it 
seems to be working or not just whether or not you're doing it. Use these response 
choices. Try to rate each item separately in your mind from the others. Make your 
answers as true FOR YOU as you can. 
 
1 = I haven't been doing this at all 
2 = I've been doing this a little bit 
3 = I've been doing this a medium amount 
4 = I've been doing this a lot 
 
 
1.  I've been concentrating my efforts on doing something about the situation I'm in. 
1                                  2                           3                          4 
 
 
2.  I've been getting emotional support from others. 
 
1  2  3  4 
 
3.  I've been giving up trying to deal with it. 
 
1  2  3  4 
 
 
4.  I've been taking action to try to make the situation better.  
1                           2                            3                            4  
5.  I've been trying to see it in a different light, to make it seem more positive. 1
                                 2                           3      4 
 
 
6.  I've been getting comfort and understanding from someone.  
1      2      3      4  
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1 = I haven't been doing this at all 
2 = I've been doing this a little bit 
3 = I've been doing this a medium amount 
4 = I've been doing this a lot 
7.  I've been giving up the attempt to cope. 
 
1  2  3  4 
 
 
8.  I've been looking for something good in what is happening.  
1      2      3      4 
9. I’ve been accepting the reality of the fact that it has happened. 
1      2      3      4 
10.  I’ve been learning to live with it. 
1      2      3      4  
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The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Below is a list of difficulties people sometimes have after stressful life events. Please 
read each item, and then indicate how distressing each difficulty has been for you 
DURING THE PAST SEVEN DAYS with respect to your cancer, i.e., how much 
were you distressed or bothered by these difficulties? 
 
Not 
at 
all 
A little 
bit  Moderately  Quite 
a bit  Extremely 
1.  Any reminder brought back 
feelings about it  0  1  2  3  4 
2.  I had trouble staying asleep  0  1  2  3  4 
3.  Other things kept making me 
think about it  0  1  2  3  4 
4.  I thought about it when I 
didn’t mean to  0  1  2  3  4 
5.  Pictures about it popped into 
my mind  0  1  2  3  4 
6.  I found myself acting or 
feeling as though I was back 
at that time  0  1  2  3  4 
7.  I had waves of strong 
feelings about it  0  1  2  3  4 
8.  I had dreams about it  0  1  2  3  4  
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Below is a list of statements that other people with your illness have said are important. By  
circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP5  I am bothered by side effects of treatment.............................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS4  My family has accepted my illness........................................
 
0  1  2  3  4 
 
GS5  I am satisfied with family communication about my 
illness.....................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been for 
you during the past 7 days. 
 
 
 
 
 
 
 
EMOTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GE1  I feel sad................................................................................
 
0  1  2  3  4 
 
GE2  I am satisfied with how I am coping with my illness ...........
 
0  1  2  3  4 
 
GE3  I am losing hope in the fight against my illness....................
 
0  1  2  3  4 
 
GE4  I feel nervous.........................................................................
 
0  1  2  3  4 
 
GE5  I worry about dying...............................................................
 
0  1  2  3  4 
 
GE6  I worry that my condition will get worse..............................
 
0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
 
ADDITIONAL CONCERNS 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
O1  I have swelling in my stomach area......................................
 
0  1  2  3  4 
 
C2  I am losing weight................................................................
 
0  1  2  3  4 
 
C3  I have control of my bowels..................................................
 
0  1  2  3  4 
 
O2  I have been vomiting.............................................................
 
0  1  2  3  4 
 
B5  I am bothered by hair loss.....................................................
 
0  1  2  3  4 
 
C6  I have a good appetite ...........................................................
 
0  1  2  3  4 
 
C7  I like the appearance of my body..........................................
 
0  1  2  3  4 
 
BMT5  I am able to get around by myself.........................................
 
0  1  2  3  4 
 
B9  I am able to feel like a woman..............................................
 
0  1  2  3  4 
 
O3  I have cramps in my stomach area........................................
 
0  1  2  3  4 
 
BL4  I am interested in sex ............................................................
 
0  1  2  3  4 
 
BMT7  I have concerns about my ability to have children................
 
0  1  2  3  4 
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Appendix G: Second baseline for pilot study 
 
 
 
Date: 
 
CA 125 level: 
 
These items deal with ways you've been coping with the stress in your life since you 
were diagnosed with ovarian cancer. These items ask what you've been doing to cope 
with the disease and treatment. Obviously, different people deal with things in different 
ways, but I'm interested in how you've tried to deal with it. Each item says something 
about a particular way of coping. I want to know to what extent you've been doing what 
the item says. How much or how frequently. Don't answer on the basis of whether it 
seems to be working or not just whether or not you're doing it. Use these response 
choices. Try to rate each item separately in your mind from the others. Make your 
answers as true FOR YOU as you can. 
 
1 = I haven't been doing this at all 
2 = I've been doing this a little bit 
3 = I've been doing this a medium amount 
4 = I've been doing this a lot 
 
1.  I've been concentrating my efforts on doing something about the situation I'm in. 
1                                  2                           3                          4 
 
2.  I've been getting emotional support from others. 
 
1  2  3  4 
 
3.  I've been giving up trying to deal with it. 
 
1  2  3  4 
 
4.  I've been taking action to try to make the situation better.  
1                           2                            3                            4  
5.  I've been trying to see it in a different light, to make it seem more positive. 1
                                 2                           3      4 
 
6.  I've been getting comfort and understanding from someone.  
1      2      3      4  
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1 = I haven't been doing this at all 
2 = I've been doing this a little bit 
3 = I've been doing this a medium amount 
4 = I've been doing this a lot 
7.  I've been giving up the attempt to cope. 
 
1  2  3  4 
 
 
8.  I've been looking for something good in what is happening.  
1      2      3      4 
9. I’ve been accepting the reality of the fact that it has happened. 
1      2      3      4 
10.  I’ve been learning to live with it. 
1      2      3      4  
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The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Below is a list of difficulties people sometimes have after stressful life events. Please 
read each item, and then indicate how distressing each difficulty has been for you 
DURING THE PAST SEVEN DAYS with respect to your cancer, i.e., how much 
were you distressed or bothered by these difficulties? 
 
Not 
at 
all 
A little 
bit  Moderately  Quite 
a bit  Extremely 
1.  Any reminder brought back 
feelings about it  0  1  2  3  4 
2.  I had trouble staying asleep  0  1  2  3  4 
3.  Other things kept making me 
think about it  0  1  2  3  4 
4.  I thought about it when I 
didn’t mean to  0  1  2  3  4 
5.  Pictures about it popped into 
my mind  0  1  2  3  4 
6.  I found myself acting or 
feeling as though I was back 
at that time  0  1  2  3  4 
7.  I had waves of strong 
feelings about it  0  1  2  3  4 
8.  I had dreams about it  0  1  2  3  4 
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Below is a list of statements that other people with your illness have said are important. By  
circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP5  I am bothered by side effects of treatment.............................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS4  My family has accepted my illness........................................
 
0  1  2  3  4 
 
GS5  I am satisfied with family communication about my 
illness.....................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been for 
you during the past 7 days. 
 
 
 
 
 
 
 
EMOTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GE1  I feel sad................................................................................
 
0  1  2  3  4 
 
GE2  I am satisfied with how I am coping with my illness ...........
 
0  1  2  3  4 
 
GE3  I am losing hope in the fight against my illness....................
 
0  1  2  3  4 
 
GE4  I feel nervous.........................................................................
 
0  1  2  3  4 
 
GE5  I worry about dying...............................................................
 
0  1  2  3  4 
 
GE6  I worry that my condition will get worse..............................
 
0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
 
ADDITIONAL CONCERNS 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
O1  I have swelling in my stomach area......................................
 
0  1  2  3  4 
 
C2  I am losing weight................................................................
 
0  1  2  3  4 
 
C3  I have control of my bowels..................................................
 
0  1  2  3  4 
 
O2  I have been vomiting.............................................................
 
0  1  2  3  4 
 
B5  I am bothered by hair loss.....................................................
 
0  1  2  3  4 
 
C6  I have a good appetite ...........................................................
 
0  1  2  3  4 
 
C7  I like the appearance of my body..........................................
 
0  1  2  3  4 
 
BMT5  I am able to get around by myself.........................................
 
0  1  2  3  4 
 
B9  I am able to feel like a woman..............................................
 
0  1  2  3  4 
 
O3  I have cramps in my stomach area........................................
 
0  1  2  3  4 
 
BL4  I am interested in sex ............................................................
 
0  1  2  3  4 
 
BMT7  I have concerns about my ability to have children................
 
0  1  2  3  4 
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Appendix H: Stress Management Protocol for pilot study (Chapter 5) 
 
Introduction (5 minutes) 
Hello.  My  name  is  Emily  Arden Close,  and  I'm  a  student  at  the  University  of 
Southampton. I'm calling about the stress management programme you agree to take part 
in. I first want to thank you for that. 
How are you feeling today? 
Before  we  start,  you  should  know  that  this  will  take  about  half  an  hour.  If  there's 
anything you don't understand, please tell me because it's my fault, not yours. 
 
My aim today is to give you some coping strategies to help you deal with difficulties you 
may have in your everyday life. 
 
[if they go on too long =>] I'm willing to listen to what you're saying, but with your 
permission, we have a lot to cover. 
 
I imagine that it has been very difficult to go through this experience, hasn't it? 
[Give empathy, listen well, and then move on]  
Brief explanation about types of coping (2 3 minutes) 
 
Every time you experience a stressful situation, there are many ways to react to it. There is 
not one correct coping style to deal with every stressor   what to do depends on the 
situation, and the person. However, research has shown that certain coping strategies 
may be more effective in certain situations. Broadly speaking, the main strategies of 
coping are problem focused coping (this is trying to do something to resolve the 
situation), and emotion focused coping (regulating your emotions, when the situation 
can't be resolved — by using relaxation, humour, etc.). 
 
I shall clarify these different types of coping strategies right now. In order to know which 
type of coping strategy you need to use, the first question you need to ask yourself is: 
'Can I do anything about the situation?'. Can you please give me a few situations in your 
daily life that you think are under your control? (For example, what you decide to eat). 
 
Very good! Now give me a few situations in your daily life that are not under your 
control (for example, the weather). 
 
Great – I would recommend that you consider the following wise sentence: 'Grant me the 
serenity to accept the things I cannot change, the courage to change the things I can, and 
the wisdom to know the difference.' 
 
We will now learn how to apply the two types of coping styles in daily life situations 
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Problem-focused coping (10 minutes) 
 
It's generally best to do something to solve a problem if you can. If it's unpleasant, it may 
be tempting to forget about it and hope it will go away, but often it won't. Research has 
shown that people who ignore problems that are under their control, tend to be more 
worried and unhappy in their everyday life, and it will give you more stress in the end. 
Remember your diagnosis of cancer. You experienced some symptoms, and they didn't go 
away, so you decided to go to a doctor. That was problem focused coping   you had a 
problem, and you did something about it. 
 
Now I'm going to teach you some structured problem solving techniques. Look at the 
leaflet. I'm going to go through those steps with you. First, I'm going to tell you what the 
steps are. 
1. Choose a problem from your daily life you wish to work on 
2, Think of ideas to solve it 
3.  Evaluate each idea 
4.  Decide which one is best 
5.  Plan how to carry it out 
6.  Review the solution 
 
Ok, I'd like you to think of a problem you've been experiencing since you were diagnosed 
with cancer, and when you're ready, you can tell me about it. Choose something that you 
think you have control over. 
 
−  Ok, so the problem is ........Very good! Now I'd like you to think of some ideas to solve 
the problem   make a note of them. Often problems can be solved in several different 
ways. 
 
Ok, very good! Now, which solution do you think would work best for you? It's up to you 
− there's no right or wrong answers. This might not be your favourite solution, it 
might just be the most practical one   that's fine. 
 
Yes, that's very good! I'd like you to try this solution out next time you experience this 
problem. Make a note of it, evaluate its success, and practice it a couple of times, so 
you're confident about what you're going to do. Many people find this approach to 
problem solving helpful, but it is necessary to think it through thoroughly. This is not an 
easy way out   many problems are only sorted out with a lot of effort. Problem solving is 
a continuous process. However, this might help you to deal with some problems in your 
everyday life which are under your control, just like we did together now. 
 
Do you have any questions about what we just did? 
Emotion-focused coping (5 minutes) 
 
OK, now, we're going to talk about something different. Can you think of any situation 
where there's nothing or little you can do to change the situation? 
 
Yes, very good! (if said nothing: for example, going for chemotherapy, going for a 
checkup). This may make you feel very worried/nervous. Emotion focused coping is 
most suitable when cannot change the situation, and all what you can do it to reduce your  
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levels of distress. One of the things you can do is "deep breathing", which I'm going to 
teach you now. Research has shown that breathing and relaxation exercises have benefits 
on QOL and immune responses in cancer patients. You do need to practice this regularly, 
to get the benefits. The instructions are in the booklet. I'll go through this with you, to 
teach you how to do it. It can be learned quickly. It's helpful if you do it every day, so 
you know how to do it whenever you want to. There are three stages to it. 
 
1.  Take 3 deep breaths. For each breath, inhale from your nose (count 1, 2, 3, 4/5  .........), 
hold your breath (count 1, 2,3, 4, 5/6 .............), and then exhale (count 1, 2,3,4,5,6,7 
............) 
Repeat that 2 more times. 
 
2.  Breath normally for 1 minute   we'll do this for half a minute, because we haven't 
got that much time. Focus on the air coming in and out of your body. 
 
3.  Breath normally   again we'll do half a minute for now. Each time you breath, tell 
yourself a calming/hopeful word. You do not need to tell me your word! 
 
Now, lets practice [counsellor instructs patient]. 
 
You can do this while you're having chemotherapy   it should make you feel better. 
There are other things you can do to make yourself feel better   can you suggest anything. 
 
Ok, try and set aside some time every day to do things that will help you relax and adjust 
Things that are partly under your control (6 minutes) 
 
In everyday life, there are many things that are partly under your control, and partly not. 
Let's think about the prescription of your medication. Do you find it partly under your 
control? 
 
(if says no). Well, it is your choice whether or not to take the medication. If your 
medication makes you feel bad (has too many side effects), you can talk to your doctor, 
and see if he/she can suggest anything different. Some people find this very 
difficult to do — do you find it hard to speak to your consultant about your 
medication? Let's practice this now. Say you were my consultant — I would need to 
tell you: Dr. Smith, the chemotherapy you prescribed me is really making me feel ill. 
Can you please help me with that? Now, pretend I'm your doctor. What would you say? 
(if says doctor doesn't listen). Well, people who are being assertive are listened to more. 
This doesn't mean being rude   it means standing up for your rights, while still respecting 
your doctor! I would recommend you try this next time you meet him/her. 
 
(if says completely under own control). Well, while you indeed decide whether you will 
eventually take your medication or not, your doctor has up to date knowledge about the 
treatment and your condition, so he/she knows which type of medicine may be best for 
you   it's really a mutual decision. 
 
Research has shown that taking control over decisions is related to better quality of life in 
cancer patients, and this is why we want you to take some control over this issue, because it 
is partly under your control! 
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Summing up (2 minutes) 
 
Well, that's all I have to say for now. Just to review, in general it's good to use 
problem focused coping when the situation is under your control, emotion focused coping 
when the situation is not under your control, and a combination of them when the 
situation is partly under your control. Before this ends, do you have any questions? If you 
think of anything that's not clear, or any questions you want to ask, you can contact me on 
ejac103@soton.ac.uk / (Yori's office tel. no)  I hope this helped and I wish you all the 
best!  
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Appendix I: Stress Management Session –Information Leaflet for pilot study (Chapter 5) 
Stress Management Session: Information leaflet 
Brief explanation about types of coping 
 
Every person often faces situations which he or she may see as stressful. Every time you 
experience a stressful situation, there are many ways to react to it. There is not one 
correct coping style to deal with every stressor   what to do depends on the situation, and 
the person. However, research has shown that certain coping strategies may be more 
effective in certain situations. The aim of this brief leaflet is to give you the skills for 
matching the best type of coping with different types of situations. Broadly speaking, the 
main strategies of coping are problem focused coping (trying to do something to resolve 
the situation), and emotion focused coping (regulating your emotions, by using 
relaxation, humour, etc.). 
Problem-focused coping: 
It's generally best to do something to solve a problem if you can. If it's unpleasant, it may 
be tempting to forget about it and hope it will go away, but often it won't. Research has 
shown that people who ignore problems that are under their control, tend to be more 
worried and unhappy in their everyday life. 
1. Choose a problem from your daily life you wish to work on 
2, Think of ideas to solve it 
3.  Evaluate each idea 
4.  Decide which one is best 
5.  Plan how to carry it out 
6.  Review the solution 
Emotion focused copinq - Relaxation: 
In situations in which you do not have control over the event, research has shown that it 
is best to focus on yourself and on regulating your reactions to the event. One type of 
emotion focused coping is relaxation. 
 
1.  Take 3 deep breaths. For each breath, inhale from your nose (count 1, 2, 3, 4/5  .........), 
hold your breath (count 1, 2,3, 4, 5/6 .............), and then exhale (count 1, 2,3,4,5,6,7 .....). 
Repeat that 2 more times. 
 
2.  Breathe normally for 1 minute. Focus on the air coming in and out of your body. 
 
3.  Breathe normally for 1 minute. Each time you breathe, tell yourself a calming/hopeful 
word of your choice. 
Remember, you can do this i.e., while you're having chemotherapy   it should make you 
feel more relaxed.  
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Assertiveness: 
In situations in which we can resolve by asking someone to change their behaviour, we 
need to be assertive. If your medication makes you feel bad (has too many side effects), 
you can talk to your doctor, and see if he/she can suggest anything different. 
Practise this sentence: 
 
Dr. Smith (or use your doctor's name), the chemotherapy you prescribed me is really 
making me feel ill. Can you please help me with that? 
 
Remember, assertiveness doesn't mean being rude   it means standing up for your rights, 
while still respecting your doctor! It's recommended that you try this next time you have 
an appointment and if you have a problem with your medication. Research has shown that 
taking control over decisions is related to better quality of life in cancer patients. 
We wish you successful coping and well-being!  
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Appendix J: Guided Disclosure Protocol (GDP) as used in pilot study (Chapter 5) 
 
 
Introduction:  
 
During  the  following  minutes,  we  will  ask  you  to  think  about  your  diagnosis  and 
treatment of ovarian cancer. You will be asked to write about it for 15 minutes per day 
over 3 days, according to the instructions given below. We wish to remind you that all 
the information you provide will remain strictly confidential.  
 
One thing that is important for the research is that you write continuously for the entire 
time.  If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
DAY 1: 
 
Please  take  a  moment  to  remember  all  the  details  of  your  diagnosis  and  treatment. 
Please describe these details in their chronological order of occurrence.  
 
For example:  
It was Friday, morning, three years ago… 
I woke up and ate… 
I spoke with friends… 
Later, in the afternoon, the phone rang, and I was told that… 
I immediately went to tell…etc.  
 
The important thing is that you describe the event in sections organized according to 
their  order  of  occurrence,  that  you  write  what  caused  what,  in  a  “journalistic”  and 
objective language, without mentioning your feelings.  
 
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
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: 2 DAY   
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.  Please 
note that there are two parts to the writing today – part 2 is on the next page. 
 
a.  Please describe in detail how you felt and what you thought at the time of your 
diagnosis. What is important is that you identify and describe in your own words 
your deepest thoughts and feelings.  
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
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b. What meaning did the diagnosis/ treatment have for you, and has it changed your 
attitude towards life (for example – has it caused you to change priorities)? 
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________  
 
250 
DAY 3: 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
Now, we are asking you please to describe your thoughts and feelings about the 
diagnosis and treatment as they are today. Are your current thoughts and feelings 
different from those you had at the time? Are you able to cope with similar situations 
better because you experienced this diagnosis/ treatment?  
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
THANK YOU FOR YOUR PARTICIPATION  
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Appendix K: Follow-up questionnaire for pilot study (Chapter 5) 
 
 
 
 
Background Information 
 
Today’s date:  
On average, how often do you do relaxation (i.e., deep breathing exercises, progressive 
muscle relaxation)? 
 
5 times a week   3 4 times a    1 2 times a  Less than   Never 
or more    week      week    once a week 
 
CA 125 level: 
 
If you had to choose one, which intervention would you recommend to others? 
 
Stress Management          Written disclosure  
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These items deal with ways you've been coping with the stress in your life since you 
were diagnosed with ovarian cancer. These items ask what you've been doing to cope 
with the disease and treatment. Obviously, different people deal with things in different 
ways, but I'm interested in how you've tried to deal with it. Each item says something 
about a particular way of coping. I want to know to what extent you've been doing what 
the item says. How much or how frequently. Don't answer on the basis of whether it 
seems to be working or not just whether or not you're doing it. Use these response 
choices. Try to rate each item separately in your mind from the others. Make your 
answers as true FOR YOU as you can. 
 
1 = I haven't been doing this at all 
2 = I've been doing this a little bit 
3 = I've been doing this a medium amount 
4 = I've been doing this a lot 
 
1.  I've been concentrating my efforts on doing something about the situation I'm in. 
1                                  2                           3                          4 
 
2.  I've been getting emotional support from others. 
 
1  2  3  4 
 
3.  I've been giving up trying to deal with it. 
 
1  2  3  4 
 
4.  I've been taking action to try to make the situation better.  
1                           2                            3                            4  
5.  I've been trying to see it in a different light, to make it seem more positive. 1
                                 2                           3      4 
 
6.  I've been getting comfort and understanding from someone.  
1      2      3      4  
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1 = I haven't been doing this at all 
2 = I've been doing this a little bit 
3 = I've been doing this a medium amount 
4 = I've been doing this a lot 
7. I've been giving up the attempt to cope. 
 
1  2  3  4 
 
 
8. I've been looking for something good in what is happening.  
1      2      3      4 
9. I’ve been accepting the reality of the fact that it has happened. 
1      2      3      4 
10.  I’ve been learning to live with it. 
1      2      3      4  
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The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you felt or 
thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Below is a list of difficulties people sometimes have after stressful life events. Please 
read each item, and then indicate how distressing each difficulty has been for you 
DURING THE PAST SEVEN DAYS with respect to your cancer, i.e., how much 
were you distressed or bothered by these difficulties? 
 
Not 
at 
all 
A little 
bit  Moderately  Quite 
a bit  Extremely 
1.  Any reminder brought back 
feelings about it  0  1  2  3  4 
2.  I had trouble staying asleep  0  1  2  3  4 
3.  Other things kept making me 
think about it  0  1  2  3  4 
4.  I thought about it when I 
didn’t mean to  0  1  2  3  4 
5.  Pictures about it popped into 
my mind  0  1  2  3  4 
6.  I found myself acting or 
feeling as though I was back 
at that time  0  1  2  3  4 
7.  I had waves of strong 
feelings about it  0  1  2  3  4 
8.  I had dreams about it  0  1  2  3  4 
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Below is a list of statements that other people with your illness have said are important. By  
circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP5  I am bothered by side effects of treatment.............................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS4  My family has accepted my illness........................................
 
0  1  2  3  4 
 
GS5  I am satisfied with family communication about my 
illness.....................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been for 
you during the past 7 days. 
 
 
 
 
 
 
 
EMOTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GE1  I feel sad................................................................................
 
0  1  2  3  4 
 
GE2  I am satisfied with how I am coping with my illness ...........
 
0  1  2  3  4 
 
GE3  I am losing hope in the fight against my illness....................
 
0  1  2  3  4 
 
GE4  I feel nervous.........................................................................
 
0  1  2  3  4 
 
GE5  I worry about dying...............................................................
 
0  1  2  3  4 
 
GE6  I worry that my condition will get worse..............................
 
0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
 
ADDITIONAL CONCERNS 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
O1  I have swelling in my stomach area......................................
 
0  1  2  3  4 
 
C2  I am losing weight................................................................
 
0  1  2  3  4 
 
C3  I have control of my bowels..................................................
 
0  1  2  3  4 
 
O2  I have been vomiting.............................................................
 
0  1  2  3  4 
 
B5  I am bothered by hair loss.....................................................
 
0  1  2  3  4 
 
C6  I have a good appetite ...........................................................
 
0  1  2  3  4 
 
C7  I like the appearance of my body..........................................
 
0  1  2  3  4 
 
BMT5  I am able to get around by myself.........................................
 
0  1  2  3  4 
 
B9  I am able to feel like a woman..............................................
 
0  1  2  3  4 
 
O3  I have cramps in my stomach area........................................
 
0  1  2  3  4 
 
BL4  I am interested in sex ............................................................
 
0  1  2  3  4 
 
BMT7  I have concerns about my ability to have children................
 
0  1  2  3  4 
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Appendix L: Debriefing Statement for pilot study (Chapter 5) 
 
The effects of written disclosure and stress management on well being 
Debriefing statement 
 
The aim of this research was to see the effects of guided written disclosure and stress 
management on distress, coping and quality of life.  It is expected that distress, coping 
and quality of life will improve as a result of these interventions.  Further, it is expected 
that there will be no differences between groups (one group had written disclosure, then 
stress management; the other stress management, then written disclosure).  Your data 
will help our understanding of the efficacy of these interventions for people with 
ovarian cancer, and will provide background information for a larger study to be carried 
out on members of Ovacome and their partners.  Once again results of this study will 
not include your name or any other identifying characteristics.  This research did not use 
deception.  Following completion of the project, I will also send you a summary of the 
research findings.  If you have any further questions please contact me, Emily Arden 
Close, at ejac103@soton.ac.uk.  Thank you for your participation in this research. 
 
If you have questions about your rights as a participant in this research, or if you feel 
that you have been placed at risk, you may contact the Chair of the Ethics Committee, 
Department of Psychology, University of Southampton, Southampton, SO17 1BJ. 
Phone: (023) 8059 3995 
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Appendix M: Covering letter from Ovacome for main study (Chapters 6-8) 
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Appendix N: Information letter for main study (Chapters 6-8) 
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_____________________________________________________________________ 
 
 
Please complete one of the following options. 
 
1. I wish to participate in the writing study. 
 
Name: ____________________________ Contact telephone number: ______________ 
 
2. I do not wish to participate in the writing study
*.   
 
* Please check the box that best explains the reason why 
I am not interested.    
I am too busy.    
I am not feeling well.    
Other (please specify where possible): _______________________________________ 
 
______________________________________________________________________  
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Appendix O: Consent form for main study  
 
The effects of guided writing on well-being  
Consent Form for Research Participants 
 
Information sheet 
I am Emily Arden Close, a PhD student at the Department of Psychology, University of 
Southampton.  I am requesting your participation in a study regarding the effects of 
writing about significant events on well being in people with ovarian cancer and their 
partners if applicable.  You will be asked to complete a series of questions, to write 
about significant events either in an emotional way or a non emotional way, for 15 
minutes once a day for 3 days, and to complete follow up questionnaires after 3 and 6 
months.   
Personal information will not be released to or viewed by anyone other than researchers 
involved in this project. Results of this study will not include your name or any other 
identifying characteristics.         
Your participation is voluntary and you may withdraw your participation at any time.  If 
you have any questions please ask them now, or contact me, Emily Arden Close, at 
ejac103@soton.ac.uk  /  Department  of  Psychology,  University  of  Southampton, 
Highfield, Southampton, SO17 1BJ. 
 
Statement of Consent 
I                                                   have read the above consent form.  
          [participants name] 
I understand that I may withdraw my consent and discontinue participation at any time 
without penalty or loss of benefit to myself.  I understand that data collected as part of 
this research project will be treated confidentially, and that published results of this 
research project will maintain my confidentially.  In signing this consent letter, I am not 
waiving my legal claims, rights, or remedies.  A copy of this consent letter will be 
offered to me. 
(Circle Yes or No) 
I give consent to participate in the above study. Yes/ No 
   
Signature                                 Date 
Name     
I understand that if I have questions about my rights as a participant in this research, or 
if I feel that I have been placed at risk, I can contact the Chair of the Ethics Committee, 
Department of Psychology, University of Southampton, Southampton, SO17 1BJ.  
Phone:  (023) 8059 3995.  Further, in the unlikely event that I experience any distress as 
a result of participation in this study, I am aware that the Ovacome helpline can be 
contacted on 02073809589. 
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Appendix P: Baseline questionnaires for main study – patients 
Code             
Date             
 
 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Initial questionnaire 
 
Thank you for agreeing to participate in this study.  We are very interested in finding 
out more about any stress and anxiety you may be experiencing as a result of your 
illness.  This will help us to find ways to reduce it. 
 
This booklet contains a number of questions about any stress and anxiety you may be 
experiencing, and the impact of your illness on your physical health and psychological 
well being. 
 
 
 
There are no right or wrong answers to these questions.  We are interested in your own 
personal views. 
 
•  We ask you to answer the questions as honestly as possible. 
 
 
This questionnaire is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed questionnaire in the attached stamped addressed 
envelope.  Please note that this questionnaire booklet consists of 8 pages. 
 
Thank you very much for your time 
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Background Information: 
 
Personal Information: 
 
1. Age: _______________ 
 
2. Occupation: ___________________ 
 
3. Highest level of education completed: ______________________ 
 
4. Marital status: ____________________ 
 
5. How long have you been married/ living with your partner? ___________ 
 
 
Illness-related information: 
 
1.  Cancer stage at diagnosis: ____________ 
 
2. Time since diagnosis: _________________ 
 
3. Time since last treatment: _______________ 
 
4. Have you had the following treatments? 
 
Surgery: Yes/ No 
 
Chemotherapy (mention drugs received if known): _________________________ 
 
Radiotherapy: Yes/ No 
 
5. How many cycles of chemotherapy have you had? _________________________ 
 
6. Please give the dates you had these cycles. _________________________________ 
 
______________________________________________________________________ 
 
7. Are you currently undergoing treatment?  Yes/ No 
 
8.  If yes, what?  ________________________ 
 
9.  CA 125 level: __________________ 
 
10. Date of last CA 125 test: _____________ 
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Information about health behaviours: 
 
1. Do you smoke? Yes/ No 
 
2. If yes, on average how many per day? _______________ 
 
3. Do you drink alcohol? Yes/ No 
 
4. If yes, on average how many units per week? _____________ 
 
5. On average, how often do you exercise? 
 
5 times a week    3 4 times a    1 2 times a  less than   Never 
or more    week      week    once a week 
 
6. What type of exercise do you do? ________________________________ 
 
 
Information about checkups/ medication: 
 
1.  Over the past 3 months, how many times have you gone to your GP or a 
consultant for: 
 
Illness_____ Injury_____ Checkup_____  
 
 
2.  Over the past 3 months, how many times have you visited an alternative 
therapist (i.e., reflexologist, aromatherapist, acupuncturist) for: 
 
Illness _____ Injury _____ Regular treatment _____  
 
 
3.  Over the past 3 months, how many times have you self treated with over the –
counter medication / alternative medicine (i.e., herbal remedies, traditional 
Chinese medicine)? 
 
Over the counter remedies _________ Alternative Medicine __________ 
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Stress Questionnaire 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you have 
felt or thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Distress experienced 
Below is a list of difficulties people sometimes have after stressful life events. Please read each item, 
and then indicate how distressing each difficulty has been for you DURING THE PAST SEVEN 
DAYS with respect to your cancer, i.e., how much were you distressed or bothered by these 
difficulties? 
 
Not 
at 
all 
A little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  Any reminder brought back feelings 
about it  0  1  2  3  4 
2.  I had trouble staying asleep 
0  1  2  3  4 
3.  Other things kept making me think 
about it  0  1  2  3  4 
4.  I thought about it when I didn’t mean 
to  0  1  2  3  4 
5.  Pictures about it popped into my mind 
0  1  2  3  4 
6.  I found myself acting or feeling as 
though I was back at that time  0  1  2  3  4 
7.  I had waves of strong feelings about it 
0  1  2  3  4 
8.  I had dreams about it 
0  1  2  3  4 
 
Feelings about your cancer 
 
Please answer the following questions with regard to your feelings about your cancer in general. 
  Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree 
Agree  Strongly 
agree 
1.  I get depressed when I think 
about my cancer    
 
         
2.  When I think about my cancer 
I get upset 
 
         
3.  My cancer makes me feel 
angry 
 
         
4.  My cancer does not worry me 
 
         
5.  Having cancer makes me feel 
anxious 
         
6.  My cancer makes me feel 
afraid 
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Living with your illness 
 
Below is a list of statements that other people with your illness have said are important. By  
circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP5  I am bothered by side effects of treatment.............................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS4  My family has accepted my illness........................................
 
0  1  2  3  4 
 
GS5  I am satisfied with family communication about my 
illness.....................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
  
 
 
 
 
 
 
 
  
 
271 
 
 
 
 
By circling one (1) number per line, please indicate how true each statement has been 
for you during the past 7 days 
 
 
 
 
 
 
FUNCTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GF1  I am able to work (include work at home)............................
 
0  1  2  3  4 
 
GF2  My work (include work at home) is fulfilling ......................
 
0  1  2  3  4 
 
GF3  I am able to enjoy life ...........................................................
 
0  1  2  3  4 
 
GF4  I have accepted my illness ....................................................
 
0  1  2  3  4 
 
GF5  I am sleeping well................................................................
 
0  1  2  3  4 
 
GF6  I am enjoying the things I usually do for fun........................
 
0  1  2  3  4 
 
GF7 
 
I am content with the quality of my life right now...............
 
0  1  2  3  4 
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Communication with your partner 
 
The following questions ask about your relationship with your partner.  Each question 
should be answered on the scale shown below. 
 
1    2    3      4    5 
Disagree  Disagree  Undecided    Agree    Agree   
Strongly                Strongly 
 
 
1.  I can express my true feelings to my partner. _____ 
 
2.  When we are having a problem, my partner often refuses to talk about it. ____ 
 
3.   My partner sometimes makes comments that put me down. _____ 
 
4.  I wish my partner were more willing to share his/her feelings with me. ____ 
 
5.  At times it is hard to ask my partner for what I want. _____ 
 
6.  Sometimes I have trouble believing everything my partner tells me. ____ 
 
7.  My partner is a very good listener. ______ 
 
8.  My partner often doesn’t understand how I feel.  _______ 
 
9.  I am very satisfied with how my partner and I talk with each other. _____ 
 
10. It is difficult for me to share negative feelings with my partner. _____ 
 
11. It is hard for me to express feelings about my illness to my partner. ______ 
 
12.  I feel comfortable discussing issues related to my illness with my partner. ____ 
 
13. My partner is reluctant to talk about my illness. ______  
 
14. My partner is willing to share his feelings about my illness with me. ______ 
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Appendix Q: Baseline questionnaires for main study – partners 
 
Code             
Date             
 
 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Initial questionnaire 
 
Thank you for agreeing to participate in this study.  We are very interested in finding 
out more about any stress and anxiety that both you and your partner may be 
experiencing as a result of her illness.  This will help us to find ways to reduce it. 
 
This booklet contains a number of questions about the stress and anxiety you may be 
experiencing, and the impact of your partner’s illness on your physical health and 
psychological well being. 
 
 
 
There are no right or wrong answers to these questions.  We are interested in your own 
personal views. 
 
•  We ask you to answer the questions as honestly as possible. 
 
 
This questionnaire is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed questionnaire in the attached stamped addressed 
envelope.  Please note that this questionnaire booklet consists of 6 pages. 
 
Thank you very much for your time 
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Stress Questionnaire 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you have 
felt or thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Distress experienced 
Below is a list of difficulties people sometimes have after stressful life events. Please 
read each item, and then indicate how distressing each difficulty has been for you 
DURING THE PAST SEVEN DAYS with respect to your wife/ partner’s cancer, 
i.e., how much were you distressed or bothered by these difficulties? 
 
Not 
at 
all 
A 
little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  Any reminder brought back feelings 
about it  0  1  2  3  4 
2.  I had trouble staying asleep 
0  1  2  3  4 
3.  Other things kept making me think about 
it  0  1  2  3  4 
4.  I thought about it when I didn’t mean to 
0  1  2  3  4 
5.  Pictures about it popped into my mind 
0  1  2  3  4 
6.  I found myself acting or feeling as 
though I was back at that time  0  1  2  3  4 
7.  I had waves of strong feelings about it 
0  1  2  3  4 
8.  I had dreams about it 
0  1  2  3  4 
 
Feelings about your wife/ partner’s cancer 
 
Please answer the following questions with regard to your feelings about your wife/ partner’s 
cancer in general. 
 
  Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree 
Agree  Strongly 
agree 
1.  I get depressed when I think 
about my partner’s cancer    
 
         
2.  When I think about my 
partner’s cancer I get upset 
 
         
3.  My partner’s cancer makes me 
feel angry 
 
         
4.  My partner’s cancer does not 
worry me 
 
         
5.  My partner having cancer 
makes me feel anxious 
         
6.  My partner’s cancer makes me 
feel afraid 
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Below is a list of statements relating to your health and everyday life which other people have 
said are important. By circling one (1) number per line, please indicate how true each 
statement has been for you during the past 7 days. 
 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been 
for you during the past 7 days. 
 
 
 
 
 
 
FUNCTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GF1  I am able to work (include work at home)............................
 
0  1  2  3  4 
 
GF2  My work (include work at home) is fulfilling ......................
 
0  1  2  3  4 
 
GF3  I am able to enjoy life ...........................................................
 
0  1  2  3  4 
 
GF5  I am sleeping well................................................................
 
0  1  2  3  4 
 
GF6  I am enjoying the things I usually do for fun........................
 
0  1  2  3  4 
 
GF7 
 
I am content with the quality of my life right now...............
 
0  1  2  3  4 
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Communication with your partner 
 
The following questions ask about your relationship with your partner.  Each question 
should be answered on the scale shown below. 
 
1    2    3      4    5 
Disagree  Disagree  Undecided    Agree    Agree   
Strongly                Strongly 
 
 
1.  I can express my true feelings to my partner. _____ 
 
2.  When we are having a problem, my partner often refuses to talk about it. ____ 
 
3.   My partner sometimes makes comments that put me down. _____ 
 
4.  I wish my partner were more willing to share his/her feelings with me. ____ 
 
5.  At times it is hard to ask my partner for what I want. _____ 
 
6.  Sometimes I have trouble believing everything my partner tells me. ____ 
 
7.  My partner is a very good listener. ______ 
 
8.  My partner often doesn’t understand how I feel.  _______ 
 
9.  I am very satisfied with how my partner and I talk with each other. _____ 
 
10. It is difficult for me to share negative feelings with my partner. _____ 
 
11. It is hard for me to express feelings about her illness to my partner. ______ 
 
12.  I feel comfortable discussing issues related to her illness with my partner. ____ 
 
13. My partner is reluctant to talk about her illness. ______  
 
14. My partner is willing to share her feelings about her illness with me. ______  
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Appendix R: Guided Disclosure Protocol (GDP) booklets for main study – patients’ 
booklet followed by partners’ booklet 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Writing task 
 
Thank you for agreeing to participate in this study on the effects of writing on well 
being in ovarian cancer patients and their partners.   
 
This booklet contains the writing task.  It is important that you follow the instructions 
given below.  I will telephone you before the writing task to arrange a convenient time 
for you to do it, and to go through the instructions with you. 
 
PLEASE DO NOT LOOK AT THE WRITING TASK BEFORE STARTING IT. 
 
The writing should be carried out for 15 minutes each day over 3 days, in a quiet room 
free from distractions.  If you prefer to type rather than write, that is also fine.  On each 
day, I will telephone you at a previously agreed time, to remind you to start writing, and 
again after 15 minutes, to remind you to stop writing. 
 
 
The writing is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed writing task in the attached stamped addressed 
envelope.  Please note that this booklet consists of 10 pages. 
 
Thank you very much for your time 
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Code             
Date             
 
 
Introduction:  
 
During  the  following  minutes,  we  will  ask  you  to  think  about  your  diagnosis  and 
treatment of ovarian cancer. You will be asked to write about it for 15 minutes per day 
over 3 days, according to the instructions given below. We wish to remind you that all 
the information you provide will remain strictly confidential.  
 
One thing that is important for the research is that you write continuously for the entire 
time.  If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
DAY 1: 
 
Please  take  a  moment  to  remember  all  the  details  of  your  diagnosis  and  treatment. 
Please describe these details in their chronological order of occurrence.  
 
For example:  
It was Friday, morning, three years ago… 
I woke up and ate… 
I spoke with friends… 
Later, in the afternoon, the phone rang, and I was told that… 
I immediately went to tell…etc.  
 
The important thing is that you describe the event in sections organized according to 
their  order  of  occurrence,  that  you  write  what  caused  what,  in  a  “journalistic”  and 
objective language, without mentioning your feelings.  
 
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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Post- writing questions 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 2: 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.  Please 
note that there are two parts to the writing today – part 2 is on the next page. 
 
a.  Please describe in detail how you felt and what you thought at the time of your 
diagnosis. What is important is that you identify and describe in your own words 
your deepest thoughts and feelings.  
 
______________________________________________________________________
______________________________________________________________________
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______________________________________________________________________
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b. What meaning did the diagnosis/ treatment have for you, and has it changed your 
attitude towards life (for example – has it caused you to change priorities)? 
 
______________________________________________________________________
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______________________________________________________________________
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Post- writing questions 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 3: 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
Now, we are asking you please to describe your thoughts and feelings about the 
diagnosis and treatment as they are today. Are your current thoughts and feelings 
different from those you had at the time? Are you able to cope with similar situations 
better because you experienced this diagnosis/ treatment?  
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Please answer the following questions at the conclusion of your writing period. 
Answer them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal". 
In answering these questions, consider all three days of your writing. 
 
 
1. Overall, how personal were the essays that you wrote: _______ 
 
2. Prior to the experiment, how much had you told other people about what you wrote? 
_________ 
 
3. Overall, how much did you reveal your emotions in what you wrote on Day 2 and 
Day 3? _______ 
 
4. How much have you actively held back from telling others about what you wrote? 
_________ 
 
5. During your normal day, to what degree have you thought about this study since it 
began? _______ 
 
6. Since the beginning of the experiment, to what degree have you thought about the 
topics that you wrote about? ________ 
 
7. Before the experiment ever began, to what degree did you think about the topics you 
wrote about? ______ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS.  
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The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Writing task 
 
Thank you for agreeing to participate in this study on the effects of writing on well 
being in ovarian cancer patients and their partners.   
 
This booklet contains the writing task.  It is important that you follow the instructions 
given below.  I will telephone you before the writing task to arrange a convenient time 
for you to do it, and to go through the instructions with you. 
 
PLEASE DO NOT LOOK AT THE WRITING TASK BEFORE STARTING IT. 
 
The writing should be carried out for 15 minutes each day over 3 days, in a quiet room 
free from distractions.  If you prefer to type rather than write, that is also fine.  On each 
day, I will telephone you at a previously agreed time, to remind you to start writing, and 
again after 15 minutes, to remind you to stop writing. 
 
 
The writing is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed writing task in the attached stamped addressed 
envelope.  Please note that this booklet consists of 10 pages. 
 
Thank you very much for your time 
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Code             
Date             
 
 
Introduction:  
 
During the following minutes, we will ask you to think about your spouse/ partner’s 
diagnosis and treatment of ovarian cancer. You will be asked to write about it for 15 
minutes per day over 3 days, according to the instructions given below. We wish to 
remind you that all the information you provide will remain strictly confidential.  
 
One thing that is important for the research is that you write continuously for the entire 
time.  If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
DAY 1: 
 
Please  take  a  moment  to  remember  as  much  as  you  can  of  your  spouse/  partner’s 
diagnosis and treatment. Please describe these details in their chronological order of 
occurrence.  
 
For example:  
It was Friday, morning, three years ago… 
I woke up and ate… 
I spoke with friends… 
Later, in the afternoon, the phone rang, and I was told that… 
I immediately went to tell…etc.  
 
The important thing is that you describe the event in sections organized according to 
their  order  of  occurrence,  that  you  write  what  caused  what,  in  a  “journalistic”  and 
objective language, without mentioning your feelings.  
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Post- writing questions 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 2: 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.  Please 
note that there are two parts to the writing today – part 2 is on the next page. 
 
a.  Please describe in detail how you felt and what you thought at the time of your 
spouse/ partner’s cancer diagnosis. What is important is that you identify and 
describe in your own words your deepest thoughts and feelings.  
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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b. What meaning did your spouse/ partner’s diagnosis/ treatment have for you, and has 
it changed your attitude towards life (for example – has it caused you to change 
priorities)? 
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Post- writing questions 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 3: 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
Now, we are asking you please to describe your thoughts and feelings about your 
spouse/ partner’s diagnosis and treatment as they are today. Are your current thoughts 
and feelings different from those you had at the time? Are you able to cope with similar 
situations better because of the experience of your spouse/ partner’s diagnosis/ 
treatment?  
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Please answer the following questions at the conclusion of your writing period. 
Answer them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal". 
In answering these questions, consider all three days of your writing. 
 
 
1. Overall, how personal were the essays that you wrote: _______ 
 
2. Prior to the experiment, how much had you told other people about what you wrote? 
_________ 
 
3. Overall, how much did you reveal your emotions in what you wrote on Day 2 and 
Day 3? _______ 
 
4. How much have you actively held back from telling others about what you wrote? 
_________ 
 
5. During your normal day, to what degree have you thought about this study since it 
began? _______ 
 
6. Since the beginning of the experiment, to what degree have you thought about the 
topics that you wrote about? ________ 
 
7. Before the experiment ever began, to what degree did you think about the topics you 
wrote about? ______ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS.  
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Appendix S: Control writing booklet for main study – patients’ booklet followed by  
partners’ booklet 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Writing task 
 
Thank you for agreeing to participate in this study on the effects of writing on well 
being in ovarian cancer patients and their partners.   
 
This booklet contains the writing task.  It is important that you follow the instructions 
given below.  I will telephone you before the writing task to arrange a convenient time 
for you to do it, and to go through the instructions with you. 
 
PLEASE DO NOT LOOK AT THE WRITING TASK BEFORE STARTING IT. 
 
The writing should be carried out for 15 minutes each day over 3 days, in a quiet room 
free from distractions.  If you prefer to type rather than write, that is also fine.  On each 
day, I will telephone you at a previously agreed time, to remind you to start writing, and 
again after 15 minutes, to remind you to stop writing. 
 
 
The writing is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed writing task in the attached stamped addressed 
envelope.  Please note that this booklet consists of 10 pages. 
 
Thank you very much for your time 
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Introduction: 
 
During the following minutes, we will ask you to think about a few things in your daily 
life, and to write about them. You will be asked to write for 15 minutes per day over 3 
days according to instructions you shall receive. We wish to remind you that all the 
information you provide will remain strictly confidential.  
 
One thing that is important for the research is that you write continuously for the entire 
time.  If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
DAY 1: 
 
Please describe in an unemotional manner what you did yesterday.  
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Post-writing questions 
 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 2: 
 
Please describe in an unemotional manner what you did yesterday.  
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
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Post- writing questions 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 3: 
 
Please describe in an unemotional manner what you did yesterday. 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
______________________________________________________________________
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Please answer the following questions at the conclusion of your writing period. 
Answer them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal". 
In answering these questions, consider all three days of your writing. 
 
 
1. Overall, how personal were the essays that you wrote: _______ 
 
2. Prior to the experiment, how much had you told other people about what you wrote? 
_________ 
 
3. Overall, how much did you reveal your emotions in what you wrote on Day 2 and 
Day 3? _______ 
 
4. How much have you actively held back from telling others about what you wrote? 
_________ 
 
5. During your normal day, to what degree have you thought about this study since it 
began? _______ 
 
6. Since the beginning of the experiment, to what degree have you thought about the 
topics that you wrote about? ________ 
 
7. Before the experiment ever began, to what degree did you think about the topics you 
wrote about? ______ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Writing task 
 
Thank you for agreeing to participate in this study on the effects of writing on well 
being in ovarian cancer patients and their partners.   
 
This booklet contains the writing task.  It is important that you follow the instructions 
given below.  I will telephone you before the writing task to arrange a convenient time 
for you to do it, and to go through the instructions with you. 
 
PLEASE DO NOT LOOK AT THE WRITING TASK BEFORE STARTING IT. 
 
The writing should be carried out for 15 minutes each day over 3 days, in a quiet room 
free from distractions.  If you prefer to type rather than write, that is also fine.  On each 
day, I will telephone you at a previously agreed time, to remind you to start writing, and 
again after 15 minutes, to remind you to stop writing. 
 
 
The writing is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed writing task in the attached stamped addressed 
envelope.  Please note that this booklet consists of 10 pages. 
 
Thank you very much for your time  
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Code             
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Introduction: 
 
During the following minutes, we will ask you to think about a few things in your daily 
life, and to write about them. You will be asked to write for 15 minutes per day over 3 
days according to instructions you shall receive. We wish to remind you that all the 
information you provide will remain strictly confidential.  
 
One thing that is important for the research is that you write continuously for the entire 
time.  If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
DAY 1: 
 
To the best of your ability, please describe in an unemotional manner what your spouse/ 
partner did yesterday.  
 
______________________________________________________________________
______________________________________________________________________
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Post-writing questions 
 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 2: 
 
To the best of your ability, please describe in an unemotional manner what your spouse/ 
partner did yesterday.  
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
PTO  
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Post- writing questions 
 
Please answer the following questions at the conclusion of your writing period.  Answer 
them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal": 
 
1. Overall, how personal was the essay that you wrote today ____ 
 
2. Overall, how much have you told other people about what you wrote today ____ 
 
3. Overall, how much did you reveal your emotions in what you wrote today ____ 
 
4. How much have you wanted to tell another person about what you wrote today ____ 
 
5. How much have you actively held back from telling others about what you wrote 
today ____ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
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DAY 3: 
 
To the best of your ability, please describe in an unemotional manner what your spouse/ 
partner did yesterday. 
 
As before, it is important for the research that you write continuously for the entire time.  
If you run out of things to say, just repeat what you have already written.  In your 
writing, don’t worry about grammar, spelling, or sentence structure.  Just write.   
 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
______________________________________________________________________
______________________________________________________________________ 
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______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
PTO  
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Please answer the following questions at the conclusion of your writing period. 
Answer them on a scale from 1 to 7 with 1 being "not at all" and 7 "a great deal". 
In answering these questions, consider all three days of your writing. 
 
 
1. Overall, how personal were the essays that you wrote: _______ 
 
2. Prior to the experiment, how much had you told other people about what you wrote? 
_________ 
 
3. Overall, how much did you reveal your emotions in what you wrote on Day 2 and 
Day 3? _______ 
 
4. How much have you actively held back from telling others about what you wrote? 
_________ 
 
5. During your normal day, to what degree have you thought about this study since it 
began? _______ 
 
6. Since the beginning of the experiment, to what degree have you thought about the 
topics that you wrote about? ________ 
 
7. Before the experiment ever began, to what degree did you think about the topics you 
wrote about? ______ 
 
 
THANK YOU FOR COMPLETING THE WRITING SESSION AND THE 
QUESTIONS. 
  
 
319 
Appendix T: Three month follow-up questionnaire for main study – patients 
 
Code             
Date             
 
 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Three month follow-up 
 
Thank you for agreeing to participate in this study.  We are very interested in finding 
out more about any stress and anxiety you may be experiencing as a result of your 
illness, and how it changes over time.  This will help us to find ways to reduce it. 
 
This booklet contains a number of questions about any stress and anxiety you may be 
experiencing, and the impact of your illness on your physical health and psychological 
well being. 
 
 
 
There are no right or wrong answers to these questions.  We are interested in your own 
personal views. 
 
•  We ask you to answer the questions as honestly as possible. 
 
 
This questionnaire is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed questionnaire in the attached stamped addressed 
envelope.  Please note that this questionnaire booklet consists of 7 pages. 
 
Thank you very much for your time 
 
 
 
 
 
 
 
 
 
 
 
  
 
320 
 
 
Background Information: 
 
Illness-related information: 
 
1.  Are you currently undergoing treatment?  Yes/ No 
 
2.  If yes, what?  ________________________ 
 
3.  CA 125 level: __________________ 
 
4.  Date of last CA 125 test: _____________ 
 
 
Information about checkups/ medication 
 
1.  Over the past 3 months, how many times have you gone to your GP or a consultant 
for: 
 
Illness_____ Injury_____ Checkup_____  
 
 
2.  Over the past 3 months, how many times have you visited an alternative therapist 
(i.e., reflexologist, aromatherapist, acupuncturist) for: 
 
Illness _____ Injury _____ Regular treatment _____  
 
 
3.  Over the past 3 months, how many times have you self treated with over the –
counter medication / alternative medicine (i.e., herbal remedies, traditional Chinese 
medicine)? 
 
Over the counter remedies _________ Alternative Medicine __________ 
 
 
Questions about the writing study 
 
Answer the following questions on a scale from 1 to 7 with 1 being “not at all” and 7 “a 
great deal.” 
 
1.  Since your participation in the writing experiment, how much have you thought 
about what you wrote? ______________ 
 
2.   Since the writing experiment, how much have you talked to other people about 
what you wrote? ________________ 
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Stress Questionnaire 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you have 
felt or thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Distress experienced 
Below is a list of difficulties people sometimes have after stressful life events. Please read each item, 
and then indicate how distressing each difficulty has been for you DURING THE PAST SEVEN 
DAYS with respect to your cancer, i.e., how much were you distressed or bothered by these 
difficulties? 
 
Not 
at 
all 
A little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  Any reminder brought back feelings 
about it  0  1  2  3  4 
2.  I had trouble staying asleep 
0  1  2  3  4 
3.  Other things kept making me think 
about it  0  1  2  3  4 
4.  I thought about it when I didn’t mean 
to  0  1  2  3  4 
5.  Pictures about it popped into my mind 
0  1  2  3  4 
6.  I found myself acting or feeling as 
though I was back at that time  0  1  2  3  4 
7.  I had waves of strong feelings about it 
0  1  2  3  4 
8.  I had dreams about it 
0  1  2  3  4 
 
Feelings about your cancer 
 
Please answer the following questions with regard to your feelings about your cancer in general. 
 
  Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree 
Agree  Strongly 
agree 
1.  I get depressed when I think 
about my cancer    
 
         
2.  When I think about my cancer 
I get upset 
 
         
3.  My cancer makes me feel 
angry 
 
         
4.  My cancer does not worry me 
 
         
5.  Having cancer makes me feel 
anxious 
         
6.  My cancer makes me feel 
afraid 
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Living with your illness 
 
Below is a list of statements that other people with your illness have said are important. By  
circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP5  I am bothered by side effects of treatment.............................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS4  My family has accepted my illness........................................
 
0  1  2  3  4 
 
GS5  I am satisfied with family communication about my 
illness.....................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been 
for you during the past 7 days 
 
 
 
 
 
 
FUNCTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GF1  I am able to work (include work at home)............................
 
0  1  2  3  4 
 
GF2  My work (include work at home) is fulfilling ......................
 
0  1  2  3  4 
 
GF3  I am able to enjoy life ...........................................................
 
0  1  2  3  4 
 
GF4  I have accepted my illness ....................................................
 
0  1  2  3  4 
 
GF5  I am sleeping well................................................................
 
0  1  2  3  4 
 
GF6  I am enjoying the things I usually do for fun........................
 
0  1  2  3  4 
 
GF7 
 
I am content with the quality of my life right now...............
 
0  1  2  3  4 
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Communication with your partner 
 
The following questions ask about your relationship with your partner.  Each question 
should be answered on the scale shown below. 
 
1    2    3    4    5 
Disagree  Disagree  Undecided  Agree    Agree   
Strongly              Strongly 
 
 
1.  I can express my true feelings to my partner. _____ 
 
2.  When we are having a problem, my partner often refuses to talk about it. ____ 
 
3.   My partner sometimes makes comments that put me down. _____ 
 
4.  I wish my partner were more willing to share his/her feelings with me. ____ 
 
5.  At times it is hard to ask my partner for what I want. _____ 
 
6.  Sometimes I have trouble believing everything my partner tells me. ____ 
 
7.  My partner is a very good listener. ______ 
 
8.  My partner often doesn’t understand how I feel.  _______ 
 
9.  I am very satisfied with how my partner and I talk with each other. _____ 
 
10. It is difficult for me to share negative feelings with my partner. _____ 
 
11. It is hard for me to express feelings about my illness to my partner. ______ 
 
12.  I feel comfortable discussing issues related to my illness with my partner. ____ 
 
13. My partner is reluctant to talk about my illness. ______  
 
14. My partner is willing to share his feelings about my illness with me. ______  
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Appendix U: Three month follow-up questionnaire for main study – partners 
 
Code             
Date             
 
 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Three month follow-up 
 
Thank you for agreeing to participate in this study.  We are very interested in finding 
out more about any stress and anxiety that both you and your partner may be 
experiencing as a result of her illness, and how it changes over time.  This will help us 
to find ways to reduce it. 
 
This booklet contains a number of questions about the stress and anxiety you may be 
experiencing, and the impact of your partner’s illness on your physical health and 
psychological well being. 
 
 
 
There are no right or wrong answers to these questions.  We are interested in your own 
personal views. 
 
•  We ask you to answer the questions as honestly as possible. 
 
 
This questionnaire is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed questionnaire in the attached stamped addressed 
envelope.  Please note that this questionnaire booklet consists of 7 pages. 
 
Thank you very much for your time 
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Questions about the writing study 
 
 
Answer the following questions on a scale from 1 to 7 with 1 being “not at all” and 7 “a 
great deal.” 
 
1. Since your participation in the writing experiment, how much have you thought 
about what you wrote? ______________ 
 
2.  Since the writing experiment, how much have you talked to other people about 
what you wrote? ________________ 
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Stress Questionnaire 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you have 
felt or thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Distress experienced 
Below is a list of difficulties people sometimes have after stressful life events. Please read each item, 
and then indicate how distressing each difficulty has been for you DURING THE PAST SEVEN 
DAYS with respect to your wife/ partner’s cancer, i.e., how much were you distressed or bothered by 
these difficulties? 
 
Not 
at 
all 
A 
little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  Any reminder brought back feelings 
about it  0  1  2  3  4 
2.  I had trouble staying asleep 
0  1  2  3  4 
3.  Other things kept making me think about 
it  0  1  2  3  4 
4.  I thought about it when I didn’t mean to 
0  1  2  3  4 
5.  Pictures about it popped into my mind 
0  1  2  3  4 
6.  I found myself acting or feeling as 
though I was back at that time  0  1  2  3  4 
7.  I had waves of strong feelings about it 
0  1  2  3  4 
8.  I had dreams about it 
0  1  2  3  4 
 
Feelings about your wife/ partner’s cancer 
 
Please answer the following questions with regard to your feelings about your wife/ partner’s 
cancer in general. 
 
  Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree 
Agree  Strongly 
agree 
1.  I get depressed when I think 
about my partner’s cancer    
 
         
2.  When I think about my 
partner’s cancer I get upset 
 
         
3.  My partner’s cancer makes me 
feel angry 
 
         
4.  My partner’s cancer does not 
worry me 
 
         
5.  My partner having cancer 
makes me feel anxious 
         
6.  My partner’s cancer makes me 
feel afraid 
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Below is a list of statements relating to your health and everyday life which other people have 
said are important. By circling one (1) number per line, please indicate how true each 
statement has been for you during the past 7 days. 
 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been 
for you during the past 7 days. 
 
 
 
 
 
 
FUNCTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GF1  I am able to work (include work at home)............................
 
0  1  2  3  4 
 
GF2  My work (include work at home) is fulfilling ......................
 
0  1  2  3  4 
 
GF3  I am able to enjoy life ...........................................................
 
0  1  2  3  4 
 
GF5  I am sleeping well................................................................
 
0  1  2  3  4 
 
GF6  I am enjoying the things I usually do for fun........................
 
0  1  2  3  4 
 
GF7 
 
I am content with the quality of my life right now...............
 
0  1  2  3  4 
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Communication with your partner 
 
The following questions ask about your relationship with your partner.  Each question 
should be answered on the scale shown below. 
 
1    2    3      4    5 
Disagree  Disagree  Undecided    Agree    Agree   
Strongly                Strongly 
 
 
1.  I can express my true feelings to my partner. _____ 
 
2.  When we are having a problem, my partner often refuses to talk about it. ____ 
 
3.   My partner sometimes makes comments that put me down. _____ 
 
4.  I wish my partner were more willing to share his/her feelings with me. ____ 
 
5.  At times it is hard to ask my partner for what I want. _____ 
 
6.  Sometimes I have trouble believing everything my partner tells me. ____ 
 
7.  My partner is a very good listener. ______ 
 
8.  My partner often doesn’t understand how I feel.  _______ 
 
9.  I am very satisfied with how my partner and I talk with each other. _____ 
 
10. It is difficult for me to share negative feelings with my partner. _____ 
 
11. It is hard for me to express feelings about her illness to my partner. ______ 
 
12.  I feel comfortable discussing issues related to her illness with my partner. ____ 
 
13. My partner is reluctant to talk about her illness. ______  
 
14. My partner is willing to share her feelings about her illness with me. ______  
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Appendix V: Six month follow-up questionnaire for main study – patients 
 
Code             
Date             
 
 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Six month follow-up 
 
Thank you for agreeing to participate in this study.  We are very interested in finding 
out more about any stress and anxiety you may be experiencing as a result of your 
illness, and how it changes over time.  This will help us to find ways to reduce it. 
 
This booklet contains a number of questions about any stress and anxiety you may be 
experiencing, and the impact of your illness on your physical health and psychological 
well being. 
 
 
 
There are no right or wrong answers to these questions.  We are interested in your own 
personal views. 
 
•  We ask you to answer the questions as honestly as possible. 
 
 
This questionnaire is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed questionnaire in the attached stamped addressed 
envelope.  Please note that this questionnaire booklet consists of 7 pages. 
 
Thank you very much for your time 
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Background Information: 
 
Illness-related information: 
 
1.  Are you currently undergoing treatment?  Yes/ No 
 
2.  If yes, what?  ________________________ 
 
3.  CA 125 level: __________________ 
 
4.  Date of last CA 125 test: _____________ 
 
Information about checkups/ medication 
 
1.  Over the past 3 months, how many times have you gone to your GP or a 
consultant for: 
 
Illness_____ Injury_____ Checkup_____  
 
 
2.  Over the past 3 months, how many times have you visited an alternative 
therapist (i.e., reflexologist, aromatherapist, acupuncturist) for: 
 
Illness _____ Injury _____ Regular treatment _____  
 
 
3.  Over the past 3 months, how many times have you self treated with over the –
counter medication / alternative medicine (i.e., herbal remedies, traditional 
Chinese medicine)? 
 
Over the counter remedies _________ Alternative Medicine __________ 
 
Questions about the writing study 
 
Answer the following questions on a scale from 1 to 7 with 1 being “not at all” and 7 “a 
great deal.” 
 
1. Since your participation in the writing experiment, how much have you thought 
about what you wrote? ______________ 
 
2.  Since the writing experiment, how much have you talked to other people about 
what you wrote? ________________ 
 
 
General questions about the research 
 
1.  Would you recommend the writing to other people? 
__________________________ 
 
2.    Do you think you were in the intervention or control group?   
Intervention    Control  
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Stress Questionnaire 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you have 
felt or thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
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Distress experienced 
Below is a list of difficulties people sometimes have after stressful life events. Please read each item, 
and then indicate how distressing each difficulty has been for you DURING THE PAST SEVEN 
DAYS with respect to your cancer, i.e., how much were you distressed or bothered by these 
difficulties? 
 
Not 
at 
all 
A little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  Any reminder brought back feelings 
about it  0  1  2  3  4 
2.  I had trouble staying asleep 
0  1  2  3  4 
3.  Other things kept making me think 
about it  0  1  2  3  4 
4.  I thought about it when I didn’t mean 
to  0  1  2  3  4 
5.  Pictures about it popped into my mind 
0  1  2  3  4 
6.  I found myself acting or feeling as 
though I was back at that time  0  1  2  3  4 
7.  I had waves of strong feelings about it 
0  1  2  3  4 
8.  I had dreams about it 
0  1  2  3  4 
 
Feelings about your cancer 
 
Please answer the following questions with regard to your feelings about your cancer in general. 
 
  Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree 
Agree  Strongly 
agree 
1.  I get depressed when I think 
about my cancer    
 
         
2.  When I think about my cancer 
I get upset 
 
         
3.  My cancer makes me feel 
angry 
 
         
4.  My cancer does not worry me 
 
         
5.  Having cancer makes me feel 
anxious 
         
6.  My cancer makes me feel 
afraid 
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Living with your illness 
 
Below is a list of statements that other people with your illness have said are important. By  
circling one (1) number per line, please indicate how true each statement has been for you 
during the past 7 days. 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP5  I am bothered by side effects of treatment.............................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS4  My family has accepted my illness........................................
 
0  1  2  3  4 
 
GS5  I am satisfied with family communication about my 
illness.....................................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
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By circling one (1) number per line, please indicate how true each statement has been 
for you during the past 7 days 
 
 
 
 
 
 
FUNCTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GF1  I am able to work (include work at home)............................
 
0  1  2  3  4 
 
GF2  My work (include work at home) is fulfilling ......................
 
0  1  2  3  4 
 
GF3  I am able to enjoy life ...........................................................
 
0  1  2  3  4 
 
GF4  I have accepted my illness ....................................................
 
0  1  2  3  4 
 
GF5  I am sleeping well................................................................
 
0  1  2  3  4 
 
GF6  I am enjoying the things I usually do for fun........................
 
0  1  2  3  4 
 
GF7 
 
I am content with the quality of my life right now...............
 
0  1  2  3  4 
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Communication with your partner 
 
The following questions ask about your relationship with your partner.  Each question 
should be answered on the scale shown below. 
 
1    2    3    4    5 
Disagree  Disagree  Undecided  Agree    Agree   
Strongly              Strongly 
 
 
1.  I can express my true feelings to my partner. _____ 
 
2.  When we are having a problem, my partner often refuses to talk about it. ____ 
 
3.   My partner sometimes makes comments that put me down. _____ 
 
4.  I wish my partner were more willing to share his/her feelings with me. ____ 
 
5.  At times it is hard to ask my partner for what I want. _____ 
 
6.  Sometimes I have trouble believing everything my partner tells me. ____ 
 
7.  My partner is a very good listener. ______ 
 
8.  My partner often doesn’t understand how I feel.  _______ 
 
9.  I am very satisfied with how my partner and I talk with each other. _____ 
 
10. It is difficult for me to share negative feelings with my partner. _____ 
 
11. It is hard for me to express feelings about my illness to my partner. ______ 
 
12.  I feel comfortable discussing issues related to my illness with my partner. ____ 
 
13. My partner is reluctant to talk about my illness. ______  
 
14. My partner is willing to share his feelings about my illness with me. ______ 
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Appendix W: Six month follow-up questionnaire for main study – partners 
 
Code             
Date             
 
 
 
The effect of guided writing on stress and anxiety in ovarian cancer 
patients and their partners 
 
Six month follow-up 
 
Thank you for agreeing to participate in this study.  We are very interested in finding 
out more about any stress and anxiety that both you and your partner may be 
experiencing as a result of her illness, and how it changes over time.  This will help us 
to find ways to reduce it. 
 
This booklet contains a number of questions about the stress and anxiety you may be 
experiencing, and the impact of your partner’s illness on your physical health and 
psychological well being. 
 
 
 
There are no right or wrong answers to these questions.  We are interested in your own 
personal views. 
 
•  We ask you to answer the questions as honestly as possible. 
 
 
This questionnaire is completely CONFIDENTIAL. 
 
It will only be seen by the researchers involved in this study. 
 
 
Please return your completed questionnaire in the attached stamped addressed 
envelope.  Please note that this questionnaire booklet consists of 7 pages. 
 
Thank you very much for your time 
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Questions about the writing study 
 
 
Answer the following questions on a scale from 1 to 7 with 1 being “not at all” and 7 “a 
great deal.” 
 
1. Since your participation in the writing experiment, how much have you thought 
about what you wrote? ______________ 
 
2. Since the writing experiment, how much have you talked to other people about 
what you wrote? ________________ 
 
 
General questions about the research 
 
1.  Would you recommend the writing to other people? 
_________________________ 
 
2.   Do you think you were in the intervention or control group?  
Intervention     Control 
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Stress Questionnaire 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate by circling how often you have 
felt or thought a certain way. 
0 = Never, 1 = Almost Never,  2 = Sometimes,  3 = Fairly Often,  4 = Very Often 
1.  In the last month, how often have you been upset because of something that 
happened unexpectedly? 
  
0     1     2     3     4 
 
2.  In the last month, how often have you felt that you were unable to control the 
important things in your life?  
 
0     1     2     3     4 
 
3.  In the last month, how often have you felt nervous and “stressed”?  
 
0     1     2     3     4 
 
4.  In the last month, how often have you felt confident about your ability to handle 
your personal problems?  
 
0     1     2     3     4 
 
5.  In the last month, how often have you felt that things were going your way?  
 
0     1     2     3     4 
 
6.  In the last month, how often have you found that you could not cope with all the 
things that you had to do?  
 
0     1     2     3     4 
 
7.  In the last month, how often have you been able to control irritations in your 
life? 
 
0     1     2     3     4 
 
8.  In the last month, how often have you felt that you were on top of things?  
 
0     1     2     3     4 
 
9.  In the last month, how often have you been angered because of things that were 
outside of your control?  
 
0     1     2     3     4 
 
10. In the last month, how often have you felt difficulties were piling up so high that 
you could not overcome them?  
 
0     1     2     3     4  
 
343 
Distress experienced 
Below is a list of difficulties people sometimes have after stressful life events. Please read each item, 
and then indicate how distressing each difficulty has been for you DURING THE PAST SEVEN 
DAYS with respect to your wife/ partner’s cancer, i.e., how much were you distressed or bothered by 
these difficulties? 
 
Not 
at 
all 
A 
little 
bit 
Moderately 
Quite a 
bit 
Extremely 
1.  Any reminder brought back feelings 
about it  0  1  2  3  4 
2.  I had trouble staying asleep 
0  1  2  3  4 
3.  Other things kept making me think about 
it  0  1  2  3  4 
4.  I thought about it when I didn’t mean to 
0  1  2  3  4 
5.  Pictures about it popped into my mind 
0  1  2  3  4 
6.  I found myself acting or feeling as 
though I was back at that time  0  1  2  3  4 
7.  I had waves of strong feelings about it 
0  1  2  3  4 
8.  I had dreams about it 
0  1  2  3  4 
 
Feelings about your wife/ partner’s cancer 
 
Please answer the following questions with regard to your feelings about your wife/ partner’s 
cancer in general. 
 
  Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree 
Agree  Strongly 
agree 
1.  I get depressed when I think 
about my partner’s cancer    
 
         
2.  When I think about my 
partner’s cancer I get upset 
 
         
3.  My partner’s cancer makes me 
feel angry 
 
         
4.  My partner’s cancer does not 
worry me 
 
         
5.  My partner having cancer 
makes me feel anxious 
         
6.  My partner’s cancer makes me 
feel afraid 
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Below is a list of statements relating to your health and everyday life which other people have 
said are important. By circling one (1) number per line, please indicate how true each 
statement has been for you during the past 7 days. 
 
 
 
 
 
 
 
PHYSICAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GP1  I have a lack of energy...........................................................
 
0  1  2  3  4 
 
GP2  I have nausea..........................................................................
 
0  1  2  3  4 
 
GP3  Because of my physical condition, I have trouble  
meeting the needs of my family.............................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
 
GP4  I have pain..............................................................................
 
0  1  2  3  4 
 
GP6  I feel ill...................................................................................
 
0  1  2  3  4 
 
GP7  I am forced to spend time in bed............................................
 
0  1  2  3  4 
 
 
 
 
 
 
 
SOCIAL/FAMILY WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GS1  I feel close to my friends........................................................
 
0  1  2  3  4 
 
GS2  I get emotional support from my family................................
 
0  1  2  3  4 
 
GS3  I get support from my friends................................................
 
0  1  2  3  4 
 
GS6  I feel close to my partner (or the person who is my 
main support).........................................................................
 
 
0 
 
1 
 
2 
 
3 
 
4 
Regardless of your current level of sexual activity, please  
answer the following question.  If you prefer not to answer  
it, please check this box           and go to the next section.     
              
 
 
      
     
 
 
Q1 
 
 
 
 
 
 
GS7  I am satisfied with my sex life...............................................0  1  2  3  4 
 
 
 
 
 
 
 
  
 
345 
By circling one (1) number per line, please indicate how true each statement has been 
for you during the past 7 days. 
 
 
 
 
 
 
FUNCTIONAL WELL-BEING 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
GF1  I am able to work (include work at home)............................
 
0  1  2  3  4 
 
GF2  My work (include work at home) is fulfilling ......................
 
0  1  2  3  4 
 
GF3  I am able to enjoy life ...........................................................
 
0  1  2  3  4 
 
GF5  I am sleeping well................................................................
 
0  1  2  3  4 
 
GF6  I am enjoying the things I usually do for fun........................
 
0  1  2  3  4 
 
GF7 
 
I am content with the quality of my life right now...............
 
0  1  2  3  4 
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Communication with your partner 
 
The following questions ask about your relationship with your partner.  Each question 
should be answered on the scale shown below. 
 
1    2    3    4    5 
Disagree  Disagree  Undecided  Agree    Agree   
Strongly              Strongly 
 
 
1.  I can express my true feelings to my partner. _____ 
 
2.  When we are having a problem, my partner often refuses to talk about it. ____ 
 
3.   My partner sometimes makes comments that put me down. _____ 
 
4.  I wish my partner were more willing to share his/her feelings with me. ____ 
 
5.  At times it is hard to ask my partner for what I want. _____ 
 
6.  Sometimes I have trouble believing everything my partner tells me. ____ 
 
7.  My partner is a very good listener. ______ 
 
8.  My partner often doesn’t understand how I feel.  _______ 
 
9.  I am very satisfied with how my partner and I talk with each other. _____ 
 
10. It is difficult for me to share negative feelings with my partner. _____ 
 
11. It is hard for me to express feelings about her illness to my partner. ______ 
 
12.  I feel comfortable discussing issues related to her illness with my partner. ____ 
 
13. My partner is reluctant to talk about her illness. ______  
 
14. My partner is willing to share her feelings about her illness with me. ______  
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Appendix X: Debriefing form for main study 
 
 
 
The effect of written disclosure on well-being 
Debriefing Statement  
                                 
The  aim  of  this  research  was  to  test  the  effects  of  you  (and  your  partner  where 
applicable) writing about your cancer diagnosis and treatment in an emotional way on 
distress, and quality of life (particularly social well being).  It is expected that writing 
about the diagnosis and treatment will lead to reduced distress, both in general and in 
relation to the illness, and improved quality of life and social interaction, particularly 
with your partner, compared to you (and your partner where applicable) writing about 
what you did the previous day.  It is further expected that any improvement you make 
will be related to the improvement made by your partner/ husband.  Your data will help 
our understanding of ways to reduce distress and improve well being in ovarian cancer 
patients  and  their  partners,  as  well  as  improving  our  understanding  of  the  reasons 
behind the beneficial effects of guided written disclosure.   
 
 
Once again results of this study will not include your name or any other identifying 
characteristics.  I can let you know the results of the study once I have completed it if 
you are interested.  I also expect to publish them in the Ovacome newsletter in summer 
2008.  If you were in the control group (writing about what you did the previous day) 
and would like to take part in the intervention in your own time, or have any further 
questions,  please  contact  me,  Emily  Arden Close  at  ejac103@soton.ac.uk  or 
02380595785.  Thank you for your participation in this research. 
 
 
If you have questions about your rights as a participant in this research, or if you feel 
that you have been placed at risk, you may contact the Chair of the Ethics Committee, 
Department of Psychology, University of Southampton, Southampton, SO17 1BJ. 
Phone:  (023) 8059 3995.  
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Appendix Y: Letter requesting permission to contact consultant for CA 125 levels 
 
 
 
 
 
Dear  
 
Thank you very much for your participation in my study on ‘The effect of writing on 
distress and quality of life in women with ovarian cancer and their partners’– it was 
greatly appreciated.   
 
We have now started analysing our data, and are finding very interesting results.  In 
order to enable dissemination of our results to the wider research community, we now 
need to check your reported CA 125 levels against medical records in order to validate 
them.  It would therefore be very helpful if you could provide us permission to confirm 
these levels with your consultant.   
 
If you are willing to give this permission, then please complete the tear off slip below 
and return it in the attached stamped addressed envelope.  Thank you very much for 
your cooperation and extra help. 
 
Yours Sincerely, 
 
 
 
Emily Arden Close 
 
 
I am willing to give permission for the researchers to contact my consultant to confirm 
my CA 125 levels for the study on ‘The effect of guided writing on well being.’ 
 
Name: ________________________ 
 
Address: _____________________________ 
 
Name of Consultant: ______________________ 
 
Hospital: _______________________________  
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Appendix Z: Letter to consultant requesting CA 125 levels (patient consent was always 
enclosed with this letter) 
 
 
 
 
 
Dear Dr  
 
Your patient (name) is participating in a research study I am carrying out at the School 
of Psychology, University of Southampton, in conjunction with Ovacome on ‘The effect 
of writing on well being.’  This study received approval from the School of Psychology 
ethics committee. 
 
We have found very novel, interesting results relating to predictors of CA 125 levels.  
Your patient provided us with details of her CA 125 levels for the dates (date)   (CA 
125 level) and (date) (CA 125 level) by self report, and has given me permission to 
contact you to validate this data.  I am therefore writing to request confirmation of these 
self reports.  I confirm that any data provided will only be used for the purposes of this 
study, and will remain strictly confidential. 
 
If you are willing to provide this information, please could you fill in the tear off slip 
below and return it to me in the attached stamped addressed envelope.  Thank you. 
 
Yours Sincerely, 
 
 
Emily Arden Close, PhD Candidate 
 
 
Name:  
 
CA 125 level Date 1: ________________ 
 
CA 125 level Date 2: ________________ 
 
 
 
 
 
 
 
 
 
 
 
  
 
350 
References 
Abbey, A., Andrews, F. M., & Halman, L. J. (1995). Provision and Receipt of 
Social Support and Disregard   What Is Their Impact on the Marital Life Quality of 
Infertile and Fertile Couples. Journal of Personality and Social Psychology, 68, 455 
469. 
Adami, H. O., Hsieh, C. C., Lambe, M., Trichopoulos, D., Leon, D., Persson, I. 
et al. (1994). Parity, age at first childbirth, and risk of ovarian cancer. Lancet, 344, 
1250 1254. 
Aiken, L. S. & West, S. G. (1991). Multiple regression: Testing and interpreting 
interactions. California: Sage Publications. 
American Joint Committee on Cancer (1997). Cancer Staging Manual. (5th ed.) 
Philadelphia, Pennsylvania: Lippincott Raven. 
Ames, S. C., Patten, C. A., Offord, K. P., Pennebaker, J. W., Croghan, I. T., Tri, 
D. M. et al. (2005). Expressive writing intervention for young adult cigarette smokers. 
Journal of Clinical Psychology, 61, 1555 1570. 
Andersen, B. L. (2002). Biobehavioral outcomes following psychological 
interventions for cancer patients. Journal of Consulting and Clinical Psychology, 70, 
590 610. 
Andersen, B. L., Woods, X. A., & Copeland, L. J. (1997). Sexual self schema 
and sexual morbidity among gynecologic cancer survivors. Journal of Consulting and 
Clinical Psychology, 65, 221 229. 
Andrykowski, M. A., Brady, M. J., & Hunt, J. W. (1993). Positive psychosocial 
adjustment in potential bone marrow transplant recipients: Cancer as a psychosocial 
transition. Psycho-Oncology, 2, 261 276. 
Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., 
Alferi, S. M. et al. (2001). Cognitive behavioral stress management intervention 
decreases the prevalence of depression and enhances benefit finding among women 
under treatment for early stage breast cancer. Health Psychology, 20, 20 32. 
Arden Close, E., Gidron, Y., & Duncan, E. (2005). Can the guided disclosure 
protocol increase sense of coherence? Psychology and Health, 20 S1, 16.  
 
351 
Ariens, G. A. M., van Mechelen, W., Bongers, P. M., Bouter, L. M., & van der 
Waal, G. (2001). Psychosocial risk factors for neck pain: A systematic review. 
American Journal of Industrial Medicine, 39, 180 193. 
Awadalla, A. W., Ohaeri, J. U., Gholoum, A., Khalid, A. O., Hamad, H. M., & 
Jacob, A. (2007). Factors associated with quality of life of outpatients with breast 
cancer and gynecologic cancers and their family caregivers: a controlled study. BMC 
Cancer, 19, 102. 
Badr, H. & Acitelli, L. K. (2005). Dyadic adjustment in chronic illness: Does 
relationship talk matter? Journal of Family Psychology, 19, 465 469. 
Baider, L. & De Nour, A. K. (1988). Adjustment to cancer: Who is the patient   
The husband or the wife? Israel Journal of Medical Sciences, 24, 631 636. 
Baider, L. & De Nour, A. K. (1999). Psychological distress of cancer couples: A 
levelling effect. New Trends in Experimental and Clinical Psychiatry, 15, 197 203. 
Baider, L., Ever Hadani, P., Goldzweig, G., Wygoda, M. R., & Peretz, T. 
(2003). Is perceived family support a relevant variable in psychological distress?  A 
sample of prostate and breast cancer couples. Journal of Psychosomatic Research, 55, 
453 460. 
Baider, L. & Kaplan De Nour, A. (2000). Cancer and couples   its impact on the 
healthy partner: Methodological considerations. In L.Baider, C. L. Cooper, & A. Kaplan 
De Nour (Eds.), Cancer and the Family (pp. 41 51). Chichester: Wiley. 
Baider, L., Koch, U., Esacson, R., & De Nour, A. K. (1998). Prospective study 
of cancer patients and their spouses: The weakness of marital strength. Psycho-
Oncology, 7, 49 56. 
Baider, L., Perry, S., Holland, J., Sison, A., & Kaplan De Nour, A. (1995). 
Couples and gender relationship: A sample of melanoma patients and their spouses. 
Family Systems Medicine, 13, 60 77. 
Balmer, C.E., Thomas, P., & Osborne, R.J. (2001). Who wants second line, 
palliative chemotherapy? Psycho-Oncology, 10, 410 418.  
 
352 
Bar Tal, Y., Barnoy, S., & Zisser, B. (2005). Whose informational needs are 
considered? A comparison between cancer patients and their spouses' perceptions of 
their own and their partners' knowledge and informational needs. Social Science and 
Medicine, 60, 1459 1465. 
Barber, H. R. K. (1993). Ovarian Carcinoma: Etiology, Diagnosis, and 
Treatment. (3rd ed.) New York: Springer Verlag. 
Barefoot, J. C., Larsen, S., von der Lieth, L., & Schroll, M. (1995). Hostility, 
incidence of acute myocardial infarction, and mortality in a sample of older Danish men 
and women. American Journal of Epidemiology, 142, 477 484. 
Basen Engquist, K., Bodurka Bevers, D., Fitzgerald, M. A., Webster, K., Cella, 
D., Hu, S. et al. (2001). Reliability and validity of the Functional Assessment of Cancer 
Therapy   Ovarian. Journal of Clinical Oncology, 19, 1809 1817. 
Bast, R. C., Klug, T. L., St John, E., Jenison, E., Niloff, J. M., Lazarus, H. et al. 
(1983). A radioimmunoassay using a monoclonal antibody to monitor the course of 
epithelial ovarian cancer. New England Journal of Medicine, 309, 883 887. 
Beck, A. T. (1967). Depression: Clinical, experimental, and theoretical aspects. 
New York: Hoeber. 
Ben Zur, H., Gilbar, O., & Lev, S. (2001). Coping with breast cancer: patient, 
spouse, and dyad models. Psychosomatic Medicine, 63, 32 39. 
Bernard, M., Jackson, C., & Jones, C. (2006). Written emotional disclosure 
following first episode psychosis: Effects on symptoms of post traumatic stress 
disorder. British Journal of Clinical Psychology, 45, 403 415. 
Bishop, F. L., Yardley, L., & Lewith, G. T. (2006). Why do people use different 
forms of complementary medicine? Multivariate associations between treatment and 
illness beliefs and complementary medicine use. Psychology & Health, 21, 683 698. 
Blanchard, C. G., Albrecht, T. L., & Ruckdeschel, J. C. (1997). The crisis of 
cancer: Pyschological impact on family caregivers. Oncology, 11, 189 194.  
 
353 
Bodurka Bevers, D., Basen Engquist, K., Carmack, C. L., Fitzgerald, M. A., 
Wolf, J. K., de Moor, C. et al. (2000). Depression, anxiety, and quality of life in patients 
with epithelial ovarian cancer. Gynecologic Oncology, 78, 302 308. 
Boehmer, U. & Clark, J. A. (2001). Communication about prostate cancer 
between men and their wives. Journal of Family Practice, 50, 226 231. 
Bolger, N., Foster, M., Vinokur, A., & Ng, R. (1996). Close relationships and 
adjustment to life crisis: The case of breast cancer. Journal of Personality and Social 
Psychology, 70, 283 294. 
Bootzin, R. R. (1997). Examining the theory and clinical utility of writing about 
emotional experiences. Psychological Science, 8, 167 169. 
Boscaglia, N., Clarke, D. M., Jobling, T. W., & Quinn, M. A. (2005). The 
contribution of spirituality and spiritual coping to anxiety and depression in women 
with a recent diagnosis of gynecological cancer. International Journal of Gynecological 
Cancer, 15, 755 761. 
Bragg, D. G. & Hricak, H. (1993). Imaging in gynecologic malignancies. 
Cancer, Supplement 15, 1648 1651. 
Brewin, C. R. & Lennard, H. (1999). Effects of mode of writing on emotional 
narratives. Journal of Traumatic Stress, 12, 355 361. 
Bristow, R. E. & Karlan, B. Y. (1996). Ovulation induction, infertility, and 
ovarian cancer risk. Fertility and Sterility, 66, 499 507. 
Broderick, J. E., Junghaenel, D. U., & Schwartz, J. E. (2005). Written emotional 
expression produces health benefits in fibromyalgia patients. Psychosomatic Medicine, 
67, 326 334. 
Broderick, J. E., Stone, A. A., Smyth, J. M., & Kaell, A. T. (2004). The 
feasiblity and effectiveness of an expressive writing intervention for rheumatoid arthritis 
via home based videotaped instructions. Annals of Behavioral Medicine, 27, 50 59. 
Brody, L. R. & Park, S. H. (2004). Narratives, mindfulness, and the implicit 
audience. Clinical Psychology: Science and Practice, 11, 147 154.  
 
354 
Burton, C. M. & King, L. A. (2008). Effects of (very) brief writing on health: 
The two minute miracle. British Journal of Health Psychology, 13, 9 14. 
Byrne Davis, L. M. T., Wetherell, M. A., Dieppe, P., Weinman, J., Byron, M., 
Donovan, J. et al. (2006). Emotional disclosure in rheumatoid arthritis: Participants' 
views on mechanisms. Psychology and Health, 21, 667 682. 
Cain, E. N., Kohorn, E., Quinlan, D. M., Latimer, K., & Schwartz, P. E. (1986). 
Psychosocial benefits of a cancer support group. Cancer, 57, 183 189. 
Cameron, L. D. & Nicholls, G. (1998). Expression of stressful experiences 
through writing, effects of a self regulation manipulation for pessimists and optimists. 
Health Psychology, 17, 84 92. 
Canada, A. L., Parker, P. A., de Moor, J. S., Basen Engquist, K., Ramondetta, 
L., & Cohen, L. (2006). Active coping mediates the association between religion/ 
spirituality and quality of life in ovarian cancer. Gynecologic Oncology, 102 107. 
Capelli, G., De Vincenzo, R. I., Addamo, A., Bartolozzi, F., Braggio, N., & 
Scambia, G. (2002). Which dimensions of health related quality of life are altered in 
patients attending the different gynecologic oncology health care settings. Cancer, 95, 
2500 2507. 
Capone, M. A., Westie, K. S., & Good, R. S. (1980). Sexual rehabilitation of the 
gynecologic oncology patient: An effective counseling model. Frontiers of Radiation 
Therapy and Oncology, 14, 123 129. 
Carlson, L. E., Ottenbreit, N., St Pierre, M., & Bultz, B. D. (2001). Partner 
understanding of the breast and prostate cancer experience. Cancer Nursing, 24, 231 
239. 
Carver, C. S. (1997). You want to measure coping but your protocol's too long: 
Consider the brief COPE. International Journal of Behavioral Medicine, 4, 92 100. 
Carver, C. S., Pozo, C., Harris, S. D., Noriega, V., Scheier, M. F., Robinson, D. 
S. et al. (1993). How coping mediates the effect of optimism on distress: A study of 
women with early stage breast cancer. Journal of Personality and Social Psychology, 
65, 375 390.  
 
355 
Cassileth, B., Lusk, E., Brown, L., & Cross, P. (1985). Psychosocial status of 
cancer patients and next of kin: Normative data from the Profile of Mood States. 
Journal of Psychosocial Oncology, 3, 99 105. 
Cella, D., Zagari, M. J., Vandoros, C., Gagnon, D. D., Hurtz, H. J., & Nortier, J. 
W. R. (2003). Epoetin alfa treatment results in clinically significant improvements in 
quality of life in anemic cancer patients when referenced to the general population. 
Journal of Clinical Oncology, 21, 366 373. 
Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in 
Oncology, 22, 73 78. 
Chan, Y. M., Lee, P. W. H., Fong, D. Y. T., Fung, A. S. M., Wu, L. Y. F., Choi, 
A. Y. Y. et al. (2005). Effect of individual psychological intervention in Chinese 
women with gynecologic malignancy: A randomized controlled trial. Journal of 
Clinical Oncology, 23, 4913 4924. 
Chan, Y. M., Ng, T. Y., Lee, P. W., Ngan, H. Y., & Wong, L. C. (2003). 
Symptoms, coping strategies, and timing of presentations in patients with newly 
diagnosed ovarian cancer. Gynecologic Oncology, 90, 651 656. 
Chan, Y. M., Ng, T. Y., Ngan, H. Y. S., & Wong, L. C. (2003). Quality of life in 
women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A 
prospective longitudinal study. Gynecologic Oncology, 88, 9 16. 
Chan, Y. M., Ngan, H. Y. S., Yip, P. S. F., Li, B. Y. G., Lau, O. W. K., & Tang, 
G. W. K. (2001). Psychosocial adjustment in gynecologic cancer survivors: A 
longitudinal study on risk factors for maladjustment. Gynecologic Oncology, 80, 387 
394. 
Chen, M. L., Chu, L., & Chen, H. C. (2004). Impact of cancer patients' quality 
of life on that of spouse caregivers. Supportive Care in Cancer, 12, 469 475. 
Classen, C., Butler, L. D., Koopman, C., Miller, E., DiMiceli, S., Giese Davis, J. 
et al. (2001). Supportive expressive group therapy and distress in patients with 
metastatic breast cancer   A randomized clinical intervention trial. Archives of General 
Psychiatry, 58, 494 501.  
 
356 
Coe, M. & Kluka, S. (1988). Concerns of clients and spouses regarding ostomy 
surgery for cancer. Journal of Enterostomal Therapy, 15, 232 239. 
Cohen, S. & Herbert, T. B. (1996). Health psychology: Psychological factors 
and physical disease from the perspective of human psychoneuroimmunology. Annual 
Review of Psychology, 47, 113 142. 
Cohen, S. & Williamson, G. (1988). Perceived stress in a probability sample of 
the United States. In S. Spacapan & S. Oskamp (Eds.), The social psychology of health: 
Claremont Symposium on applied social psychology (pp. 31 67). Newbury Park, CA: 
Sage Publications. 
Cohen, S. & Williamson, G. M. (1991). Stress and infectious disease in humans. 
Psychological Bulletin, 109, 5 24. 
Cole, S. W., Kemeny, M. E., Taylor, S. E., & Visscher, B. R. (1996). Elevated 
physical health risk among gay men who conceal their homosexual identity. Health 
Psychology, 15, 243 251. 
Coleman, M. P., Esteve, J., Damiecki, P., Arslan, A., & Renard, H. (1993). 
Trends in cancer incidence and mortality. IARC Scientific Publications 121, 477 498.  
 
           Costanzo, E. S., Lutgendorf, S. K., Rothrock, N. E., & Anderson, B. (2006). 
Coping and quality of life among women extensively treated for gynecologic cancer. 
Psycho-Oncology. 
Costanzo, E. S., Lutgendorf, S. K., Sood, A. K., Anderson, B., Sorosky, J. I., & 
Lubaroff, D. (2005). Psychosocial factors and interleukin 6 among women with 
advanced ovarian cancer. Cancer, 104, 305 313. 
Coyne, J., Stefanek, M., & Palmer, S. C. (2007). Psychotherapy and survival in 
cancer: the conflict between hope and evidence. Psychological Bulletin, 133, 367 394. 
Coyne, J. C. & Fiske, V. (1992). Couples coping with chronic and catastrophic 
illness. In T.Akamatsu (Ed.), Family and Illness:  Family Health Psychology (pp. 129 
149). Washington DC: Hemisphere.  
 
357 
Coyne, J. C., Lepore, S. J., & Palmer, S. C. (2006a). Efficacy of psychosocial 
interventions in cancer care: Evidence is weaker than it first looks. Annals of Behavioral 
Medicine, 32, 104 110. 
Coyne, J. C., Lepore, S. J., & Palmer, S. C. (2006b). Efficacy of psychosocial 
interventions in cancer care: Evidence is weaker than it first looks. Annals of Behavioral 
Medicine, 32, 104 110. 
Coyne, J. C. & Smith, D. A. F. (1991). Couples Coping with A Myocardial 
Infarction   A Contextual Perspective on Wives Distress. Journal of Personality and 
Social Psychology, 61, 404 412. 
Creamer, M., Bell, R., & Failla, S. (2003). Psychometric properties of the 
Impact of Event Scale   Revised. Behaviour Research and Therapy, 41, 1489 1496. 
Creswell, J. D., Lam, S., Stanton, A. L., Taylor, S. E., Bower, J. E., & Sherman, 
D. K. (2007). Does self affirmation, cognitive processing, or discovery of meaning 
explain cancer related health benefits of expressive writing. Personality and Social 
Psychology Bulletin, 33, 238 250. 
Danoff Burg, S., Agee, J. D., Romanoff, N. R., Kremer, J. M., & Strosberg, J. 
M. (2006). Benefit finding and expressive writing in adults with lupus or rheumatoid 
arthritis. Psychology and Health, 21, 651 665. 
de Moor, C., Sterner, J., Hall, M., Warneke, C., Gilani, Z., Amato, R. et al. 
(2002). A pilot study of the effects of expressive writing on psychological and 
behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for 
metastatic renal cancer. Health Psychology, 21, 615 619. 
de Moor, J. S., de Moor, C. A., Basen Engquist, K., Kudelka, A., Bevers, M. 
W., & Cohen, L. (2006). Optimism, distress, health related quality of life, and change in 
cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy. 
Psychosomatic Medicine, 68, 555 562. 
Dershaw, D. D. & Panicek, D. M. (1993). Radiologic evaluation of ovarian 
cancer. In M.Markman & W. J. Hoskins (Eds.), Cancer of the Ovary (p. 133). New 
York: Raven Press.  
 
358 
DeSavino, P., Turk, E., Massie, E., Riggs, D., Penkower, D., Molnar, C. et al. 
(1993). The content of traumatic memories: Evaluating treatment efficacy by analysis of 
verbatim descriptions of the rape scene. Presented at The 27th Annual Meeting of the 
Association for the Advancement of Behavior Therapy. 
Ding, Y., Zhu, Y. L., & Zhang, M. F. (2007). Quality of life of Chinese patients 
with ovarian malignancies during chemotherapy under condition of no recurrence. 
Cancer Nursing, 30, 243 251. 
Donovan, K. A., Greene, P. G., Shuster, J. L., Partridge, E. E., & Tucker, D. C. 
(2002). Psychosocial well being of women with ovarian cancer. Unpublished 
manuscript. 
Dorval, M., Guay, S., Mondor, M., Masse, B., Falardeau, M., Robidoux, A. et al. 
(2005). Couples who get closer after breast cancer: Frequency and predictors in a 
prospective investigation. Journal of Clinical Oncology, 23, 3588 3596. 
Dublin, S., Rossing, M. A., Heckbert, S. R., Goff, B. A., & Weiss, N. S. (2002). 
Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, 
and other centrally acting medications. Cancer Causes & Control, 13, 35 45. 
Duncan, E. & Gidron, Y. (1999). Written emotional expression and health: 
Evidence for a new Guided Disclosure technique. Proceedings of the British 
Psychological Society, 7, 29. 
Duncan, E., Gidron, Y., Rabin, E., Gouchberg, L., Moser, A. M., & 
Kapelushnik, J. (2007). The effects of guided written disclosure on psychological 
symptoms among parents of children with cancer. Journal of Family Nursing, 13, 370 
384. 
Eisenkop, S. M., Friedman, R. L., & Wang, H. J. (1998). Complete 
cytoreductive surgery is feasible and maximizes survival in patients with advanced 
epithelial ovarian cancer: a prospective study. Gynecologic Oncology, 69, 103 108. 
Ell, K., Nishimoto, R., Mantell, J., & Hamovitch, M. (1988). Longitudinal 
analysis of psychological adaptation among family members of patients with cancer. 
Journal of Psychosomatic Research, 32, 429 438.  
 
359 
Engel, J., Eckel, R., Schubert Fritschle, G., Kerr, J., Kuhn, W., Diebold, J. et al. 
(2002). Moderate progress for ovarian cancer in the last 20 years: prolongation of 
survival, but no improvement in the cure rate. European Journal of Cancer, 38, 2435 
2445. 
Epping Jordan, J. E., Compas, B., & Howell, D. C. (1994). Predictors of cancer 
progression in young adult women: Avoidance, intrusive thoughts, and psychological 
symptoms. Health Psychology, 13, 539 547. 
Epping Jordan, J. E., Compas, B., Osowiecki, D. M., Oppedisano, G., Gerhardt, 
C., Primo, K. et al. (1999). Psychological adjustment in breast cancer: Processes of 
emotional distress. Health Psychology, 18, 315 326. 
Ersek, M., Ferrell, B. R., Hassey Dow, K., & Melancon, C. (1997). Quality of 
life in women with ovarian cancer. Western Journal of Nursing Research, 19, 334 350. 
Esterling, B. A., Antoni, M. H., Fletcher, M. A., Margulies, S., & Schneiderman, 
N. (1994). Emotional disclosure through writing or speaking modulates latent Epstein 
Barr virus antibody titers. Journal of Consulting and Clinical Psychology, 62, 130 140. 
Esterling, B. A., Antoni, M. H., Kumar, M., & Schneiderman, N. (1990). 
Emotional repression, stress disclosure responses, and Epstein Barr viral capsid antigen 
titers. Psychosomatic Medicine, 52, 397 410. 
Esterling, B. A., L'Abate, L., Murray, E. J., & Pennebaker, J. W. (1999). 
Empirical foundations for writing in prevention and psychotherapy: Mental and 
physical health outcomes. Clinical Psychology Review, 19, 79 96. 
Evans, J., Ziebland, S., & McPherson, A. (2007). Minimizing delays in ovarian 
cancer diagnosis: an expansion of Andersen's model of 'total patient delay'. Family 
Practice, 24, 48 55. 
Fang, C. Y., Manne, S. L., & Pape, S. J. (2001). Functional impairment, marital 
quality, and patient psychological distress as predictors of psychological distress among 
cancer patients' spouses. Health Psychology, 20, 452 457. 
Fathalla, M. F. (1971). Incessant ovulation: A factor in ovarian neoplasia. 
Lancet, 716, 163.  
 
360 
Fayers, P. M., Rustin, G., Wood, R., Nelstrop, A., Leonard, R. C., Wilkinson, P. 
et al. (1993). The prognostic value of serum CA 125 in patients with advanced ovarian 
carcinoma: an analysis of 573 patients by the Medical Research Council Working Party 
on Gynaecological Cancer. International Journal of Gynecological Cancer, 3, 285 292. 
Ferrell, B., Cullinane, C. A., Ervine, K., Melancon, C., Uman, G. C., & Juarez, 
G. (2005). Perspectives on the impact of ovarian cancer: women's views of quality of 
life. Oncology Nursing Forum, 32, 1143 1149. 
Ferrell, B., Smith, S. L., Cullinane, C. A., & Melancon, C. (2003). Psychological 
well being and quality of life in ovarian cancer survivors. Cancer, 98, 1061 1071. 
Field, A. (2005). Discovering Statistics Using SPSS. (2nd ed.) London: Sage 
Publications. 
Fincham, F. D., Beach, S. R., Harold, G. T., & Osborne, L. N. (1997). Marital 
satisfaction and depression: Different causal relationships for men and women? 
Psychological Science, 8, 351 357. 
Foa, E. & Rothbaum, B. (1998). Treating the trauma of rape: Cognitive-
behavioral therapy for PTSD. New York: Guilford. 
Foa, E. B., Molnar, C., & Cashman, L. (1995). Change in rape narratives during 
exposure therapy for post traumatic stress disorder. Journal of Traumatic Stress, 8, 675 
690. 
Forsythe, C. J. & Compas, B. E. (1987). Interaction of cognitive appraisals of 
stressful events and coping: Testing the goodness of fit hypothesis. Cognitive Therapy 
and Research, 11, 473 485. 
Fowers, B. J. & Olson, D. H. (1989). Enrich Marital Inventory   A Discriminant 
Validity and Cross Validation Assessment. Journal of Marital and Family Therapy, 15, 
65 79. 
Frattaroli, J. (2006). Experimental disclosure and its moderators: a meta 
analysis. Psychological Bulletin, 132, 823 865.  
 
361 
Frisina, P. G., Borod, J. C., & Lepore, S. J. (2004). A meta analysis of the 
effects of written emotional disclosure on the health outcomes of clinical populations. 
Journal of Nervous and Mental Disease, 192, 629 634. 
Gardner, R. (2003). Checklist for statistical assessment of randomized controlled 
trials. Retrieved 19
th May 2006 from http://bmj.com/advice/checklists.shtml. 
Garssen, B. (2004). Psychological factors and cancer development: Evidence 
after 30 years of research. Clinical Psychology Review, 24, 315 338. 
Gidron, Y., Duncan, E., Lazar, A., Biderman, A., Tandeter, H., & Shvartzman, 
P. (2002). Effects of written disclosure of stressful experiences on clinic visits and 
symptoms in frequent clinic attenders. Family Practice, 19, 161 166. 
Giese Davis, J., Weibel, D., & Spiegel, D. (2000). Quality of couples' 
relationship and adjustment to metastatic breast cancer. Journal of Family Psychology, 
14, 251 266. 
Gil, K. M., Gibbons, H. E., Jenison, E. L., Hopkins, M. P., & von Gruenigen, V. 
E. (2007). Baseline characteristics influencing quality of life in women undergoing 
gynecologic oncology surgery. Health and Quality of Life Outcomes, 17, 25. 
Gillis, M. E., Lumley, M. A., Mosley Williams, A., Leisen, J. C. C., & Roehrs, 
T. (2006). The health effects of at home written emotional disclosure in fibromyalgia: A 
randomized trial. Annals of Behavioral Medicine, 32, 135 146. 
Gioiella, M. E., Berkman, B., & Robinson, M. (1998). Spirituality and quality of 
life in gynecologic oncology patients. Cancer Practice, 6, 333 338. 
Gortner, E. M., Rude, S. S., & Pennebaker, J. W. (2006). Benefits of expressive 
writing in lowering rumination and depressive symptoms. Behavior Therapy, 37, 292 
303. 
Grande, G. E., Myers, L. B., & Sutton, S. R. (2006). How do patients who 
participate in cancer support groups differ from those who do not? Psycho-Oncology, 
15, 321 334.  
 
362 
Greenberg, M. A. & Stone, A. A. (1992). Emotional disclosure about traumas 
and its relation to health: effects of previous disclosure and trauma severity. Journal of 
Personality and Social Psychology, 63, 75 84. 
Greenberg, M. A., Wortman, C. B., & Stone, A. A. (1996). Emotional 
expression and physical health: Revising traumatic memories or fostering self 
regulation? Journal of Personality and Social Psychology, 71, 588 602. 
Greimel, E., Thiel, I., Peintinger, F., Cegnar, I., & Pongratz, E. (2002). 
Prospective assessment of quality of life of female cancer patients. Gynecologic 
Oncology, 85, 140 147. 
Greimel, E. R. & Freidl, W. (2000). Functioning in daily living and 
psychological well being of female cancer patients. Journal of Psychosomatic 
Obstetrics and Gynecology, 21, 25 30. 
Gross, J. J. (1998). Antecedent  and response focused emotion regulation: 
divergent consequences for experience, expression, and physiology. Journal of 
Personality and Social Psychology, 74, 224 237. 
Guo, Y., Sheng, X. J., Liu, Y., & Hua, X. F. (2004). Evaluation on quality of 
life for gynecologic cancer patients. Chinese Journal of Cancer Research, 16, 292 296. 
Gustavsson Lilius, M., Julkunen, J., Keskivaara, P., & Hietanen, P. (2007). 
Sense of coherence and distress in cancer patients and their partners. Psycho-Oncology, 
16, 1100 1110. 
Hagedoorn, M., Buunk, B. P., Kuijer, R. G., Wobbes, T., & Sanderman, R. 
(2000a). Couples dealing with cancer: Role and gender differences regarding 
psychological distress and quality of life. Psycho-Oncology, 9, 232 242. 
Hagedoorn, M., Kuijer, R. G., Buunk, B. P., Dejong, G. M., Wobbes, T., & 
Sanderman, R. (2000b). Marital satisfaction in patients with cancer: Does support from 
intimate partners benefit those who need it the most? Health Psychology, 19, 274 282. 
Hagedoorn, M., Sanderman, R., Bolks, H. N., Tuinstra, J., & Coyne, J. C. 
(2008). Distress in couples coping with cancer: A meta analysis and critical review of 
role and gender effects. Psychological Bulletin, 134, 1 30.  
 
363 
Hakes, T. B., Chalas, E., Hoskins, W. J., Jones, W. B., Markman, M., Rubin, S. 
C. et al. (1992). Randomized prospective trial of 5 versus 10 cycles of 
cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. 
Gynecologic Oncology, 45, 284 289. 
Hamilton West, K. E. & Quine, L. (2007). Effects of written emotional 
disclosure on health outcomes in patients with ankylosing spondylitis. Psychology & 
Health, 22, 637 657. 
Hankinson, S. E., Colditz, G. A., Hunter, D. J., Willett, W. C., Stampfer, M. J., 
Rosner, B. et al. (1995). A prospective study of reproductive factors and risk of 
epithelial ovarian cancer. Cancer, 76, 284 290. 
Hannum, J. W., Giese Davis, J., Harding, K., & Hatfield, A. K. (1991). Effects 
of individual and marital variables on coping with cancer. Journal of Psychosocial 
Oncology, 9, 1 20. 
Hariri, A. R., Bookheimer, S. Y., & Mazziotta, J. C. (2000). Modulating 
emotional responses: effects of a neocortical network on the limbic system. 
Neuroreport, 11, 43 48. 
Harlow, B. L., Cramer, D. W., Baron, J. A., Titus Ernstoff, L., & Greenberg, L. 
E. (1998). Psychotropic medication use and risk of epithelial ovarian cancer. Cancer 
Epidemiology Biomarkers & Prevention, 7, 697 702. 
Harris, A. H. S., Thoresen, C. E., Humphreys, K., & Faul, J. (2005). Does 
writing affect asthma?   A randomized trial. Psychosomatic Medicine, 67, 130 136. 
Harris, R., Whittemore, A. S., & Itnyre, J. (1992). Characteristics relating to 
ovarian cancer risk: collaborative analysis of 12 US case control studies. III. Epithelial 
tumors of low malignant potential in white women.  Collaborative Ovarian Cancer 
Group. American Journal of Epidemiology, 136, 1204 1211. 
Harrison, J., Maguire, P., & Pitceathly, C. (1995). Confiding in crisis: Gender 
differences in pattern of confiding among cancer patients. Social Science and Medicine, 
41, 1255 1260.  
 
364 
Helgeson, V. S. & Cohen, S. (1996). Social support and adjustment to cancer: 
Reconciling descriptive, correlational, and intervention research. Health Psychology, 
15, 135 148. 
Helgeson, V. S., Cohen, S., Schulz, R., & Yasko, J. (2000). Group support 
interventions for women with breast cancer: Who benefits from what? Health 
Psychology, 19, 107 114. 
Helgeson, V. S., Snyder, P., & Seltman, H. (2004). Psychological and physical 
adjustment to breast cancer over 4 years: Identifying distinct trajectories of change. 
Health Psychology, 23, 3 15. 
Henderson, B., Davison, K. P., Pennebaker, J., Gatchel, R. J., & Baum, A. 
(2002). Disease disclosure patterns among breast cancer patients. Psychology and 
Health, 17, 51 62. 
Hinnen, C., Hagedoorn, M., Sanderman, R., & Ranchor, A. V. (2007). The role 
of distress, neuroticism and time since diagnosis in explaining support behaviour in 
partners of women with breast cancer: Results of a longitudinal analysis. Psycho-
Oncology, 16, 913 919. 
Hinshaw, S.P. (2007). Moderators and mediators of treatment outcome for youth 
with ADHD: Understanding for whom and how interventions work. Journal of 
Pediatric Psychology, 32, 664 675. 
Hipkins, J., Whitworth, M., Tarrier, N., & Jayson, G. (2004). Social support, 
anxiety and depression after chemotherapy for ovarian cancer: A prospective study. 
British Journal of Health Psychology, 9, 569 581. 
Hodgkinson, K., Butow, P., Fuchs, A., Hunt, G. E., Stenlake, A., Hobbs, K. M. 
et al. (2007). Long term survival from gynecologic cancer: Psychosocial outcomes, 
supportive care needs and positive outcomes. Gynecologic Oncology, 104, 381 389. 
Holahan, C. J. & Moos, R. H. (1987). Personal and Contextual Determinants of 
Coping Strategies. Journal of Personality and Social Psychology, 52, 946 955. 
Holland, J. C., Passik, S., Kash, K. M., Russak, S. M., Gronert, M. K., Sison, A. 
et al. (1999). The role of religious and spiritual beliefs in coping with malignant 
melanoma. Psycho-Oncology, 8, 14 26.  
 
365 
Hollis, S. & Campbell, F. (1999). What is meant by intention to treat analysis? 
Survey of published randomised controlled trials. British Medical Journal, 319, 670 
674. 
Holschneider, C. H. & Berek, J. S. (2000). Ovarian cancer: epidemiology, 
biology, and prognostic factors. Seminars in Surgical Oncology, 19, 3 10. 
Hoodin, F. & Weber, S. (2003). A systematic review of psychosocial factors 
affecting survival after bone marrow transplantation. Psychosomatics: Journal of 
Consultation Liasion Psychiatry, 44, 181 195. 
Horowitz, M. (1986). Stress Response Syndromes. Northvale, NJ: Aronson. 
Hoskins, C. N. (1995). Adjustment to breast cancer in couples. Psychological 
Reports, 77, 435 454. 
Hoskins, W. J. (1993). Surgical staging and cytoreductive surgery of epithelial 
ovarian cancer. Cancer, Supplement 15, 1534 1540. 
Houck, K., Avis, N. E., Gallant, J. M., Fuller, A. F., & Goodman, A. (1999). 
Quality of life in advanced ovarian cancer: Identifying specific concerns. Journal of 
Palliative Medicine, 2, 397 402. 
Janoff Bulman, R. (1992). Shattered Assumptions. New York: Free Press. 
Kartha, A., Brower, V., Saitz, R., Samet, J. H., Keane, T. M., & Liebschutz, J. 
(2008). The impact of trauma exposure and post traumatic stress disorder on healthcare 
utilization among primary care patients. Medical Care, 46, 388 393. 
Kayser, K., Watson, L. E., & Andrade, J. T. (2007). Cancer as a "We disease".: 
Examining the process of coping from a relational perspective. Families, Systems, and 
Health, 25, 404 418. 
Keane, T. M. (1998). Psychological effects of military combat. In 
B.P.Dohrenwend (Ed.), Adversity, stress and psychopathology (pp. 52 65). London: 
Oxford University Press. 
Kelley, J. E., Lumley, M. A., & Leisen, J. C. C. (1997). Health effects of 
emotional disclosure in rheumatoid arthritis patients. Health Psychology, 16, 331 340.  
 
366 
Kiecolt Glaser, J. K. & Newton, T. L. (2001). Marriage and health: His and hers. 
Psychological Bulletin, 127, 472 503. 
Kim, Y. (2008). Effects of expressive writing among bilinguals: Exploring 
psychological well being and social behaviour. British Journal of Health Psychology, 
13, 43 47. 
Kloss, J. D. & Lisman, S. A. (2002). An exposure based examination of the 
effects of written emotional disclosure. British Journal of Health Psychology, 7, 31 46. 
Koldjeski, D., Kirkpatrick, M. K., Swanson, M., Everett, L., & Brown, S. 
(2005). An ovarian cancer diagnosis seeking process:unraveling the diagnostic delay 
problem. Oncology Nursing Forum, 32, 1036 1042. 
Kornblith, A. B., Thaler, H. T., Wong, G., Vlamis, V., Lepore, J. M., Loseth, D. 
B. et al. (1995). Quality of life of women with ovarian cancer. Gynecologic Oncology, 
59, 231 242. 
Kovac, S. H. & Range, L. M. (2000). Writing projects: lessening 
undergraduates' unique suicidal bereavement. Suicide and Life-Threatening Behavior, 
30, 50 60. 
Kraemer, H.C., Wilson, T., Fairburn, C.G., & Agras, W.S. (2002). Mediators 
and moderators of treatment effects in randomized clinical trials. Archives of General 
Psychiatry, 59, 877-883. 
Kuijer, R., Ybema, J., Buunk, B. P., & DeJong, M. (2000).  Active engagement, 
protective buffering, and overprotection. Journal of Social and Clinical Psychology, 19, 
256 275. 
Kuijer, R. G., Buunk, B. P., de Jong, M., Ybema, J. F., & Sanderman, R. (2004). 
Effects of a brief intervention program for patients with cancer and their partners on 
feelings of inequity, relationship quality and psychological distress. Psycho-Oncology, 
13, 321 334. 
Kuijer, R. G., Buunk, B. P., & Ybema, J. F. (2001). Are equity concerns 
important in the intimate relationship when one partner of a couple has cancer. Social 
Psychology Quarterly, 64, 267 282.  
 
367 
Lakusta, C. M., Atkinson, M. J., Robinson, J. W., Nation, J., Taenzer, P. A., & 
Campo, M. G. (2001). Quality of life in ovarian cancer patients receiving 
chemotherapy. Gynecologic Oncology, 81, 490 495. 
Langens, T. A. & Schuler, J. (2005). Written emotional expression and 
emotional well being: The moderating role of fear of rejection. Personality and Social 
Psychology Bulletin, 31, 818 830. 
Lazarus, R. S. & Folkman, S. (1984). Stress, appraisal, and coping. New York: 
Springer. 
Le, T., Hopkins, L., & Fung Kee Fung, M. (2005). Quality of life assessment 
during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer. 
Gynecologic Oncology, 98, 39 44. 
Le, T., Leis, A., Pahwa, P., Wright, K., Ali, K., Reeder, B. et al. (2004). Quality 
of life evaluations in patients with ovarian cancer during chemotherapy treatment. 
Gynecologic Oncology, 92, 839 844. 
Lechner, S. C., Carver, C. S., Antoni, M. H., Weaver, K. E., & Phillips, K. M. 
(2006). Curvilinear associations between benefit finding and psychosocial adjustment to 
breast cancer. Journal of Consulting and Clinical Psychology, 74, 828 840. 
Lekander, M., Furst, C. J., Rotstein, S., Hursti, T. J., & Fredrikson, M. (1997). 
Immune effects of relaxation during chemotherapy for ovarian cancer. Psychotherapy 
and Psychosomatics, 66, 185 191. 
Lepore, S. J. (1997). Expressive writing moderates the relation between 
intrusive thoughts and depressive symptoms. Journal of Personality and Social 
Psychology, 73, 1030 1037. 
Lepore, S. J. & Greenberg, M. A. (2002). Mending broken hearts: Effects of 
expressive writing on mood, cognitive processing, social adjustment and health 
following a relationship breakup. Psychology and Health, 17, 547 560. 
Lepore, S. J., Ragan, J. D., & Jones, S. (2000). Talking facilitates cognitive 
emotional processes of adaptation to an acute stressor. Journal of Personality and 
Social Psychology, 78, 499 508.  
 
368 
Lepore, S. J., Silver, R. C., Wortman, C. B., & Wayment, H. A. (1996). Social 
constraints, intrusive thoughts, and depressive symptoms among bereaved mothers. 
Journal of Personality and Social Psychology, 70, 271 282. 
Liavaag, A. H., Dorum, A., Fossa, S. D., Trope, C., & Dahl, A. A. (2007). 
Controlled study of fatigue, quality of life, and somatic and mental morbidity in 
epithelial ovarian cancer survivors: how lucky are the lucky ones? Journal of Clinical 
Oncology, 25, 2049 2056. 
Lichtman, R. R., Taylor, S. E., & Wood, J. V. (1987). Social support and marital 
adjustment after breast cancer. Journal of Psychosocial Oncology, 5, 47 65. 
Lukanova, A., Toniolo, P., Lundin, E., Micheli, A., Akhmedkhanov, A., Muti, P. 
et al. (2002). Body mass index in relation to ovarian cancer: a multi centre nested case 
control study. International Journal of Cancer, 99, 603 608. 
Lutgendorf, S. K., Anderson, B., Rothrock, N. E., Buller, R. E., Sood, A. K., & 
Sorosky, J. I. (2000). Quality of life and mood in women receiving extensive 
chemotherapy for gynecologic cancer. Cancer, 89, 1402 1411. 
Lutgendorf, S. K., Anderson, B., Ullrich, P., Johnsen, E. L., Buller, R. E., Sood, 
A. K. et al. (2002a). Quality of life and mood in women with gynecologic cancer: A one 
year prospective study. Cancer, 94, 131 140. 
Lutgendorf, S. K. & Antoni, M. H. (1999). Emotional and cognitive processing 
in a trauma disclosure paradigm. Cognitive Therapy and Research, 23, 423 440. 
Lutgendorf, S. K., Johnsen, E. L., Cooper, B., Anderson, B., Sorosky, J. I., 
Buller, R. E. et al. (2002b). Vascular endothelial growth factor and social support in 
patients with ovarian carcinoma. Cancer, 95, 808 815. 
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M. 
et al. (2005). Social support, psychological distress, and natural killer cell activity in 
ovarian cancer. Journal of Clinical Oncology, 23, 7105 7113. 
Mainio, A., Tuunanen, S., Hakko, H., Niemela, A., Koivukangas, J., & Rasanen, 
P. (2006). Decreased quality of life and depression as predictors for shorter survival 
among patients with low grade gliomas: a follow up from 1990 to 2003. European 
Archives of Psychiatry and Clinical Neuroscience, 256, 516 521.  
 
369 
Manne, S. (1998). Cancer in the marital context: A review of the literature. 
Cancer Investigation, 16, 188 202. 
Manne, S. (1994). Couples coping with cancer: Research issues and recent 
findings. Journal of Clinical Psychology in Medical Settings, 1, 317 330. 
Manne, S. & Glassman, M. (2000). Perceived control, coping efficacy, and 
avoidance coping as mediators between spouses' unsupportive behaviors and cancer 
patients' psychological distress. Health Psychology, 19, 155 164. 
Manne, S., Ostroff, J., Rini, C., Fox, K., Goldstein, L., & Grana, G. (2004a). The 
interpersonal process model of intimacy: The role of self disclosure, partner disclosure, 
and partner responsiveness in interactions between breast cancer patients and their 
partners. Journal of Family Psychology, 18, 589 599. 
Manne, S., Ostroff, J., Sherman, M., Glassman, M., Ross, S., Goldstein, L. et al. 
(2003). Buffering effects of family and friend support on associations between partner 
unsupportive behaviors and coping among women with breast cancer. Journal of Social 
and Personal Relationships, 20, 771 792. 
Manne, S., Ostroff, J., Sherman, M., Heyman, R. E., Ross, S., & Fox, K. 
(2004b). Couples' support related communication, psychological distress, and 
relationship satisfaction among women with early stage breast cancer. Journal of 
Consulting and Clinical Psychology, 72, 660 670. 
Manne, S., Ostroff, J., Winkel, G., Fox, K., Grana, G., & Miller, E. (2005). 
Couple focused group intervention for women with early stage breast cancer. Journal of 
Consulting and Clinical Psychology, 73, 646. 
Manne, S., Ostroff, J., Winkel, G., Goldstein, L., Fox, K., & Grana, G. (2004c). 
Posttraumatic growth after breast cancer: Patient, partner and couple perspectives. 
Psychosomatic Medicine, 66, 442 454. 
Manne, S., Ostroff, J. S., & Winkel, G. (2007). Social cognitive processes as 
moderators of a couple focused group intervention for women with early stage breast 
cancer. Health Psychology, 26, 735 744.  
 
370 
Manne, S. & Schnoll, R. (2001). Measuring supportive and unsupportive 
responses during cancer treatment: A factor analytic assessment of the partner responses 
to cancer inventory. Journal of Behavioral Medicine, 24, 297 321. 
Manne, S. L. (1999). Intrusive thoughts and psychological distress among 
cancer patients: The role of spouse avoidance and criticism. Journal of Consulting and 
Clinical Psychology, 67, 539 546. 
Manne, S. L., Alfieri, T., Taylor, K. L., & Dougherty, J. (1999). Spousal 
negative responses to cancer patients: The role of social restriction, spouse mood, and 
relationship satisfaction. Journal of Consulting and Clinical Psychology, 67, 352 361. 
Manne, S. L. & Andrykowski, M. A. (2006). Are psychological interventions 
effective and accepted by cancer patients? II. Using empirically supported therapy 
guidelines to decide. Annals of Behavioral Medicine, 32, 98 103. 
Manne, S. L., Norton, T. R., Ostroff, J. S., Winkel, G., Fox, K., & Grana, G. 
(2007a). Protective buffering and psychological distress among couples coping with 
breast cancer: The moderating role of relationship satisfaction. Journal of Family 
Psychology, 21, 380 388. 
Manne, S. L., Ostroff, J. S., Norton, T. R., Fox, K., Goldstein, L., & Grana, G. 
(2006). Cancer related relationship communication in couples coping with early stage 
breast cancer. Psycho-Oncology, 15, 234 247. 
Manne, S. L., Pape, S. J., Taylor, K. L., & Dougherty, J. (1999). Spouse support, 
coping, and mood among individuals with cancer. Annals of Behavioral Medicine, 21, 
111 121. 
Manne, S. L., Rubin, S., Edelson, M., Rosenblum, N., Bergman, C., Hernandez, 
E. et al. (2007b). Coping and communication enhancing intervention versus supportive 
counseling for women diagnosed with gynecological cancers. Journal of Consulting and 
Clinical Psychology, 75, 615 628. 
Manne, S. L., Taylor, K. L., Dougherty, J., & Kemeny, N. (1997). Supportive 
and negative responses in the partner relationship: Their association with psychological 
adjustment among individuals with cancer. Journal of Behavioral Medicine, 20, 101 
125.  
 
371 
Markman, M., Federico, M., Liu, P. Y., Hannigan, E., & Alberts, D. (2006). 
Significance of early changes in the serum CA 125 antigen level on overall survival in 
advanced ovarian cancer. Gynecologic Oncology, 103, 195 198. 
Martire, L. (2005). The 'relative' efficacy of involving family in psychosocial 
interventions for chronic illness: Are there added benefits to patients and family 
members. Families, Systems, and Health, 23, 312 328. 
Martire, L. M., Lustig, A. P., Schulz, R., Miller, G. E., & Helgeson, V. S. 
(2004). Is it beneficial to involve a family member? A meta analysis of psychosocial 
interventions for chronic illness. Health Psychology, 23, 599 611. 
McGregor, B. A., Antoni, M. H., Boyers, A., Alferi, S. M., Blomberg, B. B., & 
Carver, C. S. (2004). Cognitive behavioral stress management increases benefit finding 
and immune function among women with early stage breast cancer. Journal of 
Psychosomatic Research, 56, 1 8. 
Meads, C., Lyons, A., & Carroll, D. (2003). The impact of the emotional 
disclosure intervention on physical and psychological health: a systematic review. 
(Report No. 43). Department of Public Health and Epidemiology, West Midlands 
Health Technology Assessment Collaboration. 
Meden, H., Metz, A., & Monkeberg Tun, E. (1994). Quality of life of patients 
with ovarian cancer after surgery and chemotherapy. Onkologie, 17, 50 56. 
Meyer, T. & Rustin, G. J. (2000). Role of tumour markers in monitoring 
epithelial ovarian cancer. British Journal of Cancer, 82, 1535 1538. 
Miller, B. E., Pittman, B., Case, D., & McQuellon, R. P. (2002). Quality of life 
after treatment for gynecologic malignancies: A pilot study in an outpatient clinic. 
Gynecologic Oncology, 87, 178 184. 
Mishel, M. H., Belyea, M., Germino, B. B., Stewart, J. L., Bailey, D. E., 
Robertson, C. et al. (2002). Helping patients with localized prostate carcinoma manage 
uncertainty and treatment side effects: Nurse delivered psychoeducational intervention 
over the telephone. Cancer, 94, 1854 1866.  
 
372 
Moher, D., Schulz, K. F., & Altman, D. G. (2001). The CONSORT statement: 
revised recommendations for improving the quality of reports of parallel group 
randomised trials. Lancet, 357, 1191 1194. 
Molassiotis, A., Chan, C. W. H., Yam, B. M. C., & Chan, S. J. (2000). Quality 
of life in Chinese women with gynaecological cancers. Supportive Care in Cancer, 8, 
414 422. 
Montazeri, A., McEwen, J., & Gillis, C. R. (1996). Quality of life in patients 
with ovarian cancer: current state of research. Supportive Care in Cancer, 4, 169 176. 
Moorman, P. G., Berchuck, A., Calingaert, B., Halabi, S., & Schildkraut, J. M. 
(2005). Antidepressant medication use for and risk of ovarian cancer. Obstetrics and 
Gynecology, 105, 725 730. 
Moss Morris, R., Weinman, J., Petrie, K. J., Horne, R., Cameron, L. D., & 
Buick, D. (2002). The revised Illness Perception Questionnaire (IPQ R). Psychology & 
Health, 17, 1 16. 
Muller, D., Judd, C.M., & Yzerbyt, V.Y. (2005). When moderation is mediated 
and mediation is moderated. Journal of Personality and Social Psychology, 89, 852 
863. 
Muscat, J. E. & Huncharek, M. S. (2008). Perineal talc use and ovarian cancer: a 
critical review. European Journal of Cancer Prevention, 17, 139 146. 
National Institue of Clinical Excellence (2005). Topotecan, pegylated liposomal 
doxorubicin hydrochloride and paclitaxel for the treatment of advanced ovarian cancer 
(review of existing guidance nos 28, 45 and 55 (for relapsed disease only)). 
National Institue of Clinical Excellence (2003). Review of the clinical 
effectiveness and cost effectiveness of paclitaxel for ovarian cancer. 
Nausheen, B., Gidron, Y., Gregg, A., Tissarchondou, H. S., & Peveler, R. 
(2007).  Loneliness, social support and cardiovascular reactivity to laboratory stress. 
Stress, 10, 37 44.  
 
373 
Neuling, S. & Winefield, H. (1988). Social support and recovery after surgery 
for breast cancer: Frequency and correlates of supportive behaviors by family, friends, 
and surgeon. Social Science and Medicine, 27, 385 392. 
Niaura, R., Herbert, P. N., McMahon, N., & Sommerville, L. (1992). Repressive 
coping and blood lipids in men and women. Psychosomatic Medicine, 54, 706. 
Nijboer, C., Triemstra, M., Tempelaar, R., Sanderman, R., & van den Bos, G. A. 
(1999). Determinants of caregiving experiences and mental health of partners of cancer 
patients. Cancer, 86, 577 588. 
Nishith, P., Resick, P. A., & Griffin, M. G. (2002). Patterns of change in 
prolonged exposure and cognitive processing therapy for female rape victims with 
posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 70, 880 
886. 
Norman, S. A., Lumley, M. A., Dooley, J. A., & Diamond, M. P. (2004). For 
whom does it work? Moderators of the effects of written emotional disclosure in a 
randomized trial among women with chronic pelvic pain. Psychosomatic Medicine, 66, 
174 183. 
Northouse, L. (1988). Social support in patients' and husbands' adjustment to 
breast cancer. Nursing Research, 37, 91 95. 
Northouse, L. L. (1989). The impact of breast cancer on patients and husbands. 
Cancer Nursing, 12, 276 284. 
Northouse, L. L., Dorris, G., & Charron Moore, C. (1995). Factors affecting 
couples' adjustment to recurrent breast cancer. Social Science and Medicine, 41, 69 76. 
Northouse, L. L., Mood, D., Templin, T., Mellon, S., & George, T. (2000). 
Couples' patterns of adjustment to colon cancer. Social Science and Medicine, 50, 271 
284. 
Norton, T. R., Manne, S. L., Rubin, S., Carlson, J., Hernandez, E., Edelson, M. 
I. et al. (2004). Prevalence and predictors of psychological distress among women with 
ovarian cancer. Journal of Clinical Oncology, 22, 919 926.  
 
374 
Norton, T. R., Manne, S. L., Rubin, S., Hernandez, E., Carlson, J., Bergman, C. 
et al. (2005). Ovarian cancer patients' psychological distress: The role of physical 
impairment, perceived unsupportive family and friend behaviors, perceived control, and 
self esteem. Health Psychology, 24, 143 152. 
O'Connor, M. F., Allen, J. J. B., & Kazniak, A. W. (2005). Emotional disclosure 
for whom: A study of vagal tone in bereavement. Biological Psychology, 68, 135 146. 
Office for National Statistics (2006). Mortality Statistics: Cause, England and 
Wales, 2005. London: National Statistics. 
Office for National Statistics (2007). Cancer Statistics registrations: 
Registrations of cancer diagnosed in 2004, England. Series MB1, Report No. 35. 
Office for National Statistics (2008). Retrieved 9
th June 2008 from 
www.statistics.gov.uk. 
Olson, D. H. & Olson, A. K. (2000). Empowering Couples: Building on Your 
Strengths. Minneapolis, MN: Life Innovations Inc. 
Pan, S. Y., Ugnat, A. M., Mao, Y., Wen, S. W., & Johnson, K. C. (2004). 
Association of cigarette smoking with ovarian cancer. International Journal of Cancer, 
111, 124 130. 
Park, C. & Blumberg, C. (2002). Disclosing trauma through writing: Testing the 
meaning making hypothesis. Cognitive Therapy and Research, 26, 597 616. 
Parker, P. A., Kudelka, A., Basen Engquist, K., Kavanagh, J., de Moor, J., & 
Cohen, L. (2006). The associations between knowledge, CA125 preoccupation, and 
distress in women with epithelial ovarian cancer. Gynecologic Oncology, 100, 495 500. 
Pearlin, L. I., Mullan, J. T., Semple, S. J., & Skaff, M. M. (1990). Caregiving 
and the Stress Process   An Overview of Concepts and Their Measures. Gerontologist, 
30, 583 594. 
Pearman, T. (2003). Quality of life and psychosocial adjustment in gynecologic 
cancer survivors. Health and Quality of Life Outcomes, 1, 1 6. 
Pennebaker, J. W. (1994). Hints on running a writing experiment. Unpublished 
manuscript.  
 
375 
Pennebaker, J. W. (1989). Confession, inhibition, and disease. In L.Berkowitz 
(Ed.), Advances in Experimental Social Psychology (pp. 211 244). New York: 
Academic Press. 
Pennebaker, J. W. (1997). Writing about emotional experiences as a therapeutic 
process. Psychological Science, 8, 162 166. 
Pennebaker, J. W. (2004). Theories, therapies and taxpayers: On the 
complexities of the expressive writing paradigm. Clinical Psychology: Science and 
Practice, 11, 138 142. 
Pennebaker, J. W., Barger, S. D., & Tiebout, J. (1989). Disclosure of traumas 
and health among Holocaust survivors. Psychosomatic Medicine, 51, 577 589. 
Pennebaker, J. W. & Beall, S. (1986). Confronting a traumatic event: Toward an 
understanding of inhibition and disease. Journal of Abnormal Psychology, 95, 274 281. 
Pennebaker, J. W., Booth, R. J., & Francis, M. E. (2007). Linguistic Inquiry and 
Word Count: LIWC 2007. Austin, TX: LIWC. 
Pennebaker, J. W., Colder, M., & Sharp, L. K. (1990). Accelerating the coping 
process. Journal of Personality and Social Psychology, 58, 528 537. 
Pennebaker, J. W. & Francis, M. E. (1996). Cognitive, emotional, and language 
processes in disclosure. Cognition and Emotion, 10, 601 626. 
Pennebaker, J. W., Francis, M. E., & Booth, R. J. (2001). Linguistic Inquiry and 
Word Count (LIWC) [Computer software]. Mahwah, NJ: Erlbaum Publishers. 
Pennebaker, J. W. & Graybeal, A. (2001). Patterns of natural language use: 
Disclosure, personality and social integration. Current Directions in Psychological 
Science, 10, 90 93. 
Pennebaker, J. W. & Harber, K. D. (1993). A social stage model of collective 
coping: The Persian Gulf War and other natural disasters. Journal of Social Issues, 49, 
125 145. 
Pennebaker, J. W., Mayne, T. J., & Francis, M. E. (1997). Linguistic predictors 
of adaptive bereavement. Journal of Personality and Social Psychology, 72, 863 871.  
 
376 
Pennebaker, J. W. & Seagal, J. D. (1999). Forming a story: The health benefits 
of narrative. Journal of Clinical Psychology, 55, 1243 1254. 
Pennebaker, J. W. & Susman, R. (1988). Disclosure of traumas and 
psychosomatic processes. Social Science and Medicine, 26, 327 332. 
Petersen, R. W., Graham, G., & Quinlivan, J. (2005). Psychologic changes after 
a gynecologic cancer. Journal of Obstetrics and Gynaecology Research, 31, 152 157. 
Petersen, R. W. & Quinlivan, J. (2002). Preventing anxiety and depression in 
gynaecological cancer: a randomised controlled trial. British Journal of Obstetrics and 
Gynaecology, 109, 386 394. 
Petrie, K. J., Booth, R. J., Pennebaker, J. W., Davison, K. P., & Thomas, M. G. 
(1995). Disclosure of trauma and immune response to a Hepatitis B vaccination 
program. Journal of Consulting and Clinical Psychology, 63, 787 792. 
Petrie, K. J., Fontanilla, I., Thomas, M. G., Booth, R. J., & Pennebaker, J. W. 
(2004). Effect of written emotional expression on immune function in patients with 
human immunodeficiency virus infection: A randomized trial. Psychosomatic Medicine, 
66, 272 275. 
Pettingale, K. W., Burgess, C., & Greer, S. (1988). Psychological response to 
cancer diagnosis: correlation with prognosis variables. Journal of Psychosomatic 
Research, 32, 255 261. 
Pike, M. C., Pearce, C. L., & Wu, A. H. (2004). Prevention of cancers of the 
breast, endometrium and ovary. Oncogene, 23, 6379 6391. 
Pistrang, N. & Barker, C. (1995). The partner relationship in psychological 
response to breast cancer. Social Science and Medicine, 40, 789 797. 
Pistrang, N., Barker, C., & Rutter, C. (1997). Social support as conversation: 
Analysing breast cancer patients' interactions with their partners. Social Science and 
Medicine, 45, 773 782. 
Preacher, K. J. & Hayes, A. F. (2004). SPSS and SAS procedures for estimating 
indirect effects in simple mediation models. Behavior Research Methods Instruments & 
Computers, 36, 717 731.  
 
377 
Ptacek, J. T., Ptacek, J. J., & Dodge, K. L. (1994). Coping with breast cancer 
from the perspectives of husbands and wives. Journal of Psychosocial Oncology, 12, 
47 72. 
Purdie, D. M., Bain, C. J., Webb, P. M., Whiteman, D. C., Pirozzo, S., & Green, 
A. C. (2001). Body size and ovarian cancer: case control study and systematic review 
(Australia). Cancer Causes & Control, 12, 855 863. 
Radcliffe, A. M., Lumley, M. A., Kendall, J., Stevenson, J. K., & Beltran, J. 
(2007). Written emotional disclosure: testing whether social disclosure matters. Journal 
of Social and Clinical Psychology, 26, 362 384. 
Radloff, L. S. (1977). 'The CES D scale: A self report depression scale for 
research in the general population. Applied Psychological Measurement, 1, 385 401. 
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A. et al. 
(2001). Cytokine associated emotional and cognitive disturbances in humans. Archives 
of General Psychiatry, 58, 445 452. 
Reis, H. & Shaver, P. R. (1988). Intimacy as an interpersonal process. In S.Duck 
(Ed.), Handbook of personal relationships: theory, research and interventions (pp. 367 
389). New York: John Wiley & Sons. 
Rime, B., Mesquita, B., Philippot, P., & Boca, S. (1991). Beyond the emotional 
event: Six studies on the social sharing of emotion. Cognition and Emotion, 5, 435 465. 
Rime, B., Philippot, P., Boca, S., & Mesquita, B. (1992). Long lasting 
consequences of emotion: Social sharing and rumination. In W.Stroebe & M. Hewstone 
(Eds.), European Review of Social Psychology (pp. 225 258). Chichester, England: 
Wiley. 
Rogers, L. J., Wilson, K. G., Gohm, C. L., & Merwin, R. M. (2007). Revisiting 
written disclosure: The effects of warm versus cold experimenters. Journal of Social 
and Clinical Psychology, 26, 556 574. 
Rosenberg, H. J., Rosenberg, S. D., Ernstoff, M. S., Wolford, G. L., Amdur, R. 
J., Elshamy, R. N. et al. (2002). The impact of an expressive disclosure intervention on 
the health of prostate cancer patients. International Journal of Psychiatry in Medicine, 
32, 37 53.  
 
378 
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994). 
Ovarian tumors in a cohort of infertile women. New England Journal of Medicine, 331, 
771 776. 
Sagy, S. & Antonovsky, A. (1992). The Family Sense of Coherence and the 
Retirement Transition. Journal of Marriage and the Family, 54, 983 993. 
Salazar, H., Godwin, A. K., Daly, M. B., Laub, P. B., Hogan, W. M., 
Rosenblum, N. et al. (1996). Microscopic benign and invasive malignant neoplasms and 
a cancer prone phenotype in prophylactic oophorectomies. Journal of the National 
Cancer Institute, 88, 1810 1820. 
Salehi, F., Dunfield, L., Phillips, K. P., Krewski, D., & Vanderhyden, B. C. 
(2008). Risk factors for ovarian cancer: An overview with emphasis on hormonal 
factors. Journal of Toxicology and Environmental Health-Part B-Critical Reviews, 11, 
301 321. 
Sarantidis, D., Thomas, A., Iphantis, K., Katsaros, N., Tripodianakis, J., & 
Katsabouris, G. (1997). Levels of anxiety, depression and denial in patients with 
myocardial infarction. European Psychiatry, 12, 149 151. 
Schilte, A. F., Portegijs, P. J. M., Blankenstein, A. H., van der Horst, H. E., 
Latour, M. B. F., van Eijk, J. T. M. et al. (2001). Randomised controlled trial of 
disclosure of emotionally important events in somatisation in primary care. British 
Medical Journal, 323, 1 6. 
Schlesselman, J. J. (1995). Net effect of oral contraceptive use on the risk of 
cancer in women in the United States. Obstetrics and Gynecology, 85, 793 801. 
Schoutrop, M. J. A., Lange, A., Hanewald, G., Davidovich, U., & Salomon, H. 
(2002). Structured writing and processing major stressful events: A controlled trial. 
Psychotherapy and Psychosomatics, 71, 151 157. 
Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical 
Evidence of Bias   Dimensions of Methodological Quality Associated with Estimates of 
Treatment Effects in Controlled Trials. Jama-Journal of the American Medical 
Association, 273, 408 412.  
 
379 
Schwartz, L. & Drotar, D. (2004). Effects of written emotional disclosure on 
caregivers of children and adolescents with chronic illness. Journal of Pediatric 
Psychology, 29, 105 118. 
Scott, J. L., Halford, W. K., & Ward, B. G. (2004). United we stand? The effects 
of a couple coping intervention on adjustment to early stage breast or gynaecological 
cancer. Journal of Consulting and Clinical Psychology, 72, 1122 1135. 
Segrin, C., Badger, T. A., Meek, P., Lopez, A. M., Bonham, E., & Sieger, A. 
(2005). Dyadic interdependence on affect and quality of life trajectories among women 
with breast cancer and their partners. Journal of Social and Personal Relationships, 22, 
673 689. 
Sheese, B. E., Brown, E. L., & Graziano, W. G. (2004). Emotional expression in 
cyberspace: Searching for moderators of the Pennebaker disclosure effect via e mail. 
Health Psychology, 23, 457 464. 
Sheffield, D., Duncan, E., Thomson, K., & Johal, S. S. (2002). Written 
emotional expression and well being: Result from a home based study. Australasian 
Journal of Disaster and Trauma Studies, 2002. 
Sherman, A. C., Mosier, J., Leszcz, M., Burlingame, G. M., Ulman, K. H., 
Cleary, T. et al. (2004). Group interventions for patients with cancer and HIV disease: 
Part I: Effects on psychosocial and functional outcomes at different phases of illness. 
International Journal of Group Psychotherapy, 54, 29 82. 
Shin, L. M., Orr, S. P., Carson, M. A., Rauch, S. L., Macklin, M. L., Lasko, N. 
B. et al. (2004). Regional cerebral blood flow in the amygdala and medial prefrontal 
cortex during traumatic imagery in male and female Vietnam veterans with PTSD. 
Archives of General Psychiatry, 61, 168 176. 
Shortt, J. W. & Pennebaker, J. W. (1992). Talking versus hearing about 
Holocaust experiences. Basic and Applied Social Psychology, 13, 165 179. 
Skerrett, K. (1998). Couple adjustment to the experience of breast cancer. 
Families, Systems, and Health, 16, 281 298. 
Skerret, K. (2003). Couples dialogues with illness: Expanding the ‘we.’ 
Families, Systems, and Health, 21, 69 80.  
 
380 
Slatcher, R. B. & Pennebaker, J. W. (2006). How do I love thee? Let me count 
the words: The social effects of expressive writing. Psychological Science, 17, 260 264. 
Sloan, D. M. & Marx, B. P. (2006). Exposure through written emotional 
disclosure: Two case examples. Cognitive and Behavioral Practice, 13, 227 234. 
Sloan, D. M. & Marx, B. P. (2004). Taking pen to hand: Evaluating theories 
underlying the written disclosure paradigm. Clinical Psychology: Science and Practice, 
11, 121 137. 
Sloan, D. M., Marx, B. P., Epstein, E. M., & Lexington, J. M. (2007). Does 
altering the writing instructions influence outcome associated with written disclosure? 
Behavior Therapy, 38, 155 168. 
Smyth, J. & Helm, R. (2003). Focused expressive writing as self help for stress 
and trauma. Journal of Clinical Psychology, 59, 227 235. 
Smyth, J. & Pennebaker, J. W. (1999). Sharing one's story: Translating 
emotional experiences into words as a coping tool. In C.R.Snyder (Ed.), Coping: The 
psychology of what works (pp. 70 89). New York: Oxford University Press. 
Smyth, J., True, N., & Souto, J. (2001). Effects of writing about traumatic 
experiences: The necessity for narrative structuring. Journal of Social and Clinical 
Psychology, 20, 161 172. 
Smyth, J. M. (1998). Written emotional expression: Effect sizes, outcome types, 
and moderating variables. Journal of Consulting and Clinical Psychology, 66, 174 184. 
Smyth, J. M., Stone, A. A., Hurewitz, A., & Kaell, A. (1999). Effects of writing 
about stressful experiences on symptom reduction in patients with asthma or rheumatoid 
arthritis: A randomized trial. Journal of the American Medical Association, 281, 1304 
1309. 
Snyder, D. K., Gordon, K. C., & Baucom, D. H. (2004). Treating affair couples: 
Extending the written disclosure paradigm to relationship trauma. Clinical Psychology: 
Science and Practice, 11, 155 159.  
 
381 
Spiegel, D., Bloom, J. R., & Yalom, I. (1981). Group support for patients with 
metastatic cancer.  A randomized outcome study. Archives of General Psychiatry, 38, 
527 533. 
Stanton, A., Danoff Burg, S., Cameron, C., Bishop, M., Collins, C., & Kirk, S. 
(2000). Emotionally expressive coping predicts psychological and physical adjustment 
to breast cancer. Journal of Consulting and Clinical Psychology, 66, 875 882. 
Stanton, A. L., Danoff Burg, S., Sworowski, L., Collins, C. A., Branstetter, A. 
D., Rodriguez Hanley, A. et al. (2002). Randomized controlled trial of written 
emotional expression and benefit finding in breast cancer patients. Journal of Clinical 
Oncology, 20, 4160 4168. 
Stewart, D. E., Wong, F., Cheung, A. M., Dancey, J., Meana, M., Cameron, J. I. 
et al. (2000). Information needs and decisional preferences among women with ovarian 
cancer. Gynecologic Oncology, 77, 357 361. 
Stewart, D. E., Wong, F., Duff, S., Melancon, C. H., & Cheung, A. M. (2001). 
"What doesn't kill you makes you stronger": An ovarian cancer survivor survey. 
Gynecologic Oncology, 83, 537 542. 
Stone, A. A., Smyth, J. M., Kaell, A., & Hurewitz, A. (2000). Structured writing 
about stressful events: Exploring potential psychological mediators of positive health 
effects. Health Psychology, 19, 619 624. 
Suedfeld, P. & Pennebaker, J. W. (1997). Health outcomes and cognitive aspects 
of recalled negative life events. Psychosomatic Medicine, 59, 172 177. 
Swensen, C. & Fuller, S. (1992). Expressions of love, marriage problems, 
commitment and anticipatory grief in the marriages of cancer patients. Journal of 
Marriage and the Family, 54, 191 196. 
Tavani, A., Bosetti, C., Dal Maso, L., Giordano, L., Franceschi, S., & La 
Vecchia, C. (2004). Influence of selected hormonal and lifestyle factors on familial 
propensity to ovarian cancer. Gynecologic Oncology, 92, 922 926. 
Thompson, S. C., Sobolewshubin, A., Galbraith, M. E., Schwankovsky, L., & 
Cruzen, D. (1993). Maintaining Perceptions of Control   Finding Perceived Control in  
 
382 
Low Control Circumstances. Journal of Personality and Social Psychology, 64, 293 
304. 
Ullrich, P. M. & Lutgendorf, S. K. (2002). Journaling about stressful events: 
effects of cognitive processing and emotional expression. Annals of Behavioral 
Medicine, 24, 244 250. 
Ullrich, P. M., Lutgendorf, S. K., & Stapleton, J. T. (2003). Concealment of 
homosexual identity, social support and CD4 cell count among HIV seropositive gay 
men. Journal of Psychosomatic Research, 54, 205 212. 
Van der Kolk, B. A. & Fisler, R. (1995). Dissociation and the fragmentary 
nature of traumatic memories: overview and exploratory study. Journal of Traumatic 
Stress, 4, 505 525. 
van Nagell, J. R., DePriest, P. D., Gallion, H. H., & Pavlik, E. J. (1993). Ovarian 
cancer screening. Cancer, Supplement 71, 1523 1528. 
Vinokur, A. D. & Vinokur Kaplan, D. (1990). In sickness and in health: Patterns 
of social support and undermining in older married couples. Journal of Aging and 
Health, 2, 215 241. 
von Georgi, R., Schubert, K., Franke, F. E., & Munstedt, K. (2002). Effects of 
sociomedical risk factors on the progression of ovarian cancer. Deutsche Medizinische 
Wochenschrift, 127, 2001 2005. 
von Gruenigen, V. E., Frasure, H. E., Jenison, E. L., Hopkins, M. P., & Gil, K. 
M. (2006). Longitudinal assessment of quality of life and lifestyle in newly diagnosed 
ovarian cancer patients: The roles of surgery and chemotherapy. Gynecologic Oncology, 
103, 120 126. 
Walker, B. L., Nail, L. M., & Croyle, R. T. (1999). Does emotional expression 
make a difference in reactions to breast cancer? Oncology Nursing Forum, 26, 1025 
1032. 
Walster, E., Walster, G. W., & Berscheid, E. (1978). Equity: Theory and 
Research. Boston: Allyn and Bacon.  
 
383 
Watson, D. & Pennebaker, J. W. (1989). Health complaints, stress, and distress: 
exploring the central role of negative affectivity. Psychological Review, 96, 234 254. 
Watson, J. P., Gaind, R., & Marks, I. M. (1972). Physiological habituation to 
continuous phobic stimulation. Behavior Research and Therapy, 10, 269 278. 
Watson, J. P., Gaind, R., & Marks, I. M. (1971). Prolonged exposure: a rapid 
treatment for phobias. British Medical Journal, 1, 13 15. 
Weinman, J., Ebrecht, M., Scott, S., Walburn, J., & Dyson, M. (2008). Enhanced 
wound healing after emotional disclosure intervention. British Journal of Health 
Psychology, 13, 95 102. 
Weiss, D. & Marmar, C. (1997). The Impact of Event Scale   Revised. In 
J.Wilson & T. Keane (Eds.), Assessing Psychological Trauma and PTSD. New York: 
Guildford. 
Wenzel, L. B., Donnelly, J. P., Fowler, J. M., Habbal, R., Taylor, T. H., Aziz, N. 
et al. (2002). Resilience, reflection, and residual stress in ovarian cancer survivorship: A 
gynecologic oncology group study. Psycho-Oncology, 11, 142 153. 
Wenzel, L. B., Robinson, S. E., & Blake, D. D. (1995). The effects of problem 
focused group counseling for early stage gynecologic cancer patients. Journal of Mental 
Health Counseling, 17, 81 93. 
Westbrook, D., Kennerly, H., & Kirk, J. (2007). An Introduction to Cognitive 
Behaviour Therapy: Skills and Applications. London: Sage Publications. 
Wetherell, M. A., Byrne Davis, L., Dieppe, P., Donovan, J., Brookes, S., Byron, 
M. et al. (2005). Effects of emotional disclosure on psychological and physiological 
outcomes in patients with rheumatoid arthritis: An exploratory home based study. 
Journal of Health Psychology, 10, 277 285. 
Whittemore, A. S., Wu, M. L., Paffenbarger, R. S. J., Sarles, D. L., Kampert, J. 
B., Grosser, S. et al. (1989). Epithelial ovarian cancer and the ability to conceive. 
Cancer Research, 49, 4047 4052. 
Worden, W. J. & Weisman, A. D. (1984). Preventive psychosocial intervention 
with newly diagnosed cancer patients. General Hospital Psychiatry, 6, 243 249.  
 
384 
Wortman, C. B. & Silver, R. C. (1989). The myths of coping with loss. Journal 
of Consulting and Clinical Psychology, 57, 349 357. 
Zabora, J., Brintzenhofeszoc, K., Curbow, B., Hooker, C., & Piantadosi, S. 
(2001). The prevalence of psychological distress by cancer site. Psycho-Oncology, 10, 
19 28. 
Zacharias, D. R., Gilg, C. A., & Foxall, M. J. (1994). Quality of life and coping 
in patients with gynecologic cancer and their spouses. Oncology Nursing Forum, 21, 
1699 1706. 
Zahlis, E. H. & Shands, M. E. (1991). Breast cancer: demands of illness on the 
patient's partner. Journal of Psychosocial Oncology, 9, 75 93. 
Zakowski, S. G., Ramati, A., Morton, C., Johnson, P., & Flanigan, R. (2004). 
Written emotional disclosure buffers the effects of social constraints on distress among 
cancer patients. Health Psychology, 23, 555 563. 
Zhang, M., Lee, A. H., & Binns, C. W. (2003). Physical activity and ovarian 
cancer risk: a case control study in China. International Journal of Cancer, 105, 838 
843. 
Zhang, M., Yang, Z. Y., Binns, C. W., & Lee, A. H. (2002). Diet and ovarian 
cancer risk: a case control study in China. British Journal of Cancer, 86, 712 717. 
 
 
 